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Abstract 
Clostridium acetobutylicum P262 is an endospore-forming Gram positive anaerobic 
bacterium, and for many years this organism has been used in the industrial 
fermentation for the production of acetone and butanol from carbohydrate 
substrates. The aims of this thesis included studies on small phosphorylated 
molecules involved in energy metabolism and cell differentiation, and an 
investigation into the genetics and molecular biology of C. acetobutylicum electron 
transport genes. 
To facilitate quantitation of nudeoside triphosphates in extracts of C. 
acetobutylicum, a chromatographic data acquisition and analysis system was 
constructed. Samples were prepared from C. acetobutylicum cultures by 
treatment with formic acid, and nucleotides contained in these extracts were 
separated by strong anion exchange HPLC. The developed manual integration 
system features the ability to collect and store chromatographic data, allowing 
for multiple integration using different calibration curves. 
Nucleoside triphosphate profiles were obtained from batch fermentations of the 
C. acetobutylicum P262 wild type, sporulation deficient (spo-1) and solvent 
deficient (ds-1) strains. The nucleoside triphosphate profiles of the wild type 
and spo-1 mutant were similar and were characterized by a trough in nucleotide 
levels which occurred just prior to the pH break point, the onset of the stationary 
growth phase, clostridial stage formation and the transition from the acidogenic 
to the solventogenic phase. The nucleoside triphosphate concentrations during 
the exponential growth phase were much lower than those found during the 
stationary phase. Exponential phase nucleotide levels in the cls-1 mutant were 
comparable to those observed in the wild type and spo-1 mutant. Unlike the wild 
type and spo-1 strains, the cls-1 mutant, which does not switch to 
solventogenesis, did not demonstrate an increase in nucleotide levels after the 
cessation of cell division. The involvement of nucleotide levels, particularly that 
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of GTP, in the differentiation of C. acetobutylicum was indicated by the effect of 
inhibitors, which have been shown to decrease ribonucleotide levels in other 
organisms and cause an increase in sporulation. 
The antibacterial agent metronidazole, was used as a tool for the isolation of C. 
acetobutylicum electron transport genes. Since it was desired to clone these genes 
in Escherichia coli, and investigation into the activation of metronidazole by E.coli 
strains was necessary. E. coli strains with lesions in their DNA repair systems 
were more susceptible to metronidazole than wild type strains. However, it has 
been reported that DNA repair deficient strains of E. coli that also had a 
diminished ability to reduce chlorates and nitrates were no more susceptible to 
metronidazole than their wild type parents (Jackson et al., 1984; Yeung et al., 
1984). To isolate a suitable E. coli cloning host for the selection of C. 
acetobutylicum electron transport genes which activated metronidazole, 
transposon mutagenesis of the recA E.coli strain CC118 with TnphoA, was used 
to construct the recA, metronidazole resistant E.coli strain Fl9. F19 was shown to 
have diminished nitroreductase activity, which was presumed to be responsible 
for the metronidazole resistant phenotype. However, the recA mutation renders 
E. coli F19 highly susceptible to the reduced toxic intermediates of 
metronidazole. 
The E.coli F19 recA, nitroreductase deficient mutant was used for the isolation of 
C. acetobutylicum genes on recombinant plasmids which activated metronidazole. 
Twenty five E. coli F19 clones which contained different recombinant plasmids 
were isolated. The clones were tested for nitroreductase, pyruvate-Fd-
oxidoreductase and hydrogenase activities. Nitroreductase and pyruvate-Fd-
oxidoreductase activity was not demonstrated in any of the isolated clones, and 
only one clone tested positive for hydrogenase activity. 
DNA hybridization and restriction endonuclease mapping revealed that four of 
the C. acetobutylicum insert DNA fragments on recombinant plasmids were 
linked in an 11.1 kb chromosomal fragment. It was determined that this 11.1 kb 
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fragment contained at least two regions responsible for activating metronidazole. 
The one gene responsible for making E. coli F19 extremely sensitive to 
metronidazole was localized to a 2 kb region. The nucleotide sequence of this 
2 kb region was determined and two truncated open reading frames and one 
complete open reading were present. The complete open reading frame was 
shown to be responsible for activating metronidazole. The deduced amino acid 
sequence of this open reading frame was determined to be 160 amino acids in 
length, and database searches showed good similarity to flavodoxin proteins 
from many organisms. Based on alignments to the amino acid sequences of 
these flavodoxins, as well as the fact that Chen and Blanchard (1979) reported 
that reduced flavodoxin can transfer electrons to metronidazole, the sequence 
corresponding to this C. acetobutylicum metronidazole activating gene was 
identified as coding for a flavodoxin gene. 
The role of flavodoxin in C. acetobutylicum and other organisms is presented. 
Possible relationships between the cloned C. acetobutylicum flavodoxin gene and 
metronidazole sensitivity are discussed. 
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Chapter 1 
General introduction and literature review 
In many countries, the development of chemical industries based on abundant 
supplies of inexpensive fossil fuels has led to the relinquishment of traditional 
fermentation routes employed for chemical production. In the consumer 
oriented western world, the economies of many nations are reliant on the 
abundance of inexpensive fossil fuels. Since the advent of the oil shortage in the 
early 1970's, there has been fresh interest in the production of chemicals by the 
fermentation of renewable resources, and the acetone-butanol-ethanol (ABE) 
fermentation by Clostridium acetobutylicum has often been included (Spivey, 
1978). 
1.0 History of the Acetone-Butanol-Ethanol fermentation 
The history and development of the ABE fermentation was recently review by 
Jones and Woods (1986a), and this review provided the basis for the majority of 
the history presented below. 
A shortage of natural rubber in the early 1900's led to investigations on the 
feasibility of producing synthetic rubber. Butyl or isoamyl alcohol could be used 
as substrates for the production of butadiene or isoprene respectively (Killeffer, 
1927; Gabriel, 1928). Chaim Weizmann was a chemist working at Manchester 
University, who chose to research the preparation of synthetic rubber. Not long 
after the start of his work, Weizmann realized that such a process could not 
succeed without an abundant supply of butanol (Hastings, 1978). 
The production of butanol by microbial fermentation was first reported by 
Pasteur in 1861, whereas the production of acetone by microbial fermentation 
was only reported later (Schardinger, 1905). Although Chaim Weizmann was 
not a bacteriologist, he investigated the feasibility of butanol production via a 
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microbial route for use in the manufacture of synthetic rubber. Between 1912 
and 1914, Weizmann isolated an organism which he called BY (Gabriel, 1928), 
later to be named C. acetobutylicum, which was able to breakdown a variety of 
starchy substrates and produce good yields of acetone and butanol (McCutchan 
and Hickey, 1954). 
Concurrent with Weizmann's investigations, the British firm of Strange and 
Graham Ltd. filed an English patent application for the production of acetone 
and butanol by microbial fermentation. This process was based on an organism 
isolated in 1911 by Fernbach, that had the ability to ferment potatoes, but not 
maize starch, to produce butanol (Gabriel, 1928; Gabriel and Crawford, 1930). In 
1914, Strange and Graham Ltd. built a plant in King's Lynn, for the production of 
butanol from potatoes (Gabriel, 1928). 
The start of World War I in August of 1914, gave impetus to further develop the 
ABE fermentation. Acetone, aside from being a general solvent, was required for 
the manufacture of cordite which is used in small arms munitions (Killeffer, 
1927). Necessary quantities of acetone were not available to the British army, 
and so the British War Office contracted Strange and Graham Ltd. to produce 
acetone at their King's Lynn plant (Gabriel and Crawford, 1930). The process of 
manufacturing acetone from potatoes using the Fernbach strain was inefficient 
and hence production did not meet the requirements of the British army 
( Gabriel, 1928). 
In his laboratory at Manchester University, Weizmann was very successful at 
producing quantities of butanol sufficient for his research (Hastings, 1978). The 
British government requested all scientists to undertake work that would 
contribute to the war effort. Although Weizmann considered acetone to be a 
by-product of the fermentation, he soon realized its importance and quickly 
brought his work to the attention of the proper authorities (Hastings, 1978). In 
due course, an official research team was assembled to work under Weizmann's 
guidance, and all supplies and materials were provided by the British 
government for the production of acetone from maize using the Weizmann 
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process (Weizmann, 1963; Walton and Martin, 1979). Pilot scale fermentation 
plants were developed at a number of sites in southern England (see Jones and 
Woods, 1986a), and eventually a full scale production facility was built at the 
Royal Naval Cordite factory where six distilleries were adapted for the 
production of acetone from maize using the Weizmann process (Gabriel, 1928). 
The Strange and Graham Ltd. plant at King's Lynn was also converted to the 
Weizmann process, resulting in increased production of acetone (Ross, 1961). 
In 1916, the British government could not afford to supply cereal grains used for 
the production of acetone via fermentation (Hastings, 1978). The fermentation 
was therefore transferred to Canada, and was operated under the guidance of 
Herbert Speakman with Weizmann remaining in London as the principal adviser 
(Gabriel, 1928; Weizmann, 1963; Hastings, 1978). The year 1917 saw the entry of 
the United States of America into the war, and ABE fermentation plants were 
initiated at two distilleries located in Terre Haute, Indiana (Ross, 1961). The 
cessation of hostilities in November of 1918, brought with it a decreased demand 
for acetone which resulted in the closure of these North American fermentation 
facilities. 
The Allied War Board auctioned the two distilleries in Terre Haute, and they 
were purchased in 1919 by a consortium of American businessmen operating 
under the name of the Commercial Solvents Corporation of Maryland (Gabriel, 
1928). At this time the E.I. DuPont de Nemours Co. of Wilmington Delaware 
was developing quick drying nitrocellulose lacquers for use in the rapidly 
recovering automobile industry (Walton and Martin, 1979). Butanol and its 
ester, butyl-acetate were necessary solvents used in the production of these 
nitrocellulose lacquers. Butanol production was re-initiated in 1920 at the Terre 
Haute plants which were now operating under the control of the Commercial 
Solvents Corporation. The Commercial Solvents Corporation obtained the 
Majestic Distillery of Peoria Illinois in 1923, where further expansion of the ABE 
fermentation took place (Gabriel, 1928). By the end of 1927 there were 96 
fermentors in operation at the Peoria plant with an additional 52 fermentors at 
the Terre Haute plants. 
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Economics eventually led to a joint venture between the Commercial Solvents 
Corporation and the Distiller's Co. of Great Britain where a fermentation facility 
was built in Brombrough England based on molasses as the fermentation 
feedstock (Gibbs, 1983). Under the guidance of J. Hastings, the ABE 
fermentation became operational at this site in 1935 using a phage immunized 
strain of C. saccharoacetobutylicum (Gibbs, 1983). Due to the success of this 
fermentation facility, the relatively inexpensive substrate, molasses, became the 
feedstock of choice for the ABE fermentation. 
The worldwide patent for the Weizmann process, in which the Commercial 
Solvents Corporation had sole licence, expired in 1936 (McCutchan and Hickey, 
1954). In the United States, the production of acetone and butanol from molasses 
expanded, with companies other than the Commercial Solvents Corporation 
building fermentation plants in the port cities of Philadelphia Pennsylvania and 
Baltimore Maryland where molasses could be obtained via waterways from 
sugar cane growing regions. Fermentation facilities for the production of 
solvents were also built in other countries including Australia, Brazil, Egypt, 
Formosa (Taiwan), India, Japan and South Africa (Rose, 1961; Ross, 1961; 
Abou-Zeid et al., 1978; Spivey, 1978). 
The Second World War brought with it another increase in the demand for 
acetone to be used in the manufacture of munitions (Hastings, 1971). Production 
of solvent containing fermentation liquor exceeded the capacity of the batch 
distillation processes employed for harvesting the solvents, and successful efforts 
were made to use multiple column continuous distillations facilities which were 
built for the industrial alcohol plants (Hastings, 1978). Difficulties in the 
importation of molasses during the Second World War, led to the demise of this 
fermentation in Great Britain (Hastings, 1971). The demand for acetone used in 
the war effort was therefore met by the production facilities in North America, 
which were operating at capacity (Wynkoop, 1943). 
The demise of this fermentation in the western world began in the late 1940's, 
when the importance of propylene and ethylene, which were by-products of the 
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cracking of petroleum, was realized by the petrochemical industry (Gibbs, 1983). 
Although the production of acetone and butanol by fermentation continued 
through the 1950's, the contribution made by fermentation to the total output 
diminished rapidly (Rose, 1961). Breakthroughs in catalysis enabled excellent 
yields of a wide variety of industrially important chemicals from petroleum, 
which were much less expensive than those derived from fermentation (Gibbs, 
1983). The incorporation of molasses into cattle feed caused an escalation in the 
price of this substrate, hence providing the final devastating blow to this 
fermentation (Hastings, 1978). 
Acetone and butanol were also produced via fermentation in eastern block 
countries including China, Czechoslovakia and the USSR (Dyr et al., 1958; 
Nakhmanovich and Shcheblykina, 1959; Yarvenko, 1964; Lukina, et al., 1972; 
Herrero, 1983). Information concerning these production facilities is however 
scattered and incomplete. 
In a few countries, a combination of political, economic and climatic factors 
enabled the survival of some ABE fermentation plants. China currently 
produces 50% of its acetone requirements using this fermentation process (J.S. 
Chiao, personal communication). In South Africa an economically viable process 
for the production of acetone and butanol from molasses operated from 1937 to 
1981 (Jones and Woods, 1986a). This plant was reopened for a short period in 
1982, however technical problems along with the quality, cost and availability of 
molasses resulted in closure of this fermentation facility (Jones and Woods, 
1986a). 
1.1 Overview of the ABE fermentation 
The bacterium, C. acetobutylicum, is a strictly anaerobic, Gram positive spore 
forming rod (O'Brien and Morris, 1971), and microscopic observations of actively 
growing cells reveal motile, straight rods with rounded ends, occurring singly 
and in pairs (Spivey, 1978). This microorganism can be isolated from many 
natural sources, including soil, corn and potatoes (Volesky et al., 1981). 
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Carbohydrates from a wide variety of sources are readily fermented to acetic and 
butyric acid intermediates, which are converted to the neutral end products, 
acetone, butanol and ethanol. The morphological (Jones et al., 1982), 
physiological (Prescott and Dunn, 1959; Walton and Martin, 1979) and 
biochemical (Duong et al., 1983; Zeikus, 1983) changes which occur during the 
course of this fermentation have been well documented (Jones and Woods, 
1986a; Rogers, 1986). 
The conventional batch ABE fermentation carried out by C. acetobutylicum 
features two distinct physiological stages (Jones et al., 1982). The initial 
acidogenic growth phase is characterized by highly motile phase dark rod 
shaped cells which are rapidly dividing. During this logarithmic phase of 
growth, sugars are converted to acetic and butyric acids, resulting in a decrease 
in the available carbohydrate nutrient supply and a drop in the pH of the 
medium (Fig. 1.1). The relative amounts of acetic and butyric acids present 
during this growth phase have been shown to be related to the ratio of acetone 
and butanol produced during the second or solventogenic growth phase (Martin 
et al., 1983). 
A switch in the carbon flow from the acid producing pathways to the solvent 
producing pathways is correlated with the onset of the solventogenic growth 
phase. At this point, the acid concentration in the medium reaches a maximum 
which corresponds to the "pH breakpoint" (Jones et al., 1982). This pH 
breakpoint was identified early on as being crucial for solventogenesis to occur 
(Speakman, 1920; Davies and Stephenson, 1941). During the solventogenic stage, 
cell division ceases and the reassimilation of organic acids begins. Continued 
uptake and consumption of carbohydrate occurs, resulting in the production of 
the neutral solvents acetone, butanol and ethanol. 
Granulose is a high molecular weight storage polyglucan containing mainly 1-4 
linked D-glucopyranose units (Reysenbach et al., 1986). Just prior to the pH 
breakpoint, there is an intracellular accumulation of granulose and a slowing of 
cell motility. The cellular morphology associated with the solventogenic phase is 
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Figure 1.1 Physiological (A) and morphological (B) profiles for a typical C. 
acetobutylicum batch fermentation. Symbols Tor graph: (A) corresf-ond to the 
following: •, glucose concentration (%, w /v); •, total acids (g -1); e, total 
solvents (g 1-1); D, log10 cell number; 0, pH. Symbols for graph (B) correspond to 
the following: •, motility; •, phase bnght dostridial cells; e, phase dark rods; 
0, forespore containing cells; D, mature spores. All data in plot (B) are 
expressea as a percentage of the total cell count. (Data from Santangelo et al., 
1989). 
characterized by phase bright, encapsulated, granulose filled, non-motile cells. 
These cells have a swollen rod, cigar shaped morphology, and are commonly 
referred to as clostridial forms (Jones et al., 1982; Long et al., 1984a; Reysenbach 
et al., 1986). Spivey (1978) reported that by monitoring these morphological 
changes associated with the stages of the ABE fermentation, an experienced 
observer can assess the progress of the fermentation to within a few hours. 
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A typical industrial ABE fermentation is carried out with a relatively low starting 
concentration of fermentable sugars (approximately 6.0 to 6.5% w /v) (Spivey, 
1978; McNeil and Kristiansen, 1985). Solvent toxicity, particularly that of 
butanol, begins at a concentration of approximately 2% (w /v) 
(van der Westhuizen et al., 1982). Since one third of the available carbohydrates 
are converted to solvents, the use of sugar levels greater than 6.0 to 6.5% (w /v) is 
futile. A typical batch ABE fermentation yields 15 to 22 g 1-1 of solvents with an 
acetone:butanol:ethanol ratio of 3:6:1 (Spivey, 1978; Jones et al., 1982). 
Industrial batch fermentations were generally stopped prior to sporulation, 
when the concentration of solvents had reached maximum levels. The loss of 
spore forming capability during continuous culture has been associated with the 
loss of ability to make solvents (Gottschal and Morris, 1981a). Similar results 
were obtained by Long et al. (1983, 1984b) who studied the relationship between 
sporulation and solvent production in batch culture. However, reports 
concerning sporulation in industrial batch fermentations show that only a small 
proportion of the cells proceed to produce mature spores (Jones et al., 1982). In 
fermentations where high solvent levels were reached, clostridial forms did not 
develop towards sporulation, but degenerated into non-viable cells. 
1.2 Biochemistry and physiology of C. acetobutylicum 
The conversion of carbohydrates to acids, gases and neutral solvents by C. 
acetobutylicum has been extensively recorded (Doelle, 1975; Gottschalk, 1979; 
Hartmanis and Gatenbeck, 1984). Reviews by Rogers (1986) and Jones and 
Woods (1986a) have outlined the general relationship between the biochemical 
pathways and the fermentation profiles of the clostridia, whereas a review by 
Haggstrom (1985) has focused primarily on energy metabolism. 
1.2.1 Central pathways 
In C. acetobutylicum, the breakdown of sugars to pyruvate proceeds via the same 
pathways in both the acidogenic and solventogenic stages of growth (Fig. 1.2). 
The catabolism of hexose sugars to pyruvate proceeds via the glycolytic pathway 
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where 1 mol of hexose yields 2 mol of pyruvate with the net production of 2 mol 
of ATP and 2 mol of NADH. C. acetobutylicum, is able to metabolize pentose 
sugars via the pentose phosphate pathway (Zeikus, 1980; Volesky and Szczesny, 
1983). Three mol of pentose are phosphorylated to pentose 5-phosphate at the 
expense of 3 mol of ATP. Three mol of pentose 5-phosphate are converted to 
2 mol of fructose 6-phosphate plus 1 mol of glyceraldehyde 3-phosphate by the 
action of phophopentose isomerase, phophopentose epimerase, transketolase 
and transaldolase enzymes. Fructose 6-phosphate and glyceraldehyde 
3-phosphate are intermediates of the glycolytic pathway which can be further 
metabolized to pyruvate. Hence the breakdown of 3 mol of pentose yields 5 mol 
of pyruvate with the net production of 5 mol of ATP and 5 mol of NADH 
(Fig. 1.2). 
The phosphoroclastic breakdown of pyruvate is accomplished by the enzyme 
pyruvate ferredoxin (Fd) oxidoreductase in the presence of coenzyme A (CoA) 
and oxidized Fd to yield carbon dioxide, acetyl-CoA and reduced Fd. 
Acetyl-CoA is one of three key intermediates for the branched fermentation 
pathways leading to both acid and solvent production. Acetyl-CoA 
acetyltransferase is the enzyme responsible for the formation of another key 
intermediate, acetoacetyl-CoA, which is formed in a single step by the 
condensation of 2 molecules of acetyl-CoA. Butyryl-CoA, the third key 
intermediate, is formed from acetoacetyl-CoA by the action of 3 enzymes: 
3-hydroxybutyryl-CoA dehydrogenase, crotonase and butyryl-CoA 
dehydrogenase. Both 3-hydroxybutyryl-CoA dehydrogenase and butyryl-CoA 
dehydrogenase consume reducing power in the form of NADH. The presence of 
these 5 enzymes responsible for the breakdown of pyruvate to butyryl-CoA has 
been demonstrated in C. acetobutylicum (Waterson et al., 1972; Hartmanis and 
Gatenbeck, 1984; Wiesenbom et al., 1988). The fate of these 3 intermediates 
differs during the acidogenic and solventogenic growth stages as discussed 
below. 
Figure 1.2 (Facing page) Biochemical eathways in C. acetobutylicum. Reactions 
which predominate cfurmg the acidogemc phase are represented by arrows with 
thick slashed lines, whereas reactions which predominate during the 
solventogenic phase are represented by arrows with thick solid lines. Reactions 
common to both pathways are reeresented by arrows with thin lines. The thick 
dashed solid line for the oxidation of reduced Fd represents a reduction in 
enzyme activity during the solventogenic growth phase. The thin dash-dot-dot 
line for the conversion of pyruvate to lactate represents an inducible pathway not 
normally operating in C. acetobutylicum. All end products of the fermentation 
(including gases) are enclosed in boxes. Enzymes are indicated by circled 
numbers as follows: (1) hexokinase; (2) phosphoglucose isomerase; (3) 
phosphofructokinase; (4) aldolase; (5) triose phosphate isomerase; (6) 
glyceraldehyde 3-phosphate dehydrogenase; (7) pnospnoglycerate kinase; (8) 
phosphoglyceromutase; (9) enolase; (10) pyruvate kinase; (11) pyruvate-Fd-
oxidoreductase; (12) NADH-Fd-oxidoreductase; (13) NADPH-Fd-
oxidoreductase; (14) hydrogenase; (15) thiolase (acetyl-CoA acetyl transferase); 
(16) 3-hydroxybutyryl-CoA dehydrogenase; (17) crotonase; (18) butyryl-CoA 
dehydrogenase; (19) phosphate acety1transferase (phosphotransacetylase); (20) 
acetate kinase; (21) acetalaehyde dehydrogenase; (22) ethanol dehydrogenase; 
(23) acetoacetyl-CoA:acetate/butyrate:CoA transferase; (24) acetoacetate 
decarboxylase; (25) phosphate butyltransferase (phosphotransbutyrylase); (26) 
butyrate kinase; (27) butyraldehyde dehydrogenase; (28) butanol dehydrogenase; 
(29) phosphoglucomutase; (30) ADP-glucose pyrophosphorylase; (31) granulose 
(glycogen) synthase; (32) granulose phosphorylase; {33) pentokinase; (34) a 
combination of phophopentose isomerase, phophopentose epimerase, 
transketolase and transaldolase; (35) lactate dehydrogenase. 
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1.2.2 Acid producing pathways 
Acetyl-CoA and butyryl-CoA are the two key intermediates in the production of 
acetic and butyric acids. The respective formation of acetate and butyrate from 
acetyl-CoA and butyryl-CoA occurs via an analogous set of reactions. However, 
the enzymes involved in these reactions have been shown to be unique to each 
branched pathway (Andersch et al., 1983; Hartmanis and Gatenbeck, 1984; Jones 
and Woods, 1986a; Rogers, 1986). The CoA containing intermediates are 
converted to their corresponding acyl-phosphates, acetyl phosphate and butyryl 
phosphate, by the action of phosphate acetyltransferase and phosphate 
butyryltransferase respectively. These acyl-phosphates are metabolized to 
acetate and butyrate by the action of acetate kinase and butyrate kinase with the 
generation of one ATP for each acyl-phosphate converted. A CoA-transferase 
has been shown to be responsible to butyrate formation in C. kluyveri (Stadtman, 
1952) and C. aminobutyricum (Hardman and Stadtman, 1963), however no such 
transferase involved in butyrate synthesis has been detected in either C. 
acetobutylicum or C. beijerinckii (Andersch et al., 1983). 
Apart from the production of acetic and butyric acids, C. acetobutylicum can also 
convert pyruvate to lactate under certain conditions (Jones and Woods, 1986a). 
The production of lactic acid does not occur under ideal conditions. This 
pathway operates as a less efficient alternative to the acetate and butyrate 
producing pathways, to allow for energy generation and the oxidation of NADH 
to continue when the mechanism for proton and electron disposal by the 
generation of hydrogen gas is inhibited (Eliasberger, 1930; Simon, 1947; Kim et 
al., 1984; Kim and Zeikus, 1985). Although not an acid, acetoin has also been 
shown to accumulate when electron disposal is blocked (Doremus et al., 1985). 
While the biosynthetic pathway for the production of acetoin in C. acetobutylicum 
remains to be elucidated, it has been suggested that this compound could be 
produced as an intermediate under conditions in which the lactate pathway 
becomes operational (Doremus et al., 1985). Acetoin production is critical in that 
it is a structural analog of acetoacetate which can reduce the efficiency of acetone 
production. 
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1.2.3 Solvent producing pathways 
While acetic and butyric acids are produced from the intermediates acetyl-CoA 
and butyryl-CoA, a switch in the carbon flow directs these same two 
intermediates towards the production of ethanol and butanol respectively 
(Fig. 1.2). Like the production of acetate and butyrate, the production of ethanol 
and butanol proceeds via a set of analogous reactions. Acetyl-CoA and 
butyryl-CoA are converted to their respective aldehydes, acetaldehyde and 
butyraldehyde, via a dehydrogenation step. It is not known whether two unique 
and independent aldehyde dehydrogenases exist, although this seem likely as 
ethanol production has been shown to occur independent of acetone and butanol 
production (Jones and Woods, 1986a; Bertram et al., 1990). Ethanol production 
may not be regulated by the same mechanisms as butanol production, and it is 
possible that ethanol is produced constitutively during both acidogenesis and 
solventogenesis. At least two separate alcohol dehydrogenases are responsible 
for the metabolism of acetaldehyde and butyraldehyde to ethanol and butanol 
respectively. It has been demonstrated in both C. acetobutylicum and C. 
beijerinckii, that butanol production occurs via a NADPH dependent butanol 
dehydrogenase (George and Chen, 1983; Rogers, 1986), whereas ethanol 
production appeared to be carried out via the action of a NADH dependent 
ethanol dehydrogenase. However, Welch et al. (1989) have recently purified and 
characterized a NADH dependent butanol dehydrogenase from C. 
acetobutylicum, indicating that multiple alcohol dehydrogenases may exist in this 
organism, and hence may function independently under various growth 
conditions. While it has been assumed for some time that a specific NADPH 
dependent alcohol dehydrogenase was responsible for the production of butanol, 
the isolation of solvent minus mutants (Bertram et al., 1990) indicates that an 
NADH specific enzyme is involved (Grupe and Gottschalk, 1990). 
The production of acetone from the third key intermediate, acetoacetyl-CoA, is a 
two step process where the enzyme acetoacetate decarboxylase carries out the 
irreversible conversion of acetoacetate to acetone with the concurrent production 
of carbon dioxide (Andersch et al., 1983; Ballongue et al., 1985). Acetoacetate is 
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provided by the acetoacetyl-CoA:acetate/butyrate:CoA transferase which acts 
upon acetoacetyl-CoA (Hartmanis et al., 1984; Wiesenborn et al., 1989a; Cary et 
al., 1990). 
Acetic and butyric acids are reassimilated during the solventogenic phase, 
resulting in an increase in the pH of the medium. This reassimilation only occurs 
with an accompanying consumption of sugars (Davies and Stephenson, 1941; 
Hartmanis et al., 1984). Early studies showed that the addition of extraneous 
acetate and butyrate enhanced the yields of acetone and butanol (Reilly et al., 
1920; Bernhauer and Kurschner, 1935). A later study by Wood et al. (1945), 
showed that when 14C labeled acetate was added to solvent producing cultures 
of C. acetobutylicum, 55% of the label was recovered in butanol and 15% of the 
label was recovered in acetone. Similarly, the addition of 14C labeled butyrate 
resulted in 85% and 2% of the label being recovered in butanol and acetone 
respectively. More recent studies also employing 14C labeled butyrate showed 
almost identical results. In these experiments, the half life of butyrate in the 
medium was determined to be approximately 20 min and a complete turnover of 
acids occurred within 2 h (P. Rogers, personal communication). Therefore, the 
majority of the acetate and butyrate taken up by C. acetobutylicum is rapidly 
converted to butanol. The effect of short chain fatty acids on the fermentation 
yields of C. acetobutylicum, has continued to be the focus of more recent studies 
(Gottschal and Morris, 1981b; Bahl et al., 1982a; Martin et al., 1983; Clark et al., 
1989; Wiesenborn et al., 1989a; Husemann and Papoutsakis, 1990). 
Although a number of different mechanisms have been postulated for the uptake 
of acetic and butyric acids (see Jones and Woods, 1986a), recent results indicate 
that this reassimilation is directly coupled to the production of acetone by way of 
acetoacetyl-CoA:acetate/butyrate:CoA transferase. A study by Andersch et al. 
(1983) clearly showed that acetate and butyrate can both act as a CoA acceptor 
during the conversion of acetoacetyl-CoA to acetoacetate resulting in the 
conservation of the CoA unit by the simultaneous production of acetyl-CoA or 
butyryl-CoA. The decarboxylation of acetoacetate by the acetoacetate 
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decarboxylase has been postulated to pull the transferase reaction toward the 
formation of acetoacetate (Hartmanis et al., 1984). 
1.2.4 Energy and electron distribution 
Ferredoxin (Fd) is a major electron carrier in the metabolic pathways of C. 
acetobutylicum. It is a small acidic iron-sulfur containing protein that is capable of 
accepting and donating electrons at a very low potential (Jones and Woods, 
1986a). In C. acetobutylicum 4 enzymes are known to require Fd for complete 
functionality. As mentioned above, the pyruvate-Fd-oxidoreductase transfers 
electrons from the phosphoroclastic breakdown of pyruvate to oxidized Fd to 
yield reduced Fd. The hydrogenase enzyme in turn utilizes the electrons carried 
by reduced Fd and together with protons, forms molecular hydrogen. The 
enzyme NADPH-Fd-oxidoreductase can also utilize reduced Fd in the controlled 
production of NADPH. This may be the only route for the production of 
NADPH, which is required for biosynthesis, since most clostridia appear to lack 
the enzymes required for the oxidation of glucose 6-phosphate that produce 
NADPH (Jungermann et al., 1973). The analogous yet separate enzyme, NADH-
Fd-oxidoreductase, cycles electrons between Fd and NADH, and hence is key to 
the electron distribution in this organism (Jungermann et al., 1973; Petitdemange 
et al., 1976). 
The growth of anaerobes is limited by the rate of energy producing reactions 
(Thauer et al., 1977). In C. acetobutylicum the glycolytic breakdown of 1 mol 
glucose to 2 mol pyruvate yields a net production of 2 mol ATP and 2 mol of 
NADH. During acidogenesis, 1 mol of ATP is produced per mole of acyl 
phosphate converted to acid end product. Therefore, the net energy yield 
obtained when 1 mol of glucose is converted to 2 mol of acetate is 4 mol of ATP. 
Since 2 mol of acetyl-CoA are require for the production of 1 mol of butyryl-CoA, 
the net energy yield obtained when 1 mol of glucose is converted to 1 mol of 
butyrate is 3 mol of ATP. In a normal batch fermentation, the acetate to butyrate 
ratio is approximately 2:3 (mol:mol) (Jones and Woods, 1986a). Accounting for 
the acetate to butyrate ratio, Rogers (1986) calculated the ATP yield for the 
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acidogenic growth phase to be about 3.25 mol ATP per mol of glucose consumed, 
with a thermodynamic efficiency of approximately 62%. Apart from ATP 
produced during glycolysis, no further ATP production occurs during 
solventogenesis via the synthesis of acetone, butanol and ethanol. Therefore, the 
ATP balance for the solventogenic growth phase drops to 2 mol ATP per mol of 
glucose consumed. 
The energetically more favourable production of acetate results in a net 
generation of 2 mol NADH. During both acidogenesis and solventogenesis 
2 mol of reducing power, in the form of NADH, are consumed in the conversion 
of 2 mol of acetyl-CoA to 1 mol of butyryl-CoA. Therefore, even though butyrate 
production yields less ATP than does acetate production, it is redox neutral. 
Since the breakdown of glucose to acetyl-CoA yields 2 mol of NADH, and 
considering that only a portion of the resulting acetyl-CoA is converted to 
butyrate, excess NADH must either accumulate, or be cycled through Fd via the 
NADH-Fd-oxidoreductase. The latter would result in reduced Fd and hence 
require increased hydrogen production for electron disposal and recycling of Fd 
to its oxidized state. The solvent producing pathways, but not the acid 
producing pathways, provide additional routes for the disposal of NADH, where 
both aldehyde dehydrogenases, as well as the alcohol dehydrogenases, each 
consume 1 mol of NADH per mol of substrate converted to product. This 
indicates that any accumulation of NADH and hence the activities of the NADH-
Fd-oxidoreductase and hydrogenase enzymes, all play a role in the switching of 
the carbon flow from acid production to solvent production. 
1.3 Triggers and regulation in C. acetobutylicum 
Both the induction of solventogenesis and the induction of sporulation appear to 
be linked to the inhibition of vegetative growth and normal cell division (Jones 
and Woods, 1986a). The development of chemically defined media that support 
the complete life cycle of C. acetobutylicum (Andersch et al., 1982; Long et al., 
1983; Monot and Engasser, 1983) has greatly facilitated studies involved in the 
elucidation of the external triggers that influence differentiation to solvent 
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production and to sporulation. Furthermore, the development of mutagenic 
systems and the isolation of C. acetobutylicum mutants (Jones et al., 1982; Long et 
al., 1984a; Bowring and Morris, 1985; Jones and Woods, 1986b) has also aided this 
area of research. However, the mechanisms by which these signals are 
interpreted to molecular events which adjust specific enzyme activities are only 
just starting to be realized. 
1.3.1 Regulation of solvent production 
The external catalysts that trigger the metabolic shift from acid production to 
solvent production have been extensively studied. A number of significant 
changes in the fermentation pattern are associated with the end of the initial 
phase of growth. A decrease in the pH of the medium, which is related to an 
increase in the concentration of acid end products, cessation of cell division and a 
decrease in the rate of hydrogen production all characterize the onset of the 
solventogenic growth phase. 
The role of pH has long been recognized as being important to the outcome of 
the ABE fermentation. Almost all studies concerning the ABE fermentation 
mention the importance of a "pH breakpoint" in allowing the fermentation to 
proceed to solventogenesis. Studies have shown that cultures which are 
maintained at a high pH produce mainly acids, whereas cultures maintained at a 
low pH produce solvents (Jones and Woods, 1986a; Rogers, 1986). The pH 
optima for solvent production does however vary from strain to strain (see Jones 
and Woods, 1986a). While attainment of a low pH is necessary for solvent 
production, it has been shown that this low pH is not in itself a sufficient trigger 
for solvent production (Gottschal and Morris, 1981b; Long et al., 1984a). 
The fall in the pH of the medium is a consequence of the production of acetate 
and butyrate. These organic acids are toxic, and in their undissociated form they 
are able to partition in the cell membrane and behave as uncouplers which 
permit the entry of protons into the cell (Kell et al., 1981; Husemann and 
Papoutsakis, 1986). A recent study showed that a transition from a neutral pH to 
an acidic pH resulted in the formation of transmembrane lipids that increase the 
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rigidity of the cell membrane which in turn alters the bioelectrochemical 
processes that occur across this membrane (G. Zeikus, personal communication). 
At sub-critical concentrations, the accumulation of acid end products results in a 
decrease in the specific growth rate of the cell, although substrate utilization and 
cell metabolism continue (Herrero, 1983). It has been suggested that the switch 
to solvent production is a detoxification mechanism which allows the cell to 
avoid the inhibitory effects that would occur if acid end products were allowed 
to reach critical levels (Jones and Woods, 1986a). 
The pH of the cell environment determines the percentage of acids which are in 
their undissociated form. Undissociated butyric acid in particular, was shown to 
be essential in the regulation of solvent production (Bahl et al., 1982a). If the 
critical level of undissociated butyric acid was not obtained because of either too 
high a pH or too low an initial substrate concentration, solvent production did 
not occur (Bahl et al., 1982a; Bahl and Gottschalk, 1985). 
Monot et al. (1984) showed that blocking the function of the membrane bound 
ATPases results in a decrease in the internal pH of the cell. By decreasing the 
internal pH, the concentration of undissociated acids is increased. Under these 
conditions, there was a reduction in the maximum biomass levels with an 
enhancement of solvent production. Unlike most other organisms, bacteria that 
produce weak acids are not able to maintain a constant internal pH (Riebeling et 
al., 1975; Baronofsky et al., 1984). In these organisms, the proton translocating 
A TPase is used to control the internal pH in response to fluctuations in the 
external pH. By altering the internal pH at the expense of ATP, C. acetobutylicum 
is able to maintain a more or less constant pH gradient across it's membrane as 
the pH of the external medium decreases (Bowles and Ellefson, 1985; Gottwald 
and Gottschalk, 1985; Huang et al., 1985; Andreesen et al., 1989). The shift to 
solvent production and the reassimilation of acids may therefore be a necessary 
event so that the cell is able to maintain this pH gradient across its membrane. If 
the concentration of undissociated acids was allowed to rise, the cost to the cell 
in terms of ATP, would eventually be greater than the amount of ATP produced 
by the generation of these acids. 
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Solvent production only occurs with accompanying glucose consumption. 
Studies of fermentations where the carbon source was limited showed that 
solvent production did not occur and hence only acids were produced (Gottschal 
and Morris, 1981a; Bahl et al., 1982a; Fond et al., 1984; Long et al., 1984a). In these 
studies, the concentration of acid end products did not reach the threshold 
concentration required for the initiation of solvent production. Attempts to 
produce solvents under conditions of nitrogen limitation in the presence of 
excess glucose, yielded similar results. Using batch cultures, Long et al. (1984a) 
showed that low concentrations of ammonia (9.0 mM) resulted in the 
consumption of less than one-third of the available glucose and no solvent 
production. Studies using ammonium limited chemostat cultures also showed 
that solvent production did not occur (Gottschal and Morris, 1981a; Andersch et 
al., 1982). Apparently the threshold level of acids was not reached and therefore 
no induction of solventogenesis occurred. Limiting the concentration of 
phosphate or sulfate in batch and continuous cultures displayed more success at 
inducing solvent production than did glucose or ammonium limitation (Bahl et 
al., 1982b; Bahl and Gottschalk, 1985). High yields of acetone and butanol were 
obtained in a phosphate limited two-stage continuous culture, and apparently 
this process was uninterrupted for 1 year without a change in cell activity (Bahl 
et al., 1982b). 
1.3.2 Regulation of electron flow 
In the solvent producing clostridia, the pathways for acid production alone do 
not provide for the disposal of excess NADH produced during glycolysis. These 
clostridia have the ability to produce hydrogen and therefore can process both 
excess electrons and protons through this route. During acidogenesis, a major 
portion of the electron flow is directed to hydrogen production, whereas the 
carbon flow is directed to acid production. Recent studies have shown that 
during this growth phase more hydrogen is produced than is theoretically 
possible from the phosphoroclastic breakdown of pyruvate alone (Martin et al., 
1982; Kim and Zeikus, 1985). 
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The 2 enzymes NADH-Fd-oxidoreductase and hydrogenase play a pivotal role in 
controlling the direction of electron flow, as well as the acetate:butyrate ratio 
(Jones and Woods, 1986a). Hydrogenase activity is reduced when the partial 
pressure of hydrogen is high, and studies with C. butyricum showed that an 
increase in the partial pressure of hydrogen resulted in an increase in the amount 
of butyrate produced with respect to acetate (Crabbendam et al., 1985). An 
increase in the carbon flow through the glycolytic pathway results in an increase 
in the level of acetyl-CoA, and this increase has been shown to stimulate the 
activity of NADH-Fd-oxidoreductase in the clostridia (Jungermann et al., 1976). 
Therefore, an efficient route for the disposal of excess NADH is provided, 
allowing for the more energy favourable production of acetate. 
In C. acetobutylicum the shift from acidogenesis to solventogenesis is 
accompanied by a decrease in hydrogen production and an increase in CO2 
production. Less hydrogen is produced than would be expected from the 
oxidation of pyruvate, indicating that during this growth phase both carbon and 
electron flow are primarily directed to solvent production. This switch in carbon 
flow appears to be directly linked to the reduction of hydrogen production, and 
Kim and Zeikus (1985) observed that the specific rate of hydrogen production 
decreased in stages during the course of a batch fermentation. As expected, the 
highest rate of hydrogen production occurred during the initial growth phase, 
which could be correlated with a high rate of glucose consumption. A decrease 
in the metabolic activity resulted in a decrease in hydrogen production, however 
specific hydrogenase activity associated with the whole cell did not alter. It was 
concluded that this decrease in hydrogen production was due to a decline in the 
availability of reduced Fd resulting from a decrease in glucose consumption. 
These authors noted a second, more significant, decrease in the rate of hydrogen 
production which correlated with the shift from acid production to solvent 
production. In this case the specific hydrogenase activity with respect to the 
whole cell did decrease. 
The specific hydrogenase activity in whole cells from acid producing cultures 
was shown to be approximately 2.2 times higher than that measured from 
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solvent producing cultures (Kim and Zeikus, 1985). Kim and Zeikus (1985) 
demonstrated that hydrogenase activity was not affected by either pH or acid 
concentration, and concluded that a decrease in hydrogen production during 
solventogenesis is a result of regulation of hydrogenase production as opposed 
to an inhibition of enzyme activity. In contrast to these findings, Andersch et al. 
(1983) reported that hydrogenase activity was similar in both acid and solvent 
producing cells. However, hydrogenase activity in solvent producing cells could 
only be detected in the assay after an initial lag period of 10 to 15 min. These 
authors concluded that the hydrogenase from the solvent producing cells was 
present in an inactive form and the conditions used for the assay activated the 
enzyme after a lag period. 
Hydrogenase activity, and therefore solvent production, could be altered by 
changing the partial pressure of hydrogen in the culture vessel. It was shown 
that by using hydrogen to increase the headspace pressure to between 100 and 
250 kPa, the yields of butanol and ethanol could be increased (Gapes et al., 1982). 
Increasing the partial pressure of hydrogen in the headspace resulted in a 
decrease in hydrogenase activity. A similar study was carried out by Yerushalmi 
et al. (1985), where the headspace of the fermentation vessel was pressurized 
with either hydrogen .or helium. When hydrogen was used to pressurize the 
fermenter to between 270 and 1 500 kPa, butanol and ethanol yields were 
increased by an average of 18 and 13% respectively. A much lower increase in 
butanol and ethanol production was noted when helium was used to pressurize 
the culture vessel. A similar, yet weaker effect was noted when C. acetobutylicum 
cultures were not agitated, allowing for the partial pressure of hydrogen to rise 
naturally (Doremus et al., 1985; Yerushalmi and Volesky, 1985). Together, these 
results verify that when conditions are reached where the partial pressure of 
hydrogen is increased, there is a resulting decrease in hydrogen production and 
a stimulation of butanol and ethanol production, but not acetone production. 
Under these conditions, the H+ /H2 redox potential is lowered and the flow of 
electrons from reduced Fd to molecular hydrogen is thermodynamically 
unfavourable (Jungermann et al., 1971b). Because the hydrogenase was 
Introduction 21 
inhibited, the flow of electrons from reduced Fd was shifted to the generation of 
NADH and NADPH via the actions of the respective Fd-oxidoreductase. 
Stimulation of ethanol and butanol production was therefore necessary for the 
disposal of electrons carried by these reduced pyridine nucleotides. 
Carbon monoxide (CO) is known to reversibly inhibit the function of 
hydrogenases by reacting with iron present in the active site of the enzyme 
(Thauer et al., 1974; Mortenson and Chen, 1975). Sparging cultures of C. 
acetobutylicum with CO has been shown to alter the fermentation balance, 
resulting in an increase in the butanol yield (Kim et al., 1984; Datta and Zeikus, 
1985; Meyer et al., 1985). Acetate and butyrate uptake can also be enhanced 
when cultures are sparged with CO. Increasing the partial pressure of the 
culture vessel with CO to between 100 and 150 kPa resulted in a 50% decrease in 
hydrogen production, a 50 to 200% increase in butyrate uptake and a 10 to 15% 
increase in butanol yield (Datta and Zeikus, 1985). It is also important to note 
that CO has been shown the inhibit the acetoacetate decarboxylase enzyme 
which is responsible for the formation of acetone. Therefore, the ratio of solvents 
can be controlled by a combination of CO sparging and the addition of organic 
acids (Datta and Zeikus, 1985). 
The fate of reduced Fd determines the electron distribution in the cell in that it 
can either transfer electrons via hydrogenases to produce hydrogen, or electrons 
can be transferred via the appropriate Fd-oxidoreductase to yield reduced 
pyridine nucleotides. Therefore, the activities of NADH-Fd-oxidoreductase, 
NADPH-Fd-oxidoreductase and hydrogenase in effect control the direction of 
carbon flow by controlling the electron flow within the cell (Jungermann et al., 
1973, 1976; Jones and Woods, 1986a). Glyceraldehyde 3-phosphate 
dehydrogenase and NADH-Fd-oxidoreductase both function in controlling the 
levels of NAD+ and NADH in the cell. Furthermore, CoA and acetyl-CoA are 
known to act as allosteric inhibitors and activators of NADH-Fd-oxidoreductase 
respectively (Jungermann et al., 1973). Since a high concentration of NADH 
inhibits the production of NADH via the NADH-Fd-oxidoreductase, and 
considering the role of CoA and acetyl-CoA in controlling this enzyme, the ratios 
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of acetyl-CoA:CoA and NAD+:NADH must play a principal role in the 
regulation of electron flow, and hence carbon flow, in C. acetobutylicum (Datta 
and Zeikus, 1985; Jones and Woods, 1986a). In addition, it has been postulated 
that the ratios of these compounds can function as sensors for both ATP 
regeneration and hydrogen production (Datta and Zeikus, 1985). 
1.3.3 Sporulation and stationary phase events 
Bacillus subtilis has been the organism of choice for studying the metabolic and 
genetic events associated with endospore formation in bacteria. From these 
studies the process of endospore formation has been simplified as occurring in 
two discrete phases: (i) the initiation phase where growing cells recognize and 
respond to changes in the environment where rapid growth is no longer 
supported, and (ii) the differentiation phase where genes whose products are 
required for sporulation are expressed in a defined and genetically determined 
order (Sonenshein, 1985). It has been extensively demonstrated that in B. subtilis 
spore formation can be initiated by exposing rapidly multiplying cells in a liquid 
medium to a nutritionally poor medium (Sterlini and Mandelstam, 1969; Losick 
et al., 1986; Sonenshein, 1989). Unfortunately, similar nutrient shift down 
procedures do not induce sporulation in the clostridia, and it has been shown 
that these organisms sporulate only under conditions where growth is limited in 
the presence of an exogenous carbon and energy source (Murrell, 1967; Hickey 
and Johnson, 1981; Woods and Jones, 1986). In C. acetobutylicum in particular, 
neither glucose nor ammonium limitation succeeded in the induction of 
solventogenesis or sporulation (Long et al., 1983, 1984a). In fact, these studies 
showed that at intermediate concentrations of glucose or ammonia, the yield of 
endospores was proportional to the substrate concentration. 
It appears that in C. acetobutylicum, sporulation is initiated by the same factors 
which induce solvent formation, which include a decrease in pH and the 
accumulation of acid end products. This suggests that a parallel switch for both 
solventogenesis and sporulation exists. As mentioned previously, the findings of 
Gottschal and Morris (1981a) that correlated a loss of spore forming ability with a 
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loss of the ability to produce solvents, support this idea of a parallel switch. 
However, the isolation of asporogenous mutants that maintain the ability to 
produce solvents, demonstrates that initiation of spore formation is not a 
prerequisite for solvent production. Asporogenous C. acetobutylicum mutants 
blocked before (SPO 0) or after (SPO II-VD forespore septum initiation, retained 
the ability to produce solvents (Jones et al., 1982; Long et al., 1984b). 
Gottschal and Morris (1981a) and Jones et al. (1982) both reported the isolation of 
a second class of asporogenous C. acetobutylicum mutants. Apart from being 
asporogenous, these isolates, termed els mutants (Jones et al., 1982), did not 
develop into clostridial forms and therefore lacked all the stationary phase 
characteristics associated with solventogenesis. Solvent production, capsule 
production, granulose production and endospore formation were all absent in 
these els mutants (Long et al., 1984a, 1984b). The els mutants derived from C. 
acetobutylicum P262, were isolated after treatment with ethyl methane sulfonate 
(EMS). EMS is a direct mutagenic agent know to cause point mutations by 
alkylating purine bases (Birge, 1981). Assuming that the els mutants were 
derived from single point mutations, the observation that normal wild type 
characteristics are restored by reversion of such mutations suggests that the 
induction of the stationary phase events is linked by some common regulatory 
mechanism. However, it is not known if the els mutation is a result of a defect in 
coordinate induction of the events associated with solventogenesis or if it is 
related to . an inability to attain or maintain a particular physiological state 
necessary for the onset of solventogenesis (Jones and Woods, 1986a). 
Apart from the solvent producing asporogenous mutants mentioned above, 
mutants lacking other individual stationary phase events have been isolated 
(Jones and Woods, 1988). These include mutants that are unable to produce 
granulose or extracellular capsule material, as well as mutants that produce 
altered levels of solvents (Long et al., 1984b; Durre et al., 1986; Reysenbach et al., 
1986; Rogers, 1986). The isolation of these mutants demonstrates that although 
the induction of stationary phase events may be linked, the individual pathways 
leading to these events function independently. While solvent production, 
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granulose accumulation and capsule formation do not appear to be sporulation 
specific events (Long et al., 1984b), the initiation of these events may be a 
prerequisite for initiation of sporulation. Definitive experimental support for 
this hypothesis is limited, however it is interesting to note that a single 
mutagenic treatment has never been reported to lead to the isolation of a C. 
acetobutylicum mutant that lacks all stationary phase events except sporulation. 
1.4 Genetic studies of C. acetobutylicum 
The development of systems for the transfer of nucleic acids into C. 
acetobutylicum has lagged behind the ability to study genes from this bacterium 
in other organisms such as E.coli and B. subtilis. High levels of extracellular and 
cell bound deoxyribonuclease (DNAse) activity are associated with the majority 
of C. acetobutylicum strains (see Jones and Woods, 1986b). This has hampered 
attempts at transferring DNA into C. acetobutylicum via many methods such as 
protoplast fusion and transfection. Recent advances in the construction of 
suitable cloning vectors and transformation techniques for C. acetobutylicum, 
have provided the much needed basis for future genetic manipulations of this 
organism. The rapid progress in these areas has been the subject of recent 
publications (Jones and Woods, 1986b; Jones and Woods, 1988; Young et al., 
1989a, 1989b; Minton et al., 1990a, 1990b). 
1.4.1 Ooned C. acetobutylicum genes 
Apart from chemical mutagenesis, the initial approach used for genetic studies of 
C. acetobutylicum, was to clone and study clostridial genes in well characterized 
bacteria such as E.coli (Jones and Woods, 1986b). 
The first genes cloned from C. acetobutylicum included an endoglucanase, a 
xylanase and some amino acid utilization genes (Efstathiou and Truffant, 1986; 
Zappe et al., 1986, 1987, 1988). These genes appeared to be expressed from their 
own promoters, thereby demonstrating that C. acetobutylicum genes could 
function in E.coli. The importance of nitrogen metabolism in the life cycle of C. 
acetobutylicum led to the cloning of a glutamine synthetase gene (Usdin et al., 
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1986). This glnA gene was also expressed from its own promoter and was 
regulated by nitrogen levels in E.coli (Janssen et al., 1988, 1990). Other C. 
acetobutylicum genes that have been cloned into E.coli include a lactate 
dehydrogenase (Contag et al., 1990), an a-amylase (J. van der Leyden, personal 
communication) and the endonuclease Cac824I (E.T. Papoutsakis, personal 
communication). 
Attainment of a molecular level understanding of acidogenic and solventogenic 
pathway gene regulation has focussed most efforts towards cloning of these 
genes. Genes coding for the central pathway enzymes thiolase (G.N. Bennett, 
personal communication) and 3-hydroxybutyryl CoA dehydrogenase 
(Youngleson et al., 1989a) have been cloned and studied in E.coli. Initial reports 
(Youngleson et al., 1989a, 1989b) indicated that the 3-hydroxybutyryl CoA 
dehydrogenase formed part of a but operon which included an alcohol 
dehydrogenase. However, recent experiments reveal that while these two genes 
are linked on the C. acetobutylicum chromosome, they may function 
independently. (D.R. Woods, personal communication). 
Acidogenic pathway genes coding for the two enzymes, butyrate kinase and 
phosphotransbutyrylase which are responsible for the conversion of 
butyryl-CoA to butyrate, have been cloned and were also found to be linked on a 
contiguous stretch of C. acetobutylicum chromosomal DNA (Cary et al., 1988; 
Wiesenborn et al., 1989b). 
A NADPH dependent alcohol dehydrogenase was the first solvent pathway gene 
to be cloned (Youngleson et al., 1988, 1989b). Recently a NADH dependent 
butanol dehydrogenase has been cloned (G.N. Bennett, personal 
communication), indicating that more than one enzyme may be able to carry out 
the conversion of butyraldehyde to butanol. Other cloned solvent pathway 
genes include the acetoacetate decarboxylase (Gerischer and Durre, 1990; 
Petersen and Bennett, 1990) and the acetoacetyl-CoA:acetate/butyrate:CoA 
transferase (Cary et al., 1990). Both of these genes were cloned in two 
independent laboratories, with each group isolating these genes from unique C. 
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acetobutylicum strains. Both groups showed that these two genes were linked on 
a contiguous piece of C. acetobutylicum chromosomal DNA (G.N. Bennett and P. 
Durre, personal communications). 
1.4.2 Genetic manipulation of C. acetobutylicum 
The development of efficient gene transfer systems for C. acetobutylicum is 
essential for future genetic manipulations of this organism. Protoplast fusion 
and regeneration using C. acetobutylicum strain P262 (Allcock et al., 1982; Jones et 
al., 1985) and C. saccharoperbutylacetonicum strain Nl-4080 (Reysset et al., 1987, 
1988) has been reported. The efficiency of these systems was however low, most 
likely due to the high nuclease and autolysin activities associated with these 
organisms (Jones and Woods, 1986b). An autolysin deficient mutant (Nl-4081) of 
strain Nl-4080 was isolated, and proved to be more easily regenerated (Reysset 
et al., 1988). 
Conjugal transfer of DNA into C. acetobutylicum was first reported by Reysset 
and Sebald (1985), who showed that the streptococcal plasmid pAM~l could be 
transferred to C. acetobutylicum strains 903 and A TCC 824 at a frequency 
approaching lQ-6 per donor. The plasmid pAM~l was also shown to be 
conjugatively transferred to C. acetobutylicum strain NCIB 8052 using either 
Streptococcus lactis or B. subtilis as the donor (Oultram and Young, 1985; Oultram 
et al., 1987). Several other broad host range plasmids such as pIP501, pJH4, and 
pVA797 have been transferred to C. acetobutylicum via conjugation (Young et al., 
1989a, 1989b). Furthermore, plasmids pVA797 and pAT187 have been shown to 
mobilise non conjugative plasmids such as pAM610 into C. acetobutylicum strains 
P262 (Yu and Pearce, 1986) and NCIB 8052 (Young et al., 1989a, 1989b) 
respectively. Recently, Williams et al. (1990) developed a conjugative transfer 
system using E. coli as the donor and C. acetobutylicum NCIB 8052 as the 
recipient. However, these authors reported that they were unable to successfully 
apply this system to other C. acetobutylicum strains such as DSM 1731, ATCC 824 
and P262. Since E.coli has generally been utilized as the standard organism for 
genetic manipulations, this conjugation system is very attractive. 
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Transposons have been extensively employed in genetic studies of many 
organisms. In E.coli transposons have been used to identify promoters, to test 
for export mechanisms, to clone genes and to generate specific and polar 
mutations (de Bruijn and Lupski, 1984). Conjugative transposons are able to 
function in a wide variety of Gram positive hosts (Clewell and Gawron-Burke, 
1986) including C. acetobutylicum (Young et al., 1989a, 1989b). Yu and Pearce 
(1986) reported the successful expression of the streptococcal transposon Tn917 
in C. acetobutylicum, however these authors did not demonstrate whether the 
tran'sposon was incorporated into the host chromosome, or remained on the 
plasmid used for transfer. Woolley et al. (1989) demonstrated that the 
conjugative transposons Tn916 and Tn1545 could be transferred from 
Enterococcus faecalis to C. acetobutylicum NCIB 8052. Both of these transposons 
harbour a tetracycline resistance (TcR) marker, and while Tn1545 was able to 
insert into the C. acetobutylicum chromosome at multiple sites, Tn916 had 
favoured sites of insertion. Bertram and Durre (1989) showed that the 
conjugative transposons Tn925, Tn916 and Tn925:Tn917 could also be efficiently 
transferred from E. faecalis to the chromosome of C. acetobutylicum. Exemplifying 
the differences amongst C. acetobutylicum strains, these authors demonstrated 
that Tn916 could insert at multiple sites in the chromosome of strains ATCC 824, 
DSM 792 and DSM 1731. 
Using the Tn916 conjugation/mutagenesis system, Bertram et al. (1990) isolated 
three types of mutants of C. acetobutylicum DSM 792, by selecting for colonies that 
were resistant to either allyl alcohol or 2-bromobutyrate. The type I mutant 
lacked the ability to produce acetone and butanol, type II produced reduced 
levels of solvents and type III showed an increase in butanol production. These 
mutants were asporogenous and lacked the ability to accumulate granulose. 
These latter characteristics could however be due to an effect of tetracycline 
(transposon marker), in an analogous fashion to the effect of chloramphenicol 
which inhibits sporulation in B. subtilis. These authors showed that the type I 
mutant contained only one copy of Tn916, and considering that both acetone and 
butanol production was absent, the hypothesis that there is global regulation for 
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the initiation of solventogenesis is strongly supported. The ability of the type I 
mutant to produce ethanol suggests that ethanol production may be independent 
from the induced solvent pathways for acetone and butanol production. 
Subculturing the above transconjugants 15 times in the absence of selective 
pressure (Tc) for the transposon, resulted in approximately 50% of the colonies 
becoming sensitive to tetracycline while maintaining the mutant phenotype. 
Hybridization studies revealed that these Tcs revertants did not contain the 
Tn916 transposon. This suggests that transposon excision in C. acetobutylicum is 
not precise, which is in contrast to results obtained with Tn916 in E.coli 
(Gawron-Burke and Clewell, 1984). 
As an alternative to conjugation, lytic and lysogenic phages known to infect C. 
acetobutylicum could be developed into possible cloning vectors. Bacteriophages 
have been identified as the cause of abnormal fermentations (McCoy et al., 1944), 
and the initial characterization of some of these phages has been carried out 
(Hongo et al., 1968; Ogata and Hongo, 1979; Nieves et al., 1981). Although whole 
cell transduction of C. acetobutylicum has not been reported, the successful 
development of lysogenic phages such as q,105 as cloning vectors for B. subtilis 
(Errington, 1984) indicates that an analogous system could be developed for C. 
acetobutylicum. Further efforts to characterize and develop C. acetobutylicum 
phages are currently in progress (D.T. Jones, personal communication). 
A procedure by which a high voltage electric discharge through a cell suspension 
facilitates the introduction of DNA into the cells, offers yet another alternative to 
conjugation. This procedure, known as electroporation, is believed to induce 
transient pores in the cell membrane through which exogenous DNA can enter 
the cell (reviewed by Fiedler and Wirth, 1988; Wirth et al., 1989). Successful 
transformation via electroporation has been reported for a number of Gram 
positive bacteria including members of the genera Streptomyces, Streptococcus, 
Lactobacillus and Bacillus (see Lucansky et al., 1988). Recently, Oultram et al. 
(1988) reported that C. acetobutylicum NCIB 8052 could be transformed by 
electroporation at frequencies approaching 3 X 103 transformants per µg DNA. 
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The convenience of transforming naked DNA and the ease of use of this 
procedure, may render it the method of choice for the introduction of foreign 
DNA into C. acetobutylicum. 
1.4.3 Cloning vectors for C. acetobutylicum 
Concurrent with developments concerning the introduction of DNA into C. 
acetobutylicum was the construction of suitable cloning vectors for use in this 
organism. While the occurrence of plasmids in the clostridia has been noted, 
none of these plasmids contain selectable markers suitable for genetic 
manipulations (Minton and Thompson, 1990). This has necessitated the in vitro 
construction of vectors by combining replicons and antibiotic resistance genes 
known to function in C. acetobutylicum (Truffaut et al., 1989; Minton et al., 1990a, 
1990b; Yoshino et al., 1990). 
As a starting point, Minton and co-workers cloned the antibiotic resistance genes 
for Erythromycin (Em), Tetracycline (Tc) and Chloramphenicol (Cm) into the 
pUC like cloning vectors pMTL20 and pMTL21 (Chambers et al., 1988) to yield 
pMTL20/21E, pMTI20/21T and pMTL20/21C respectively. The next step was 
to include replicons known to function in the clostridia. Four different sources of 
clostridial replicons were cloned into these vectors, and provided resultant 
plasmids that were able to function in C. acetobutylicum (Minton et al., 1990a). 
Interestingly, none of these replicons supported efficient plasmid replication in 
B. subtilis, indicating that clostridial replicons are functionally distinct from those 
found in aerobic Gram positive bacteria (Gruss and Ehrlich, 1989). 
Features such as a broad host range and structural stability, led these workers to 
base further C. acetobutylicum vector construction on the streptococcal plasmid 
pAMj31, and therefore a detailed study of the replication region of this plasmid 
was performed (Swinfield et al., 1990). As a result of this analysis, a 2.9 kb 
EcoRl-HpaI fragment carrying the replication region of pAMj31 was cloned into 
the plasmid pMTL20E resulting in plasmid pMTLSOOE (Swinfield et al., 1990; 
Minton et al., 1990b). Plasmid pMTLSOOE retains all of the desirable features of 
the pUC like cloning vector pMTI20. These features include a multiple cloning 
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site polylinker which resides within the lacZ' region, the bla gene for ampicillin 
selection in E.coli and an E.coli origin of replication. Due to the broad host range 
of pAM~l, the vector pMTLSOOE is also able to replicate in B. subtilis as well as 
C. acetobutylicum. Analogous procedures led to the construction of plasmids 
pMTLSOOC and pMTLSOOT (from pMTL20C and pMTL20T) where the Gram 
positive antibiotic resistance markers were chloramphenicol and tetracycline 
respectively. 
Segregational instability in the absence of selective pressure, has been shown to 
be a problem with vectors constructed for use in C. acetobutylicum (Truffaut et al., 
1989; Yoshino et al., 1990). In the absence of Em, pMTLSOOE also showed 
segregational instability in both B. subtilis and C. acetobutylicum (Minton et al., 
1990a). Janniere et al. (1989) showed that certain pAM~l derived cloning vectors 
for use in B. subtilis also showed segregational instability. However, one of these 
B. subtilis vectors, pHV1431, contained an additional 2.12 kb of pAM~l DNA and 
was much more stable in the absence of selective pressure. Insertion of this 
2.12 kb fragment into the multiple cloning site of pMTLSOOE (=pMTL531E) 
significantly improved the segregational stability in both B. subtilis and C. 
acetobutylicum (Minton et al., 1990a). Molecular analysis of the 2.12 kb region 
revealed 2 open reading frames, one of which coded for a protein that showed 
good similarity to the resolvases of the Gram positive transposon Tn917 (Minton 
et al., 1990a). It has been suggested that the resolvase like proteins present on 
other Gram positive plasmids such as pI524 and pIP404, can mediate plasmid 
stability by maintaining the plasmid population in the monomeric state (Gamier 
et al., 1987; Rowland and Dyke, 1988). A similar role may be carried out by the 
resolvase like protein identified on pMTL531E (Minton et al., 1990a). Since the 
multiple cloning site of pMTL531E was disrupted by the resolvase containing 
DNA, the plasmid pMTLSOOE(res+) was constructed such that the multiple 
cloning site of pMTLSOOE remained intact (Minton et al., 1990a). This plasmid 
had a similar segregational stability to pMTL531E. 
To further enhance the usefulness of the pMTLSOO series of vectors, the lac 
promoter element of pMTLSOOE was replaced with the C. pasteurianum Fd 
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promoter element, such that the AUG start codon of Fd became that of the lacZ' 
gene. To allow for regulatory control, a synthetic lac operator was inserted 
between the -10 region and the ribosome binding site of this promoter element 
(at position +1) (Minton et al., 1990b). The resulting plasmid was designated 
pMTLSOOF, and it was shown that in E.coli, transcription from the Fd promoter 
could be regulated by a lac! repressor protein produced from a coexisting 
plasmid (Minton et al., 1990a). A similar control mechanism for pMTLSOOF in C. 
acetobutylicum is currently being developed (Minton et al., 1990a) analogous to a 
system that was developed for B. subtilis (Peschke et al., 1985). 
1.5 Future prospects for the ABE fermentation 
The lack of economic competitiveness of the ABE fermentation for the 
production of chemical feedstocks currently inhibits exploitation of this process. 
Knowledge gained with respect to the biochemistry, physiology, molecular 
biology and genetics of C. acetobutylicum has just about moved the prospects for 
this fermentation from being future to being current. 
Marketing techniques in the western world have altered the perceptions of the 
consumer, such that the purchase of naturally derived products is desirable at all 
costs. With particular respect to the ABE process, there may be a small niche for 
products which contain solvents derived via fermentation. One example is 
fingernail polish remover, where the acetone content is low enough that the 
additional cost for the naturally derived solvent may not prohibitively increase 
the price of the final product. 
The utilization of inexpensive alternative substrates such cellulosic waste, are of 
concern to many fermentations. However, application of future developments in 
this area to the ABE process will depend on the ability to genetically introduce 
these systems into C. acetobutylicum. Methods for the genetic manipulation of C. 
acetobutylicum have been successfully developed, and indeed Minton et al. 
(1990a, 1990b) have shown good expression of C. thermocellum celA and celC genes 
in C. acetobutylicum. 
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Complementing the genetic manipulation of C. acetobutylicum by introduction of 
foreign DNA, the development of conjugative transposon mutagenesis systems 
provides a powerful and convenient route for the isolation of C. acetobutylicum 
strains with desirable fermentation characteristics. 
Although it was not discussed in this introduction, advances in the areas of 
process technology and downstream processing will no doubt have a marked 
affect on the re-emergence of the ABE fermentation (Gottschalk and Bahl, 1981). 
Despite the current abundance of oil, it is a non-renewable resource. If nations 
truly want to eliminate oil as the basis for their economies, fundamental and 
applied research on the ABE fermentation must be welcomed and encouraged. 
1.6 Overview of metronidazole 
Metronidazole was used extensively in this study, thereby necessitating a brief 
discussion on this compound. This introduction is not intended to be a 
comprehensive review of the scientific literature, but rather provides enough 
information to allow for an understanding of why and how it was used as a 
research tool. 
1.6.1 History and development of metronidazole 
Similar to the history and development of the ABE fermentation, the history and 
development of metronidazole is colourful and a joy to discover. 
Catteral (1976) wrote that in the 1950's, "at the majority of clinics there were 
queues of sad looking unhappy women ... with wet and stained underwear and 
poor morale ... nor was there any satisfactory treatment to offer them". The 
disease was known as trichomoniasis, and the causative agent had been shown 
to be Trichomonas vaginalis. Infection could persist for many years, making life a 
misery for the patient. 
In 1954, the laboratories of Rhone-Poulenc in Paris, France instituted a research 
programme to search for a compound effective against T. vaginalis (McFadzean, 
1986). Many compounds were tested, and in 1956, Despois et al. reported that a 
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crude extract from a streptomycete was active against the parasite. The active 
antibiotic was shown to be azomycin (Fig. 1.3) which had been discovered two 
years previously by Japanese workers (McFadzean, 1986). Following this lead, 
many derivatives of azomycin were synthesized and eventually in 1957, 
metronidazole was born (Fig. 1.3). Of all the compounds developed, 
metronidazole provided the best balance between activity and toxicity. Using 
mice infected with T. vagina/is, Cosar and Julou (1959) were the first to report the 
effectiveness of orally administered metronidazole. Clinical trials were instituted 
shortly thereafter (Durel et al., 1959), and metronidazole was introduced for 
prescription use in 1960 in France and the UK. 
It is common for more active or better tolerated drugs to overtake their 
predecessors in the marketplace. This has not occurred with metronidazole 
(McFadzean, 1986) and after 30 years, it is still the drug of choice for the 
treatment of trichomoniasis. 
This may have been the end of the story for metronidazole if it was not for the 
careful observations of certain people such as a dental surgeon named David 
Shinn. Shinn was a registrar at King's College Dental School in London, and in 
1962 he had been treating a female patient with acute ulcerative gingivitis 
(McFadzean, 1986). The patient received the normal treatment of chromic acid 
and peroxide which was applied to the ulcers. On her next consultation, the 
patient's gingivitis was cured. Not believing that the miraculous results were 
due to his treatments, Shinn questioned this patient and discovered that she was 
receiving metronidazole treatment for trichomoniasis. Intrigued by his 
discovery, he treated six more ulcerative gingivitis cases with metronidazole, 
and all were rapidly cured. Shinn reported his results and encouraged others to 
test the effectiveness of metronidazole against acute ulcerative gingivitis (Shinn, 
1962). 
It had previously been established that large numbers of two organisms, Borrelia 
vincenti and Bacteroides fusiformis, were present in the ulcerative lesions of this 
gingivitis. In conjunction with May and Baker pharmaceuticals, who distributed 
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Figure 1.3 A comparative drawing showing the chemical composition of 
azomycin, and the chemical composition of its derivative, metronidazole. 
metronidazole in the UK, Shinn was able to show in vitro killing of B. fusiformis 
by metronidazole. A confirmation of these results was published (Davies et al., 
1964), and Shinn became one of the best known dentists in the world. Sponsored 
by May and Baker, Shinn visited dental schools in Canada and the USA with a 
view of moving there to practise dentistry. On his return to the UK, he 
announced his decision to remain in England as he was not prepared to give up 
the pleasure of watching Arsenal play football on a Saturday (McFadzean, 1986). 
It was also shown that in vitro, metronidazole was active against Entamoeba 
histolytica, the causative agent of amoebic dysentery (Powell, et al., 1966). This 
amoeba, the trichomonad and the two bacteria associated with ulcerative 
gingivitis all had one thing in common; they grew anaerobically. May and Baker 
decided to test metronidazole against other anaerobic bacteria, particularly 
members of the genus Clostridium. Again, metronidazole was show to have in 
vitro activity which was at least as effective as reference antibiotics used as 
controls (Freeman et al., 1968). 
It had been shown that 98% of the viable bacteria of the large intestine were 
anaerobic, and were primarily members of the genus Bacteroides (Drasar et a1., 
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1966). Furthermore, clostridial infections were known to be a problem in causing 
gas gangrene shortly after limb amputation, and the source of the infection was 
believed to be from the patients own faeces (Parker, 1969). It was proposed to 
administer metronidazole to prevent this auto-infection, however this proposal 
did not gain acceptance for quite a number of years (McFadzean, 1986). 
Advances were made in the ability to culture anaerobic bacteria, and so the 
realization of their importance in disease was becoming clear. However, this 
realization was only being recognized by small groups of people willing to 
challenge common medical opinion (McFadzean, 1986). Studies had shown that 
prophylactic metronidazole treatment was virtually 100% effective in controlling 
post operative sepsis by Bacteroides species following elective gynaecological 
surgery (Willis et al., 1974, 1975). These and other reports were viewed with 
great scepticism by the medical community, and even the highly regarded New 
England Journal of Medicine published a somewhat cynical report entitled "Beware 
- the anaerobe bandwagon" (Page, 1974). More and more results showed the 
efficacy of metronidazole in the treatment of post operative sepsis. Eventually 
institutions such as the Luton and Dunstable Hospital north of London, where 
many of the initial metronidazole studies were performed, concluded that it was 
unethical to withhold metronidazole prophylaxis when undertaking 
hysterectomy operations. In 1978, the Luton group stated that after 618 
hysterectomies where metronidazole treatment was included, there had been no 
post operative anaerobic infections (McFadzean, 1986). 
Similar results and conclusions were found when using prophylactic 
metronidazole treatment prior to and after other types of abdominal surgery. 
Metronidazole treatment was shown to be effective in controlling post operative 
sepsis after colonic surgery (Goldring et al., 1975; Willis et al., 1977), 
appendicectomy (Leigh et al., 1974; Willis et al., 1976) and obstetric surgery 
(Willis et al., 1978). 
Since anaerobic bacteria are the principal agents behind sepsis following 
abdominal surgery, it is not surprising that metronidazole was found to be very 
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effective at treating other, non-surgically induced anaerobic infections. 
Metronidazole treatment has been effective against brain abscesses (Ingham et 
al., 1975, 1977), dental infections (Hood, 1978; Rood and Murgatroyd, 1979), 
bacterial meningitis (Berman et al., 1978), lung infections (Tally et al., 1975) and 
many other important and miscellaneous infections (see Kucers and Bennett, 
1987). In fact, the number of reports demonstrating the medical usefulness of 
metronidazole numbers well into the thousands (McFadzean, 1986). 
Because of their specific role in the development and production of Flagyl 
(metronidazole), May and Baker Ltd. was presented with the Queen's Award for 
Technological Achievement in 1982. It is virtually impossible to determine the 
world usage of metronidazole today, particularly in light of the expiration of 
most patents in 1974. However, one can form an idea by observing that between 
April 1984 and March 1985, a total of 8.6 tonnes of metronidazole preparations 
were used in the U.K. alone (McFadzean, 1986). 
1.6.2 Spectrum of metronidazole activity 
Metronidazole, 1- (~ -hydroxyethyl)- 2- methyl-5 - nitroimidazole, is a 
nitroimidazole drug similar to tinidazole, nimorazole, ornidazole, carnidazole 
and secnidazole (Edwards, 1980; Kucers and Bennett, 1987). From the history 
and development of metronidazole, it is clear that this compound is highly toxic 
to organisms growing in anaerobic environments. 
Metronidazole is active against some anaerobic protozoa. T. vaginalis, E. 
histolytica, Giardia lamblia and Balantidium coli all show some degree of 
susceptibility to metronidazole (Kucers and Bennett, 1987). Despite some initial 
reports that metronidazole could be used to treat leishmaniasis (Long, 1973; 
Jones, 1979) and trypanosomiasis (Davies, 1967), it appears that this compound 
has little or no effect on the responsible aetiological agents (Keithly and 
Langreth, 1983). 
Investigations have clearly shown that metronidazole is active against most 
obligately anaerobic bacteria (Tally et al., 1981; Noble and Tally, 1984). Most 
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Bacteroides species, Fusobacterium species and Clostridium species are uniformly 
susceptible to metronidazole and other nitroimidazoles. Anaerobic organisms 
such as Peptococcus, Peptostreptococcus and Eubacterium species are generally 
susceptible to metronidazole, however occasional resistance is known (Tally et 
al., 1981; Dubreuil et al., 1984). The two medically important capnophilic 
organisms, Campylobacter fetus and Haemophilus vaginacola have also been shown 
to be susceptible to metronidazole (Chow et al., 1978; Pheifer et al., 1978). 
Generally, most aerobic and microaerophilic bacteria show uniform resistance to 
metronidazole, however recent evidence suggests that certain facultative 
anaerobes are susceptible to metronidazole if grown under anaerobic conditions 
(see Chapter 4). 
Resistance to metronidazole among susceptible species is rare (Miiller, 1982), 
however resistant strains of T. vaginalis have been isolated from patients with 
refractory trichomoniasis (Thurner and Meingassner, 1978; Forsgren and 
Forssman, 1979; Heyworth et al., 1980; Lossick, 1981; Waitkins and Thomas, 1981; 
Kulda et al., 1982). Ingham et al. (1978) isolated a metronidazole resistant strain 
of B. fragilis from a patient who was on long term therapy with metronidazole for 
Chron's disease. No extrachromosomal DNA was found in this strain and there 
was no transfer of resistance determinants using filter mating techniques which 
have been successful for intraspecies transfer of clindamycin, erythromycin and 
tetracycline resistance in B. fragilis (Tally et al., 1981). Using radiolabelled 
metronidazole, it was shown that this resistant strain had a reduced ability to 
take up the drug (Tally et al., 1979). This was confirmed in a later study where 
metronidazole resistant B. fragilis strains were selected after mutagenic treatment 
with N-methyl-N-nitro-N-nitrosoguanidine (Britz and Wilkinson, 1979). Five 
metronidazole resistant mutants were isolated from different B. fragilis strains. 
In all cases, the mechanism of resistance was a reduced ability to take up the 
drug. 
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1.7 Mode of action of metronidazole 
The mechanisms behind the mode of action of metronidazole have not been 
completely elucidated, however a good understanding is available. Muller 
(1983) described the essential action of metronidazole to occur in four steps: 
1) entry of the drug into the cell, 2) reductive activation of the drug, 3) the toxic 
effects of the reduced product or products, and 4) release of the inactive end 
products. 
1.7.1 Metronidazole entry 
It is generally assumed that entry of metronidazole into the cell occurs via 
passive diffusion, however the supporting evidence is indirect and therefore 
active transport can not be totally ruled out (Ings et al., 1974). Using 14<: labelled 
metronidazole, Ings et al. (1974) showed that T. vaginalis cells rapidly 
accumulated the 14<: label. Non sensitive cells such as Tetrahymena pyriformis did 
not accumulate the 14<: label, although it was shown that metronidazole can 
diffuse into these cells. Various imidazoles and biologically active or inactive 
nitroimidazole derivatives in high concentrations do not inhibit this 
accumulation (Edwards, 1980; Muller, 1983). Because metronidazole undergoes 
metabolic modification after entry into sensitive cells, it has been suggested that 
this modification decreases the intracellular concentration of the unchanged drug 
and thus forms a transmembrane concentration gradient which promotes further 
drug uptake (Ings et al., 1974; Muller and Lindmark, 1976; Tally et al., 1978). 
Muller (1983) pointed out that because studies using 14<: labelled metronidazole 
showed that labelled products leave the cell, it is likely that the measured 
accumulation of the label in these studies underestimates the total drug entry. 
1.7.2 Metronidazole activation 
The fact that metronidazole is a prod.rug is fortuitous, and was never envisioned 
when the drug was first synthesized and used (McFadzean, 1986). It has been 
suggested repeatedly that reduction of the nitro group of metronidazole is 
necessary for drug activation. The actual mechanisms of reduction of 
metronidazole have not been directly elucidated. Possible theories on how 
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metronidazole is reduced include direct electron transfer via reduced electron 
carriers, as well as active reduction via enzymatic routes. These possibilities are 
discussed in the next two sections. 
Metronidazole reduction most likely occurs in single electron steps, assumed to 
lead firstly to the formation of a free radical anion, which can be reoxidized by 
oxygen to the original compound with the production of superoxide (Muller, 
1983). Further reduction can yield a nitroso derivative, a nitroso free radical and 
a hydroxylamine derivative (Muller, 1983). These reduced intermediates are 
very short lived, and none of these compounds have been isolated. Using anoxic 
mammalian liver microsome preparations and electron paramagnetic resonance 
spectroscopy, Perez-Reyes et al. (1979) demonstrated the existence of the one 
electron free radical. 
1.7.2.1 Role of electron carriers 
O'Brien and Morris (1972) showed that when sub-lethal concentrations of 
metronidazole were added to exponentially growing C. acetobutylicum cultures, 
the drug rapidly disappeared from the culture medium. When metronidazole 
was added to crude extracts of C. acetobutylicum, hydrogen production was 
halted until no metronidazole remained in the assay flask. The production of 
CO2 was not altered, indicating that the phosphoroclastic breakdown of pyruvate 
to acetyl-CoA continued. The effect of metronidazole on the uptake of hydrogen 
by the purified C. pasteurianum hydrogenase was also examined. It was shown 
that metronidazole caused no inhibition of the hydrogenase, and in fact extended 
the phase of rapid consumption of hydrogen. For each µmol of metronidazole 
supplied, approximately 3 µmol of additional hydrogen was utilized. These 
authors therefore concluded that, in C. acetobutylicum, metronidazole did not 
directly inhibit the hydrogen production, but inhibited the action of the 
hydrogenase by serving as an alternative and preferred acceptor of electrons 
from reduced Fd. 
Non-enzymatic transfer of electrons to metronidazole was implied to occur in a 
hydrogenase linked assay system developed by Chen and Blanchard (1979). In 
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the reverse reaction, a purified hydrogenase consumes hydrogen gas forming 
reduced Fd (or flavodoxin), which in turn transfers electrons to metronidazole 
forming it's reduced intermediate(s). Therefore the concentration of the electron 
carrier (Fd or flavodoxin) determines the amount of metronidazole that is 
reduced. After stopping the reaction, the amount of unreduced metronidazole 
was measured spectrophotometrically. Critical to the design and working of this 
assay are the facts that the reduction of metronidazole is irreversible and that 
once reduced, metronidazole loses its absorption peak at 320 nm. 
Lockerby et al. (1984) clearly demonstrated the requirement of Fd for the 
activation of metronidazole. Cell free extracts of C. pasteurianum were capable of 
reducing metronidazole as measured by the uptake of hydrogen gas. The uptake 
of hydrogen gas only occurred in the presence of metronidazole. However, 
removal of Fd from the cell free extracts by DEAE cellulose treatment eliminated 
hydrogen uptake in the presence of metronidazole. These authors concluded 
that metronidazole preferentially scavenges electrons from reduced Fd, thereby 
depriving other Fd linked systems of essential reducing equivalents. The 
existence of a "metronidazole reductase" system that enzymatically transfers 
electrons from reduced Fd to metronidazole was suggested, however no 
evidence or speculation was provided concerning the components of this system. 
1.7.2.2 Role of enzymes 
The role of enzymes in the reduction of metronidazole has been postulated for a 
number years. Unfortunately, many reports simply cite the responsible enzyme 
or enzymes as being "nitroreductases" (Edwards et al., 1973; Rosenkranz and 
Speck, 1975; Wardman and Clarke, 1976; Tally et al., 1978; Chrystal et al., 1980; 
McLafferty et al., 1982). This term most likely arose from the fact that the nitro 
group of metronidazole needs to be reduced in order for activation, and may not 
refer to specific nitroreductase systems found in many microorganisms. 
Since metronidazole inhibits anaerobic organisms and not aerobic organisms, it 
has been postulated that metronidazole interacts with enzymes present only in 
the biochemical pathways found of obligate anaerobes (Edwards et al., 1973; Ings 
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et al., 1974; Noble and Tally, 1984). Edwards and Mathison (1970) first noted that 
metronidazole inhibited hydrogen production in T. vaginalis, and similar results 
were found when metronidazole was added to cultures of C. acetobutylicum 
(O'Brien and Morris, 1972). 
With particular reference to the clostridia, the production of hydrogen gas is the 
final step of a major pathway for the disposal of electrons. Electrons derived 
from the catabolism of pyruvate are transferred to oxidized Fd to form reduced 
Fd with the concomitant production of acetyl-CoA and CO2 (see section 1.2.4). 
Electrons carried by reduced Fd are in turn transferred to protons to form 
hydrogen gas. Since the redox potential of metronidazole has been estimated to 
be very close to that of Fd (O'Brien and Morris, 1972), it can be postulated that 
enzymes capable of transferring electrons to Fd can also transfer electrons to 
metronidazole. In the clostridia the two principal enzymes that require Fd for 
complete functionality are the pyruvate-Fd-oxidoreductase and the hydrogenase. 
The implication of pyruvate degrading enzymes in the activation of 
metronidazole was noted by Britz and Wilkinson (1979). Using chemical 
mutagenesis, these authors isolated metronidazole resistant mutants of B. fragilis. 
All of the metronidazole resistant mutants showed reduced levels of pyruvate 
dehydrogenase, which is an analogous enzyme to the pyruvate-Fd-
oxidoreductase found in the clostridia (Narikawa and Nakamura, 1987). 
Narikawa (1986) correlated pyruvate-Fd-oxidoreductase activity with 
metronidazole susceptibility. Metronidazole uptake, p-nitro benzoic acid 
reduction, pyruvate-Fd-oxidoreductase activity and metronidazole sensitivity, 
was determined for 41 different species covering 19 different genera. All of the 
obligate anaerobes tested and 4 of the facultative anaerobes were capable of 
reducing p-nitro benzoic acid. The ability to reduce p-nitro benzoic acid 
correlated directly with an ability to decrease the concentration of metronidazole 
in the culture medium. However, only the obligate anaerobes were identified as 
being susceptible to metronidazole, and this susceptibility correlated with 
pyruvate-Fd-oxidoreductase activity. 
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Lockerby et al. (1985) studied the effects of metronidazole reduction on the 
phosphoroclastic breakdown of pyruvate. It was shown that the addition of 
metronidazole to cell free extracts of C. pasteurianum caused an increase in acetyl 
phosphate production. It was also shown that Fd removal from the cell free 
extracts resulted in the complete loss of acetyl phosphate production. It was 
concluded that the role of the phosphoroclastic reaction with respect to 
metronidazole activation was to provide electrons through reduced Fd that 
would normally be evolved as hydrogen gas. Furthermore, stimulation of 
phosphoroclastic activity was presumed to be due to the fact that the reduction 
of metronidazole recycles Fd to its oxidized state more rapidly than the 
hydrogenase. This indicates that hydrogenase activity is the rate limiting step in 
the phosphoroclastic breakdown of pyruvate. Again, the presence of a 
"metronidazole reductase" system was assumed to carry out the transfer of 
electrons from reduced Fd to metronidazole, however no evidence was provided 
as to the components of this system. 
In an elegant study Church et al. (1988) demonstrate that the bidirectional 
hydrogenase-1 of C. pasteurianum is in fact the "metronidazole reductase" that 
these authors (nee Lockerby) mentioned previously. Strong stoichiometric 
evidence was presented indicating that metronidazole replaces protons as the 
substrate for the hydrogenase enzyme. Together with reduced Fd, the 
hydrogenase transfers electrons to metronidazole yielding oxidized Fd and 
reduced metronidazole. In this case no hydrogen gas would be produced, which 
is in agreement with previous reports that showed hydrogen production was 
inhibited in the presence of metronidazole (Edwards and Mathison, 1970; 
O'Brien and Morris, 1972). A similar role for this hydrogenase enzyme has been 
shown in reducing 2-, 4-, and other 5-nitroimidazole drugs (Church et al., 1990). 
1.7.3 Cytotoxicity 
Because the biologically active reduction products of metronidazole have never 
been isolated, the actual mechanisms involved in the cytotoxic action of this drug 
remain largely unknown. Although the existence of multiple targets within 
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sensitive cells has been suggested (Buchner and Edwards, 1975; Carosi et al., 
1977; Miiller, 1983), an interaction with DNA is the most widely held explanation 
for metronidazole's cytotoxicity (Ings et al., 1974; Goldstein et al., 1977). Model 
experiments where metronidazole was reduced in the presence of various target 
macromolecules showed primary interaction with DNA (Edwards, 1977; 
LaRusso et al., 1977). Neither the unreduced drug nor the drug reduced prior to 
macromolecule addition reacted with DNA. Surprisingly, no interaction with 
RNA has been observed (Muller, 1983). Although there is some binding of the 
drug to nucleic acid (LaRusso et al., 1977), it is more important to note the 
occurrence of single strand and double strand breaks in the DNA and the release 
of nucleotide phosphates (Knight et al., 1978; Rowley et al., 1979, 1980; Edwards 
et al., 1980). 
1. 7.4 Inactive end products 
The end products of reduction of metronidazole, such as acetamide (Koch et al., 
1979) and 2-hydroxyethyl oxamic acid (Koch and Goldman, 1979), represent 
fragments of the parent molecule (Chrystal et al., 1980; Beaulieu et al., 1981; 
Muller, 1983). No cytotoxic activity has been demonstrated for any of these end 
products (Ings and Constable, 1975). 
Chrystal et al. (1980) proposed that the amount of acetamide accumulated by the 
reduction of metronidazole is proportional to the amount of reduced toxic 
intermediate(s). This allowed for kinetic studies correlating the rate of 
metronidazole reduction by various bacteria with a decrease in the number of 
viable cells (Chrystal et al., 1980; McLafferty et al., 1982). The results suggested 
that the microbicidal activity of metronidazole depends not only on the capacity 
of the microorganism to produce the toxic intermediates, but also on the 
microorganism's specific susceptibility to these reduced toxic intermediates. In 
particular, the efficiency of a cell's DNA repair mechanisms partly determines it's 
sensitivity towards metronidazole. Studies by Jackson et al. (1984) and Yeung et 
al. (1984), where the in vitro activity of metronidazole against DNA repair 
mutants of E.coli was measured, verified this hypothesis (see also Chapter 4). 
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1.8 Aims and overview of this thesis 
C. acetobutylicum is an important industrial microorganism with tremendous 
potential for the fermentative production of solvents. Although this organism 
has been utilized for solvent production for a number of decades in this century, 
only recently have the mechanisms behind the regulation of these solvent 
producing pathways started to become clear. 
The fundamental goals of this thesis are essentially divided into two parts. First, 
it was considered important to develop and utilize a suitable extraction and 
assay procedure for the measurement of nucleotide levels in C. acetobutylicum 
P262. As mentioned previously, fluctuations in nucleotide levels have been 
shown to be important in the regulation of other differentiating bacteria such as 
B. subtilis. Furthermore, ATP is the currency by which one measures energy in a 
cell and therefore following the concentration of this molecule through the 
course of a C. acetobutylicum fermentation was desired. While the content is far 
removed from the subject of microbiology, the second chapter describes the 
development of an analysis system for chromatographic data. The application of 
this system is demonstrated throughout the third chapter, where nucleotide 
profiles were obtained and analysed with an insight into how nucleotide levels 
affect or are affected by changes in the fermentation pattern of C. acetobutylicum. 
The second part of this thesis shows a move from physiological studies into the 
realm of molecular genetic analysis of C. acetobutylicum. The biochemistry of the 
C. acetobutylicum fermentation clearly shows the importance of electron transport 
in determining the direction of carbon flown. Little is known about these 
electron transport genes, and the same is true for their regulation. The fourth 
chapter describes the development of a metronidazole based negative selection 
screening system for C. acetobutylicum electron transport genes in E.coli. The 
fifth chapter demonstrates the application of this system and the isolation of 
E.coli clones containing possible C. acetobutylicum electron transport genes which 
activate metronidazole. The sixth chapter describes the molecular genetic 
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analysis of C. acetobutylicum DNA from selected clones. Throughout this half of 
the study, efforts are made to relate the results to the activation of the medically 
important drug metronidazole. 
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Chapter 2 
Development of a chromatographic analysis system with 
particular application for measuring nucleoside phosphate 
levels in C. acetobutylicum P262 
2.0 Summary 
A chromatographic data acquisition and analysis system was developed for 
measuring the concentrations of ribonucleotides in bacterial cell extracts. The 
availability of multi-channel analog to digital converters provides a platform for 
application of this system to many types of gaussian analog output, which 
encompasses most analytical chromatographic techniques. 
A manual integration system for the analysis of chromatographic data is 
described. The system features the ability to collect and store chromatographic 
data allowing for uninterrupted sequential runs to proceed. The data can be 
integrated many times using different calibration curves, permitting multiple 
analyses. The long term storage of data allows the user to assess changes in the 
system being employed, an important feature in chromatography systems where 
the columns and reagents are subject to constant change. The analog output 
produced by an absorbance monitor is passed to a non-inverting signal amplifier. 
This amplified signal is sent to an IBM PC where an analog to digital converter is 
used to digitize the data. A set of six computer programs which collect, store 
and analyze these data are discussed. This system was used to analyze the 
nucleotide content C. acetobutylicum P262 by strong anion-exchange HPLC. 
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2.1 Introduction 
Since their introduction into universities and research establishments in the early 
1960s, computers have been widely used by biologists (Ireland and Long, 1985). 
This has been facilitated by the use of analog to digital (A/D) converters, which 
take an analog input (a current or voltage) and convert it into a representative 
digital value. Because the analog signal is digitized into discrete values, the total 
number of values represents a subset of the total range of possible values 
generated by the analog source. The more bits available to digitize the analog 
signal, the greater the, number of discrete values, and hence the greater the 
accuracy of the conversion. For example 8-bit resolution permits the 
decomposition of an analog signal into 256 (28) discrete units, whereas 12 bit 
resolution permits the same analog range to be divided into 4096 (212) discrete 
units. This translates into a resolution of 0.39% for an 8-bit A/D converter and 
0.02% for a 12-bit AID converter. In comparison, a good quality chart recorder 
has a mechanical resolution around 0.1 to 0.2% (Beynon, 1985). 
High performance liquid chromatography (HPLC) is an important technique in 
the biological sciences. Most HPLC applications produce output via a detector 
that generate an analog signal. This analog signal is typically directed to a chart 
recorder which may be associated with an integrator. A number of automated 
microprocessor-controlled integration systems are commercially available for 
HPLC applications. In general, these automated analysis systems rely on the 
presence of a flat and stable baseline and peaks that are sharp and gaussian. 
When relying on quantitation by peak height, adherence to these parameters is of 
utmost importance. Quantitation by peak area is more flexible, but is still 
sensitive to sloping baselines and trailing peaks, which are common when a 
gradient mobile phase is used. 
Many methods for separating and quantitating nucleoside phosphates by anion 
exchange HPLC have been reported (Hartwick and Brown, 1975; Khym, 1975; 
Payne and Ames, 1982; Freese et al., 1984a). Bacterial cell extracts contain many 
UV absorbing compounds (Khym et al., 1977; Khym et al., 1978). Separation of 
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nucleoside phosphates in these complex bacterial extracts by anion exchange 
HPLC generally involves the use of a gradient buffer system, which inherently 
results in a chromatogram with a sloping baseline. Nucleotide triphosphates 
elute on or just prior to the most sloped region of the baseline. Measurement of 
nucleotide phosphate levels in cell extracts of C. acetobutylicum was a goal in this 
study. Therefore it was necessary to develop a reliable chromatographic analysis 
package for separation and quantitation of nucleotide triphosphates in these cell 
extracts 
This chapter presents a system for interfacing a HPLC detector to an IBM PC or 
compatible microcomputer via an A/D converter, and a set of six computer 
programs which collect, store and manipulate the HPLC data. 
These programs can be conveniently utilized to manually integrate complex 
chromatograms. The programs are written to be highly flexible and can be 
applied to many different types of chromatographic data (including other types 
of flow cell monitoring chromatography as well as densitometry). Raw data is 
collected, stored on disk and can be immediately integrated or integrated at a 
later stage, allowing for sequential runs to proceed without data analysis. Once 
integrated, the quantitation data is stored and the chromatogram can be re-
integrated at any time. 
2.2 Materials and Methods 
2.2.1 Instrumentation 
A diagram of the chromatographic and computer hardware systems is shown in 
Fig. 2.1. The HPLC system (Beckman Instruments Inc., Berkely, CA, USA) 
consisted of two solvent delivery modules (mod.el 114M), a flow rate and 
gradient controller (mod.el 421), a mixer-organizer (mod.el 340), a constant 
volume injector (model 210A) and a fixed wavelength absorbance detector 
(mod.el 160). The analytical column (25 mm long X 4.6 mm i.d.) used on this 
HPLC system contained the strong anion-exchanger Partisil 10-SAX (Whatman 
Inc., Clifton, NJ, USA). The analytical column was protected by a guard column 
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Figure 2.1 A diagrammatic representation of the computer and HPLC 
hardware systems. 
containing Pellionex SAX media. The details of the chromatographic conditions 
are described in section 3.2.5. 
2.2.2 Application 
The HPLC-computer integration system was designed for evaluating the 
ribonucleotide composition of cell extracts of C. acetobutylicum P262. The 
nucleotides of interest were ATP, CTP, GTP and UTP, as well as the 5'-di and 5'-
monophophates of these purine and pyrimidine bases. Nucleotide extracts of C. 
acetobutylicum cells were prepared as described in section 3.2.4. 
2.2.3 Signal amplifier 
The low output signal (0-20 mV) from the fixed wavelength detector necessitated 
the use of a signal amplifier. The circuit shown in Fig. 2.2 was used to amplify 
+15V 
HELIPOT 
250R 
Computer analysis of chromatographic data 50 
0.33 MFD 
>6~_.,_ ________ ..... 0UTPUT 
(0-12V) 
12V ZENER 
INPUT (0-20mV) 
Figure 2.2 A diagram of the circuit used to amplify the 0-20 m V analog signal 
produced by the HPLC absorbance detector. The LM308AH operational 
amplifier was manufactured by National Semiconductor. 
the output signal produced by the model 160 detector. The circuit is a 
non-inverting amplifier and its gain was determined by the ratio: 
Rl +R4 
---+1 
R2+R3 
By inserting the shown resistor values, the gain of the amplifier was calculated to 
be approximately 400. The 250 n HELIPOT and associated components were 
used to provide an offset facility and determine baseline levels. The 12 V zener 
diode connected to the output of the amplifier ensured that the signal to the 
computer did not go below -0.6 V or above 11 V. 
2.2.4 Computer hardware 
The computer system consisted of an IBM PC with 640 kbyte RAM, a green 
monochrome screen, a Data Products 8010 dot matrix printer, a Hercules 
compatible monochrome graphics/printer adapter and an Eagle Electronics 
(PC-26) 16 channel 12-bit analog to digital converter card. 
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2.2.5 Interfacing 
The amplified analog signal from the HPLC was connected to channel one of the 
AID card in the IBM PC. The HPLC controller has four internal relays which 
can be programmed to be open or closed during the chromatographic run. One 
of these relays was used to send a 9 V signal (external trigger) to channel zero of 
the AID card which initiated the computer to sample the incoming data on 
channel one. 
2.2.6 Language, files and compilation 
Two versions of these programs were written. The first version was written for 
the Hercules HBASIC interpreter. This allowed for normal IBM BASIC graphics 
commands to be implemented on the monochrome monitor; however this 
version was found to be too slow for routine use. Although it has not been 
tested, this version could be compiled and run on and IBM PC with a color 
graphics adapter and monitor, with little or no modification. 
The second version of these programs was written in IBM BASIC using edition 
1.1 of the Hercules GRAPH-X on screen utilities package (Hercules Computer 
Technology Inc., Berkeley, CA, USA), and was compiled using version 1.0 of the 
Microsoft QuickBASIC compiler (Microsoft corporation, Redman, WA, USA). 
The Hercules GRAPH-X subroutines were CALLed from within the main 
program and the GRAPHIX library was linked to the compiled object modules 
using the Microsoft Link program provided with the QuickBASIC compiler. The 
complete source code for this second version of these is located in appendix F. 
2.3 Algorithm 
Six computer programs were written to handle the interfacing and data 
collection from the HPLC: STARTUP, HPLC, MANINT, MANINTST, DISPLAY 
and CALIBRA T. 
The STARTUP program was included to load the compiler runtime module and 
the GRAPHIX runtime module. This program puts a logo on the screen and 
CHAINed the HPLC program. 
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The HPLC program was the menu generating program that provided the main 
entry and exit mechanism for the software system. Menu choices were (i) data 
collection and manual integration, (ii) manual integration of a stored 
chromatogram, (iii) display a stored chromatogram, (iv) record calibration 
chromatograms and (v) exit to DOS. 
MANINT (data collection and manual integration) and MANINTST (manual 
integration of a stored chromatogram) were the two quantitation programs in the 
series. MANINT was the data collection - integration program and the user 
could select if the raw data was to be immediately integrated, or integrated at a 
later time. The MANINTST program was used for integrating these stored 
chromatograms, as well as re-integrating stored chromatograms. 
Selecting the MANINT program from the HPLC menu initialized the 8255 
programmable peripheral interface on the PC-26 AID card. It prompted the user 
for the name of a file for data storage and asked if an external trigger was being 
used to initiate sampling. The time versus absorbance axes were drawn on the 
display and sampling of the A/D card began. If an external trigger was being 
used to initiate data input, channel zero of the A/D card was sampled until a 
value greater than 2 500 (approximately 7 V) was read. Once channel zero was 
high (> 7 V) sampling of the incoming data on channel one was initiated. The 
digitized data was stored in an integer array and the corresponding sample time 
was stored in a double precision array. The display was set to mimic a chart 
recorder and the incoming data was actively plotted on the screen during the 
course of the chromatographic run. To encompass the part of the chromatogram 
of interest for this application, the total sampling time was set to 30 min. The 
maximum sampling rate of the PC-26 card was 2 500 Hz and this sampling rate 
would generate an impractical 4.5 million samples. Therefore the program was 
designed to sample channel one every 0.36 sec., which yielded approximately 
5 000 samples per chromatogram. For nucleotide analysis, the average peak 
width at the baseline was approximately 2 min. Therefore, each peak was 
characterized by approximately 300 samples which was more than adequate for 
integration. During a run, the date, time of day, runtime and number of samples 
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taken were displayed in a menu area at the bottom of the display. After the 30 
min sampling period the raw data was stored on disk along with the date, 
injection time (real time) and the total number of samples taken. The user could 
then continue with manual integration, perform another chromatographic run or 
exit to the HPLC program. If the option to quantitate the data was chosen, the 
chromatogram remained displayed and manual integration continued as 
described below. 
MANINTST prompted the user for the file name containing the raw data. The 
data was read from disk, the absorbance versus time axes were drawn and the 
data was plotted. From this point on, the MANINT and MANINTST programs 
were identical. 
An integration command menu describing the control keys appeared below the 
displayed chromatogram. A vertical marker line could be moved left or right 
using the cursor keys on the numeric keypad. This vertical marker was used to 
locate the peak starts and peak ends. When this was positioned at a peak start 
and the 'S' key was depressed, a mark was made on the chromatogram indicating 
a selected peak start. Similarly, if the 'E' key was depressed a mark was made on 
the chromatogram indicating a selected peak end. Other options included 
CLEAR entry which removed an incorrectly selected peak start or peak end, 
REDO from start which removed all selected peak starts and peak ends, QUIT 
integration which abandoned the integration procedure and returned control to 
the HPLC program and finally PROCESS data which integrated the selected 
peaks. 
When the PROCESS data option was chosen, selected peak starts and peak ends 
were sorted with respect to time. The starts and ends were checked for pairs and 
checked that they were in the correct order. If no errors were found, the area 
under each peak as well as the peak retention time were calculated. The peak 
retention time was determined using the Savitzky and Golay (1964) method of 
calculating a smoothed first derivative. The baseline was calculated using the 
'rubber band' technique of Caesar and Klier (1974). The peak area was 
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determined as the sum of trapezoids from data point to data point between the 
selected peak start and peak end. 
Peak start and peak end marks were removed from the display and the retention 
times were written above each selected peak as they were calculated. Upon 
completion of these calculations, a hardcopy of the chromatogram was obtained 
using the graphics dump facility provided with the Hercules GRAPH-X package. 
A short assembly language subroutine, PRTSCH, was written to invoke this 
graphics dump from within the program. 
The calculated retention times were then compared to the retention times of 
known compounds (standards) which had been stored on disk using the 
CALIBRAT calibration program. If the calculated retention time fell within a 
pre-set threshold level surrounding the mean retention time for the standard, the 
peak was presumed to be the same as the standard. Using the stored standard 
curve, the calculated peak area was extrapolated to the same units of 
measurement used when creating the standard curve. These data were printed 
in tabular form on the dot matrix printer and all quantitated data were stored on 
disk. The user then had the option to repeat the program or return to the HPLC 
program. 
The DISPLAY program read the raw data from disk and drew the chromatogram 
on the screen. If the chromatogram had been integrated, this data was also read 
from disk and was presented in tabular form on the second graphics page of the 
Hercules card. By toggling between graphics pages, both the chromatogram and 
the quantitated data could be viewed on the display. A hardcopy of the 
chromatogram and the quantitated data could also be obtained if desired. The 
user then had the option to view another chromatogram or return to the HPLC 
program. 
For the entire package to work a calibration file must be created using the 
CALIBRA T program. This file, contained the names and retention times of 
known compounds, and the standard curves (least square regression lines) of the 
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quantity of material versus the peak area for each known compound. A mixture 
of known compounds was injected into the HPLC and recorded by the 
CALIBRAT program. At the end of the chromatographic run, the user selected 
peak starts and peak ends from which the retention times and peak areas were 
calculated. In this respect the CALIBRA T program was similar to the MANINT 
and MANINTST programs. The user was prompted for the peak (compound) 
name and the quantity injected. The quantity injected could be expressed in any 
units the user desired. A hardcopy of the chromatogram as well as the entered 
data could be obtained at this point. This process was repeated and all the 
information entered was stored in a temporary file. When desired, this data 
could be processed and mean retention times and least square regression lines 
calculated. The standards file used by the MANINT and MANINTST programs 
was updated with these new values. This was a very powerful feature of this 
system, since it allowed the user to re-integrate chromatograms using different 
calibration files. If desired, the user had the option to halt the calibration 
procedure and save the temporary file, thus freeing the computer for other uses. 
Upon starting the CALIBRA T program, the presence of a saved temporary file 
was searched for. The user also had the option to abandon the calibration 
procedure in which case the temporary file was destroyed. The date of 
calibration was stored in the standards file and was noted on chromatograms 
integrated with the MANINT and MANINTST programs. 
2.4 Implementation 
The programs and system described above were used to analyze the 
ribonucleotide composition of cell extracts of C. acetobutylicum P262. The 
chromatographic run time was approximately 45 min, with the nucleotide di-
and tri-phosphates eluting from 20 min onwards. Since the beginning of the 
chromatogram was not of interest, sampling of absorbance data was initiated 
from the model 421 controller (external trigger) 15 min after injection of the 
sample. Absorbance was measured at a wavelength of 254 nm, which is near 
optimal for most nucleotide phosphates (Freese et al., 1984a). The absorbance 
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Figure 2.3 Chromatograms of (A) a standard mixture of nucleotides and (B) an 
extract of C. acetobutylicum. The absorbance (0.04 OD units = full scale) was 
measured at 254 nm. 
range of the model 160 detector was set so that 0.04 OD units equaled the full 
scale value on the analog output (20 m V). 
The computer section was initiated from DOS through the STARTUP program 
which gives control to the menu generating HPLC program. Data collection was 
carried out with the MANINT program, unless the system was being calibrated, 
in which case the CALIBRA T program was utilized. Data collection started at 15 
min after injection when the external trigger from the 421 controller went high 
(approximately 9 V). At 45 min, data collection was stopped and the raw data 
stored on disk. This was followed by manual integration which generated the 
quantitated data which was also stored on disk. Fig. 2.3 shows a typical 
hardcopy output of a chromatogram obtained on the dot matrix printer. All data 
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stored on disk could be accessed for re-integration by using the MANINTST 
program or could be viewed with the DISPLAY program. If the calibration 
program, CALIBRA T, had been run, the standards file was updated and control 
was returned to the HPLC program. Access to DOS was obtained through the 
HPLC program, thereby assuring restoration of the graphics card and the 
operating system to their default values. 
2.5 Discussion 
A program for analyzing chromatograms has been written for use on a 
mainframe computer (Caesar and Klier, 1974). Although this program was 
originally developed for use with gas chromatography, the algorithm is 
applicable to liquid chromatography. Furthermore, Freese et al. (1984a) reported 
a full spectrum analysis package for analyzing liquid chromatograms on a DEC 
PDP 11/10 microcomputer (Digital Equipment Corp., Maynard, MA, USA) 
which allows for the manual integration of data. These two algorithms were 
used to form the basis of a general purpose data collection and manual 
integration package for use with analog output chromatography systems. 
In designing this system, it was important to maintain accuracy while being 
frugal. The use of a 12-bit AID converter divides the analog signal produced by 
the fixed wavelength detector into 4096 (212) discrete units. This yields a 
resolution of approximately 0.02% (Beynon, 1985), which was more than 
adequate for this application. Since microcomputers have become standard 
items in the scientific laboratory, this system did not require a large capital 
expenditure. The equipment required to assemble this system cost far less than 
the purchase price of an automatic integrator. 
In any chromatography system, peak identification is of utmost importance. 
Peaks are often identified by comparing their retention times with retention 
times of known compounds. In order to identify compounds with some degree 
of certainty, more than one identification method should be employed. In 
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biological extracts where there are numerous compounds present, retention time 
comparison alone is not an adequate means of identification (Brown et al., 1980). 
The system described here does not provide a foolproof computer analysis for 
the identification of unknown compounds. It is assumed that the user fully 
understands the analytical methods being employed. Although these programs 
used retention time to identify peaks, this identification was only tentative. 
Fractions were routinely collected from the absorbance detector and a full 
spectrum scan was performed for comparison to scans of known compounds. 
Not only did this provide a method of peak identification, it also allowed for the 
determination of peak purity. If the scan demonstrated the presence of a 
co-eluting compound that absorbed strongly at or near 254 nm, the quantitation 
data for that peak was assumed invalid. In this system, the user can choose 
which peaks are to be integrated by selecting the appropriate peak starts and 
peak ends. Therefore, preliminary identification is carried out by the user prior 
to any retention time comparison by the computer. This is a major advantage of 
this system in contrast to automatic integrators, since it requires the user to make 
the initial decision as to peak identification. 
Once a peak has been identified, it is normally required to quantitate the amount 
of material represented by that peak. The quantity of the eluted compound is 
generally expressed in terms of some property of the curves produced by the 
detector. Peak area was chosen to measure the quantity of the substance 
represented by a peak since it was found to be more accurate than peak height. 
Peak area is a widely used method for quantitation of chromatographic data and 
many techniques are available for estimating this value. Peak area was estimated 
geometrically by summation of the trapezoids formed from data point to data 
point produced by digitizing the amplified analog signal of the absorbance 
detector. 
The system was routinely calibrated by injection of at least seven different 
concentrations of a standard nucleotide mixture containing the 5'-di and 
5'-triphosphates of adenosine, cytosine, uridine and thymidine. In an experiment 
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where the standard curves calculated by the CA LIBRA T program were 
challenged with 40 different known quantities of nucleotides, the mean deviation 
of estimated concentration versus known concentration was 3.68% of the known 
concentration. Furthermore, the largest deviation of an estimated concentration 
from the known concentration in an individual case was 6.51 % of the known 
concentration. 
Least squares regression line calculations (Snedecor and Cochran, 1980) were 
used in the CALIBRAT program to derive the standard curves. The correlation 
coefficients for peak area versus amount were found to be 0.94, 0.93, 0.96 and 
0.91 for ATP, GTP, CTP and UTP, respectively. Similarly high (>0.9) correlation 
coefficients were found for the nucleotide di-phosphates. It was found that all 
calibration curves were linear in the absorbance range (0.04 OD units full scale) 
used on the model 160 detector. Since access to an automatic integration system 
was not available, an appropriate experimental comparison could not be 
performed. It is believed that the advantages of this manual analysis system far 
outweigh the conveniences of automated integration for analyzing complex 
biological materials. It has been reported that manual integration is more 
reliable when compared to automatic integration (Freese et al., 1984a) and this 
conclusion is supported by these results. 
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Nucleoside triphosphate levels in C. acetobutylicum 
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deficient strains 
3.0 Summary 
60 
The role of GTP and other ribonucleoside phosphates in the differentiation of C. 
acetobutylicum and two sporulation deficient mutants was investigated. The 
clostridial stage (cls-1) mutant was unable to produce the clostridial stage, 
solvents, granulose, capsules or endospores, whereas the sporulation deficient 
(spo-1) mutant produced the clostridial stage, solvents, granulose and capsules, 
but did not form a forespore septum. The nucleoside triphosphate profiles of the 
wild type and spo-1 mutant were similar and were characterized by a trough in 
nucleotide levels which occurred just prior to the pH break point, the onset of the 
stationary growth phase, clostridial stage formation and the transition from the 
acidogenic to the solventogenic phase. The nucleoside triphosphate 
concentrations during the exponential growth phase were much lower than 
those found during the stationary phase. The nucleotide levels in the cls-1 
mutant during the exponential phase were comparable to those observed in the 
wild type and spo-1 mutant. However, the nucleotide levels in the cls-1 mutant 
did not increase during the stationary growth phase. The involvement of 
nucleotide levels, particularly that of GTP, in the differentiation of C. 
acetobutylicum was indicated by the effect of inhibitors, which have been shown 
to decrease ribonucleotide levels in other organisms and cause an increase in 
sporulation. 
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3.1 Introduction 
In B. subtilis sporulation occurs when the cells encounter certain adverse 
nutritional conditions which no longer allow rapid growth. Nutrient deprivation 
causes the cells to divide asymmetrically, and the two membranes separating the 
smaller cell compartment from the larger mother cell, envelope the smaller 
compartment thus producing a forespore. Synthesis of spore specific proteins is 
derepressed which may be a result of an altered metabolic environment within 
the forespore caused by a membrane that does not allow for normal active 
transport (Freese, 1981). Freese and co-workers developed the theory that there 
is ultimately one compound of low molecular weight which in combination with 
a protein, suppresses sporulation. The theory being that when the concentration 
of this compound reaches critical levels, sporulation is induced. 
Early studies analyzed the initiation of sporulation by using sporulation minus 
mutants and chemical inhibitors. Mutants that were auxotrophic for certain 
amino acids led to the conclusion that amino acid limitation, which initiated 
sporulation, also evoked the stringent response (Ochi et al., 1981). This response 
included the synthesis of guanosine tetraphosphate (ppGpp) and guanosine 
pentaphosphate (pppGpp), which resulted in a decrease of GTP and GDP (Lopez 
et al., 1981). Ochi et al. (1981) showed that relaxed mutants (relA) which lacked 
the stringent response did not demonstrate a sufficient decrease in the level of 
GTP to initiate sporulation. This evidence implicated GTP as the low molecular 
weight compound that suppresses sporulation in B. subtilis. 
GTP was further implicated as the trigger for sporulation by the observation that 
sporulation could be induced in a nutrient rich environment by the partial 
reduction in synthesis of purine nucleotides (Freese et al., 1978). This condition 
of sporulation was achieved by purine removal in leaky purine requiring 
mutants or by the· addition of inhibitors of the purine biosynthetic pathway. A 
preferential decrease of GTP, but not ATP, was observed in the sporulating 
cultures. It has been proposed that the partial starvation for purine creates a new 
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biosynthetic balance which is conducive to the positioning of a septum in a polar 
rather than a central position within the cell (Mitani et al., 1977). 
A similar decrease in GTP or S-adenosylmethionine content was shown to be 
associated with differentiation (meiosis and sporulation) in Saccharomyces 
cerevisiae (Freese et al., 1984b). Aerial mycelium formation in Streptomyces 
MA406-A-1 has also been linked with a decrease in GTP content (Ochi, 1986). 
In some strains of C. acetobutylicum, such as the industrial strain P262, the onset 
of solvent production and sporulation is characterized by a change in 
morphology from a highly motile, acid producing, vegetative rod to a swollen, 
granulose containing, phase-bright, cigar shaped, solvent producing, 'clostridial' 
cell (Long et al., 1983; Jones and Woods, 1986a). An understanding of the 
triggers which lead to the onset of solvent production and differentiation is 
important for developments aimed at improving the acetone butanol 
fermentation. 
Since the role of GTP and other ribonucleoside phosphates in the differentiation 
of C. acetobutylicum has not been reported prior to this investigation (Santangelo 
et al., 1989) a study into the changes in ribonucleoside phosphate pools of the 
wild type strain P262 and two sporulation deficient mutants was undertaken. 
The clostridial stage (ds-1) mutant is unable to form the clostridial stage and can 
not produce solvents, capsule, granulose or endospores (Jones et al., 1982). The 
second mutant (spo-1) forms the clostridial stage and produces solvents, capsule 
and granulose but does not form a forespore septum (Jones et al., 1982). 
3.2 Materials and Methods 
Commonly used materials and techniques are presented in the Appendices. The 
details provided below are included for completeness. 
3.2.1 Bacterial strains 
The wild-type C. acetobutylicum strain P262 was obtained from National 
Chemical Products (NCP), Germiston, South Africa, and has been described 
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previously (Jones et al., 1982). The cls-1 and spo-1 mutants were isolated from 
this strain by mutagenesis with ethyl methanesulphonate as described by Jones 
et al. (1982). 
3.2.2 Media and culture conditions 
The C. acetobutylicum strains were grown in the C. acetobutylicum minimal 
medium (CAMM) of Long et al. (1983), with the glucose concentration reduced 
from 60 g 1-1 to 50 g 1-1 and the nitrogen source changed from ammonium 
phosphate to ammonium nitrate (7.2 g 1-I). The clostridial basal medium (CBM) 
of O'Brien and Morris (1971) was inoculated with spores activated by heat shock 
at 75 ·c for 2 min and then cooled on ice for 45 sec. A 5 µl sample of the heat 
shocked spore suspension was used to inoculate 10 ml of medium. Cultures 
were incubated at 34 ·c until the cells reached mid exponential phase (OD600 0.45 
to 0.50). CAMM (400 ml) was inoculated with 40 ml exponential phase cells 
harvested from CBM and washed once with distilled water. Cultures were 
incubated at 34 ·c and shaken gently every 6 h. All manipulations and 
incubations were carried out under stringent anaerobic conditions in an 
anaerobic glove box containing an atmosphere of oxygen-free N2, CO2 and H2 
(85:10:5 by volume). 
3.2.3 Growth, morphology and end product determination 
Total cell counts, clostridial stage counts, forespore counts and spore counts were 
determined with a Thoma counting chamber (Weber Scientific International, UK) 
and a Zeiss photomicroscope fitted with phase- and interference-contrast optics. 
Growth was measured turbidometrically at 600 nm with a Corning colorimeter 
(model 252) using Hungate tubes. Acetate, butyrate, acetone, butanol and 
ethanol were determined by gas chromatography on a Hewlett Packard 5880A 
gas chromatograph fitted with a flame ionization detector, using 2-propanol as 
an internal standard. The column and running conditions have been described 
previously (Long et al., 1984a). 
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3.2.4 Preparation of nucleotide extracts 
Nucleotide extracts were prepared from C. acetobutylicum cells grown in CAMM. 
The extraction methods of Olempska-Beer and Freese (1984) and Payne and 
Ames (1982) were combined and modified for use with C. acetobutylicum. Cells 
(100 ml) were rapidly collected on a 100 mm diameter nitrocellulose filter 
(Schleicher and Schull BA 84 or AE 95) by vacuum filtration. The filter was 
placed cell side down in a glass Petri dish containing 5 ml of ice-cold 3 M formic 
acid saturated with 1-butanol. After a 30 min extraction period, the liquid was 
removed and the filter and Petri dish were washed twice with ice-cold sterile 
water. The above manipulations were carried out in an anaerobic glove box, and 
all solutions were pre-reduced for at least 24 h. The three liquid fractions were 
combined, removed from the anaerobic chamber and adjusted to pH 8.8 with 
25% (w /v) ammonia solution. The salt concentration of the extract was 
increased to 1 M by the addition of 3 M ammonium acetate, pH 8.8. Debris was 
removed by centrifugation at 40 000 X g for 20 min. The supernatant was 
applied to a column (1.5 cm long X 1 cm i.d.) packed with Affi-Gel 601 (Bio-Rad 
Laboratories, Richmond, CA, USA) which had been equilibrated with 1 M 
ammonium acetate, pH 8.8. The absorbance of the effluent was monitored at 
254 nm using an Isco flow cell monitor (model UAS fitted with a type 6 optical 
unit) and unwanted and interfering components were washed through the 
column with a mobile phase of 1 M ammonium acetate, pH 8.8. When the A254 of 
the effluent reached baseline, the mobile phase was changed to 100 mM acetic 
acid to initiate elution of the nucleotides. The desired sample which contained 
the nucleotides (about 10 ml) was collected and freeze-dried. The freeze-dried 
sample was resuspended in 100 µl of water, centrifuged and assayed by HPLC. 
The reliability of this extraction method was routinely tested by performing 
duplicate extractions where a known concentration of a standard nucleotide 
mixture was added to one sample just prior to the formic acid treatment (Freese 
et al., 1984a). 
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3.2.5 Chromatographic conditions 
The Partisil-10 SAX column described in section 2.2.1 was operated at room 
temperature at a flow rate of 1 ml min-1. A 50 µl sample volume was injected and 
the nucleotides were separated using a multi-step gradient profile. The initial 
buffer (A) contained 7 mM potassium dihydrogen phosphate which was 
adjusted to pH 4 with HCl. The high ionic strength buffer (B) used to elute the 
nucleotides contained 0.5 M potassium dihydrogen phosphate and 0.5 M sodium 
sulfate, and was adjusted to pH 5 with potassium hydroxide. After injection, the 
mobile phase contained 100% buffer A for 12 min. A linear gradient was 
employed such that the mobile phase contained 50% buffer B after another 21 
min (33 min run time). The slope of the gradient was then increased such that 
the mobile phase contained 100% buffer B after an additional 10 min (43 min run 
time). The mobile phase was maintained at 100% B for another 7 min (50 min 
run time), after which the mobile phase was changed to 100% buffer A in 5 min. 
The column was equilibrated at 100% A for 20 min prior to injection of the next 
sample. After 5 consecutive runs, the column was regenerated by the passage of 
150 ml of 0.5 M sodium sulfate, pH 2 with sulfuric acid, followed by 50 ml of 
buffer B. This removed highly ionized, strongly bound impurities. Once a week 
the column was washed with 100% HPLC grade methanol to remove adsorbed 
organic impurities. The salts used to prepare the al:x>Ve buffers were all Aristar 
grade (BDH chemical) and were dissolved in 18 MQ water (Milli-Q). 
3.2.6 Analysis of nucleotide extracts 
The computer-HPLC data collection and analysis system used to analyze the 
nucleotide composition of the extracts has been reported previously (Santangelo, 
1988) and is described in Chapter 2. All experiments were performed at least 
three times, with similar results; representative data are presented. 
3.2.7 Nucleotide synthesis inhibitors 
Decoyinine and psicofuranine were generously donated by Dr. R.L. Keen, 
Upjohn Company, Kalamazoo, Ml, USA. Caffeine and 3-methylxanthine were 
obtained from the Fluka Chemical Company. Theobromine, theophylline, 
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6-mercaptopurine, 2-amino-6-mercaptopurine and 6-azathymine were purchased 
from the Sigma Chemical Company. Since CAMM supports a near maximum 
spore titre for C. acetobutylicum P262, it was an unsuitable medium for inhibitor 
studies where an increase in sporulation was to be determined. The tryptone, 
yeast extract, glucose medium (TYG) of Hongo et al. (1968), which resulted in a 
lower sporulation level, was therefore used for these studies. The inhibitors 
were added during the mid exponential growth phase, when the OD600 of the 
culture was between 0.40 to 0.45. Percentage sporulation was determined after 
48h. 
3.3 Results 
3.3.1 Growth, physiology and morphology 
The ABE fermentation profile typical of C. acetobutylicum P262 in CAMM is 
shown in Fig. 3. l(a,b). Cells transferred to this medium show a characteristic 
15 h lag phase after which cell numbers begin to increase (Long et al., 1983). The 
exponential growth phase, from 15 to 35 h, was characterized by highly motile, 
rod-shaped cells. During this stage, glucose consumption resulted in acid 
production. The pH break point occurred when the acid concentration reached a 
maximum of approximately 4 g 1-1 (between 30 and 35 h). The break point was 
associated with the onset of the stationary growth phase and clostridial stage 
formation. Just prior to the pH break point, the cell morphology began to change 
from motile rods to phase-bright, granulose filled clostridial cells, and by 40 h 90 
to 100% of the cells had converted to the clostridial stage. The physiological 
changes associated with the pH break point included a decrease in acid 
concentration, initiation of solvent production, and an increase in the rate of 
glucose consumption. After 45 h, the acid concentration stabilized at 
approximately 2.7 g 1-1. Glucose exhaustion occurred at approximately 50 h and 
shortly thereafter solvent levels reached a peak of approximately 10 g 1-1. At this 
time a maximum number of cells containing forespore septa (60%) was observed, 
as well as a small percentage of mature spores (15%). The highest proportion of 
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phase-bright spores (approximately 50%) was observed at the end of the 
fermentation (67 h). 
A similar fermentation profile for the spo-1 mutant is shown in Fig. 3.l(c,d). The 
exponential phase was characterized by motile rods, glucose consumption and 
acid production. The pH break point (pH 5.3) was reached between 35 and 40 h 
and was associated with a peak in acid levels. Stationary phase occurred after 
approximately 40 h and by 55 h 90 to 100% of the cells were phase-bright 
clostridial forms. Solvents were first detected immediately after the pH break 
point and reached a maximum of 9.6 g 1-1 at the end of the fermentation (67 h). 
The major difference between this and the wild type fermentation was that no 
forespore septa or mature spores were observed, indicating that the spo-1 mutant 
was an early sporulation mutant (spoO). Minor differences involving for example 
maximum cell number, time of peak in motility, and residual glucose levels were 
observed between the fermentation profiles of the P262 wild type and the spo-1 
strains. 
The cls-1 mutant showed a normal motile, acid producing, glucose consuming 
exponential phase, but the switch to solvent production did not occur and no 
clostridial stage cells were observed (Fig 3.1e,f). After approximately 35 h the 
rate of glucose consumption slowed and acid levels continued to increase. By 
55 h the fermentation ceased and virtually no solvents were produced 
(<0.25 g 1-t). Only 30% of the available glucose was utilized and approximately 
7 g acids 1-1 were produced. 
3.3.2 Nucleotide profiles 
The nudeoside triphosphate profile for the wild type C. acetobutylicum P262 
strain showed that throughout the fermentation ATP was the most abundant 
nucleoside triphosphate followed by UTP, GTP and CTP (Fig 3.2a). The 
nucleoside triphosphate concentrations during the exponential growth phase (15 
to 35 h) were much lower (by as much as 40-fold in the case of ATP) than the 
values obtained during most of the stationary growth phase (40 to 50 h). From 
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Figure 3.1 Morphological and physiological profiles for C. acetobutylicum. (a,b) 
Profiles for the wild-type strain P262; k,d) profiles for the spo-1 mutant; (e,f) 
profiles for the cls-1 mutant. Symbols for graphs (a), (c) and (e) correspond to the 
following: •, glucose concentration (%, w1v); •, total acids (g 1-I); e, total 
solvents (g 1-I); 0, log10 cell number; 0, pH. The plots in (b), (ii) and (f) are 
expressed as percentas.es of the total cell count, and the symbols correspond to 
the following: •, motility; •, phase bright clostridial cells; e, phase dark rods; 
0, forespore containing cells; 0, mature spores. In (f), only motility is shown as 
the cls-1 mutant remained as 100% phase dark rods throughout the fermentation. 
17 to 23 h there was a gradual decrease in the concentration of all the nucleoside 
triphosphates, and just prior to the pH break point (25 to 35 h) the concentration 
of all the nucleoside triphosphates decreased to almost zero (27 h). The 
nucleotide levels then increased rapidly as the morphology of the culture 
changed from phase-dark rods to phase-bright clostridial cells. The highest pool 
values for all the nucleoside triphosphates coincided with the peak in the 
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number of clostridial stage cells and the onset of forespore septum development, 
indicating that the nucleoside triphosphate pool values were higher in the 
stationary phase clostridial stage cells than in the exponential phase rods. The 
decrease in the number of clostridial cells after 47 h correlated with a decrease in 
the nucleoside triphosphate concentrations, maximum solvent levels and the 
initiation of spore maturation. 
The nucleoside triphosphate profile for the spo-1 mutant (Fig. 3.2b) was similar to 
that for the wild type P262 strain. ATP was the most abundant nucleoside 
triphosphate in exponential phase cells, followed by GTP, UTP and CTP. The 
spo-1 mutant did not produce forespore septa, but the cells did produce a 
clostridial stage. The concentrations of all nucleoside triphosphates increased as 
the percentage of clostridial cells increased, and the peak concentrations 
coincided with the peak in the percentage of clostridial stage cells. In contrast to 
the wild type strain, the decrease in the nucleoside triphosphate levels after 50 h 
was not associated with a decrease in the percentage of clostridial stage cells. 
However, the metabolism of the spo-1 mutant culture slowed down as solvent 
levels reached their maximum and the glucose concentration decreased. 
The cls-1 mutant was unable to produce solvents or to sporulate and did not 
differentiate into clostridial stage cells. The nucleotide levels in exponential 
phase cells of this mutant (Fig. 3.2c) were comparable to those observed in the 
wild type strain and the spo-1 mutant. ATP was the most abundant nucleoside 
triphosphate, followed by GTP, UTP and CTP. The nucleoside triphosphate 
levels decreased as the cell number increased and acids were produced, reaching 
almost zero by 35 h. At this time, the cells had stopped dividing and the rate of 
acid production and glucose consumption had decreased. In contrast to the 
nucleoside triphosphate profiles obtained with the wild type strain and the spo-1 
mutant, the nucleoside triphosphate levels did not increase during the stationary 
phase, and after 40 h UTP and CTP were not detected. 
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Figure 3.2 Nucleoside triphosphate profiles for C. acetobutylicum: (a) wild type 
strain P262, (b) the spo-1 mutant, and (c) the cls-1 mutant. In all plots the symbols 
correspond to the following:•, ATP; e, GTP; .A., CTP; 'Y, UTP. 
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Table 3.1. Percentage sporulation of wild type C. acetobutylicum P262 with and 
without the addition of compounds known to alter nucleotide levels. 
Compound 
Cordycepin 
Deco yin me 
Psicofuranine 
2-Aminomercaptopurine 
6-Mercaptopunne 
Caffeine 
3-Methylxanthine 
Theobromine 
Theophylline 
6-Azathymine 
Optimum 
Concentrationa 
(µg ml-I) 
300 
100 
400 
500 
400 
500 
500 
200 
500 
100 
% Sporulation 
Without With 
Addition Addition 
33 42 
31 44 
35 53 
39 60 
31 51 
31 60 
35 60 
32 63 
36 57 
36 56 
a The optimum concentration of these compounds is the concentration that gave 
the greatest increase in percentage sporulation. 
3.3.3 Nucleotide synthesis inhibitors 
Ten compounds which increased the percentage of sporulating cells are shown in 
Table 3.1. Cordycepin, decoyinine and psicofuranine are adenosine analogues 
altered in the ribose moiety (Zain-ul-Abedin et al., 1983). Psicofuranine and 
decoyinine, which both inhibit GMP synthetase (Freese et al., 1979), were more 
effective than cordycepin at increasing the percentage of sporulating cells. The 
mercaptopurines (6-mercaptopurine and 2-aminomercaptopurine) were the next 
most effective compounds. The methylxanthines caffeine and theobromine 
provoked the largest increase in percentage sporulation, whereas the other two 
methylxanthines tested, theophylline and 3-methylxanthine, increased 
sporulation to a lesser extent. The pyrimidine analogue 6-azathymine also 
increased the percentage of sporulating cells. 
3.4 Discussion 
Nutrient shift-down experiments, in which rapidly dividing cells from a rich 
medium are transferred to a nutrient depleted medium, have been used to 
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induce sporulation in Bacillus species (Sterlini and Mandelstam, 1969). However, 
nutrient depletion does not induce sporulation in C. acetobutylicum P262, which 
sporulates only under conditions where growth is limited in the presence of 
excess glucose and ammonia (Long et al., 1984a). These studies were therefore 
carried out in the minimal medium CAMM, of Long et al. (1983), which provides 
a sufficiently synchronous developmental cycle to allow for correlative 
morphological, physiological and biochemical studies (Woods and Jones, 1986). 
Nucleotides were quantitatively extracted from C. acetobutylicum cells by 3M 
formic acid saturated with 1-butanol. The nucleotide extraction method of 
Olempska-Beer and Freese (1984) utilized 1 M formic acid saturated with 
1-butanol. The concentration of formic acid had to be increased to 3 M to 
overcome the high buffering capacity of CAMM which contained calcium 
carbonate. This was consistent with the results of Bagnara and Finch (1972) who 
reported that formic acid was unsatisfactory for the extraction of nucleotides if 
the buffering capacity of the culture medium caused the pH of the extractant to 
rise above approximately pH 3. The formic acid extract had to be purified prior 
to HPLC analysis. Similar purification procedures were also reported as an 
essential step for the analysis of nucleotides from plant tissues (Meyer and 
Wagner, 1985) and from bacterial cells (Payne and Ames, 1982). 
ATP was the most abundant nucleoside triphosphate produced by the wild type 
strain and the spo-1 and cls-1 mutants. An interesting observation was the 
extremely high concentrations of nucleotides in non-growing clostridial stage 
cells of the wild type strain and the spo-1 mutant, since the fermentation of 
glucose to solvents yields 2 mol ATP per mol glucose, as compared to 
approximately 3.3 mol ATP per mol glucose when acids are produced (Jones and 
Woods, 1986a). However, the clostridial cells do not appear to elongate or divide 
and the nucleotides may accumulate as a result of the absence of growth. The 
high pool values of these energy rich compounds may explain the association of 
energy consuming processes such as granulose formation and capsule 
production with the clostridial stage (Reysenbach et al., 1986). 
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The decrease in ATP levels during the acidogenic phase could also be a result of 
rapid ATP consumption for maintenance of a constant ~pH by proton extrusion. 
Acid production results in a decrease in the pH of the medium, and the cell must 
maintain a more or less constant ~pH at the expense of ATP (Gottwald and 
Gottschalk, 1985; Huang et al., 1985). These results agree with the expected, in 
that the lowest ATP levels are associated with the pH breakpoint (Grupe and 
Gottschalk, 1990). The rate of proton extrusion, and hence the rate of ATP 
consumption, would be highest at the pH breakpoint where the external pH is at 
a low. The switch to solventogenesis and the reassimilation of acetic and butyric 
acids results in a rise in the pH of the medium. The maintenance of a ~pH 
would therefore require less ATP and the ATP levels would begin to rise. 
Interestingly, in the case of the cls-1 mutant, which was unable to switch to 
solventogenesis, ATP levels never rose. 
The units that been used for reporting nucleoside triphosphate levels in B. subtilis 
are pmol per OD600 unit (Ochi and Freese, 1983; 2.ain-ul-Abedin et al., 1983) or 
pmol per AM unit (Freese et al., 1981), where one AM unit is the amount of cells 
that produces an OD600 of 1 if suspended in 1 ml. Unfortunately, these authors 
make no reference to cell number, nor do they mention the path length used in 
the optical density measurements. Therefore, the results presented here, which 
are based on cell number, are not directly comparable to those above which are 
based on optical density. With the C. acetobutylicum P262 strain, 108 cells ml-1 
gives an OD600 of approximately 1 if a 1 cm path length is used. Therefore if the 
maximum nucleoside triphosphate concentrations reported by 2.ain-ul-Abedin et 
al. (1983) are converted from pmol per OD600 unit tong per OD600 unit, the values 
obtained are approximately 375, 115, 91 and 41 for ATP, GTP, UTP and CTP 
respectively. Therefore, the nucleoside triphosphate levels for 1 X 108 C. 
acetobutylicum cells fall within the same range as reported for 1 OD600 unit of 
B. subtilis cells. 
The isolation of various classes and combinations of sporulation, clostridial cell, 
solvent, granulose and capsule mutants demonstrates that although the 
individual pathways function independently of each other, the induction of these 
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events appears to be linked by some common regulatory mechanism (Woods 
and Jones, 1986). The spo-1 and cls-1 mutants are examples of independent 
pathway and common regulatory mutants respectively. The concentrations of 
nucleoside triphosphates in the wild type strain and in the cls-1 and spo-1 
mutants decreased during the late exponential growth phase and reached their 
lowest levels just prior to the pH break point. This trough also coincided with a 
decrease in motility and rate of cell division. In the wild type strain and the spo-1 
mutant the conversion of cells to the non-dividing clostridial stage and the onset 
of solvent production coincided with a rapid and very large increase in 
nucleotide pools. In the cls-1 mutant, which failed to produce solvents or the 
clostridial stage, no increase in the level of nucleoside triphosphates was 
detected. The accumulation of high concentrations of nucleoside triphosphates 
in the spo-1 mutant suggests that the increase in these compounds was associated 
with the conversion of cells to the solvent producing clostridial stage and was 
not dependent on spore formation. 
A decrease in GTP has been shown to be associated with the initiation of 
differentiation and sporulation in B. subtilis (Lopez et al., 1979; Freese, 1981; Ochi 
and Freese, 1983), Saccharomyces cerevisiae (Freese et al., 1984b), and a 
streptomycete (Ochi, 1986). A variety of inhibitors which are known to decrease 
ribonucleotide levels in B. subtilis bring about an increase in sporulation (Freese 
et al., 1979; Ochi and Freese, 1983; Zain-ul-Abedin et al., 1983). Although there is 
no direct evidence implicating the low levels of GTP which occur during the late 
exponential growth phase in C. acetobutylicum P262 it is possible that a decrease 
in this or other nucleoside triphosphates plays a role in differentiation of C. 
acetobutylicum. The involvement of these compounds is supported by the 
increase in sporulation which was obtained in cultures treated with the various 
inhibitors shown in Table 3.1. When these inhibitors were added to stationary 
phase cultures just after the pH break point, little or no increase in sporulation 
occurred. This observation supports the suggestion of a common regulatory link 
between the shift to the clostridial stage and endospore formation. The 
methylxanthines were the most effective compounds in stimulating sporulation, 
which is consistent with the results of Sacks and Thompson (1977). One inhibitor 
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which would not be expected to affect purine ribonucleotide levels is the 
pyrimidine analogue 6-azathymine. This compound also caused an increase in 
sporulation in C. acetobutylicum. Similar results were obtained by Craven and 
Blankenship (1982) with C. perfringens. It can be speculated that a cascade of 
events must occur in order for C. acetobutylicum to sporulate. The initial trigger 
in the cascade would therefore take place at the switch from acidogenesis to 
solventogenesis. Although it is not direct evidence, it is interesting to note that a 
sporulating clostridial stage mutant has never been reported. 
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Chapter4 
Metronidazole activation and E.coli 
4.0 Summary 
E.coli strains with lesions in their DNA repair systems were more susceptible to 
metronidazole than wild type strains. The effect was more severe in recA 
mutants than in uvr mutants. The sensitivity of E.coli to metronidazole was 
tested under aerobic, anaerobic respiration and fermentation conditions. 
Anaerobically grown cultures were more sensitive to metronidazole than 
aerobically grown cultures, which were killed only when exposed to high levels 
of metronidazole. The lower redox potential of E.coli cells grown under 
fermentation conditions rendered them slightly more susceptible to 
metronidazole than anaerobically respiring cells. No synergistic effect between 
ampicillin and metronidazole was observed when testing the susceptibility of 
E.coli strains harbouring plasmid vectors which contained the l}-lactamase gene. 
To isolate a suitable E.coli cloning host for the selection of C. acetobutylicum 
electron transport genes which activated metronidazole, transposon mutagenesis 
of the recA E.coli strain CCl 18 with TnphoA, was used to construct a recA, 
metronidazole resistant mutant (F19). F19 was shown to have diminished 
nitroreductase activity, which was presumed to be responsible for the 
metronidazole resistant phenotype. The recA mutation renders E.coli F19 highly 
susceptible to the reduced toxic intermediates of metronidazole. Thus, selecting 
for increased sensitivity to metronidazole makes F19 a suitable cloning host for 
the isolation of C. acetobutylicum electron transport genes which activate 
metronidazole, in E. coli. 
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4.1 Introduction 
Although the spectrum of activity of metronidazole transcends many taxonomic 
boundaries, initial reports suggested that its toxicity was mainly limited to strict 
anaerobes and microaerophiles (Edwards, 1980), and that it was inactive against 
aerobes and facultative anaerobes except in concentrations that far exceeded 
those therapeutically attainable (Prince et al., 1969; Benazet et al., 1970; Ralph 
and Clarke, 1978; Onderdonk et al., 1979). Prince et al. (1969) tested 
metronidazole on a group of facultative anaerobes, and concluded that it had 
little or no clinical use for treatment of infections caused by these organisms. 
These authors did report that E.coli was slightly more sensitive than the other 
organisms tested, but the antibiotic concentration necessary for bacteriocidal 
action was still well above the obtainable serum concentrations at the 
recommended dosage. Edwards et al. (1979) reported a low incidence of clinical 
failure with metronidazole when treating patients for Trichomonas vaginalis 
infections. Swabs from these refractory patients yielded mixed cultures which 
typically contained Streptococcus faecalis and E.coli. The theory proposed for the 
clinical failures was that organisms other than T. vaginalis were able to absorb 
and bind metronidazole and hence decrease the concentration of the drug at the 
site of infection. 
A comprehensive study by Onderdonk et al. (1979) was carried out where the 
pelvic cavity of Wistar rats was injected with either E. coli or a mixture of E. coli 
and &lcteroides fragilis. The rats that did not receive metronidazole all died due 
to E.coli septicemia, regardless of whether they were injected with E.coli or 
E. coli and B. fragilis. When the rats were treated with metronidazole, 2 out of 10 
(20%) with mixed infections died, whereas 17 out of 20 (85%) with E.coli 
infections died. These authors carried this study one step further and analyzed 
the effect of metronidazole on continuous cultures of E.coli or E.coli and B. 
fragilis. In the case of E.coli alone, metronidazole was not being reduced and was 
therefore not biologically active. In the mixed culture, B. fragilis rapidly 
disappeared when the calculated concentration of metronidazole reached 
1 µg ml-1• Concomitant with this was a temporary reduction in the viable 
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number of E.coli. The E.coli concentration returned to pre-treatment levels 
within 24 h. These authors concluded that B. fragilis reduced metronidazole to its 
active intermediate, and this intermediate escaped from the B. fragilis cells, and 
then entered and killed the E.coli cells. These results were supported in a later 
study by Soriano et al. (1982) where the antimicrobial activity of metronidazole 
was also measured against pure and mixed cultures of E.coli and B. fragilis. 
Chrystal et al. (1980) demonstrated that the presence of E.coli enhanced the 
bacteriocidal effect of metronidazole against B. fragilis. They used a control 
culture where B. fragilis was inoculated into centrifuged and filtered medium 
that had supported the growth of E.coli. These authors also proposed that the 
reduced active intermediates of metronidazole were stable enough to diffuse 
from one cell to another. Hence they concluded that E.coli reacted with 
metronidazole to form a more active derivative which then diffused into the 
B. fragilis cells resulting in death. Their belief was that B. fragilis was more 
sensitive than E.coli to this particularly active derivative of metronidazole. 
Therefore, the presence of E.coli increased the concentration of this active 
derivative and this was responsible for the enhanced activity against B. fragilis. 
Ingham et al. (1980) tested the effect of metronidazole on anaerobically grown 
cultures of E.coli. These authors showed that in the presence of 10 µg ml-1 of 
metronidazole, there was an initial increase in the viable counts of E.coli cultures 
to 5 X 107 CFU ml-1 during the first 4 h. Thereafter the viable count dropped and 
eventually reached 4 X 104 CFU ml-1 after 24 h. This effect was faster and greater 
at a metronidazole concentration of 100 µg ml-1, and was independent of 
inoculum size. In control cultures that were not treated with metronidazole, 
stationary phase was reached and the viable cell count after 24 h was 1 X 10s 
CFU ml-1. Eight other strains of E.coli, 3 strains of Klebsiella and 6 out of 7 strains 
of Proteus gave almost identical results. Metronidazole had no effect on 6 strains 
of Staphylococcus aureus or 5 strains of S faecalis. These authors refute the work of 
Onderdonk et al. (1979), and state that the presence of B. fragilis causes a decrease 
in the oxidation reduction potential of the environment, and hence 
metronidazole is more active against E.coli. They conclude that the killing of 
Metronidazole and E.coli 79 
facultative anaerobes does not require prior reduction of metronidazole, but 
merely an appropriately low redox environment. In a subsequent report 
(Ingham et al., 1981) these authors challenged the work of Chrystal et al. (1980). 
They prepared mixtures of B. fragilis or B. fragilis plus viable or heat killed E.coli. 
They also inoculated B. fragilis into centrifuged and filtered medium that had 
supported the growth of E.coli. In all cases they measured the redox potential 
(Eh), pH and dissolved oxygen concentration (p02). They confirmed that the 
rate of killing of B. fragilis was enhanced in the presence of viable or heat killed 
E.coli when compared to the control culture where B. fragilis was inoculated into 
medium that had previously supported the growth of E.coli. However, when 
compared to a control culture where B. fragilis was inoculated into freshly 
prepared medium, this enhanced rate of killing was not observed. Oxygen 
concentration measurements and redox measurements showed that the viable 
E.coli medium, the heat treated E.coli medium and the freshly prepared medium 
all had low p02 and Eh values. The centrifuged and filtered medium however 
had greater p02 and Eh values. They concluded that centrifugation and filtration 
introduced oxygen into the medium, which resulted in a slower killing rate of 
B. fragilis by metronidazole. 
Moran et al. (1987) reported a 68% decrease in the viable cell count of E.coli 
cultures when treated with 10 µg ml-I of metronidazole and a 99% decrease when 
treated with 100 µg ml-I of metronidazole. They also showed that there was 
enhanced metronidazole sensitivity of both E.coli and B. fragilis when grown in 
mixed culture. It was suggested that this enhanced lethal effect against B. fragilis 
was due to a more reduced environment, and the enhanced lethal effect on E.coli 
was due to the presence of reduced intermediates excreted by B. fragilis. In a 
letter, Ingham and Sisson (1988) point out that these workers failed to employ 
stringent conditions of anaerobiosis, and that their conclusion that B. fragilis 
excreted metabolites of metronidazole was unjustified. The implication being 
that under strict anaerobic conditions, metronidazole was being reduced by 
E.coli. 
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The bacteriocidal toxic derivatives of metronidazole have been shown to cause 
DNA damage (Knight et al., 1978). Chrystal et al. (1980) proposed that reduced 
metronidazole can interact with either DNA to exert the bacteriocidal effect, or 
with water to form acetamide. Measuring metronidazole sensitivities of various 
E.coli strains which carried one or more genetic lesions in their DNA repair 
systems, Jackson et al. (1984) confirmed that DNA was the target molecule in this 
organism. The wild type strains were the least susceptible to metronidazole, 
whereas lesions in DNA repair genes conferred greater sensitivity to 
metronidazole. In all E.coli strains tested, metronidazole disappeared from the 
culture medium indicating that E.coli has the capacity to reduce metronidazole. 
In a similar study, Yeung et al. (1984) also tested the bacteriocidal activity of 
metronidazole against DNA repair mutant strains of E.coli. These DNA repair 
mutants of E.coli were killed more efficiently by metronidazole than their 
respective parental strains. However, if these DNA repair mutants also lacked 
the ability to reduce nitrate and chlorate, they were no more susceptible to 
metronidazole than their wild type parents. It was shown that metronidazole 
disappeared from the culture medium more slowly in the these nitroreductase 
deficient strains. Since acetamide concentration is proportional to the 
concentration of the active derivatives of metronidazole, these authors expressed 
metronidazole sensitivity in terms of acetamide concentration. This 
demonstrated that all of the strains with lesions in DNA repair genes were more 
susceptible to the reduced active derivatives of metronidazole than the wild type 
strains, whether or not they had diminished nitroreductase activity. This 
indicates that in E. coli, nitroreductase activity is obligatory for the activation of 
metronidazole, but not for the DNA damaging activity of the reduced 
derivatives. There are therefore two mechanisms of resistance to metronidazole, 
a decrease in the rate of formation of the reduced active derivatives, or an 
increased resistance at the target molecule, DNA. 
In the absence of oxygen, E.coli cells breakdown pyruvate to produce formate 
and acetyl CoA by the action of the pyruvate formate lyase enzyme. Formate can 
be metabolized via the fermentative formate degradation pathway or via the 
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respiratory nitrate linked route (reviewed in Stewart, 1988). In the presence of a 
terminal electron acceptor such as nitrate, reduction is coupled to NADH 
oxidation to generate a proton motive force for membrane energization and 
hence energy production. In the fermentative pathway, formate is converted to 
carbon dioxide and hydrogen by the formate hydrogenlyase system (Peck and 
Gest, 1957). Formate hydrogenlyase consists of formate dehydrogenase, 
unknown electron carriers and hydrogenase (Stewart, 1988). The syntheses of 
the formate dehydrogenase and hydrogenase components of the formate 
hydrogenlyase pathway in E.coli are known to be repressed under aerobic 
conditions and anaerobically by nitrate (Wimpenny and Cole, 1967). 
Two types of formate dehydrogenase activities have been identified in E.coli, 
and these may be distinguished by their activities with artificial electron 
acceptors (Stewart, 1988). Formate dehydrogenase-N (FDHN) is present in 
nitrate respiring cells and is active with the artificial electron acceptors 
methylene blue, phenazine methosulfate, and dichlorophenolindolphenol. In 
contrast, the formate dehydrogenase-H (FDHH), which is a component of the 
fermentative formate hydrogenlyase pathway, is active with methyl viologen 
and benzyl viologen as artificial electron acceptors. It can be inferred from the 
oxidation reduction potential of these artificial electron acceptors, that the redox 
environment is lower under fermentation conditions than under conditions of 
anaerobic respiration. 
Since the redox environment has been shown to play a crucial role in 
metronidazole susceptibility (Ingham et al., 1981), it is imperative to determine, 
in the case of facultative anaerobes, if metabolism is occurring via anaerobic 
respiration or fermentation. The purpose of this study was to determine the 
effect of metronidazole on various strains of E.coli, under conditions of 
fermentation and anaerobic respiration with the view to creating a suitable 
system for the cloning of C. acetobutylicum electron transport genes that may 
activate metronidazole. 
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4.2 Materials and Methods 
Commonly used materials and techniques are presented in the Appendices. The 
details provided below are included for completeness. 
4.2.1 Bacterial strains 
The bacterial strains used in this study are shown in Table 4.1, and are described 
in Appendix C. The nitroreductase deficient E.coli strain F19 was derived from 
the recA E. coli strain CCl 18 (araD139~(ara, leu)7697 ~lacX74 phoA~20 galE galK thi 
rpsE rpoB argEam recAl) (Manoil and Beckwith, 1985) by transposon 
mutagenesis. Phage Ab221rex::TnphoA cl857 Pam3 was a gift from C. Manoil 
(Gutierrez et al., 1987). 
4.2.2 Media and culture conditions 
E.coli was grown aerobically in Luria-Bertani (LB) medium. Anaerobic growth 
of E.coli was carried out in an anaerobic glove box (Forma Scientific Inc., 
Marietta, Ohio). The medium used for growth of E.coli under conditions of 
anaerobic respiration was LB medium containing 0.1 % glucose and 0.5% sodium 
nitrate (LBR). The medium used for fermentative growth of E.coli was either LB 
medium containing 1.0% glucose (LBF) or the complex medium (pH 8.0) 
described by Clark and Cronan (1980) supplemented with 1 % glucose (ECAM). 
When necessary, 1.5% agar was added to these media. 
4.2.3 Determination of MIC 
An anaerobically grown overnight liquid culture of E.coli was diluted lQ-4 with 
anaerobic sterile water, and 100 µl was spread onto pre-reduced agar medium 
containing various concentrations of metronidazole. The MIC was taken as the 
amount of antibiotic (per ml) that totally inhibited growth after incubation for 
24 hat 34°C. 
4.2.4 Transposon mutagenesis 
TnphoA is a derivative of Tn5 which contains the structural gene for E.coli 
alkaline phosphatase (phoA) cloned into the transposon (Manoil and Beckwith, 
1985). The alkaline phosphatase portion of TnphoA was not needed for the 
desired E.coli chromosomal mutation, and hence TnphoA was merely used in 
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preference to Tn5 because it was readily available. Transposon insertions of 
TnphoA into E.coli (CC118) were obtained using an adaptation of the protocol of 
Gutierrez et al. (1987). A sample (1 ml) of an overnight culture of E.coli CC118 in 
LB containing 10 mM magnesium sulfate was mixed with phage A.::TnphoA at a 
multiplicity of infection of approximately 1, and was incubated at 30°C for 4 h to 
allow for outgrowth of the phage. Samples (100 µI each) were plated onto LB 
plates containing 30 µg ml-1 of kanamycin and incubated overnight at 30°C. 
Colonies from each plate were pooled into 1 ml of sterile water. From each 
cell/water pool, 100 µl was plated onto LBR medium containing 30 µg ml-1 of 
kanamycin and 30 µg ml-1 metronidazole and incubated anaerobically at 34 ·c. 
Metronidazole resistant mutants were tested for recA reversion and 
ni trored uctase activity. 
4.2.5 Nitroreductase assay 
To test the ability of E. coli to reduce nitro-heterocyclic compounds, the 
conversion of p-nitrobenzoic acid (PNBA) top-aminobenzoic acid (PABA) was 
monitored. PABA concentration was measured using an assay procedure 
originally developed for sulfanilamide determination (Bratton and Marshall, 
1939). One ml of an anaerobically grown overnight culture of E.coli was added 
to 5 ml of pre-reduced LB supplemented with 120 µg ml-1 of PNBA (final 
concentration of PNBA = 100 µg ml-1). A 100 µI sample was removed 
immediately and assayed for PABA (time 0), and the remainder was incubated 
anaerobically at 34 ·c. Samples were then assayed for PABA at hourly intervals 
for six hours. To assay for PABA, the 100 µl sample was placed in a test tube 
containing 2.3 ml of water, 600 µl of 15% tri-chloroacetic acid, and 300 µl of 0.1 % 
sodium nitrite. After standing for at least 3 min, 300 µI of 0.5% ammonium 
sulfamate was added to the tube. After standing for another 3 min, 300 µl of 
0.1 % N-(1-naphthyl)ethylene diamine dihydrochloride was added to the tube. 
The absorbance was measured at 540 nm against a blank of LB containing 
100 µg ml-1 PNBA, which was similarly treated. The PABA concentration was 
calculated using the least squares regression line equation determined by 
assaying known concentrations of P ABA. 
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Table 4.1. The relationship between DNA repair mutations and 
metronidazole sensitivity of E.coli strains. 
DNA 
Strain MIC.a repair Reference 
mutation 
C600 150 Wood, 1966 
JM103 150 Yanisch-Perron et al., 1985 
CSH50 150 Miller, 1972 
YMCll 150 Backman et al., 1981 
K514 150 Zabeau & Stanley, 1982 
ET8051 150 Pahel & Tyler, 1979 
AB1157 150 DeWit & Adelberg, 1962 
AB1886 35 uvrA Howard-Flanders et al., 1966 
AB1885 35 uvrB Howard-Flanders et al., 1966 
AB1884 35 uvrC Howard-Flanders et al., 1966 
N14-4 40 uvrD Ogawa et al., 1968 
HB101 20 recA Boyer & Roulland-Dussoix, 1969 
JA221 20 recA Beggs, 1978 
CC118 20 recA Manoil & Beckwith, 1985 
LKlll 15 recA Zabeau & Stanley, 1982 
CSR603 15 recA, uvrA Sancar & Rupert, 1978 
F19 35 recA this study 
a All MIC values are in µg ml-1. Media used for MIC determinations was LB 
supplemented with 0.5% (w/v) NaN03 and 0.1% (w/v) glucose which was 
incubated anaerobically at 34 ·c. 
4.2.6 Testing for RecA phenotype 
The standard UV dose experiment described by Maniatis et al. (1982) was used 
to test the stability of DNA repair mutations. A fluence of 1 J m2 sec-1 was used 
to irradiate single streaks of the various E.coli strains. RecA mutants were unable 
to grow after a 5 sec exposure, whereas wild type strains survived a 25 sec 
exposure. 
4.3 Results 
4.3.1 DNA repair mutations and metronidazole sensitivity 
E.coli strains containing various DNA repair mutations were tested for their 
susceptibility to metronidazole (Table 4.1). Strains with a complete and 
functional DNA repair system were not as sensitive to metronidazole as strains 
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Table 4.2 Metronidazole sensitivity of E.coli strains grown under aerobic 
(LB), anaerobic respiration (LBR) and fermentation (LBF and ECAM) 
conditions. 
Mediuma E.coli Strain MIC 
(Incubation) (Plasmid) (µg ml-1) 
CC118 20 
CCl 18 [pBR322] 20 
LBR F19 35 
(anaerobic) F19 [pBR322] 35 
C600 150 
C600 [pBR322] 150 
CC118 6 
CCl 18 [pBR322] 6 
LBF F19 15 
(anaerobic) F19 [pBR322] 15 
C600 110 
C600 [pBR322] 110 
CC118 6 
CCl 18 [pBR322] 6 
ECAM F19 15 
(anaerobic) Fl 9 [pBR322] 15 
C600 110 
C600 [pBR322] 110 
CC118 100 
CCl 18 [pBR322] 100 
LB F19 200 
(aerobic) F19 [pBR322] 200 
C600 1500 
C600 [pBR322] 1500 
11 Media used to support growth of E. coli cells which contained plasmids 
was supplemented with 100 µg ml-1 of ampicillin. 
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with mutations in their DNA repair systems. Strains with uvr mutations were 
more sensitive to metronidazole than wild type strains, and strains with recA 
mutations were even more sensitive than strains with uvr mutations. 
4.3.2 Growth conditions and metronidazole sensitivity 
E.coli strains grown under aerobic, anaerobic respiration and fermentation 
conditions were tested for their susceptibility to metronidazole (Table 4.2). All 
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Figure 4.1 Nitroreductase activity of E.coli Fl9 (e) as compared to its parent, 
E.coli CC118 (0). Nitroreductase activity was determined by incubating cells 
with p-nitrobenzoic acid and measuring the resulting p-aminobenzoic acid 
(PABA) concentration with respect to time. 
strains were more sensitive to metronidazole when grown under anaerobic 
conditions. E.coli strains grown under fermentation conditions were more 
sensitive to metronidazole as compared to strains grown under anaerobic 
respiration. Ampicillin (100 µg ml-1) was added to media used to support the 
growth of E.coli strains containing the plasmid pBR322. No synergistic effect 
between metronidazole and ampicillin was demonstrated. 
4.3.3 Transposon mutagenesis 
E.coli CC118 was a suitable strain for transposon mutagenesis since it has a 
stable recA mutation, is not a A-lysogen, is readily transformable and is a proven 
host for TnphoA (Manoil and Beckwith, 1985). Following transposon 
mutagenesis, 222 metronidazole resistant mutants were isolated. 
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4.3.4 Nitroreductase activities and recA stability 
The 222 metronidazole resistant mutants isolated by transposon mutagenesis 
were tested for stability of mutation, recA reversion, and nitroreductase activity. 
Of the 222 mutants, 10 were not stable and were unable to grow in the presence 
of metronidazole after subculturing. A further 29 were recA revertants, while 50 
did not show reduced nitroreductase activity. The remaining 133 mutants had a 
diminished ability to reduce nitroheterocyclic compounds. Mutant F19 
consistently showed the lowest level of nitroreductase activity, and the 
nitroreductase activity of this mutant is compared to that of its parent CC118 in 
Fig. 4.1. Mutant F19 was therefore chosen to screen the C. acetobutylicum gene 
bank for genes which cause an increase in sensitivity towards metronidazole (see 
chapter 5). 
4.4 Discussion 
Chrystal et al. (1980) proposed a model relating metronidazole metabolism to 
bacteriocidal action, and a similar model is presented in Fig. 4.2. Metronidazole 
is reduced to its active form M*, which can react with DNA resulting in DNA 
damage. If the rate of DNA damage (K;;) is greater than the rate of repair (K;;;), 
cell death occurs. Therefore a cell with an efficient DNA repair mechanism is 
able to tolerate higher levels of M* than a cell with a less efficient DNA repair 
system. Since the rate of formation of M* (K;) is proportional to the rate of DNA 
damage, two mechanisms of resistance to metronidazole exist. One mechanism 
involves an efficient DNA repair system and the other involves the lack of the 
ability to reduce metronidazole to its active intermediate M*. 
In agreement with Jackson et al. (1984) and Yeung et al. (1984), the results in 
Table 4.1 show that of all the E.coli strains tested, those with one or more lesions 
in their DNA repair systems were more susceptible, to varying degrees, than 
strains with complete and functional DNA repair system. An MIC of 40 µg ml-I 
was observed for the uvrD mutant (N14-4), while the next susceptible strains 
were the uvrA (AB1886), uvrB (AB1885) and uvrC (AB1884) strains, which had an 
MIC of 35 µg ml-I. With the exception of strain LK111 which has an MIC of 
Kiiii Kii 
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Figure 4.2 A model relating metabolism of metronidazole to cell death. 
Metronidazole is reduced to its active derivative M* by the cell. M* reacts with 
DNA causing damage, which can be repaired by the host cell's DNA repair 
systems. Ki 1s the rate of reduction of metronidazole, Kii is the rate of DNA 
damage, and Kiii is the rate of DNA repair. If the rate of DNA damage (Kii) is 
greater than the rate of DNA repair (KiiJ, cell death occurs. 
15 µg ml-1, all of the recA only mutants had an MIC of 20 µg ml-1. Therefore, with 
respect to single lesions in the DNA repair systems, the recA mutation proved to 
have the largest effect. As shown by the MIC of strain CSR603 (recA, uvrA), 
additional lesions in DNA repair systems caused an enhanced effect. Similar 
results were reported by Jackson et al. (1984) with lexA, uvrA and recA, uvrA 
double mutants. E.coli strain F19 was specifically developed to be resistant to 
metronidazole, as is discussed in more detail below. 
Under aerobic conditions, E.coli cells respire which leads to the transfer of 
electrons to oxygen. Metronidazole is an artificial electron acceptor for low 
redox potential electrons (Miiller, 1983). Therefore, metronidazole is in 
competition with oxygen for available electrons in aerobically grown cells. It is 
believed that the reduction of metronidazole occurs in single electron steps, 
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leading to the formation of a free radical anion (Perez-Reyes et al., 1979). In the 
presence of oxygen metronidazole can be reduced, albeit slowly, to the single 
electron transfer free radical anion, which is reoxidized by oxygen with the 
production of superoxide. It can be speculated that the superoxide radical, 
which is known to cause DNA damage, may be responsible for the bacteriocidal 
effect high concentrations of metronidazole have on aerobically grown E.coli 
cells (Table 4.2), and that metronidazole itself is not directly involveq. Under 
anaerobic conditions, the cellular redox potential is related to the reduction of 
metronidazole to its active derivative or derivatives (beyond single electron 
transfer). As is shown in Table 4.2, anaerobically respiring E.coli cells are 
slightly less susceptible than fermenting cells, presumably due to the slightly less 
negative intracellular redox potential. The results in Table 4.2 also support the 
data in Table 4.1, where E.coli strains CC118 and F19, which are recA mutants, 
are more susceptible to metronidazole than the wild type C600 strain. This 
observation occurred even in aerobically grown cells, indicating that DNA 
damage is still the mechanism by which cell death occurs. 
Ampicillin did not have a synergistic effect when used in conjunction with 
metronidazole. This is an important observation in lieu of the development of an 
E.coli cloning host for use with vectors containing a ~-lactamase resistance 
marker. This desired cloning host should lack the ability to reduce 
metronidazole to its active intermediates, while being highly susceptible to these 
active compounds. As shown in Table 4.1, DNA repair deficient mutants of 
E.coli are more susceptible to metronidazole than their wild type parents. 
However, Yeung et al. (1984) demonstrated that nitrate reductase, DNA repair 
double mutants were no more susceptible to metronidazole than their wild type 
parents. Furthermore, these authors showed that these double mutants were 
equally sensitive to the active intermediates of metronidazole, when compared to 
other DNA repair mutants, but they reduced metronidazole at a slower rate. The 
latter feature was presumed to be due to the nitrate reductase mutation. Nitrate 
reductase mutants of E.coli are easily obtained by selecting for chlorate 
resistance (Begg et al., 1977; Graham et al., 1980; Stewart and McGregor, 1982). 
Since a primary goal of this study was to isolate an E. coli mutant with 
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diminished ability to reduce metronidazole, it was decided to select directly for 
metronidazole resistance as opposed to chlorate resistance. Furthermore, as 
metronidazole is not a nitrate compound per se, but rather a nitroheterocyclic 
compound, further screening of these metronidazole resistant mutants was 
carried out by measuring their ability to reduce PNBA to PABA. Transposon 
mutagenesis of E. coli CC118 yielded 133 stable metronidazole resistant, recA 
mutants. Mutant F19 consistently showed the lowest level of nitroreductase 
activity (Fig. 4.1). This mutant has the desired traits of a diminished ability to 
reduce metronidazole, presumably due to the low level of nitroreductase, while 
remaining highly sensitive to the reduced active derivatives of metronidazole, 
due to the recA mutation. F19 was therefore chosen as the cloning host to screen 
for recombinant plasmids containing C. acetobutylicum DNA coding for electron 
transport genes that activate metronidazole (see Chapter 5). Since this mutant 
was developed to be used as a cloning host, and not for physiological studies of 
the effects of metronidazole on E.coli, no efforts were made to further 
characterize the mutation induced by TnphoA. 
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Chapter 5 
Isolation and classification of C. acetobutylicum genes 
which activate metronidazole 
5.0 Summary 
91 
The E.coli Fl9 recA, nitroreductase deficient mutant (Chapter 4) was used for the 
isolation of C. acetobutylicum genes on recombinant plasmids which activated 
metronidazole. These genes rendered the E.coli Fl9 strain sensitive to 
metronidazole. Twenty five E.coli Fl9 clones which contained different 
recombinant plasmids were isolated and classified into five groups (I-V) based 
on their sensitivity to metronidazole. With respect to metronidazole 
susceptibility, class I isolates were the least sensitive group whereas class V 
isolates were the most sensitive group. The clones were tested for 
nitroreductase, pyruvate-Fd-oxidoreductase and hydrogenase activities. 
Nitroreductase and pyruvate-Fd-oxidoreductase activity was not demonstrated 
in any of the isolated clones. Only one clone pMET15B2, which is a class I 
isolate, tested positive for hydrogenase activity. DNA hybridization and 
restriction endonuclease mapping revealed that four of the C. acetobutylicum 
insert DNA fragments on recombinant plasmids were linked in an 11.1 kb 
chromosomal fragment. Three of these clones, pMET13A, pMET030 and 
pMET190, were class V isolates, whereas the fourth clone was the hydrogenase 
positive isolate pMET15B2. The 11.1 kb chromosomal fragment therefore 
contained at least two regions responsible for activating metronidazole. The 
region responsible for class V sensitivity to metronidazole was localized to a 2 kb 
EcoRI-EcoRV fragment, which was present in each of the clones pMET13A, 
pMET030 and pMET190. Based on the orientation of the insert DNA with 
respect to vector DNA it was concluded that the gene responsible for class V 
sensitivity to metronidazole located on this 2 kb region was transcribed from a 
promoter present on the insert. 
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5.1 Introduction 
Based on the principal that electron flow can control carbon flow (Kim et al., 
1984; Jones and Woods, 1986a), genes encoding electron transport proteins and 
enzymes may play an important role in genetic manipulations of C. 
acetobutylicum aimed at improving the fermentation. Furthermore, an 
understanding of the mechanisms involved in the activation of metronidazole is 
important for the development of improved analogs for use in medicine. To gain 
knowledge of both metronidazole activation and C. acetobutylicum electron 
transport genes, a negative selection system was developed for cloning C. 
acetobutylicum electron transport genes in E.coli that activate metronidazole (see 
also chapter 4). The cloning strategy involved the use of the nitroreductase 
deficient, recA E.coli F19 mutant. C. acetobutylicum genes on recombinant 
plasmids which activate metronidazole would complement this mutant's 
deficiency in reducing the drug. These genes can be identified by observing an 
increased sensitivity to metronidazole. 
There have been conflicting reports as to what proteins or enzymes are 
responsible for the reduction of metronidazole to its active derivatives. Edwards 
and Mathison (1970) reported that reduced ferredoxin could directly transfer 
electrons to metronidazole, forming the reduced toxic derivatives. This theory is 
supported by the hydrogenase linked assay system developed by Chen and 
Blanchard (1979) for measuring ferredoxin and flavodoxin, using metronidazole 
as the indicator compound. These authors report that hydrogenase transfers 
electrons from hydrogen gas to ferredoxin or flavodoxin which then transfer 
electrons to metronidazole forming the reduced toxic intermediates. It has also 
been reported that metronidazole is reduced enzymatically by the action of 
pyruvate-Fd-oxidoreductase (Narikawa, 1986). The most recent theory has been 
put forward by Church et al (1988, 1990) who have shown that metronidazole as 
well as other nitroimidazole drugs are reduced by hydrogenase 1 of C. 
pasteurianum. Any of the clostridial genes encoding electron carriers or enzymes 
involved in the phosphoroclastic breakdown of pyruvate and the concomitant 
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production of hydrogen gas are therefore likely candidates to be isolated using 
this cloning strategy. 
The work described in this chapter involved the screening of a C. acetobutylicum 
DNA fragment library in E.coli F19 for genes that activate metronidazole. 
5.2 Materials and Methods 
Commonly used materials and techniques are presented in the Appendices. The 
details provided below are included for completeness. 
5.2.1 Chemicals 
Restriction endonucleases were obtained from several sources (Amersham 
International, Anglian Biotec, Boehringer Mannheim Biochemicals GmbH, New 
England Biolabs, and the Promega Corp.) [a-32p] labelled dA TP was obtained 
from Amersham International. Metronidazole was obtained from the Sigma 
Chemical Co. All other chemicals were analytical grade and were purchased 
from various local agents and suppliers. 
5.2.2 Bacterial strains and plasmids 
C. acetobutylicum P262 (Jones et al., 1982) was used as the source of DNA. E.coli 
strain F19 (Santangelo et al., 1991) was used as the recipient strain for 
recombinant plasmids. Construction of the nitroreductase deficient, recA E.coli 
strain F19 is described in Chapter 4. For hydrogenase assays, plasmids were 
transformed into the E.coli SE53 hydA mutant which was derived from E. coli 
strain Puig426 (Lee et al., 1985). The plasmid vector pEcoR251 (Appendix E) 
which was a gift from M. Za.beau, Biotechnology Business Development, Ghent, 
Belgium, was used to prepare a genomic library of C. acetobutylicum 
chromosomal DNA (Za.ppe et al., 1986). pEcoR251 is a positive selection vector 
containing the E.coli EcoR1 gene under the control of the A-rightward promoter, 
the pBR322 ampicillin resistance gene and the pBR322 origin of replication. The 
EcoRI gene product, when expressed at high levels by the A promoter is lethal 
unless insertionally inactivated, or regulated by a resident A prophage. The 
EcoRI gene has single restriction enzyme sites for Hindlll, Bglll and Sspl. Positive 
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selection is obtained through insertional inactivation of the EcoRl endonuclease 
gene, by cloning foreign DNA into one of these single restriction enzyme sites. 
pEcoR251 was derived from the pCL series of plasmids described by Zabeau and 
Stanley (1982). 
5.2.3 Media and growth conditions 
C. acetobutylicum P262 was grown under strict anaerobic conditions in the 
Clostridium basal medium (CBM) of O'Brien and Morris (1971) as described by 
Allcock et al. (1982). E.coli F19 was grown as described in section 4.2.2. 
5.2.4 Determination of MIC 
MIC values were determined as described in section 4.2.3. 
5.5.5 Preparation of DNA 
Plasmid DNA was prepared by the alkali-hydrolysis method of Ish-Horowicz 
and Burke (1981). The small-scale (miniprep) and large-scale (maxiprep) 
methods of plasmid isolation are described in Appendix B. C. acetobutylicum 
cellular DNA was prepared by the method of Marmur (1961), which was 
modified (Zappe et al., 1986) to overcome the high nuclease activity exhibited by 
this organism (Drano et al., 1983). E.coli cellular DNA was prepared as 
described by Maniatis et al. (1982). 
5.2.6 Genebank construction 
The genomic library (Zappe et al., 1986) contained sucrose fractionated Sau3A1 
endonuclease fragments (4 to 7 kb from a partial digestion) of C. acetobutylicum 
P262 chromosomal DNA which were ligated with pEcoR251 which had been 
restricted with Bglll endonuclease. 
5.2.7 Ooning of C. acetobutylicum genes which activate metronidazole 
E.coli F19 cells containing recombinant pEcoR251 plasmids were selected on LB 
agar containing ampicillin (100 µg ml-I). Colonies were duplicated onto LBR 
agar containing ampicillin (100 µg ml-I) or ampicillin plus metronidazole 
(30 µg ml-1). These plates were incubated anaerobically at 34 ·c for 24 h, and 
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colonies that were resistant to ampicillin and sensitive to metronidazole were 
chosen for further study. 
5.2.8 Preparation of cell extracts 
Cell extracts of E.coli were prepared from overnight cultures (400 ml) grown 
anaerobically in the presence of ampicillin (100 µg ml-I). Cell extracts of C. 
acetobutylicum were prepared from exponential phase cells grown anaerobically 
in CBM. Cell extracts were prepared under anaerobic conditions by the 
procedure of Clark and Cronan (1980) and stored at -70°C to preserve enzyme 
activity. Protein concentrations in the extracts were determined by the biuret 
method as described by Cornall et al. (1949). 
5.2.9 Enzyme assays 
Nitroreductase activity was assayed by determining the conversion of PNBA to 
PABA according to the method of Bratton and Marshall (1939), as described in 
section 4.2.5. 
Pyruvate-Fd-oxidoreductase was assayed using the method of Wahl and 
Orme-Johnson (1987). The reaction mix contained 10 mM sodium pyruvate, 
250 µM 2-mercaptoethanol, 250 µM coenzyme A, 50 µM thiamine pyrophosphate 
and 2 mM methyl viologen in 50 mM Tris-HCl (pH 7.5). The reaction was 
initiated by the addition of the cell free extract (500 µg protein). The reaction was 
monitored by following the absorbance at 600 nm. All manipulations and 
measurements were carried out under strict anaerobic conditions in an anaerobic 
cabinet. 
Hydrogenase activity was determined by testing the ability of cell free extracts to 
produce hydrogen gas from the reduced artificial electron acceptor, methyl 
viologen (Church et al., 1988). Assays were performed using a Warburg 
apparatus with a water bath temperature of 30°C. Warburg flasks were gassed 
out for 20 min with helium. The centre well contained 200 µl of 20% potassium 
hydroxide to absorb any carbon dioxide which evolved during the reaction. The 
rim of the centre well was coated with a thin layer of vacuum grease to prevent 
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creeping of the potassium hydroxide. The reaction flask contained 10 mM 
methyl viologen and 15 mM sodium dithionite in 50 mM Tris-HCl (pH 7.5). The 
reaction was started by tipping a volume of the cell free extract equivalent to 
3 mg of protein, into the main compartment of the reaction vessel. The final 
volume in the reaction flask was always 2 ml, and hydrogen production was 
monitored over 10 min. The volume of hydrogen produced was calculated 
according to the methods described by Umbreit et al. (1972). 
5.2.10 SOS polyacrylamide gel electrophoresis 
SDS polyacrylamide gel electrophoresis (PAGE) was carried out by following the 
methods of Laemmli (1970), using 50 µg per lane of proteins from crude cell 
extracts. The gels were electrophoresed at 35 mA constant current using a 
Hoeffer SE 600 vertical gel apparatus. The 1.5 mm thick gels consisted of 10% 
acrylamide with 2.7% crosslinking. After electrophoresis, proteins were stained 
with Coomassie blue R-250. 
5.2.11 Restriction mapping 
Recombinant plasmids were characterized by restriction mapping using 
standard procedures (Maniatis et al., 1982). 
5.2.12 Preparation of radiolabelled probe DNA 
Plasmids containing C. acetobutylicum DNA inserts, or isolated DNA fragments 
were nick translated (Rigby et al., 1977) with [a..32P]dATP using the nick 
translation kit of Amersham International (code N.5500). Nick translated probes 
were prepared according to the manufacturer's instructions. 
5.2.13 DNA hybridization 
Plasmid DNA, C. acetobutylicum chromosomal DNA and E. coli chromosomal 
DNA were digested to completion with the appropriate endonucleases, and the 
resulting fragments were fractionated by electrophoresis in either 0.8% or 1.2% 
(w/v) agarose gels in Tris-acetate buffer, as appropriate. The DNA was 
transferred monodirectionally to a Hybond N + nylon membrane (Amersham 
International) according to the manufacturer's instructions. Radiolabelled DNA, 
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described above, was used to probe these membranes (Southern, 1975; Smith and 
Summers, 1980). 
5.3 Results 
5.3.1 Screening of the C. acetobutylicum gene library 
E.coli F19 was used as the host to screen the C. acetobutylicum gene library for 
genes conferring metronidazole sensitivity. Although this mutant was very 
sensitive towards the reduced toxic derivative(s) of metronidazole due to a recA 
mutation, it was resistant to metronidazole since it was deficient in 
nitroreductase activity associated with the reduction of metronidazole. The 
screening of the C. acetobutylicum gene library in E.coli F19 selected for genes that 
complement the metronidazole reducing ability which is lost in this mutant. 
Twenty six stable clones were isolated that showed an increased sensitivity 
towards metronidazole. Plasmid involvement in metronidazole susceptibility 
was confirmed by retransformation experiments with plasmids isolated from the 
26 clones. Plasmids from each clone retransformed into E.coli F19 produced 
similar numbers of ampicillin resistant and metronidazole sensitive 
transformants. 
5.3.2 Oassification of clones based on MIC 
The 26 metronidazole sensitive clones were classified into five groups (1-V) based 
on their susceptibility to metronidazole, where class V was the most sensitive 
group and class I was the least sensitive group (Table 5.1). All clones were more 
sensitive to metronidazole than the E.coli F19 mutant. 
5.3.3 Tests for enzyme activity 
Since it has been reported that clostridial enzymes, pyruvate-Fd-oxidoreductase 
(Narikawa, 1986) and hydrogenase (Church et al., 1988, 1990) may be responsible 
for the reduction of metronidazole, cell extracts of all 26 clones were tested for 
these enzymes. Since the enzyme activity responsible for the reduction of 
metronidazole in E.coli involves a nitroreductase (Yeung et al., 1984), the 26 
clones were also tested for nitroreductase activity. No significant nitroreductase 
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Table 5.1 Metronidazole sensitivity of the twenty six E.coli clones containing 
recombinant plasmids with DNA inserts from C. acetobutylicum gene library. 
MIC's were determined under conditions of anaerobic respiration and 
fermentation. 
Isola tea 
MIC (µg ml-1) 
respiration fermentation 
Sensitivity 
Classb 
F19c 35 15 -
CC11Bc 20 6 -
pMET11B <5 <1 V 
pMET13A <5 <1 V 
pMET13Cl <5 <1 V 
pMET030 <5 <1 V 
pMET190 <5 <1 V 
pMET4B 10 3 IV 
pMET5E 10 3 IV 
pMET10B 10 3 IV 
pMET9D 12 4 III 
pMETlOD 12 4 III 
pMET14B 12 4 III 
pMET2D 15 5 II 
pMET4A 15 5 II 
pMET8E 15 5 II 
pMETlA 20 6 I 
pME17A 20 6 I 
pME17C 20 6 I 
pMET9A 20 6 I 
pMET13B 20 6 I 
pMET13C2 20 6 I 
pMET15B2 20 6 I 
pMET15D 20 6 I 
pMET020 20 6 I 
pMET040 20 6 I 
pMET130 20 6 I 
pMET140 20 6 I 
11 All isolates represent C. acetobutylicum DNA cloned into plasmid pEcoR251 
which was transformed into E.coli F19. 
b Sensitivity class is a arbitrary numbering system based on the observed MIC. 
Class Vis the most sensitive class towards metronidazole whereas Class I is the 
least sensitive class. 
c E.coli strains CC118 and F19 are included as controls for comparative 
purposes. Plasmid pBR322 was transformed into these control strains m order 
to determine the MIC on the same medium as the clones, which contained 
ampicillin. 
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Table 5.2 Hydrogenase activity in cell free extracts of E.coli strains and 
C. acetobutylicum P262. 
Strain 
C. acetobutylicum P262 
E.coli Puig426 [pBR322] 
E. coli SE53 [pBR322] 
E.coli SE53 [pMET15B2] 
Hydrogenase Activity 
(µl H2 mg protein-I min-I) (µmol H2 mg protein-I min-I) 
28.18 
4.04 
0.22 
1.98 
1.152 
0.165 
0.008 
0.081 
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activity or pyruvate-Fd-oxidoreductase activity was detected in any of the clones. 
To test for hydrogenase activity, plasmids were transformed into E.coli SE53, 
which is a hydA mutant (Lee et al., 1985). Cell extracts prepared from the parent 
of E.coli SE53, E.coli Puig426, were used as a positive control along with cell 
extracts prepared from C. acetobutylicum P262. E.coli SE53 containing plasmid 
pMET15B2 was the only isolate that consistently tested positive for hydrogenase 
activity. Crude extracts of E.coli SE53 [pMET15B2] had approximately half the 
activity of E.coli Puig426 extracts and only 7% of the activity of C. acetobutylicum 
P262 extracts (Table 5.2). All other clones showed hydrogenase levels 
comparable to the negative control which was E. coli SE53 containing plasmid 
pBR322. 
5.3.4 PAGE studies 
SDS-PAGE was carried out on crude extracts of the 26 clones in an attempt to 
determine if any obvious extra protein bands were present. A crude extract of 
E.coli F19 transformed with pBR322 was used as a control. The presence of one 
extra protein band was noted in each of the clones pMET7 A, pMET7C and 
pMET14B (Fig. 5.1). Clones pMET7 A and pMET7C are class I isolates, whereas 
clone pMET14B is a class III isolate. These extra protein bands had an apparent 
Mr of approximately 33, 105 and 44 kDa for clones pMET7 A, pMET7C and 
pMET14B respectively. 
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Fi~e 5.1 SOS-PAGE of extracts of E.coli F19[pMET14B] cells (lane B), E.coli 
F19[pME17 A] cells (lane D), E. coli F19[pME17C] cells (lane E) and E. coli 
F19[pBR322] cells (lane F). Lanes A, C and G contained Pharmacia low 
molecular weight standards (phosphorylase b, 94 kDa; bovine serum albumin, 
67 kDa; ovalbumin, 43 kDa; and carbonic anhydrase, 30 kDa). The arrows 
indicate the positions of the extra protein bands in extracts of clones pME17 A, 
pME17C and pMET14B. 
5.3.5 DNA hybridization studies 
To determine the relatedness of the 26 clones, DNA hybridization studies were 
performed. Each plasmid as well as pEcoR251 with no insert, was nick 
translated to yield a total of 27 radiolabelled probes. Unlabelled plasmids were 
digested to completion with HinF1 endonuclease which has a four base pair 
recognition sequence, and were fractionated by electrophoresis in 1.2% (w /v) 
agarose gels in Tris-acetate buffer. Since HinF1 is a four base pair cutter, it was 
assumed that at least one fragment consisting of only C. acetobutylicum insert 
DNA would be generated for each plasmid. Twenty seven agarose gels were 
prepared, each containing HinF1 digestions of all 26 plasmids plus pEcoR251. 
Each of these agarose gels was blotted onto a nylon membrane and probed with 
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Table 5.3 Results of cross hybridization studies of the twenty six plasmids 
isolated from the C. acetobutylicum gene library. All plasmids were composed of 
the pEcoR251 vector containing C. acetobutylicum insert DNA. 
Plasmid Insert Cross Hybridized with 
Probe Size (kb) Plasmid Plasmid Plasmid 
pMETlA 5.15 - - -
pMET2D 4.90 pMET14B - -
pMET4A 1.20 - - -
pMET4B 4.30 pMET5E - -
pMET5E 4.30 pMET4B - -
pMET7A 6.35 - - -
pMET7C 6.05 pMET140 - -
pMET8E 5.35 pMET13B - -
pMET9A 5.20 - - -
pMET9D 4.75 - - -
pMETlOB 2.25 pMET040 - -
pMETlOD 6.75 - - -
pMETllB 7.60 - - -
pMET13A 6.65 pMET15B2 pMET030 pMET190 
pMET13B 6.10 pMET8E - -
pMET13Cl 4.80 - - -
pMET13C2 5.65 - - -
pMET14B 9.90 pMET2D - -
pMET15B2 1.00 pMET13A pMET030 -
pMET15D 9.60 pMET130 - -
pMET020 6.25 - - -
pMET030 7.05 pMET13A pMET15B2 pMET190 
pMET040 3.35 pMETlOB - -
pMET130 4.75 pMET15D - -
pMET140 5.25 pMET7C - -
pMET190 7.95 pMET13A pMET030 -
a different plasmid probe. Probing one of these gels with radiolabelled 
pEcoR251 (no insert) yielded an autoradiograph showing all DNA fragments 
containing vector DNA. The other plasmid probes yielded autoradiographs 
showing the extent of cross hybridization between the clones (Table 5.3). 
From restriction endonuclease digests and these DNA hybridization studies, 
only isolates pMET4B and pMETSE contained identical inserts (Fig. 5.2). 
Therefore, of the 26 clones, 25 individual cloning events were represented. Ten 
of the clones hybridized only with themselves, 12 hybridized with one other 
clone, and 4 hybridized with two or more clones. The 12 clones that hybridized 
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Figure 5.2 A 0.8% (w /v) agarose gel showing the identity between clones 
pMET4B and pMETSE. Lanes C and H contain stze markers of bacteriophage A 
DNA which was digested to completion with Pstl. Lanes A, D, F and I contain 
pMET4B plasmid DNA which was digested with Hindi, Pstl, Sspl and HinDIII 
respectively. Correspondingly, Lanes B, E, G and J contain pMETSE plasmid 
DNA which was digested with Hincll, Pstl, Sspl and HinDill respectively. In all 
cases, the digestion pattern of both pMET4B and pMETSE were identical. 
with one other clone may represent different size fragments of the same region of 
C. acetobutylicum DNA. Therefore, the area of C. acetobutylicum DNA containing 
the active region may be completely contained on each of the two clones or 
alternatively, a truncated version may exist on one of the clones. The latter may 
explain why there are differences in the sensitivity class of two clones that 
hybridized with each other. The four clones, pMET13A, pMET15B2, pMET030 
and pMET190, make up the most intriguing group, ie. those clones that 
hybridized with 2 or more other clones. It is interesting to note that with the 
exception of clone pMET15B2, all of the isolates in this group have a class V 
sensitivity to metronidazole. This may indicate that clones pMET13A, pMET030 
and pMET190 all contain the same active region from the C. acetobutylicum 
chromosome. This is supported by the fact that pMET13A, pMET030 and 
pMET190 
pMET030 
pMET13A 
pMET1582 
== 
-
-~~_g 
J: J:X 
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Figure 5.3 Restriction endonuclease map showing the relationship between 
clones pMET13A, pMET15B2, pMET030 and pMET190. The arbitrary 
metronidazole sensitivity class is shown on the right of each clone ma?· The 
striped region represents the area necessary to exhibit the class V metromdazole 
sensitivity phenotype in E.coli F19. 
pMET190 all hybridized with each other, whereas clone pMET15B2 only 
hybridized with clones pMET13A and pMET030. 
5.3.6 Restriction endonuclease mapping and deletion studies 
The relationship between clones pMET13A, pMET15B2, pMET030 and pMET190 
was determined by restriction endonuclease mapping. The restriction map of the 
insert DNA of these four clones is shown in Fig. 5.3. As can be seen from these 
restriction maps, insert DNA of clone pMET15B2 is completely contained within 
clones pMET13A and pMET030. Furthermore, insert DNA of clone pMET15B2 
overlaps slightly with clone pMET190, however this was not identified in the 
hybridization studies. This is most likely due to the experimental design of the 
hybridizations, in that the probes used contained insert DNA as well as 
pEcoR251 vector DNA. The small overlap from clone pMET190 was most likely 
linked to pEcoR251 vector DNA and was therefore disregarded, as it hybridized 
with the pEcoR251 (vector only) probe. Although pMET030 and pMET13A 
contained the same region as pMET15B2, which showed hydrogenase activity, 
these two plasmids did not express hydrogenase activity in E. coli SE53. 
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Figure 5.4 Southern blot analysis of five clones that show class V sensitivity 
towards metronidazole. The agarose gel is shown on the left and the 
corresponding autoradiograph on the right. The 1.6 kb Styl-EcoRV fragment 
from pMET13A was nick translated and used to probe against Styl-EcoRV 
digested DNA from: E.coli chromosome (lane A); C. acetobutylicum chromosome 
(lane B); pMET13A plasmid (lanes C, D, and E); pMETllB plasmid (lane G); 
pMET13C1 plasmid (lane H); pMET030 plasmid (lane I); and pMET190 plasmid 
(lane J) . Lane F contains Pstl digested A DNA as size standards. 
By performing restriction endonuclease deletions of the insert DNA of clone 
pMET13A, the region responsible for class V sensitivity to metronidazole was 
localized to a 2 kb EcoRI-EcoRV fragment (Fig. 5.3). To verify that this DNA 
originated from C. acetobutylicum P262, Southern blot analysis was performed 
using the Styl-EcoRV fragment from clone pMET13A as a probe (Fig. 5.4). 
Chromosomal DNA isolated from C. acetobutylicum and E. coli (negative control), 
as well as plasmid DNA isolated from clones pMETl 1 B, pMET13A, pMET13C1, 
pMET030 and pMET190 was digested with Styl and EcoRV and the resulting , 
fragments were separated by electrophoresis in 0.8% (w /v) agarose in Tris-
acetate buffer. The Styl-EcoRV probe hybridized to Styl-EcoRV fragments of 
identical size from clones pMET13A, pMET030 and pMET190, as well as a 
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Styl-EcoRV fragment of identical size from C. acetobutylicum chromosomal DNA 
No hybridization to the E.coli chromosomal DNA was demonstrated. This 
indicates that the region of DNA responsible for class V sensitivity in clone 
pMET13A is contained within clones pMET030 and pMET190, and also verifies 
that this DNA originated from the C. acetobutylicum chromosome. Plasmids 
pMET11B and pMET13Cl were included in this Southern blot analysis because 
they also demonstrated class V sensitivity to metronidazole. Since the active 
region from pMET13A did not hybridize with either pMETl 1 B or pMET13Cl, 
the class V sensitivity to metronidazole associated with these clones is separate 
and unique from that found on clones pMET13A, pMET030 and pMETl 90. 
5.4 Discussion 
The E.coli F19 recA, nitroreductase deficient mutant proved to be a most suitable 
host for the isolation of recombinant plasmids. Screening experiments resulted 
in the isolation of 25 different recombinant plasmids which contain C. 
acetobutylicum DNA coding for genes involved in the activation of 
metronidazole. The E.coli F19 mutant can be utilized for the isolation of genes 
from other bacteria which are involved in the reduction of metronidazole. 
Furthermore, a recA+ revertant of E.coli F19 has been isolated (Fig. 5.5). 
Therefore, a battery of E.coli strains and C. acetobutylicum genes exists for testing 
the activities of novel antimicrobial compounds related to metronidazole. It can 
be inferred whether a compound needs to be reduced to become active and 
whether the active compound is related to DNA repair by comparing the 
sensitivity of the various strains, with and without the cloned genes, to these 
novel compounds. 
In choosing enzyme systems which may be controlled by the 25 plasmids, it was 
obvious that nitroreductase activity should be analyzed. However, in strict 
anaerobes such as C. acetobutylicum, where oxygen can not be utilized as the 
terminal electron acceptor, other electron transport mechanisms also exist. These 
electron transport systems typically operate at a much lower redox potential than 
nitroreductase systems. Ferredoxin is a low molecular weight, iron-sulfur 
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Figure 5.5 Results of a UV dose experiment demonstrating the recA- and recA+ 
isolates of E.coli strain F19. The recA+ isolate (top streak) survived a 25 sec 
exposure to UV light (1 J m2 sec-I), whereas the recA- isolate (bottom streak) was 
killed with a 10 sec exposure. 
containing protein which can accept and donate electrons at a very low potential 
approaching that of the hydrogen electrode (E0' = -410 mV) (Jones and Woods, 
1986a). This molecule plays a crucial role as an electron carrier in electron 
distribution in the cell. Oxidized ferredoxin accepts electrons during the 
phosphoroclastic conversion of pyruvate to acetyl CoA. The enzyme responsible 
for this conversion and electron transfer is the pyruvate-Fd-oxidoreductase. 
Reduced ferredoxin can transfer electrons to the iron-containing hydrogenase 
which uses protons. as the final electron acceptor. A simplified schematic of this 
electron transport system is shown in Fig. 5.6. Like ferredoxin, flavodoxin is a 
small acidic molecule that functions as a low potential electron transfer protein 
(Krey et al., 1988). The redox potential of the semiquinone/hydroquinone couple 
is approximately -450 mV (Mayhew and Ludwig, 1975). Flavodoxin was first 
isolated from C. pasteurianum grown under iron deficient conditions (Knight et 
al., 1966) and it was shown to be able to replace ferredoxin as an electron carrier 
(Knight and Hardy, 1966; Knight and Hardy, 1%7). 
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Figure 5.6 A simplified schematic of the C. acetobutylicum electron transport 
system. The relationship between oxidized ferredoxin (Fd0 x), reduced ferredoxin (Fdred), pyruvate-Fd-ox1doreductase (A) and hydrogenase (B) is shown. In the 
absence of metronidazole, electrons are transferred to Fd0 x by pyruvate-Fd-
oxidoreductase. Hydrogenase transfers electrons from Fdred to protons to form 
hydrogen gas. In the presence of metronidazole, electrons may fie transferred to 
metronidazole (MET) by pyruvate-Fd-oxidoreductase to form the reduced toxic 
derivative of metronidazole (M*), which causes DNA damage (Narikawa, 1986). 
Alternatively, [MET] may re_Elace protons and be reduced to [M*] by the action 
of the hydrogenase enzyme (Church et al., 1988, 1990). 
The theory proposed by Narikawa (1986) that the enzyme pyruvate-Fd-
oxidoreductase is responsible for the reduction of metronidazole to its active 
intermediates, assumes that metronidazole replaces oxidized ferredoxin in the 
phosphoroclastic breakdown of pyruvate to acetyl CoA (Fig. 5.6). It is therefore 
surprising that none of the clones isolated in this study demonstrated 
nitroreductase or pyruvate-Fd-oxidoreductase activity, but this does not rule out 
the possibility that C. acetobutylicum nitroreductase or pyruvate-Fd-
oxidoreductase can reduce metronidazole to its active form. The assay system 
used to measure pyruvate-Fd-oxidoreductase activity uses the artificial electron 
acceptor, methyl viologen, as the indicator of enzyme activity. In principal, 
pyruvate-Fd-oxidoreductase transfers electrons from the breakdown of pyruvate 
to oxidized methyl viologen, which is colourless. This in tum forms reduced 
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methyl viologen which is blue in colour and can be measured 
spectrophotometrically at 600 nm. Unfortunately, extracts prepared from 
anaerobically respiring E.coli cells are able to reduce methyl viologen in the 
absence of additional pyruvate. No increase in the rate of reduction of methyl 
viologen was observed in extracts prepared from the isolated clones. One or 
more of the clones may indeed contain the gene for the pyruvate-Fd-
oxidoreductase, however these can only be identified by employing more 
specific and sensitive techniques. 
O'Brien and Morris (1972) studied the effects of metronidazole on hydrogen 
production in C. acetobutylicum. These authors reported that when sub-inhibitory 
concentrations of metronidazole were added to C. acetobutylicum cultures, 
hydrogen evolution ceased until the presence of metronidazole could no longer 
be detected. Despite the inhibitory effect of metronidazole on hydrogen 
production, no alteration in carbon dioxide production occurred. This indicates 
that electrons normally utilized for hydrogen production were siphoned away 
for metronidazole reduction. The lack of hydrogen production could have been 
caused by electrons being transferred to metronidazole instead of ferredoxin. In 
this case, no electrons would be available for the hydrogenase enzyme 
component of the C. acetobutylicum electron transport cycle. Alternatively, in 
support of the theory of Church et al. (1988, 1990), the hydrogenase enzyme 
could have been responsible for the reduction of metronidazole, where 
metronidazole replaced protons as the final electron acceptor. Another 
possibility is that reduced ferredoxin directly transfered electrons to 
metronidazole without enzyme action. In all of these cases, electrons would not 
be available for the production of hydrogen gas (Fig. 5.6). 
The enzymes NADH- and NADPH-Fd-oxidoreductase (Jungermann et al., 1973; 
Jungermann et al., 1976; Petitdemange et al., 1976) may operate at a low enough 
redox potential to activate metronidazole. Attempts were made to assay these 
enzymes in E.coli using NAD(P)H as the indicator. Unfortunately, extracts 
prepared from anaerobically respiring E.coli cells were able to efficiently reduce 
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these indicator compounds, making it extremely difficult to specifically assay for 
these oxidoreductases. 
E.coli [pMET15B2] was the only transformant that demonstrated hydrogenase 
activity, which was approximately half of the activity of the wild type E. coli 
strain Puig426 (Table 5.2). Voordouw et al. (1985) reported very low levels of 
hydrogenase activity for the Desulfovibrio vulgaris hydrogenase cloned into E.coli. 
E.coli therefore may not be a suitable host for expressing hydrogenase activity 
and perhaps lacks the necessary electron carriers required by the C. 
acetobutylicum hydrogenase. The fact that E. coli [pMET15B2] was a class I isolate 
may be related to the low levels of hydrogenase activity. Since only one of the 25 
different recombinant plasmids encoded an enzyme that was likely to be 
involved in metronidazole reduction suggests that either these enzyme activities 
are unstable and difficult to assay in E.coli or there are some interesting genes 
encoding proteins not before considered to be involved in metronidazole 
reduction. 
Since the insert DNA of plasmid pMET15B2 is completely contained in the insert 
DNA of plasmids pMET13A and pMET030, it is surprising that hydrogenase 
activity was not detected in cell free extracts prepared from E.coli SE53 
transformed with these plasmids. It can be speculated that the hydA mutation in 
E. coli SES3 can only be complemented by pMET15B2 because it lacks the 
additional DNA found in pMET13A and pMET030. Another possibility is that 
other coding regions contained on pMET13A and pMET030 interfere with the 
hydrogenase assay. 
DNA hybridization and restriction endonuclease mapping revealed that 
pMET13A, pMET15B2, pMET030 and pMET190 were linked. The total length of 
chromosomal DNA from C. acetobutylicum represented by pMET13A, pMET15B2, 
pMET030 and pMET1_90 is approximately 11.1 kb. This 11.1 kb DNA fragment 
from C. acetobutylicum contained at least two genes involved with electron 
transfer systems capable of activating metronidazole. The insert DNA in 
pMET190 and pMET13A are in opposite orientations with respect to the vector 
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DNA indicating that in E.coli, the gene responsible for metronidazole activation 
is most likely transcribed from a promoter present on the insert. 
Restriction endonuclease deletion studies, and Southern blot analysis (Fig 5.4) 
revealed that the region responsible for class V sensitivity to metronidazole on 
clones pMET13A, pMET030 and pMET190 was contained on a 2 kb EcoRI-EcoRV 
fragment (Fig. 5.3). Since difficulties were encountered in measuring C. 
acetobutylicum electron transport enzymes in E.coli, and considering that this 
class V active region was independently cloned three times, it was decided to 
proceed with nucleotide sequence analysis in an effort to determine what gene 
product or products are coded for by this 2 kb fragment. Nucleotide sequencing 
and analysis of this region are the topics of the next chapter. 
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Chapter 6 
Nucleotide sequencing and sequence analysis of selected 
metronidazole sensitive clones 
6.0 Summary 
The 2 kb EcoRI-EcoRV from pMET13A was shown to be the region responsible 
for class V sensitivity to metronidazole (Chapter 5). The nucleotide sequence of 
this fragment was determined and found to be 1 902 bp in length. Analyses of 
the sequence data revealed the presence of two truncated open reading frames 
(ORF1 and ORF3) and one complete open reading frame (ORF2) which was 
responsible for class V sensitivity of E.coli F19 [pMET13A]. The deduced amino 
acid sequence (160 amino acids) of ORF2 showed good similarity with amino 
acid sequences of flavodoxin proteins from many organisms. Based on 
alignments to the amino acid sequences of these flavodoxins, as well as the fact 
that Chen and Blanchard (1979) reported that reduced flavodoxin can transfer 
electrons to metronidazole, the sequence corresponding to ORF2 was identified 
as coding for a flavodoxin gene from C. acetobutylicum. Analyses of the deduced 
amino acid sequences of ORF1 and ORF3 did not result in the identification of 
these gene products. 
Analysis of the nucleotide sequence of other cloned C. acetobutylicum genes 
resulted in the compilation of a codon usage table. Comparison of these codon 
usage statistics with the codon usage in the nucleotide sequence of the 
EcoRI-EcoRV fragment of pMET13A revealed that ORF1, ORF2 and ORF3 
contained relatively few rare C. acetobutylicum codons. The presence of putative 
consensus promoter and termination sequences relating to these open reading 
frames is discussed. 
Partial nucleotide sequence data of the C. acetobutylicum insert DNA on plasmid 
pMET11B is presented. E.coli F19 [pMET11B] also showed class V sensitivity 
towards metronidazole. One large open reading frame was located in this 
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sequence and the deduced amino acid sequence showed good similarity with 
spoIID proteins from B. subtilis and B. amyloliquefaciens 
The role of flavodoxin in C. acetobutylicum and other organisms is presented. 
Possible relationships between the cloned C. acetobutylicum flavodoxin gene and 
metronidazole sensitivity are discussed. 
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6.1 Introduction 
Chapter 5 described the isolation of 25 E.coli F19 clones which carried different 
recombinant plasmids containing C. acetobutylicum DNA coding for genes 
involved in the activation of metronidazole. These 25 clones were classified into 
5 groups (I-V) based on their sensitivity towards metronidazole. The class V 
group, which was most sensitive to metronidazole, consisted of 5 clones of which 
3 (pMET13A, pMET030 and pMET190) contained overlapping insert DNA. All 
three of these clones contained the 2 kb EcoRI-EcoRV fragment identified as being 
responsible for the class V activity. Since no enzyme activity could be detected in 
any of the class V isolates, and since the active EcoRI-EcoRV fragment was 
isolated as 3 independent cloning events, obtaining the DNA sequence of this 
region was deemed necessary for identification of the gene or genes responsible 
for metronidazole activation. 
This chapter describes the DNA sequencing, characterization and amino acid 
homology of the 2 kb EcoRI-EcoRV fragment responsible for class V activity in 
the above 3 clones. Preliminary sequence data and analysis of another class V 
isolate (pMET11 B) is also presented. 
6.2 Materials and Methods 
Commonly used materials and techniques are presented in the Appendices. The 
details provided below are included for completeness. 
6.2.1 Chemicals 
Restriction endonucleases were obtained from several sources and were used as 
specified by the manufacturers. The enzymes exonuclease Ill, 51 nuclease and 
DNA polymerase I Kienow fragment (PolIK) were obtained from Boehringer 
Mannheim Biochemicals. [a-355] dATP was obtained from Amersham 
International. All other chemicals were analytical grade and were purchased 
from various local suppliers 
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6.2.2 Bacterial strains and plasmids 
The E.coli strains used throughout this study are described in Appendix C. 
E.coli strain LK111 (Zabeau and Stanley, 1982) was used as the host for the 
exonuclease III shortened templates, whereas E.coli F19 was used as the host for 
the determination of MIC values. Plasmid pMET13A was used as the primary 
source of DNA. The M13 derived "BlueScript" phasmid vector (Stratagene, San 
Diego, CA) was used for the preparation of templates for DNA sequencing as 
described below. 
6.2.3 Media and buffers 
All media and buffers not described in the text are presented in Appendix A. 
The E. coli strains were grown as described in section 4.2.2. 
6.2.4 Preparation of DNA 
Plasmid DNA was prepared by the alkali-hydrolysis method of Ish-Horowicz 
and Burke (1981). The small-scale (miniprep) and large-scale (maxiprep) 
methods of plasmid isolation are described in Appendix B. To ensure high 
quality preparations, plasmid DNA used for nucleotide sequencing was always 
purified on a cesium chloride gradient (Appendix B). 
6.2.5 Sequencing strategy 
Restriction endonuclease mapping and deletion studies of plasmid pMET13A 
(chapter 5), showed that the region responsible for class V sensitivity to 
metronidazole was contained on a 2 kb EcoRI-EcoRV restriction fragment. This 
EcoRI-EcoRV fragment was subcloned into the BlueScript vector (orientation KS) 
which had been linearized with EcoRI and HinCII endonucleases, to yield 
plasmid pSEQ13A (Fig. 6.1). The BlueScript vectors have a large multiple 
cloning region which contains 26 unique restriction sites. This large multiple 
cloning region made it possible to chose a unique restriction site for DNA 
shortening, using the exonuclease III technique (Henikoff, 1984, 1987). Since the 
active region of pMET13A had been subcloned into the middle of this large 
multiple cloning region, pSEQ13A was suitable for the generation of shortened 
fragments from both directions of the insert. 
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6.2.6 Exonudease III shortening 
Progressive deletions of plasmid pSEQ13A from both the 5' and 3' ends of the 
insert were generated by unidirectionally digesting BstXI-BamHI and KpnI-ClaI 
restriction endonuclease fragments with exonuclease III (Henikoff, 1984, 1987). 
After digestion, the linearized plasmid (approximately 12 µg) was precipitated 
with isopropanol, resuspended in 100 µl Exo-buffer, and equilibrated at 37°C for 
5 min. Eleven microfuge tubes containing 25 µl of ice cold 51 nuclease mixture 
were prepared just prior to initiation of the shortening reaction and were kept on 
ice. A time zero sample (9 µ1) was removed to a tube containing 51 nuclease 
mixture before exonuclease III addition. The shortening reaction was carried out 
at 37°C and was initiated by the addition of 300 units of exonuclease III. 
Samples (9 µ1) were removed at 20 second intervals and immediately added to 
the 10 remaining microfuge tubes containing the 51 nuclease mixture. After the 
last sample was taken, the microfuge tubes were incubated at room temperature 
for 30 min for the 51 nuclease to digest single stranded DNA. The 51 nuclease 
reaction was stopped by the addition of 3.4 µl (per tube) of 51 stop solution, 
followed by incubation at 70°C for 10 min. The extent of shortening was checked 
by electrophoresis of approximately 200 ng of DNA (7 µl) from every second 
tube in 0.8% (w /v) agarose gels in Tris-acetate buffer. To facilitate the blunting 
of the exonuclease III generated ends, 0.5 units of PolIK was added to each tube 
followed by incubation for 5 min at room temperature. A further 5 min 
incubation was carried out in the presence of a mixture of dNTP's (0.125 mM 
each, A, C, G and T). The shortened DNA was recircularized by the addition of 
120 µI of ligation mixture to each tube, and these tubes were incubated at 15 ·c 
for 4 h. Competent E. coli LKl 11 cells were transformed with the ligation 
mixtures and transformants were selected on LB agar plates containing 
ampicillin (100 µg ml-1). 
6.2.7 Nucleotide sequencing 
The nucleotide sequence of both strands of the pMET13A active region was 
determined using overlapping DNA fragments generated by exonuclease III 
digestion as described above. Small scale (miniprep) preparations of 
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recombinant plasmids resulting from exonuclease III digestion of linearized 
pSEQ13A DNA were analyzed by restriction endonuclease mapping before large 
scale CsCl purified plasmid DNA was prepared for nucleotide sequencing. 
DNA sequencing was carried out by the dideoxynucleotide triphosphate chain 
termination method developed by Sanger et al. (1977), according to the protocol 
of Tabor and Richardson (1987), using the Sequenase DNA sequencing kit (U.S. 
Biochemical Corporation, Clevland, OH). The DNA chains were radiolabelled 
with [a..35S)dA TP (1 200 Ci mmol-1). The complete sequencing protocol, 
including preparation of template DNA, primer annealing, sequencing reactions, 
gel electrophoresis and autoradiography, is described in Appendix B. 
6.2.8 Sequence analysis 
The nucleotide and deduced amino acid sequences were analyzed on a 
VAX 6000-330 computer using the Genetics Computer Group Inc. suite of 
sequence analysis programs (Devereux et al., 1984). The databases GenBank 
(release 65.0, September 1990; Bilofsky et al., 1986), EMBL (release 24.0, August 
1990; Hamm and Cameron, 1986), SWISS-Protein (release 15.0, August 1990; 
Hamm and Cameron, 1986), NBRF-Nucleic (release 36.0, April 1990; George et 
al., 1986) and NBRF-Protein (release 25.0, June 1990; George et al., 1986) were 
searched for related nucleotide and amino acid sequences. Since the EMBL, 
GenBank and Swiss-protein databases are updated daily, further homology 
studies were later carried out via electronic mail to the GenBank file server 
(SEARCH@GENBANK.BIO.NET) (Yudin, 1990) and the EMBL file server 
(FASTA@EMBL.BITNET) (Stoehr and Omond, 1989). 
6.3 Results 
6.3.1 Isolation of sequencing templates 
The exonuclease III shortening method was utilized to obtain overlapping 
shortened fragments for the sequencing of pSEQ13A insert DNA in both 
directions. It was necessary to subclone one small fragment (H2) to complete the 
sequence. Eleven overlapping clones were required to complete the sequence of 
the coding strand, and similarly, 11 clones were necessary to complete the 
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Figure 6.1 Sequencing strategy for plasmid pSEQ13A containing insert DNA 
from C. acetobuty1icum P262. The insert DNA is indicated by the bold line and the 
thin line represents BlueScript KS vector DNA. The arrows indicate the extent of 
sequence obtained from each clone. Clone names are written below each arrow. 
Clone H2 was constructed from a HinFI-Xhol fragment of clone L21. This 
fragment was subcloned into BlueScript KS vector that had been restricted with 
EcoRV and Xhol. This subclone was necessary to complete the sequence of the 
coding strand. The three identified open readmg frames ORF1, ORF2 and ORF3 
are indicated by the hatched regions. The clone L12 (indicated by a dashed line) 
was not necessary to complete the sequence of the coding strand, but was used to 
locate the region responsible for metronidazole activation. 
sequence of the non-coding strand. The extent of the sequence obtained from 
each clone is depicted in Fig. 6.1. 
6.3.2 DNA sequence data 
The nucleotide sequence of the EcoRI-EcoRV active region of pMET13A was 
determined to be 1 902 bp in length, and is shown in Fig 6.2. The nucleotide 
sequence of this fragment showed that two partial open reading frames (ORF1 
and ORF3 in Figs. 6.1 and 6.2) and one complete open reading frame (ORF2 in 
Figs. 6.1 and 6.2) were present. The first partial open reading frame (encoding 
159 amino acids) was truncated by the EcoRI site, and similarly the second partial 
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720 740 760 780 
EcoRI I I I I I I I I 
GA ATT CCT TTT A.TT ATT CCA GTC MT ACA GAG CCA GM ATA ATT AAA GCT CAA TTA GM MT GTA GAT GGA CTT ATT TTA TCA GGT GGT 
l P F I l P V N T E P E l K A Q L E N V D G L l L S G G 
800 820 840 860 880 
I I I I I I I I 
CAT GAT GTT AAC CCA TTA TTA TTT AAT GM GM CCA CAT MG CTT TTG GGA AAT ACA ATG AAT GM AGA GAC ACA TTT GAT TCT ATG TTA 
H D V N P L L F N E E P H K L L G N T M N E R D T F D S M L 
900 920 940 960 
I I I I I I ! I I 
ATA AAA TAT GCA TTT GM ATG GM MG CCT ATC TTA GGT ATT TGT AGG GGA TGC CAA ATT TTA AAT GTT GTA TGT GGT GGA ACA TTA TAT 
! K Y A F E M E K P l L G l C R G C Q l L N V V C G G T L Y 
980 1000 1020 1040 1060 
I I I I I I I I I 
CAA GAT TGT TCC TTG GCA AAG GAT TCG TAT ATA AAA CAT TGT CAA GGG CAT ACA CCA GCA CAA CCT TCT CAT ACG ATA CAG ATT GAA AAA 
Q D C S L A K D S Y I K H C Q G H T P A Q P S H T l Q I E K 
1080 1100 1120 1140 
I I I I I I I I I 
AAT TCT GAA TTA TAT ACT ATT TTA GGA GAA AAA GCT CTT GCA AAT TCA TTT CAT CAT ATG TCT ATA AAA GAT GTT GCG GAT GGA TTT AAG 
N S E L Y T ! L G E K A L A N S F H H M S I K D V A D G F K 
1160 1180 1200 1220 1240 
I I I I I I I I I 
GTA GTA GCT ATA GCT AAT GAT GAA ATT ATT GAA GCA ATA GAG AAG GTA GAT GGT TCT TTT GCA CTT GGA ACA CAA 
E K V D G S F A L G T Q 
TGG CAT CCA GAA ATG 
W H P E M V V A l A N D E l l E A I 
1260 1280 1300 1320 
I I I I I I I I I 
ATG GCA AGC AGT GAT GAA AAT ATG CTG AAA ATA TTT AAA TTA TTT ATA TCT AAA TGT AAG AAT AGT AGA TTA TAG AATGAGTAAAAATAAATTT 
M A S S D E N M L K l F K L F I S K C K N S R L 
1340 1360 1380 1400 1420 1440 
I I I I I I I I I I I I 
GAATTTTAAATTATATAGTTACTGAGTATTAATATTCATGATAAAAAAAATGATAGCAAAAACTAAAATGTTACTATAAATTATTTTGGTATTAACAAAAGCATTGTGCATGATGTGGA 
1460 1480 1500 1520 1540 1560 
I I I I I I I I I I I 
ATTATTAATTCCAAGATGATACAATAAGTCTAAAATATACAATTTAATTATTTTAAACAATATAGTTTTTAATTIQQtQQ•TTTTATCA ATG AAA ATA TCA ATA CTA TAC 
M K I S I L Y 
1580 1600 1620 1640 
I I I I I I I I I 
AGT AGC AAG ACA GGA AAA ACC GAA AGA GTT GCC AAG TTA ATT GAA GAA GGT GTG AAG AGG TCT GGA AAT ATT GAA GTA AAA ACT ATG AAT 
S S K T G K T E R V A K L I E E G V K R S G N I E V K T M N 
1660 1680 1700 1720 1740 
I I I I I I I I I 
TTA GAT GCA GTT GAT AAA AAG TTC TTA 
L D A V D K K F L 
CAA GAA TCA GAA GGA ATT ATT TTT GGA ACA CCA ACT TAT TAT GCC AAC ATA TCA TGG GAA ATG 
Q E S E G I I F G T P T Y Y A N I S W E M 
1760 1780 1800 1820 
I I I I I I I I I 
AAA AAA TGG ATA GAT GAA TCA TCA GAA TTT AAT TTA GAA GGA AAA CTT GGA GCA GCA TTT TCA ACA GCT AAC TCT ATT GCT GGT GGT TCA 
K K W I D E S S E F N L E G K L G A A F S T A N S I A G G S 
1840 1860 1880 1900 1920 
I I I I I I I I I 
GAT ATA GCA TTA CTT ACA ATT TTA AAT CAT CTT ATG GTA AAA GGA ATG TTA GTA TAT TCA GGT GGA GTT GCT TTT GGA AAA CCA AAG ACT 
D I A L L T I L N H L M V K G M L V Y S G G V A F G K P K T 
1940 
I I I 
CAT TTA GGA TAT GTG CAT ATA AAT GAA ATA 
H L G Y V H I N E I 
1960 1980 2000 
I I I I I I 
CAA GAA AAT GAA GAT GAA AAT GCG AGA ATA TTT GGT GAA AGA ATT GCA AAC AAA GTC AAA 
Q E N E D E N A R I F G E R I A N K V K 
2020 2040 2060 2080 2100 2120 
I I I I I I I I I I I 
CAA ATA TTT TAA TGTAAAAATGTATATATAAATTGATTAATAATTTAAAAATATACAATATTATAATATTGAGAGCGAAGTTTATAATATGTTATAAATTAATAAAAATAGATGG 
Q I F 
2140 2160 
I I I I 
AiaGiiilATGTTATT ATG AAT GAA GTA TTA CAA 
M N E V L Q 
2180 
I I I 
AAT ATT TTA ACA AGA AGA AGT GTA AGA AAA TTT AAA 
N I L T R R S V R K F K 
2200 2220 
I I I 
CAA GAA CAA ATA AAA GAT GAG GAA 
Q E Q l K D E E 
2240 2260 2210 2300 
I I I I I I I I I 
CTA GAT TTA ATA TTA AAA GCT GGA GTA TAT GCA CCA AGT GGT ATG AAC AAG CAA AGT TGG CAG TTT ACA GTT GTT CAA AAT AAA GAA AAA 
L D L I L K A G V Y A P S G M N K Q S W Q F T V V Q N K E K 
2320 2340 2360 2380 2400 
I I I I I I I I I 
ATA GAA TCT CTT GCT AAA GTA GTC AGG GAA GCA TTA GGT AGA GAT GCA GGA TAT AAT TTT TAT GCA CCT CCT ACT TTA ATT ATG TTA TCT 
I E S L A K V V R E A L G R D A G Y N F Y A P P T L I M L 5 
2420 2440 2460 2480 
I I I I I I I I I 
AAT GAC AAA GAA AAT ACT AAT GGA TTG GCA GAT TGT TCT TGT GCA TTA GAA AAT ATA TTC TTA ATG GCT AAT TCA TTG GGT ATA GGT TCA 
N D K E N T N G L A D C S C A L E N I F L M A N S L G I G S 
2500 
I 
TGT TGG ATT AAT 
C W I N 
2520 2540 2560 2580 
I I I I I I I I 
CAA TTG AAA ACT ATT TGT GAT GAA AAG GAA GTA AGA GAA TTA TTA ACA AGC TTT GGA ATA CCA GAA AAC CAT ATT GTA 
Q L K T I C D E K E V R E L L T S F G I P E N H I V 
2600 
I I EcoRV 
TGG GGA ATG GCA TCG ATT GGA Tate 
W G M A S I G 
Nucleotide sequencing and analysis 119 
open reading frame (164 amino acids) was truncated by the EcoRV site. Further 
nucleotide sequence is necessary to complete these open reading frames. The 
complete open reading frame (160 amino acids) that lies between the two 
truncated open reading frames, is preceded by a 230 nucleotide intergenic region 
and followed by an 88 nucleotide intergenic region. This nucleotide sequence 
has been assigned the GenBank DNA sequence database accession number 
M36770. 
To determine the minimum sequence required for the activation of 
metronidazole, the plasmids resulting from exonuclease III shortening of 
pSEQ13A were transformed into E.coli F19 and tested for their ability to activate 
metronidazole. Loss of the ability to activate metronidazole was obtained with 
upstream shortenings after position 1 497 (shortened clones L12 through LS), 
which was 46 bp upstream from the ATG start codon for ORF2 (Figs. 6.1 and 6.2). 
In the opposite direction, shortened clones R9 through R24 were unable to 
activate metronidazole. Shortened clone R9 was missing DNA from position 
2 012 and resulted in the deletion of the last 4 amino acids of the protein product 
coded for by ORF2. This clearly indicated that ORF2 was responsible for the 
activation of metronidazole. 
6.3.3 Codon usage 
The GenBank database (release 65) contains six nucleotide sequences from C. 
acetobutylicum, and their locus names are as follows: CLOADH (Youngleson et 
al., 1989b), CLOBHBD (Youngleson et al., 1989a), CLOCBA (Hancock et al., 1991), 
CLOEGLA (.2appe et al., 1988), CLOGLNSA (Janssen et al., 1988) and CLOXYNB 
(.2appe et al., 1990). Furthermore, Gerischer and Diirre (1990) have submitted 
the nucleotide sequence for an acetoacetate decarboxylase (CLOADC) for 
inclusion in release 66 of the GenBank database. From the seven nucleotide 
sequences mentioned above, eight genes have been positively identified: an 
alcohol dehydrogenase (CLOADH), a J3-hydroxybutyryl CoA dehydrogenase 
(CLOBHBD), a P-galactosidase (CLOCBA), a J3-galactosidase regulatory protein 
(CLOCBA), an endoglucanase (CLOEGLA), a glutamine synthetase 
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(CLOCLNSA), a xylanase (CLOXYNB) and an acetoacetate decarboxylase 
(CLOADC). Using the coding regions for these eight genes, a codon frequency 
table was constructed (Table 6.1). The codon usage of these 8 genes reveals a 
bias towards the use of codons in which A and U predominate. In these 8 genes, 
11 codons(GCC,CGG,CGC,CUG,CUC,CCG,CCC,UCG,UCC,ACG,GUC) 
were used less than 5% of the time as compared to synonymous codons coding 
for the same amino acid. In the 3 identified open reading frames ORF1, ORF2 
and ORF3, 46, 40 and 41 of the possible 61 codons were utilized respectively. 
Furthermore, in all three of these open reading frames, only 35 codons were used 
more than once, and 9 codons (CGC, CGA, CGU, CGC, GGC, CAC, CUC, CCG, 
CCC) were not used at all. It is also interesting to note that in the 8 genes 
contained in the GenBank database, as well as in the 3 identified open reading 
frames from pSEQ13A, the stop codon UGA was never used to terminate the 
reading frame. 
Table 6.1 Codon usa9:e of 8 known C. acetobutylicum genes as compared to 
the 3 identified open rea ing frames of pSEQ13A. 
Identified C. iuetobutyliCMm genes b Totals pSEQ13A ORFs 
aa COD 11 A B C D E F G H Sum %' 1 2 3 
Ala CCC 4 0 3 0 0 1 1 3 12 6.0 1 1 0 
GCA 12 9 20 2 6 24 8 8 89 44.3 7 5 7 
CCU 18 21 10 0 21 15 3 6 94 46.7 4 3 3 
CCC 1 0 1 0 2 0 1 1 6 3.0 0 2 0 
Arg AGG• 0 1 2 2 0 0 0 2 7 6.6 1 1 1 
AGA• 9 9 27 1 3 19 4 4 76 71.0 2 3 5 
CCC- 0 0 0 0 0 0 0 0 0 0.0 0 0 0 
CGA• 0 0 4 2 0 0 2 1 9 8.4 0 0 0 
CCU 0 0 5 0 2 0 1 3 11 10.3 0 0 0 
CCC 0 0 1 1 0 0 1 1 4 3.7 0 0 0 
Asn AA~ 13 4 46 4 27 29 13 8 144 80.9 11 7 10 
AAC 1 4 8 3 4 6 7 1 34 19.1 1 3 2 
Asp GAU 18 15 51 3 20 26 5 17 155 85.2 10 5 5 
GAC 2 1 7 3 5 4 4 1 27 14.8 1 0 1 
Cys UGU 4 2 4 1 2 5 2 3 23 65.7 5 0 4 
UCC 1 1 3 3 2 1 1 0 12 34.3 1 0 0 
Gln CAG 0 0 10 0 6 0 6 2 24 27.6 1 0 1 
CAA 9 6 19 1 11 11 4 2 63 72.4 6 3 6 
Qu GAG 2 0 15 0 2 3 2 6 30 14.6 2 0 1 
CAA 30 22 63 3 11 31 7 8 175 85.4 14 15 12 
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Cly ccc• 1 0 8 2 0 1 1 2 15 7.2 1 0 0 
GGA• 14 20 32 1 15 23 9 10 124 59.6 7 10 6 
GGU 8 4 13 0 8 5 5 1 44 21.2 5 5 4 
GGC 3 1 3 0 6 3 9 0 25 12.0 0 0 0 
His CAU 10 1 11 0 5 8 5 41 75.9 8 3 1 
CAC 1 1 7 0 1 0 2 13 24.1 0 0 0 
lie AUN 9 4 24 5 23 3 6 7 81 38.0 9 9 6 
AUU 16 16 30 3 10 15 7 10 107 50.2 11 7 6 
AUC 2 8 5 1 2 3 3 1 25 11.8 1 0 0 
Leu uuc• 1 1 9 1 3 1 3 3 22 9.9 2 0 3 
UUA" 23 12 28 5 12 32 6 10 128 57.4 12 8 11 
cue 0 0 2 1 1 1 0 1 6 2.7 1 0 0 
CUA 6 1 8 1 0 4 0 0 20 9.0 0 1 1 
cuu• 2 5 16 1 4 1 4 9 42 18.8 4 3 1 
CUC" 0 0 1 1 2 0 0 1 5 2.2 0 0 0 
Lys AAG 14 7 21 5 8 7 5 6 73 30.8 6 5 2 
AAA 20 17 51 4 24 25 13 10 164 69.2 9 11 9 
Met AUG 16 11 22 4 11 13 6 9 92 100.0 7 5 5 
Phe uuu 15 7 34 1 17 16 8 7 105 80.1 9 6 4 
uuc 4 4 9 1 1 5 2 0 26 19.9 0 1 1 
Pro CCC 1 0 5 0 0 0 0 0 6 4.9 0 0 0 
CCA• 15 6 18 1 6 17 4 6 73 59.3 6 2 2 
ccu• 3 2 10 2 9 3 3 8 40 32.5 3 0 2 
CCC" 0 0 0 0 0 0 0 4 4 3.3 0 0 0 
Sa- AGU• 2 0 10 3 12 3 13 2 45 22.1 2 1 3 
AGC 0 3 7 2 4 0 5 5 26 12.7 1 1 1 
ucc• 1 0 0 1 1 1 0 1 5 2.4 1 0 1 
UCA• 13 12 24 2 19 4 6 1 81 39.7 2 8 2 
ucu 2 1 12 4 14 6 1 2 42 20.6 6 2 3 
ucc 0 0 2 1 1 0 1 0 5 2.5 1 0 0 
Tor ACG 0 0 3 0 0 0 4 2 9 4.5 1 0 0 
ACA• 16 5 23 4 21 12 12 6 99 49.0 6 4 3 
ACU 8 8 17 2 26 8 10 4 83 41.1 1 3 3 
ACC 0 0 2 2 2 0 4 1 11 5.4 0 1 0 
Trp UGG 2 1 21 0 10 4 7 1 46 100.0 1 2 3 
Tyr UAU 14 6 51 6 16 13 13 13 132 83.5 4 4 3 
UAC 1 1 9 1 6 4 3 1 26 16.5 0 1 0 
Val GUG 2 0 7 1 0 1 1 2 14 7.9 0 2 0 
CUA 12 8 20 0 10 13 4 7 74 41.6 5 3 6 
GUU 6 14 23 3 12 12 6 6 82 46.1 3 3 2 
GUC 1 0 0 0 2 1 3 1 8 4.4 1 1 1 
END UGA 0 0 0 0 0 0 0 0 0 0.0 0 0 0 
UAG 0 0 1 0 0 0 0 0 1 12.5 1 0 0 
UAA 1 1 0 1 1 1 1 1 7 87.5 0 1 0 
ii E.coli rare codons are marked by an asterisk (Ernst, 1988). 
b Identified C. acetobutylicum ~enes are as follows: A, alcohol dehydrogenase 
(Youngleson et al., 1989b; B, (3-hydroxybut[iZl CoA dehydrogenase 
(Youngleson et al., 1989a); C, (3-galactosidase ancock et al., 1991); D, 
(3-galactosidase rerlatory protein {Hancock et al., 1991); E, endoglucanase 
(Zappe et al., 1988; F, glutamine synthetase (Janssen et al., 1988); G, xylanase 
(Zappe et al., 1990); H, acetoacetate decarboxylase (Gerischer and Durre, 1990). 
c % total is expressed as the percentage of use within the group of synonymous 
codons. 
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It has been suggested that codon preference represents a bias for abundant 
tRNAs, thereby facilitating the biosynthesis of high levels of proteins utilizing 
these codons (Bennetzen and Hall, 1982; Sharp et al., 1986; de Boer and Kastelein, 
1986). In E.coli the following codons are regarded as minor codons and are 
rarely utilized: GGA (Gly), UUA (Leu), AAU (Asn), CCA (Pro), AGA (Arg), UCA 
(Ser) and ACA (Thr) (Konigsberg and Godson, 1983; Allf-Steinberger, 1984; 
Ernst, 1988). In the 8 genes contained in the GenBank database, these codons 
were used preferentially over all other synonymous codons coding for the same 
amino acids. Despite the use of a high percentage of E.coli rare codons by these 
cloned genes, enough protein was produced to allow for detection via enzyme 
assays. Similarly ORF2 used a large percentage of E.coli rare codons, however 
this did not effect the ability of the E.coli clones pMET13A, pMET030 and 
pMET190, to produce enough protein product to allow for the metronidazole 
sensitive phenotype. 
Using the computer program CodonPreference (Devereux et al., 1984) in 
conjunction with the constructed codon frequency table for C. acetobutylicum 
(Table 6.1), the graphs and diagrams shown in Fig. 6.3 were assembled. Rare 
codons were determined according to protocol described by Gribskov et al. 
(1984) and the third position compositional bias was calculated as described by 
Bibb et al. (1984). Fig. 6.3 shows that rare C. acetobutylicum codons are used less 
frequently in the identified open reading frames ORFl, ORF2 and ORF3, than in 
the intergenic regions. The compositional bias for each reading frame is the 
fraction of the third position in each codon that is either A or T, using a sliding 
window of 100 nucleotides. From these AT bias plots, it can be seen that the 
three identified open reading frames ORFl, ORF2 and ORF3, all have above 
average values for a bias towards codons that have an A or U in the third 
position. The opposite is seen for the non-coding regions of this sequence. 
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Figure 6.3 Third ~ition AT bias and open reading frame display for the 
three forward reading frames of pSEQ13A. The dashed horizontal line m each of 
the three plots represents the mean AT bias for this sequence. All possible open 
reading frames are shown as boxes beneath the plot for their respective reading 
frames. Start codons are shown as short lines that extend above the height of the 
box, and stop codons are marked by lines that extend below the bottom of the 
box. Only the start and stop codons at the beginning and end of an open reading 
frame are displayed. C. acetobutylicum rare codons in each reading frame are 
marked below the open reading frame display by short vertical lines. A rare 
codon threshold (p) of 0.10 was used for these plots [see Gribskov et al., (1984) 
for an explanation of the calculation of p]. The positions of the three open 
reading frames ORFl, ORF2 and ORF3 are marked as boxes below the X-axis. 
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Figure 6.4 The percent G +Cina sliding window of 100 nucleotides over the 
length of the C. acetobutylicum insert DNA contained on plasmid pSEQ13A. The 
window was shifted along the sequence in 3 nucleotide stegs. The positions of 
the three identified open reading frames ORFl, ORF2 and RF3 are marked as 
boxes below the X-axis. 
6.3.4 G + C content 
The overall G + C content of the seven nucleotide sequences contained in the 
GenBank database is 28.70 (CLOADH), 30.76 (CLOBHBD), 30.45 (CLOCBA), 
30.33 (CLOEGLA), 30.31 (CLOGLNSA), 31.57 (CLOXYNB) and 33.84% 
(CLOADC). These values are slightly higher than the overall G + C content for 
C. acetobutylicum which is 28% (Cummins and Johnson, 1971). The overall G + C 
content for the C. acetobutylicum insert DNA contained in plasmid pSEQ13A was 
determined to be 28.07%. Calculating the percent G + C in a sliding window of 
100 nucleotides, which is moved along the sequence in 3 nucleotide steps, 
resulted in the plot shown in Fig. 6.4. The G + C content dropped dramatically in 
the intergenic regions between the three identified open reading frames. The 
G + C content of ORF1, ORF2 and ORF3 is 30.72, 30.43 and 30.06% respectively, 
whereas the G + C content of the intergenic regions between these open reading 
frames drops to 18.34 and 15.00% respectively. As mentioned in the previous 
section, C. acetobutylicum preferred codons were biased towards an A or Tin the 
third position (Fig. 6.3), which is contrary to the overall G + C content being 
higher in the coding regions. The higher G + C content in the coding regions 
must therefore reflect the necessity for G's and C's in the first two positions of the 
codons in order to allow for translation to include all amino acids. 
The coding regions of the seven sequences contained in the GenBank database 
also have higher G + C values when compared to the overall values given above. 
The G + C values for the coding regions of these seven sequences are as follows: 
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32.56 (CLOADH), 33.92 (CLOBHBD), 32.70 (CLOCBA), 32.74 (CLOEGLA), 31.76 
(CLOGLNSA), 37.53 (CLOXYNB) and 37.01 % (CLOADC). Since the C. 
acetobutylicum nucleotide sequences contained in the GenBank database all 
resulted from the isolation of known coding regions, they contain relatively 
small amounts of non-coding sequence. This could account for the slightly 
higher overall G + C values of these sequences as compared to the 28% reported 
by Cummins and Johnson (1971). 
6.3.5 Putative RBS, promoter and termination sequences 
The process of translation, in which the mRNA nucleotide sequence is translated 
into an amino sequence, is initiated by the interaction between the 165 ribosomal 
RNA (rRNA) and a specific sequence on the mRNA know as the ribosome 
binding site (RBS). In E.coli and B. subtilis, ribosome binding sites are generally 
characterized by the start codon and a purine rich (SD) sequence 4 to 15 
nucleotides upstream of the start codon (Shine and Dalgarno, 1974). The 
consensus SD sequence 5'-AGGAGG-3' is complementary to the 3' end of 16S 
rRNA (Gold et al., 1981, Gold, 1988). The start codon is usually AUG, but 
prokaryotic ribosomes occasionally start at a GUG or UUG codon (Kozak, 1983). 
It has been shown that B. subtilis and other Gram positive organisms have a 
much higher frequency for non-AUG initiation codons than E.coli (Hager and 
Rabinowitz, 1985). 
The ribosome binding sites of both ORF2 and ORF3 were characterized by the 
presence of a SD region and a AUG start codon. The AUG start codon of ORF2 is 
located at position 1 543 and is preceded by a putative SD region (AGGAGG) 
9 bp upstream of the AUG codon (Fig. 6.2). This putative SD site resembled that 
reported for the S. aureus ~lactamase gene (Mclaughlan et al., 1981) and the C. 
acetobutylicum endoglucanase gene (Zappe et al., 1988) (Fig. 6.5). The AUG start 
codon of ORF3 is located at position 2144 and is preceded by a putative SD site 
(AGGAAG) 8 bp upstream of the AUG codon (Fig. 6.2). 
In Gram positive organisms such as B. subtilis, transcription of genes expressed 
during growth are dependent on the CJ factor identified as cr43 (Graves and 
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C. acetobutylicum ORF2 
S. aureus bla 
C. acetobutylicum eglA 
5' A G G A G G A T T T T A T C A 3' 
5' A G G A G G A G A T A A A A 
5' A G G G G G T A T T A A C 
3' 
3' 
Figure 6.5 Putative ribosome binding site of the pSEQ13A ORF2 as compared 
to the ribosome binding sites for the S. aureus ~-lactamase (bla) gene and the C. 
acetobutylicum endoglucanase (eglA) gene. The Shine-Dalgarno region is 
underlined. In all tnree cases, a start codon follows immediately after the last 
nucleotide shown. 
Rabinowitz, 1986). Promoter regions for a43 dependent transcription show 
structural similarities with the E. coli cr70 promoters (see Fig 6.6). It is apparent 
that besides the traditional core regions of these Gram positive promoters, 
upstream and downstream regions also display conserved sequences. It is these 
upstream and downstream regions that have given rise to the term "extended 
Gram positive promoters" (Graves and Rabinowitz, 1986). Conservation of 
nucleotide sequences in the extended regions can compensate for a lack of 
conservation in the core regions. For example, a TG pair starting 3 base pairs 
upstream of the TATAAT Pribnow box has been shown to be sufficient to 
compensate for the absence of a specific -35 region (Ponnambalam et al., 1986; 
Keilty and Rosenberg, 1987). 
As mentioned earlier (Chapter 5), the insert DNA in pMET190 and pMET13A 
are in opposite orientations with respect to the vector DNA indicating that in 
E.coli, the gene responsible for metronidazole activation (ORF2) is most likely 
transcribed from a promoter present on the insert. The high A+ T content of the 
intergenic regions between the three open reading frames on the pSEQ13A insert 
DNA makes it very difficult to identify possible promoters from the sequence 
data alone. Speculation leads to 10 possible promoters for the 5' upstream region 
of ORF2 and 4 possible promoters for the 5' upstream region of ORF3 (Fig. 6.6). 
The location of these promoters with respect to the ribosome binding site, as well 
as the distance between the -10 and -35 regions, easily eliminates some of them as 
candidates, however they are all included as a matter of completeness. Another 
EC 
G+ 
Gene 
EGl 
EG2 
GS1 
GS2 
Position 
1485-1531 
1457-1501 
1450-1499 
1446-1494 
1438-1483 
1414-1466 
1414-1460 
1390-1434 
1372-1416 
1351-1398 
Position 
2070-2116 
2062-2106 
2038-2085 
2034-2082 
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a t TTGACa t t t tg _TAtAA_! 
TA AAAAA TTGAcA a A a T TG TATAAT AAtAt 
-
-35 -10 
TTTTATATATAT TTGTAT TAAATTA-------ACTTTAATGT TACAAT GTTCT 
AATAAAAAAAAA TTATTA ATGTAAA----AATATACTAAGTA TAGAAT AATAG 
TAAAAAAATCAC TTGATT TCTTAAA------AAAAAGGGAAG TATAAT TTAGT 
TGAGCAAAGGCG TCCGAT AGAAGTT-------TATACTTGTC TATTGT GCGCT 
-35 ORF2 -10 
AAAATATACAAT TTAATT ATTTTAA------ACAATATAGTT TTTAAT TAGGA 
ATTAATTCCAAG ATGATA CAATAAG--------TCTAAAATA TACAAT TTAAT 
TGGAATTATTAA TTCCAA GATGATA---CAATAAGTCTAAAA TATACA ATTTA 
GATGTGGAATTA TTAATT CCAAGAT----GATACAATAAGTC TAAAAT ATACA 
TTGTGCATGATG TGGAAT TATTAAT-------TCCAAGATGA TACAAT AAGTC 
ATTATTTTGGTA TTAACA AAAGCATTGTGCATGATGTGGAAT TATTAA TTCCA 
ATTATTTTGGTA TTAACA AAAGCAT------TGTGCATGATG TGGAAT TATTA 
GCAAAAACTAAA ATGTTA CTATAAA--------TTATTTTGG TATTAA CAAAA 
ATGATAAAAAAA ATGATA GCAAAAA--------CTAAAATGT TACTAT AAATT 
AGTTACTGAGTA TTAATA TTCATGA-----TAAAAAAAATGA TAGCAA AAACT 
-35 ORF3 -10 
AATATTATAATA TTGAGA GCGAAGT------TTATAATATGT TATAAA TTAAT 
AAATATACAATA TTATAA TATTGAG--------AGCGAAGTT TATAAT ATGTT 
TATATAAATTGA TTAATA ATTTAAA-----AATATACAATAT TATAAT ATTGA 
TGTATATATAAA TTGATT AATAATT----TAAAAATATACAA TATTAT AATAT 
Figure 6.6 Possible Gram positive consensus promoter sequences for ORF2 
and ORF3. The top panel snows two promoter consensus sequences: EC, the 
E.coli cr7o consensus sequence (McClure, 1985) and G+, the extended consensus 
sequence reported to be a feature of the cr43 RNA polymerase recognition site of 
B. subtilis and other Gram positive bacteria (Graves and Rabinowitz, 1986). In 
this panel, highly conservea bases (>70%) are indicated by underlined capital 
letters; >50% conservation are capital letters and >41 % conservation are lower 
case letters (after Graves and Rabinowitz, 1986). The second panel shows the 
sequence of four identified C. acetobutylicum promoters. The aboreviations are as 
follows: EGl and EG2 are two promoters identified for the endoglucanase gene 
(Zappe et al., 1988), and GS1 and GS2 are two promoters identified for the 
glutamine synthetase gene (Janssen et al., 1990). The third and fourth panels are 
the positions and sequences of possible cr43 typeJromoters for ORF2 and ORF3 
respectively. The sequence positions correspon to Fig. 6.2. Nucleotides with 
identity to the consensus sequence are shown in bold typeface. All sequences are 
aligned by the -35 and Pribnow (-10) regions. 
assumption in this analysis is that ORF2 and ORF3 have cr43 Gram positive 
consensus type promoters. This assumption is based simply on the fact that the 
5' upstream regions of these 2 open reading frames did not contain any promoter 
consensus elements which have been reported as recognition sites for other 
Gram positive holoenzymes such as cr37, cr32, cr29 or cr2s (Doi and Wang, 1986). For 
comparison, previously identified promoters for two C. acetobutylicum genes are 
included in Fig 6.6. 
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Like initiation, the termination of transcription by RNA polymerase is a key 
event in gene expression. Prokaryotic terminators, particularly those found in 
E.coli, fall into 2 classes: factor dependent and factor independent terminators. 
Factor dependent terminators require the presence of rho-protein (Roberts, 1969), 
or of other factors (Kingston and Chamberlin, 1981) for termination to occur. The 
nucleotide sequence of these factor dependent terminators show little similarity 
amongst themselves, as well as with factor independent terminators (Holmes et 
al., 1983). On the other hand, factor independent terminators have been shown 
to be functionally active in in vitro assays in the absence of any protein factors 
other than RNA polymerase (Brendel and Trifonov, 1984). 
Factor independent terminators show a region of dyad symmetry downstream of 
the 3' stop codon of an open reading frame. This dyad symmetry is typically rich 
in GC base pairs and allows for the formation of a stable hairpin structure in the 
RNA transcript. On average, the stem contains 77% GC base pairs and is stable 
with a free energy of .1.G = -18.0 ± 7.3 kcal mol-t (Brendel and Trifonov, 1984). A 
typical hairpin stem has a length of 8 ± 2 base pairs and a loop of 5 ± 1 base pairs. 
Furthermore, just downstream of this region of dyad symmetry, there is a stretch 
of consecutive thymine residues. Typically, this stretch is 10 base pairs long 
containing at least 7 thymine residues. The region of dyad symmetry has been 
implicated in slowing down the polymerase, whereas the thymine rich region 
allows for the formation of a rU·dA hybrid that may facilitate release of the 
transcript (Martin and Tinoco, 1980). 
Using the above criteria, sequences that could resemble factor independent 
terminators were searched for in the pSEQ13A insert DNA sequence 
immediately downstream of both ORF1 and ORF2. No structures resembling 
factor independent terminators were identified in these searches. As in any 
living system, there are exceptions to the rules (for examples see Brendel and 
Trifonov, 1984). Regardless of the biological implications of some of these 
exceptions, it does not appear that a region of dyad symmetry and an adjacent 
stretch of thymine residues unequivocally characterize the termination signal. 
These features may be enough to provide the proper conditions necessary for 
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termination, however they are apparently not required (Brendel and Trifonov, 
1984). 
The structures that characterize factor independent transcription terminators 
have primarily been identified from studies of genes isolated from E.coli and 
other enterobacteria (Brendel and Trifonov, 1984). With a few exceptions 
(Mongkolsuk et al., 1985; Pulido and Jimenez, 1987), very little has been 
documented about such structures in Gram positive organisms. Gram positive 
organisms may therefore have alternative termination systems which may be 
either dependent or independent of protein factors. 
It would be necessary to isolate RNA from C. acetobutylicum in order to 
determine what promoters and termination signals are functioning for these 
open reading frames. Since the objectives of this study were to identify C. 
acetobutylicum electron transport genes that are able to activate metronidazole, 
such RNA studies were deemed to be beyond the scope of this project. 
6.3.6 Amino acid similarity studies 
The deduced amino acid sequences of the open reading frames ORFl, ORF2 and 
ORF3 were used to search the GenBank, EMBL, SWISS-Protein, NBRF-Nucleic 
and NBRF-Protein databases using the PASTA and TFASTA computer programs 
described by Pearson and Lipman (1988). 
The best similarity to the deduced amino acid sequence from the complete open 
reading frame, ORF2, was obtained with the flavodoxin sequences from 
Azotobacter vinelandii (Bennett et al., 1988), Clostridium MP (Tanaka et al., 1974), 
Anabaena variabilis (Leonhardt and Straus, 1989) and Klebsiella pneumoniae 
(Drummond, 1985). GAP (Devereux et al., 1984), the alignment program based 
on the methods of Needleman and Wunsch (1970), was used to compare this 
deduced amino acid sequence to the above flavodoxin sequences. The amino 
acid sequence of the A. vinelandii flavodoxin had 29% identity and 55% similarity 
to the deduced amino acid sequence of ORF2. Likewise, the amino acid 
sequences of the Clostridium MP, Ana. variabilis and K. pneumoniae flavodoxins 
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1 MAIIGILGTPYNTVERSPFWWNKVSYTRQSFIDVFQELGHTVIVLPVD-K 49 
••:::II:• 
1 ----------------------------------------IPFIIPVNTE 10 
50 TENIKNYLPLVDKIVLTGGVDVSPYLYGEEPHAQLGTTDPIRDRFELAAI 99 
•I II• I• II ::1•11 ll•l•l:•1111 11•1 II I: I 
11 PEIIKAQLENVDGLILSGGHDVNPLLFNEEPHKLLGNTMNERDTFDSMLI 60 
100 KAALEANKPILGVCRGLQLLNVYFGGTLYQDLSLT-SSQIKHLQSPTPQE 148 
I 1:1 :11111:111 1:111 1111111 II· •I Ill l:•11•: 
61 KYAFEMEKPILGICRGCQILNVVCGGTLYQDCSLAKDSYIKHCQGHTPAQ 110 
149 VPTHHISVEKEVL------------------------------------- 161 
I • I I : I I : 
111 -PSHTIQIEKNSELYTILGEKALANSFHHMSIKDVADGFKVVAIANDEII 159 
Figure 6.7 Comparison of the amino acid sequence of the 3'-truncated open 
reading frame wnich is downstream of the L. lactis X-prolyl dipeptidyl 
aminopeptidase (pepXP) sene (Nardi et al., 1991) (top strand) with the pSEQ13A 
5'-truncated open readmg frame (ORF1) (bottom strand). The symbol 
comparison table described by Gribskov and Burgess (1986) was used to 
calculate percentage similarity and percentage identity. The symbols between 
the sequences are as follows: I, represents identity;:, and • represent closer and 
further evolutionary distance between similar amino acids respectively. 
had 29, 26 and 24% identity and 51, 55 and 56% similarity respectively. All 
figures referring to percent identity and percent similarity reflect data obtained 
from the entire length of the respective amino acid sequences. Based on the 
alignments to these and other flavodoxins, the fact that ORF2 has been identified 
as the gene responsible for class V sensitivity to metronidazole, as well as the 
report by Chen and Blanchard (1979) that shows reduced flavodoxin can transfer 
electrons to metronidazole, the sequence corresponding to ORF2 is identified as 
coding for a flavodoxin from C. acetobutylicum P262 (Santangelo et al., 1991). 
No conclusive information was obtained from database searches using the amino 
acid sequence derived from 5'-truncated open reading frame, ORF1, as the query 
sequence. However, this amino acid sequence can be easily aligned with an 
unidentified open reading frame that is truncated at the 3' end (Fig. 6.7). This 
3'-truncated unidentified open reading frame is downstream of the X-prolyl 
dipeptidyl aminopeptidase gene from Lactococcus lactis NCD0763 (Nardi et al., 
1991). The alignment, which was generated using the GAP program described 
above, shows a 64.5% similarity and a 51.2% identity between the two amino 
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10 30 50 70 
I I I I I I I 
G GM ATA ATG AMATA GTT MT CGA ATT GGC MG MT ATG AGA TTA TTA ATA ATA ATG ACT TTA ATT ATT TTT GCT GTA CTA ATA ATT 
E I H K V N R I G K N H R L L I I H T L I I F A V L I I 
90 110 130 150 l 70 
I I I I I I I I I 
TTA CCT CTA ATT ATT TTA AM GGT AGT GGA TTT AGT ATT AGC AM TTC MT TTA GAT MC AM MT TTA GTG 11M MT TCA CM ATA ACT 
L p L I I L K G s G F s I s K F N L D N K N L V K N s Q I T 
190 210 230 250 
I I I I I I 
TTT CCG GTT MT GGT MG GTT AM TTA TAC CAT 11M MG GAT MC TCA GTT GM GAG TTA GAT TTG GM GAT TAT ATA ATG GGG GTT GTA 
F p V N G K V K L y H K K D N s V E E L D L E D y I H G V V 
270 290 310 330 350 
I I I I I I I I I 
TCA AGT GM GTT CCA GCA MT TTT GAG GM GM GCT TTA MG GCT CM GCT GTA GCA GCT AGA ACA TTC TAT ATG MC MG AGA MT CM 
s s E V p A N F E E E A L K A Q A V A A R T F y H N K R N Q 
370 390 410 430 
I I I I I I I 
CCT TGT MT TAT GCA AM GM AM GGT GCA GM ATT TGC GAT ACA ACT CAT TGT CM GTT TAT ATG AGT MG GM GM A.GA ATG AAA AGC 
p C N y A K E K G A E I C D T T H C Q V y H s K E E R M K s 
450 470 490 510 530 
I I I I I I 
TGG AGC AGT AGT GM GCA AAA AGT GAT TGG GM AAA A.TT GAG AGG GCT GTT GM GM ACA AM GGA CM GTA TTA ACT TAT MT GGA CM 
w s s s E A K s D w E K I E R A V E E T K G Q V L T y N G Q 
550 570 590 610 
I I I I I I I I I 
GTG CTC GM TAT CAG MT TTT TCG CTA TTA GTT CTG GM /\M ACA GAG GAT GCT MG GAC GTA TTT TCT GTT GAT GTA CCA TAT CTT /\M 
V L E y Q N F s L L V L E K T E D A K D V F s V D V p y L K 
630 650 670 690 710 
I I I I I I I I I 
TCA GM GM AGT /\M GGT GM GAG ATA GCG CCT AM TAT AM ACA TCT GTA CAG ATT GCT ACA MT GAT TTT GTT MT AM ATT MT MC 
s E E s K G E E I A p K y K T s V Q I A T N D F V N K I N N 
730 750 770 790 
I I I I I I I I I 
AM TAT TCA AM GCA MT ATA AGT AM AGT MT TTA GCG TCT TAT ATT AM ATA AM AGC TAT ACT GM GCT GGA AGT GTA AM GM ATT 
K y s K A N I s K s N L A s y I K I K s y T E A G s V K E I 
810 830 850 870 890 
I I I I I I I I I 
CM ATA GGA MT GM GTT ATA MG GGA ACA GM TTT AGA GM TTA TTG GGA TTA MT TCA ACA MT TTC ACC TTG GAT TTT GGA ACC MT 
Q I G N E V I K G T E F R E L L G L N s T N F T L D F G T N 
910 930 950 970 
I I I I I I I I 
GCA GTA ACT GTA MT TGT MG GGG TAT GGT CAT GAC GTA GGA ATG AGT CM TGG GGA GCT MT GTA ATG GCG /\M MT GGG GCT MG TAT 
A V T V N C K G y G H D V G H s Q w G A N V H A K N G A K y 
990 1010 1030 1050 1070 
I I I I I I I I I 
AGT GM ATC CTA AM CAT TAT TAT GTT GGA GTT GM ATT ACT CM ATA AM TAT ATG CGT AM TTA TTT GM GTT TAT MT TAT GTG GCA 
s E I L K H y y V G V E I T Q I K y H R K L F E V y N y V A 
1090 
I I I 
ATA ACG CTG MT AM TM ATATGGCTTTTTA 
I T L N K 
FiSU!e 6.8 Nucleotide sequence of the 1109 base pair fraraent of C. 
acetobutylicum insert DNA of plasmid pMET11B. The deduce amino acid 
sequence is given in single letter code (see Appendix D). 
acid sequences, with virtually no need to introduce gaps in either of the amino 
acid sequences. 
No conclusive information was obtained from database searches using the amino 
acid sequence derived from 3'-truncated open reading frame, ORF3, as the query 
sequence. The matches obtained from this database search were either over very 
short lengths of the sequence, or it was necessary to introduce frequent and 
lengthy gaps in order to obtain alignment. 
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6.3.7 pMET11B sequence 
The sequence of a 1 109 base pair fragment of the C. acetobutylicum insert DNA of 
pMET11B was determined by a post-doctoral researcher in the Anaerobe Unit at 
the University of Cape Town. Since pMET11B was isolated in this study, the 
sequence of this fragment is reported here. A single open reading frame of 364 
amino acids was coded for by 1 092 of the 1 109 base pairs, and was truncated at 
the 5' end (Fig. 6.8). 
Using the deduced acid sequence (Fig. 6.8) as a query sequence to carry out 
database searches, it was determined that this open reading frame coded for a 
spoIID gene from C. acetobutylicum. Alignment of this sequence with the B. 
subtilis and B. amyloliquefaciens SpoIID protein sequences showed 55.8 and 52.5% 
similarity and 36.5 and 34.0% identity respectively. It was however determined 
that this 1 109 base pair fragment was not the region on pMET11B responsible for 
class V sensitivity towards metronidazole. 
6.4 Discussion 
From the exonudease III shortened clones, it was determined that the complete 
open reading frame, ORF2, was the gene responsible for class V sensitivity 
toward metronidazole in clones pMET13A, pMET030 and pMET190. The 
nucleotide sequence of ORF2 has the coding capacity for a 17 763 Mr protein. 
Based on the deduced amino acid sequence of this open reading frame and the 
ability of this gene product to activate metronidazole, it has been identified as a 
C. acetobutylicum flavodoxin gene. The amino acid sequence of nine other 
flavodoxins has been determined by direct amino acid sequencing, or deduced 
from their nucleotide sequence. Wakabayashi et al. (1989) aligned seven of these 
flavodoxin sequences, and this alignment was used as the basis for the 
comparison shown in Fig. 6.9, which includes the C. acetobutylicum flavodoxin. 
The C. acetobutylicum flavodoxin shows some degree of similarity to the other 
flavodoxins. The invariant regions are located primarily at the FMN binding 
domains (the redox-active prosthetic group), which are included in positions 
11-23, 58-64 and 101-114 (Wakabayashi et al., 1989). 
Clostrtdium acetobutyl.1cwn 
Anabaena var.1ab1l1s 
Chondrus crispus 
Anacystis nidulans 
Azotobdcter v1nelandii 
Klebsiella pnewnoniae 
Enterobacter agglomerans 
Desulfov1br.10 vulqaris 
Clostr1d1-u.m MP 
l•teqasphera eldensi.i 
60 
IIFGTPTY 
LIIGCPTW 
Lt'LGAPTWNTG 
IIGCPTW 
70 
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Figure 6.9 Comparison of the amino acid sequence of the C. acetobutylicum 
flavodoxin to nine other flavodoxin amino acid sequences. The flavodoxin 
sequences are from A. variabilis (Leonhardt and Straus, 1989), Chondrus crispus 
(Wakabayashi et al., 1989), Anacystis nidulans (Laudenbach et al., 1988), A. 
vinelandii (Bennett et al., 1988), K. pneumoniae (Drummond, 1985), Enterobacter 
agglomerans (W. Klingmiiller, personal communication), Desulfovibrio vulgaris 
(Dubourdieu and Fox, 1977; Krey et al., 1988), Clostridium MP (Tanaka et al., 
1974) and Megasphera eldensii (Tanaka et al., 1973). The boxed regions indicate 
sequences with identical amino acid residues. Chemically related amino acids 
are not indicated. 
While iron-containing ferredoxin is one of the most important components of 
biological electron transport chains, it can be degraded as a source of iron under 
iron limiting conditions (Schonheit et al., 1979; Ragsdale and Ljungdahl, 1984). 
Certain organisms, such as members of the genus Clostridium, induce the 
synthesis of the non-iron containing electron transfer protein flavodoxin under 
conditions of iron stress (Pardo et al., 1990). Ragsdale and Ljungdahl (1984) 
showed that when C. formicoaceticum was grown in a medium with a low iron 
content, the concentration of flavodoxin reached at least 2% of the total soluble 
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protein. Flavodoxins mediate electron transfer at a low redox potential between 
prosthetic groups of microbial proteins in an analogous fashion to ferredoxin. 
When the production of flavodoxin is induced (as in the clostridia) it generally 
replaces ferredoxin in many oxidation reduction reactions, but at a slower rate 
(Ragsdale and Ljungdahl, 1984). However, in other organisms such as A. 
vinelandii, flavodoxin is constitutively produced and hence has a unique 
biological function (Tollin and Edmondson, 1980). 
In the clostridia and in other anaerobes, the principal role of flavodoxin is in the 
phosphoroclastic breakdown of pyruvate to acetyl-CoA. In C. acetobutylicum 
electrons derived from pyruvate reduce an iron-sulfur moiety in the enzyme 
pyruvate ferredoxin oxidoreductase (Meinecke et al., 1989). Under iron limiting 
conditions, these electrons are then used to reduce flavodoxin, which in turn is 
reoxidized by hydrogenase with the accompanying formation of molecular 
hydrogen via the actions of the hydrogenase enzyme. It has been shown that in 
C. acidi-urici reduced electron carriers such as ferredoxin and flavodoxin, are also 
used as the electron source in the uric acid fermentation (Valentine et al., 1962). 
Flavodoxin can also be oxidized and reduced by the action of the clostridial 
NADH- and NADPH-ferredoxin oxidoreductases (Ragsdale and Ljungdahl, 
1984). In C. pasteurianum and C. kluyverii, where CO2 fixation (essentially the 
reverse of pyruvate catabolism) is known to occur, reduction of ferredoxin and 
flavodoxin occurs by reduced pyridine nucleotides via the action of these 
enzymes (Jungerrnann et al., 1971a, 1971b; Thauer et al., 1971). 
In obligate anaerobic nitrogen fixers, the endogenous donor of electrons to 
nitrogenase is ferredoxin or flavodoxin (Mortenson, 1964; Benemann et al., 1969; 
Yoch et al., 1969). A. vinelandii however, constitutively produces a flavodoxin to 
serve this function (Scherings et al., 1977). Haaker and Veeger (1977) showed 
that in A. vinelandii, reducing equivalents are produced at a site localized at the 
cytoplasmic membrane which is specifically mediated by the action of a NADH-
flavodoxin oxidoreductase. Hence, this oxidoreductase operates at a site of low 
pH (ca. pH=S), where the semiquinone-hydroquinone potential is high enough 
to allow NADH to function as a reductant. Membrane energization in turn 
Nucleotide sequencing and analysis 135 
brings the flavodoxin hydroquinone to a low enough potential such that it can 
serve as the electron donor to the nitrogenase. Like A. vinelandii, K. pneumoniae 
and E. aerogenes also have specific genes (nifF) for the production of a flavodoxin 
which is used as the electron carrier for the nitrogenase component of nitrogen 
fixation (Drummond, 1985; W. Klingmtiller personal communication). 
Other known functions for flavodoxins include the mediation of electron transfer 
between hydrogen and sulfite in D. vulgaris (Hatchikian et al., 1972). Flavodoxin 
has also been shown to function in the light dependent reduction of NADP+ by 
plant chloroplasts (Smillie, 1965). 
All known flavodoxins have low molecular weights (14 500 to 23 000 g mol-t) and 
are usually anionic (Tollin and Edmondson, 1980). In general, flavodoxins from 
non-photosynthetic bacteria have a molecular weight of approximately 15 000 
(short flavodoxins), while flavodoxins from cyanobacteria and algae have a 
molecular weight of approximately 20 000 (long flavodoxins) (Wakabayashi et 
al., 1989). A. vinelandii flavodoxin is an exception in that it is produced by a non-
photosynthetic bacteria and falls into the class of long chain flavodoxins. This 
flavodoxin is also unique in that it is the only flavodoxin known to contain a 
phosphodiester linkage (Dreef-Tromp et al., 1989; Taylor et al., 1990). 
Dubourdieu and Fox (1977) reported that amino acid similarity amongst the long 
chain flavodoxins ranged from 36 to 39% whereas amino acid similarity amongst 
the short chain flavodoxins ranged from 25 to 35%. The amino acid similarity of 
the short chain C. acetobutylicum flavodoxin to other flavodoxins falls within the 
latter range. 
Flavodoxins consist of a single polypeptide chain lacking disulfide bonds 
(cysteine content varies from 1 to 5 residues). Flavodoxins non-covalently bind 
one mole of FMN, and binding studies indicate that all flavodoxins have 
structurally analogous coenzyme binding sites (D'Anna and Tollin, 1972). 
Amino acid alignments support this theory, as the ribityl phosphate binding 
regions of different flavodoxins have a similar primary structure. With reference 
to Fig 6.9, Ser-11, Thr-13 and Thr-16 hydrogen bond to the FMN phosphate, 
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whereas Thr-64 and Asp-176 hydrogen bond to the 4'-hydroxy group of the 
ribityl side chain (Wakabayashi et al., 1989). 
E.coli is known to produce small amounts of ferredoxin and flavodoxin. While 
the biological role of ferredoxin in E. coli has not been completely elucidated, the 
role of flavodoxin has been established. Reduced flavodoxin has been show to 
be involved in the conversion of pyruvate formate lyase from an inactive to an 
active form (Knappe et al., 1974, 1984; Conradt et al., 1984). The mechanism of 
the reduction of flavodoxin in E.coli was elucidated by Blaschkowski et al. 
(1982), who showed that two enzymes exist capable of carrying out this 
reduction. The first enzyme is the CoA acetylating pyruvate flavodoxin 
oxidoreductase, which is analogous to the pyruvate ferredoxin oxidoreductase 
more commonly associated with the phosphoroclastic breakdown of pyruvate in 
anaerobes. The second enzyme is an NADPH dependent oxidoreductase which 
these workers identified as the flavoprotein "component R" previously described 
by Fujii and Huennekens (1974). 
If the cloned C. acetobutylicum flavodoxin is responsible for activating 
metronidazole in E.coli F19 [pMET13A] by direct electron transfer, reasonable 
amounts of this flavodoxin must exist in a reduced form. The pyruvate 
flavodoxin oxidoreductase and the NADPH dependent oxidoreductase are both 
minor proteins in E.coli and hence may not be present in large enough amounts 
to reduce significant quantities of the cloned flavodoxin. This suggests that 
either the cloned flavodoxin is reduced by other mechanisms, or that it is not 
entirely responsible for activating metronidazole. Since reduced flavodoxin is 
capable of converting the pyruvate formate lyase to its active form, perhaps the 
cloned flavodoxin merely enhances this effect. This could result in a higher 
conversion rate of pyruvate to acetyl CoA and formate, which may in tum lead 
to induction of the FDHH enzyme (see Chapter 4). This would reduce the overall 
oxidation reduction potential of the cell which has been shown to cause an 
increase in metronidazole sensitivity in E.coli (Onderdonk et al., 1979). 
Nucleotide sequencing and analysis 137 
It is interesting to note that the addition of extraneous formate (as sodium 
formate) to culture medium increased the sensitivity of E.coli strains towards 
metronidazole (data not shown). It was also observed that this effect was 
reversed by increasing the nitrate concentration in the medium. Unfortunately, 
these formate and nitrate experiments were carried out early on in this study in 
an effort to determine the ideal medium for genebank screening, and hence 
metronidazole sensitivity of E.coli F19 [pMET13A] was not tested with media 
containing additional formate. However, in one experiment where a calculation 
error resulted in a ten fold increase in the nitrate concentration of the growth 
medium, no change in the MIC values for E.coli F19 [pMET13A] was observed. 
This indicates that with this clone, there was essentially no formate effect to 
overcome. Since one of the objectives of this study was to isolate electron 
transport genes from C. acetobutylicum, the identification of this flavodoxin gene 
fulfills this goal. However, not enough evidence was obtained to elucidate the 
mechanisms involved in the activation of metronidazole. 
While the structure-function relationships of ferredoxins have been studied 
extensively, these studies are not as advanced for the flavodoxins. Flavodoxins 
are among the smallest flavoproteins, and therefore represent the simplest 
models for studying the chemistry and biochemistry of this group of proteins 
(Mayhew and Ludwig, 1975). Since the production of flavodoxin in the clostridia 
occurs under conditions of iron limitation, the cloned C. acetobutylicum 
flavodoxin can provide a platform for studying the genetics of induction in this 
industrially important microorganism. Furthermore, since iron limitation is a 
form of stress, this is the first account of the cloning of this type of gene from C. 
acetobutylicum. Since solvent toxicity also represents a form of stress to this 
organism, it is exciting to note that the spoIID gene was isolated using the same 
screening method. Sporulation is a response of this organism to solvent toxicity, 
and although the spoIID gene was not directly involved in the activation of 
metronidazole, it may be linked to other sporulation genes present on plasmid 
pMET11B. 
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Chapter 7 
General conclusions 
The endospore forming Gram positive rod, C. acetobutylicum, has been used for 
many years in the industrial fermentation of carbohydrates to produce the 
neutral solvents acetone, butanol and ethanol. Economic pressures have placed 
this fermentation into the history section of general microbiology textbooks, 
perhaps only temporarily. 
The aims of this thesis included studies on small phosphorylated molecules 
involved in energy metabolism and cell differentiation. One of the main themes 
in studies on C. acetobutylicum has been the regulation of cell differentiation, 
particularly the switch from acidogenesis to solventogenesis and the induction of 
sporulation. In B. subtilis, sporulation is induced when the concentration of GTP 
reaches a critically low threshold level. A change in the level of GTP has also 
been implicated in controlling cell differentiation of other organisms. It was 
therefore desired to measure the nucleotide triphosphate levels in C. 
acetobutylicum . in order to determine if GTP and perhaps other NTP's, play a 
similar role in cell differentiation. 
The separation of nucleoside triphosphates in cell extracts can be accomplished 
using strong anion exchange HPLC. The lack of a readily available automatic 
integration system for chromatographic data, along with the complexity of 
chromatograms associated with the separation of nucleotides in biological 
materials, led to the development of a manual computer-linked integration 
system. This system was designed to be flexible so that it could be applied to 
other analytical equipment that generates gaussian output curves. Advances in 
microprocessor technology and diode-array spectrophotometric detectors has all 
but made this system redundant, however it is still used for general 
chromatographic work in our laboratory. 
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A comparison of nucleoside triphosphate profiles from batch fermentations of 
the C. acetobutylicum P262 wild type, sporulation deficient (spo-1) and solvent 
deficient (cls-1) strains was obtained. In the wild type strain and the spo-1 
mutant, there was a sharp decrease in the nucleotide triphosphate levels just 
prior to the pH breakpoint and the switch from acid production to solvent 
production. After the switch to solvent production, the nucleotide triphosphate 
levels rapidly increased to reach much higher levels than were seen during 
acidogenesis. Exponential phase nucleotide levels in the cls-1 mutant were 
comparable to those observed in the wild type and spo-1 mutant. Unlike the wild 
type and spo-1 strains the cls-1 mutant, which does not switch to solventogenesis, 
did not demonstrate an increase in nucleotide levels after the cessation of cell 
division. 
While the drop in nucleotide levels just prior to the pH break point in the two 
differentiating C. acetobutylicum strains does not categorically demonstrate their 
role in the switch to solventogenesis and hence the induction of sporulation, this 
observation does coincide with previous results on cell differentiation in other 
organisms. The effect of nucleotide synthesis inhibitors, which decrease 
nucleotide triphosphate levels, add further support to the role of nucleotide 
triphosphates (particularly GTP) in differentiation of C. acetobutylicum. It is 
interesting to note that in the wild type strain, these nucleotide synthesis 
inhibitors only increase the spore titre when they were added to the fermentation 
medium prior to the switch to solventogenesis. 
ATP is the primary currency by which a cell passes energy from one metabolic 
operation to another. In the wild type and spo-1 mutant, ATP levels during 
acidogenesis were much lower than during solventogenesis. These results are 
somewhat surprising since the production of acids generates more ATP per mole 
of glucose than does the production of solvents. These low acidogenic phase 
ATP levels could perhaps be accounted for by considering that ATP must be 
expended in order to maintain a constant pH gradient across the cell membrane. 
Furthermore, the ATP calculations were based on cell number and the cessation 
of rapid cell division could alter the perception of the total ATP levels. 
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In analyzing the results of the nucleotide profile studies, it must be kept in mind 
that these levels represent a value for the "pool" quantity of these molecules. No 
conclusions can therefore be drawn on the actual turnover rates of these 
molecules. These difficult to interpret results merely indicate a general trend of 
what may be happening to the levels of these phosphorylated molecules with 
respect to the changing metabolism of C. acetobutylicum. 
In addition to these nucleotide studies, an initial investigation into the genetics 
and molecular biology of C. acetobutylicum electron transport genes was 
performed. The antibacterial agent metronidazole played a pivotal role in the 
development of a negative selection system for the isolation of these electron 
transport genes. Metronidazole is a prod.rug that needs to be reductively 
activated. The reduced intermediates of metronidazole cause DNA damage and 
hence cell death. It has been shown that E.coli strains with lesions in their DNA 
repair systems are more susceptible to metronidazole than their wild type 
parents. However, if these DNA repair deficient strains also lacked the ability to 
reduce chlorates and nitrates, they were no more susceptible to metronidazole 
than the wild type strains. The lack of availability of nitrate and chlorate 
reductase, DNA repair deficient mutants of E.coli led to the construction of 
E.coli F19 via transposon mutagenesis with TnphoA. This strain has a 
diminished ability to reduce p-nitrobenzoic acid, while retaining the recA 
mutation of its parent strain CC118. These characteristics make E.coli F19 an 
ideal candidate for the isolation of C. acetobutylicum electron transport genes able 
to activate metronidazole. The recA mutation of F19 renders it highly susceptible 
to the reduced toxic intermediates of metronidazole, while the nitroreductase 
deficiency renders F19 more resistant to the prodrug. E.coli F19 forms the basis 
of this negative selection system where C. acetobutylicum electron transport genes 
were cloned on recombinant plasmids that are able to activate metronidazole 
and overcome the nitroreductase deficiency of this strain. 
Since E.coli F19 was developed to be used as a cloning host, and not for 
physiological studies of the effects of metronidazole on E.coli, no efforts were 
made to further characterize the mutation induced by TnphoA. However, it 
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would be interesting for future work to develop along these lines and hence to 
determine the exact nature of this mutation which renders this E.coli strain less 
susceptible to metronidazole. 
Using E.coli F19 as a cloning host to screen a C. acetobutylicum gene library, 25 
different C. acetobutylicum chromosomal DNA fragments on recombinant 
plasmids which activated metronidazole were isolated. These clones were 
classified into five groups (1-V) based on their sensitivity to metronidazole. With 
respect to metronidazole susceptibility, class I isolates were the least sensitive 
group, whereas class V isolates were the most sensitive group. After testing 
these 25 clones for nitroreductase, hydrogenase and pyruvate-Fd-oxidoreductase 
activities, it was determined that only one clone expressed weak hydrogenase 
activity. No positive activity was found for either nitroreductase or pyruvate-Fd-
oxidoreductase in any of the clones. The hydrogenase positive clone, pMET15B2, 
was a class I isolate. Assuming that the metronidazole sensitive phenotype is 
due to the hydrogenase activity demonstrated by this clone, the relatively low 
levels of hydrogenase activity may account for the class I susceptibility grouping. 
Although the hydrogenase enzyme plays a critical role in electron flow in C. 
acetobutylicum, it was desired to further classify all 25 isolates and to determine 
what C. acetobutylicum genes were responsible for class V susceptibility to 
metronidazole. Therefore, no further effort was made to specifically characterize 
the hydrogenase positive clone pMET15B2. Due to the possible extent of work 
involved in the characterization of this clone, it was determined that this should 
form the basis of a separate research project stemming from these initial studies. 
Using DNA hybridization and restriction endonuclease mapping techniques, it 
was revealed that four of the metronidazole activating C. acetobutylicum insert 
DNA fragments on recombinant plasmids were linked in an 11.1 kb 
chromosomal fragment. Three of these clones, pMET13A, pMET030 and 
pMET190, were class V isolates, whereas the fourth clone was the hydrogenase 
positive isolate pMET15B2. Therefore, the 11.1 kb chromosomal fragment 
contained at least two regions responsible for activating metronidazole. The 
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region responsible for class V sensitivity to metronidazole was localized to a 2 kb 
EcoRI-EcoRV fragment present in each of the clones pMET13A, pMET030 and 
pMET190. 
The nucleotide sequence of this 2 kb region was determined and a gene coding 
for a flavodoxin-like protein was identified. Although direct electron transfer 
from reduced electron carriers has been implicated in the activation of 
metronidazole, recent evidence strongly suggests that metronidazole is reduced 
via enzymatic routes. It would be interesting to identify how this C. 
acetobutylicum flavodoxin protein is activating metronidazole in E.coli Fl 9. There 
is a strong possibility that the overproduction of flavodoxin in E.coli alters the 
anaerobic metabolic pathways such that the redox environment is lowered. 
Hence the flavodoxin itself may not be responsible for reducing metronidazole, 
but rather may be activating low redox potential enzymes in E.coli capable of 
reducing metronidazole. 
Much work can continue from this initial study, and indeed some research 
projects are already underway in our laboratory. Apart from the 
characterization of the hydrogenase positive clone pMET15B2, the two remaining 
class V isolates, pMET11 B and pMET13C1, are being characterized using 
molecular genetic techniques. PAGE studies of cell extracts of the 25 isolates 
revealed that 3 clones, pME17 A, pME17C and pMET14B, had a visible extra 
protein product. Furthermore, 2 of these clones, pME17C and pMET14B, cross 
hybridized with clones pMET140 and pMET2D. Molecular genetic 
characterization of all 5 of these clones is also underway. 
It was never intended to study the mode of action of metronidazole, and 
therefore this drug was primarily used as a tool for the isolation of C. 
acetobutylicum electron transport genes. However, the medical importance of this 
drug warrants further investigation into how these cloned C. acetobutylicum 
genes may be involved in metronidazole activation. Another advantage of this 
system is that it provides the capability to test novel analogs of metronidazole for 
their mutagenic activity. A recA+ revertant of E.coli F19 has been isolated, and in 
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conjunction with the cloned metronidazole activating genes, we are able to easily 
determine if an analog of metronidazole needs to be reductively activated and if 
this active product causes DNA damage. Since the DNA is the site of action for 
metronidazole, it is inherently mutagenic. Medically, it is desirable to obtain a 
similar drug that needs to be reductively activated, yet has a different site of 
activity. Indeed we have already used this system to test 5 novel compounds, 
which are related to metronidazole, and initial evidence suggest that one of these 
compounds may not act upon DNA. 
Electron transport systems in C. acetobutylicum play a pivotal role in determining 
the carbon flow during the fermentation of carbohydrates. Characterization of 
these electron transport genes may eventually lead to knowledge that will allow 
for enhancement of the productivity of the ABE fermentation. In view of recent 
developments concerning the genetic manipulation of C. acetobutylicum, it is 
likely that some electron transport genes will be specific targets for mutation 
aimed at improving C. acetobutylicum strains. 
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Appendix A 
Media, buffers and solutions 
Media, buffers and solutions were sterilized by autoclaving at 121 ·c for 20 min 
when required. Heat labile substances were sterilized by filtration through 
0.22 µm membrane filters (Millipore). 
A.1 Media 
The methods of Moore (1966) and Hungate (1969) were used to prepare pre-
reduced, oxygen-free media. Most of the oxygen was driven off by gentle boiling 
of media for 15-20 min. Aliquots (10 ml) of the warm medium were dispensed 
into Hungate tubes and perfused with H2 and CO2 prior to sterilization by 
autoclaving. Large volume culture media were not perfused with H2 and CO2, 
but rather autoclaved and transferred to an anaerobic atmosphere in the 
anaerobic glove box at least 15 h prior to inoculation. Media containing agar was 
autoclaved, poured into petri dishes and stored in anaerobic jars (flushed with 
H2 and CO2 for 20 min), with silica gel in muslin bags. Cysteine hydrochloride 
was added to most anaerobic media to scavenge any residual oxygen. 
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A.1.1 Clostridium acetobutylicum minimal medium (CAMM) (Long et al., 1983) 
Ingredient 
Glucose 
Ammonium nitrate 
Calcium carbonate 
Salts stock solution11 
MgS04•7H20 (20% w/v) 
MnS04•4H20 (1% w/v) 
FeS04•7H20 (1 % w /v) 
ZnS04•7H20 (5% w /v) 
NaMo04•2H20 (1% w/v) 
p-Aminobenzoic acid (0.1 % w /v) 
Thiamine HCl (0.1% w/v) 
Biotin (0.02% w /v) 
Cysteine HCl 
Arnount/1 
50.0 g 
7.2 g 
20.0 g 
40.0 ml 
1.0 ml 
1.0 ml 
1.0 ml 
1.0 ml 
1.0 ml 
1.0ml 
1.0 ml 
250.0 µl 
0.5 g 
Sterile potassium phosphate buffer (1.0 M), pH 7.0, was added to the autoclaved 
broth at a final concentration of 0.05 M. 
11 Salts stock solution contained/1: 
0.2 g 
0.2 g 
1.0 g 
1.0 g 
10.0 g 
2.0 g 
A.1.2 Clostridium basal medium (CBM) (O'Brien and Morris, 1971) 
Ingredient 
Glucose 
Casein hydrolysate 
Yeast extract 
MgS04•7H20 (20% w /v) 
MnS04•4H20 (1% w/v) 
FeS04•7H20 (1 % w /v) 
p-Aminobenzoic acid (0.1% w/v) 
Thiamine HCl (0.1% w/v) 
Biotin (0.0002% w /v) 
NaHC03 
Cysteine HCl 
Resazurin stock solution (0.02% w /v) 
Amount/1 
10.0 g 
4.0 g 
4.0 g 
1.0 ml 
1.0 ml 
1.0ml 
1.0ml 
1.0ml 
250.0 µl 
1.0 g 
0.5 g 
10.0 ml 
The required percentage agar (1.5% w /v) was added to CBM medium made as 
above. Cysteine HCL (10.0 ml) and NaHC03 (20 ml) were added as sterile stock 
solutions after the medium had been autoclaved and prior to pouring. The solid 
medium did not contain the anaerobic indicator, resazurin. 
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A.1.3 Luria-Bertani medium (LB) 
Ingredient 
Tryptone 
Yeast extract 
NaCl 
Agar (solid medium only) 
A.1.4 2x Yf medium 
Ingredient 
Tryptone 
Yeast extract 
NaCl 
Agar (solid medium only) 
A.1.5 Escherichia coli anaerobic medium (ECAM) 
Ingredient 
Glucose 
Tryptone 
Yeast extract 
NaCl 
NaHC03 
Tris-base 
Agar (solid medium only) 
Amount/I 
10.0g 
5.0 g 
5.0 g 
15.0 g 
Amount/I 
16.0 g 
10.0 g 
5.0 g 
15.0 g 
Amount/I 
10.0 g 
10.0 g 
1.0 g 
5.0 g 
840.0 mg 
12.1 g 
15.0 g 
The pH of this media was adjusted to 8.0 with HCl prior to autoclaving. 
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Media were cooled to 50°C before addition of antibiotics, XGal, XP or IPTG. 
Plates containing these additives were stored for no longer than one week at 4 ·c. 
A.2.1 Antibiotics 
Antibiotic stock solutions were as follows: 
Ampicillin 
Chloramphenicol 
Kanamycin 
Tetracycline 
100 mg/ml water 
20 mg/ml ethanol (96%) 
62.5 mg/ml water 
12.5 mg/ml ethanol (50%) 
All antibiotics were filter sterilized and stored at -20°C, except for tetracycline 
which was always made fresh 
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A.2.2 IPTG (isopropyl-b-D-thio-galactopyranoside) 
IPTG (100 mM) 
Distilled water 
This solution was stored in aliquots at-70°C. 
A.2.3 XGal (5-bromo-4-chloro-3-indolyl-b-galactoside) 
XGal (2% w/v) 
Dime thy lformamide 
This solution was stored at -70°C. 
A.2.4 XP (5-bromo-4-chloro-3-indolyl phosphate) 
XP 
Dime thy lsulfoxide 
This solution was stored at-70°C. 
A.3 Buffers and solutions 
A.3.1 Agarose gel electrophoresis solutions 
A.3.1.1 DNA loading solution (6x) 
Bromophenol blue 
Sucrose 
Distilled water 
This solution was stored at 4 ·c. 
A.3.1.2 Tris acetate buffer (S0x) 
Tris-base 
Acetic acid 
EDT A (0.5 M, pH 8.0) 
Distilled water 
A.3.1.3 Tris borate buffer (Sx) 
Tris-base 
Boric acid 
EDT A (0.5 M, pH 8.0) 
Distilled water 
23.4 mg 
1.0 mf 
0.2 g 
10.0 ml 
80.0 mg 
1.0 mf 
250.0 mg 
40.0g 
to 100.0 ml 
242.0 g 
57.1 ml 
100.0 ml 
to 1000.0 ml 
54.0g 
27.5 g 
20.0 ml 
to 1000.0 ml 
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A.3.2 Biuret solution for protein determination 
CuS04°5H20 
NaKC48'06°4H20 (NaK-tartrate) 
Distilled water 
1.5 g 
6.0 g 
to 500.0 ml 
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With constant stirrins, add 300 ml of 10% (w/v) NaOH. Make up to 1 liter with 
H20. Solution is an mtense blue color and must be stored in a cfark glass bottle 
to protect from light. 
A.3.3 DNA hybridization solutions 
A.3.3.1 Alkali fixation solution 
NaOH (0.4 M) 
Distilled water 
A.3.3.2 Denaturing solution 
NaCl (1.5 M) 
NaOH (0.5 M) 
Distilled water 
A.3.3.3 Denhardt's solution (SOx) 
Bovine serum albumin (1 % w /v) 
Ficoll (1 % w /v) 
Polyvinylpyrrolidone-40 (1 % w /v) 
Distilled water 
This solution was stored in aliquots (10 ml each) at-20°C. 
A.3.3.4 Hydrolysing solution 
HCl, concentrated (0.25 M) 
Distilled water 
A.3.3.5 Neutralizing solution 
EDT A (1.0 mM) 
NaCl (1.5 M) 
Tris-base (0.5 M) 
Distilled water 
This solution was adjusted to pH 7.2 with HCL 
16.0 g 
to 1000.0 ml 
87.6g 
20.0 g 
to 1000.0 ml 
1.0 g 
1.0 g 
1.0 g 
to 100.0 ml 
26.0 ml 
to 1000.0 ml 
372.0 mg 
87.6g 
60.5 g 
to 1000.0 ml 
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A.3.3.6 Salmon sperm DNA 
A 10 mg/ml solution was made in TE buffer. The DNA solution was sonicated 
at full power (20 microns) for 10 min in a MSE Soniprep sonicator. The solution 
was afiquoted and stored at -20°C. Immediately before use the DNA was 
denatured by boiling for 10 min followed by cooling on ice. 
A.3.3.7 SSC (20x) 
NaCl (3.0 M) 
Sodium citrate (0.3 M) 
Distilled water 
175.3 g 
88.2g 
to 1000.0 ml 
This solution was adjusted to pH 7.0 with NaOH and autoclaved. 
A.3.4 Exo-nuclease III shortening solutions 
A.3.4.1 Exo buffer 
Tris-HCl buffer (1 M, pH 8.0) 
MgC12 (0.1 M solution) 
Distilled water 
A.3.4.2 Klenow mixture 
Tris-HCl buffer (1 M, pH 8.0) 
MgC12 (1 M solution) 
Distilled water 
One µl of klenow was added per µg of DNA just prior to use. 
A.3.4.3 Ligase mixture 
Ligation buff er (1 Ox) 
T 4 ligase (1 U / µl) 
Distilled water (sterile) 
A.3.4.4 St buffer (10x) 
KOAc (3 M, pH 4.6 solution) 
NaCl (5 M solution) 
Glycerol 
ZnS0430.0 mg 
A.3.4.5 s1 mixture 
S1 buffer (1 Ox) 
S1 nuclease (40 U/µl) 
Distilled water (sterile) 
660.0 µI 
66.4 µl 
9.3ml 
3.0 µI 
6.0 µl 
20.0 µl 
144.0 µI 
24.0 µl 
1282.0 µI 
1.1 ml 
5.0ml 
5.0ml 
41.0 µl 
1.5 µI 
259.0 µI 
A.3.4.6 S1 stop 
EDT A (0.05 M) 
Tris-base (0.3 M) 
Distilled water (sterile) 
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372.2 mg 
726.6 mg 
20.0 mf 
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The pH of this solution was not adjusted as alkaline conditions are required to 
inactivate the S1 nuclease. 
A.3.5 General DNA manipulation solutions 
A.3.5.1 ATP (10x) 
Adenosine S'-triphosphate 
Distilled water (sterife) 
30.0 mg 
5.0m[ 
This solution was adjusted pH to 7.0, and stored in 100 µl aliquots at -70°C. 
A.3.5.2 DIT (1M) 
Di thiothrei tol 
Sodium acetate (10 mM, pH 5.2 solution) 
This solution was filtered and stored in aliquots at -20°C 
A.3.5.3 EDT A (0.SM, pH 8.0) 
EDTA 
Distilled water 
3.1 g 
20.0 ml 
168.1 g 
to 1000.0 ml 
The EDTA did not dissolve until the pH was raised to 8.0 with approximately 
20 g of solid NaOH. This was autoclaved and stored at room temperature. 
A.3.5.4 Ethidium bromide solution 
(2,7-diamino-10-ethyl-9-phenyl-phenanthridinium bromide). A solution of 10 
mg/ml was made in distilled water and stored in a dark bottle. 
A.3.5.5 Isopropanol (salt saturated) 
Isopropanol was saturated with aqueous 5 M NaCl, 10 mM Tris-HCl and 1 mM 
EDT A (pH 8.0). 
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A.3.5.6 Klenow (DNA polymerase I) buffer 
The buffer was made according to the following table and stored at -20°C. 
Stock solution 
Tris-HCl (1 M, pH 7.6) 
MgC12 (1 M) 
NaCl (5 M) 
2-mercaptoethanol 
Distilled water 
A.3.5.7 Ligase dilution buffer 
Final cone. 
0.1 M 
0.1 M 
O.SM 
0.7M 
Amount/10 ml 
1.0 ml 
1.0 ml 
1.0 ml 
50.0 µl 
7.0 ml 
The buffer was made according to the following table and stored at -20°C. 
Stock solution 
Tris-HCl (1 M, pH 7.6) 
EDT A (0.5 M, pH 8.0) 
DTT (0.5 M) 
KCl (1 M) 
Glycerol 
Distilled water 
A.3.5.8 Ligation buffer (10x) 
Final cone. 
20mM 
lmM 
5mM 
60mM 
44% (v/v) 
Amount/10 ml 
0.2ml 
2.0 µl 
10.0 µl 
0.6ml 
4.4 ml 
4.8ml 
The buffer was made according to the following table and stored at-70°C. 
Stock solution 
Tris-HCl (1 M, pH 7.6) 
MgC~ (1 M) 
ATPW.1 M) 
DTT 
Distilled water 
A.3.5.9 Phenol (TE saturated) 
Final cone. 
66mM 
6mM 
lmM 
100mM 
Amount/10 ml 
660.0 µl 
66.0 µl 
100.0 µl 
15.4 mg 
174.0 µl 
Phenol (200 g) was melted at 65 ·c and 0.3 g of 8-hydroxyquinoline was added. 
The phenol was extracted three times with TI (10x) or until the aqueous phase 
was approximately pH 7.6. The phenol was stored under TE (lx) at -20°C. 
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A.3.5.10 Restriction enzyme buffers 
Stock solution 
Tris-HCl buffer (1 M, pH 7.9) 
MgC12 (1 M) DIT (0.5 M) 
BSA (10 mg/ml) 
Glycerol 
NaCl (5 M) 
Final cone. 
0.1 M 
0.1 M 
10.0mM 
1 mg/ml 
44% (v/v) 
0, 50, 100 or 150 mM 
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These restriction enzyme buffers were made according to the following table and 
stored at -20°C. 
Salt concentration (mM) 
Stock solution 0 50 100 150 
Tris-HCl (1 M, pH 7.9) 1 ml 1 ml 1 ml 1 ml 
M~l2 (1 M) 1 ml 1 ml 1 ml 1 ml 
D (0.5 M) 0.2 ml 0.2ml 0.2 ml 0.2ml 
BSA (10 mg/ml) 1 ml 1 ml 1 ml 1 ml 
Glycerol 4.4ml 4.4ml 4.4ml 4.4ml 
NaCl (5 M) 1 ml 2ml 87.7mff 
Distilled water 2.4ml 1.4 ml 0.4 ml 2.4m 
A.3.5.11 Restriction enzyme dilution buffer 
This buffer was made according to the following table and stored at -20°C. 
Stock solution Final cone. Amount/10 ml 
Tris-HCl (1 M, pH 7.5) 10 mM 0.1 ml 
KCl (1 M) 50 mM 0.1 ml 
Distilled water 5.3 ml 
Filter sterilize this solution and then add the following constituents: 
2-mercaptoethanol 10 mM 7.0 µl 
Gelatin (10 mg/ml) 100 µg/ml 0.1 ml 
Glycerol 44% (v /v) 4.4 ml 
A.3.5.12 Smal restriction endonuclease buffer 
This buffer was made according to the following table and stored at-20°C. 
Stock solution 
Tris-HCl (1 M, pH 8.0) 
KCl (1 M) 
MgC12 (1 M) DTI (0.5 M) 
Glycerol 
Distilled water 
Final cone. 
0.1 M 
0.2M 
0.1 M 
10mM 
44% (v /v) 
Amount/10 ml 
1.0 ml 
2.0ml 
1.0 ml 
0.2 ml 
4.4ml 
1.4 ml 
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A.3.5.13 Tris-EDT A (TE) buffer (100x) 
Component 
Tris-base 
EDTA (0.5 M, pH 8.0 solution) 
Distilled water 
Amount 
121.1 g 
200.0 ml 
to 1000.0 ml 
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Adjust to desired pH (eg. 7.5, 7.6 or 8.0) with HCl and autoclave. Dilute with 
sterile water before use. 
A.3.6 Plasmid preparation solutions 
A.3.6.1 Solution I (10x) 
Component 
Glucose (anhydrous) 
Tris-base 
EDTA (disodium salt) 
Distilled water 
Final cone. 
SOOmM 
250mM 
100mM 
Amount 
9.01 g 
3.03 g 
3.72g 
to 100.00 ml 
Adjust to pH 8.0 with HCl and autoclave. Dilute with sterile water before use. 
A.3.6.2 Solution II 
This solution was prepared fresh on a weekly basis according to the following 
table: 
Component 
NaOH (10 N solution) 
SDS (10% w/v solution) 
Distilled water 
A.3.6.3 Solution III 
Component 
K-acetate 
Acetic acid (glacial) 
Distilled water 
Final cone. 
0.2N 
1.0 % 
Amount 
0.5 ml 
2.5 ml 
22.0 ml 
Amount 
147.0 g 
pH to4.8 
to 500.0 ml 
The potassium acetate was dissolved in as little water as possible, and the pH 
was adjusted to between 4.8 and 5.0 with acetic acid before bringing the volume 
up to 500 ml. 
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A.3.7 Polyacrylamide gel electrophoresis (PAGE) solutions 
A.3.7.1 Acrylamide solution 
Acrylamide 
Bis-acrylamide 
Distilled water 
29.2g 
0.8 g 
to 100.0 ml 
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This solution was filtered through Whatman's No.1 paper and stored in a dark 
bottle at 4 ·c. 
A.3.7.2 Ammonium persulphate solution 
A 10% (w/v) ammonium persulphate solution was freshly prepared as needed. 
A.3.7.3 Coomassie blue staining solution 
Coomassie blue R250 
Destain solution (see below) 
2.5 g 
to 500.0 ml 
This solution was stirred overnight to ensure complete dissolving of the dye. 
The following day, it was filtered through Whatman's No.1 paper. 
A.3.7.4 Destain solution 
Acetic acid (glacial) 
Methanol 
Distilled water 
A.3.7.5 Reservoir buffer 
Tris-base 
Glycine 
SOS (10% w /v solution) 
Distilled water 
The pH of this solution should be approximately 8.5. 
A.3.7.6 Resolving gel buffer 
Tris-base 
Distilled water 
The pH of this solution was adjusted to 6.8 with HCl. 
250.0 ml 
750.0 ml 
1.5 1 
15.15 g 
72.05 g 
50.00 ml 
to 5.001 
18.17 g 
to 100.00 ml 
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A.3.7.7 Sample treatment buffer 
Stacking gel buffer (see below) 
SDS (10% w /v solution) 
Glycerol 
2-mercaptoethanol 
Distilled water 
This solution was stored in aliquots at-20°C. 
A.3.7.8 SDS solution 
A 10% (w /v) solution of SDS was prepared as required. 
A.3.7.9 Stacking gel buffer 
Tris-base 
Distilled water 
The pH of this solution was adjusted to 6.8 with HCL 
2.5 ml 
4.0 ml 
2.0 ml 
1.0 ml 
0.5 ml 
6.06g 
to 100.00 ml 
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AppendixB 
General techniques 
B.1 Plasmid preparations 
B.1.1 Small scale (miniprep) 
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Plasmid was isolated from a 5 ml overnight culture (LB + Ap, 100 µg/ml) as 
described by Ish-Horowicz and Burke (1981). Cells from a 1.5 ml sample of the 
culture were harvested by centrifugation in an Eppendorf microfuge tube for 1 
min. The pellet was resuspended in 200 µl Solution I (50 mM glucose; 25 mM 
Tris-HCl, pH 8.0), incubated for 5 min at room temperature, and then 400 µl of 
Solution II (0.2 M NaOH, 1 % (w /v) SDS) was added. The sample was vortexed 
briefly and placed on ice for 5 min, before the addition of 300 µlice-cold Solution 
III (5 M KOAc, pH 4.8). The sample was vortexed briefly, and, after 5 min on ice, 
cellular debris and denatured chromosomal DNA were pelleted by 
centrifugation for 5 min. The supernatant (750 µ1) was removed to a fresh tube 
and sedimented by centrifugation with an equal volume of isopropanol for 
5 min. The pellet was resuspended in TE (600 µ1), NaC104 was added (60 µl, 5 
M), and the DNA was sedimented with an equal volume of isopropanol, washed 
with 70% ethanol, air dried and resuspended in 50 µl TE buffer. 
B.1.2 Large scale (maxiprep) 
A 200 ml culture was grown overnight at 37°C in the presence of the appropriate 
antibiotic. The cells were harvested by centrifugation at 6 000 g for 5 min and 
then resuspended in 4 ml Solution I. After 5 min at room temperature 8 ml 
Solution II was added, and the mixture was kept on ice for 5 min, before the 
addition of 6 ml ice cold Solution Ill. After a further 5 min on ice the cellular 
debris was removed by centrifugation at 12 000 g for 10 min. An equal volume of 
isopropanol was added to the supernatant and the DNA was precipitated by 
centrifugation at 27 000 g for 15 min. The pellet was washed with 70% ethanol 
and resuspended in 4.2 ml TE buffer, and purified by isopicnic CsCl-EtBr 
ultracentrifugation (Maniatis et al. 1982). The plasmid preparation was prepared 
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for ultracentrifugation by the addition of CsCl (1 mg/ml) and EtBr (0.5 ml of a 10 
mg/ml stock). The solution was centrifuged at 27 000 g for 15 min to precipitate 
any remaining protein debris. The refractive index of the supernatant was 
adjusted to 1.396, the sample sealed in Beckman Quickseal ultracentrifuge tubes 
and centrifuged for 12 hat 55 000 rpm at 15°C in a Beckman Vti 65.2 rotor. The 
plasmid DNA band was visualized by long wave UV light (350 nm), and 
removed in the smallest volume possible. The EtBr was removed by extraction 
(3 times) with equal volumes of NaCl-saturated isopropanol. The DNA was 
precipitated from the CsCl solution by the addition of two volumes of water 
followed by an equal volume of isopropanol, and centrifugation in an Eppendorf 
microfuge for 15 min. The pellet was resuspended in 200 µl TE buffer and the 
concentration was determined spectrophotometrically by measuring the 
absorbance of 10 µl (diluted in TE) between 220 and 310 nm. The concentration 
was determined by using the relationship A2w = 1 for 50 µg/ml double-stranded 
DNA. 
B.2 Restriction endonuclease digestion 
Restriction digests were carried out using one of the four restriction buffers 
(Appendix A) according to the salt requirements of the particular enzyme. The 
enzyme Smal required a unique buffer (Appendix A). Digestion volumes were 
routinely 20 µl containing 300-500 ng DNA and one unit of restriction enzyme. 
Digestions were done at 37°C (most enzymes) for 1 h. Concentrated enzyme 
stocks were diluted to 1 or 2 units using universal restriction enzyme dilution 
buffer (Appendix A). For electrophoretic analysis, the digestions were 
terminated by the addition of 5 µl DNA loading solution (Appendix A) to the 20 
µl digestions. If the sample was to be used for ligation the digestion was 
terminated by a phenol-chloroform extraction. The DNA solution was extracted 
with the addition of phenol (1/10 volume, TE-saturated) and an equal volume of 
chloroform:isoamyl alcohol (24:1). The mixture was vortexed briefly, and the 
two phases were separated by centrifugation. The aqueous phase was extracted 
twice with water-saturated ether. The DNA was precipitated by the addition of 
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SM NaC104 (1/10 volume), an equal volume of isopropanol, and 15 min 
centrifugation. If the DNA concentration was less than 2 µg/100µ1 E.coli tRNA 
was added (2 µg) before precipitation. After centrifugation the pellet was 
washed with 70% ethanol and resuspended in TE buffer. 
B.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was carried out using a horizontal submerged gel 
system. Tris-acetate buffer (Appendix A) was routinely used, however Tris-
borate buffer (Appendix A) was occasionally used. Sigma type II agarose was 
used at varying concentrations. The amount of DNA loaded/lane also varied 
with the sizes and number of fragments but under normal circumstances about 
300 ng of plasmid DNA was used. The gels were electrophoresed at 2 V /cm for 
16 h. Gels were stained in electrophoresis buffer containing EtBr (0.5 µg/ml) for 
15-30 min. DNA bands were visualised using a 254 nm transilluminator. A 
310 nm transilluminator was used if the DNA was to be recovered from the gel. 
Gels were photographed using a Polaroid CU-5 Land camera fitted with a red 
filter and a fixed focal length attachment. Polaroid type 667 film (ASA 3 000) was 
used with an exposure time of 1-2 sec at f4.7. If a negative was required then a 
Polaroid type 665 film (ASA 64) with an exposure of 120-140 sec at f 4.7 was 
used. 
B.4 DNA ligation reactions 
DNA ligation reactions were of two basic types: recircularization of plasmids for 
the isolation of deletion clones (use low DNA concentrations, 1 pmole DNA/ml) 
and recombination reactions, for example in subcloning (use 5 pmole DNA/ml). 
DNA concentration was calculated using the formula 1 pmole = (0.662 x kb)µg. 
Ligation reactions containing DNA, ligation buffer (Appendix A) and water to 
the required volume, were performed in sterile microfuge tubes. Sticky-end 
ligations were performed at room temperature for 3 h or at 15 ·c overnight using 
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0.1-0.25 U of ligase, whereas blunt-end ligations were performed at room 
temperature for 3-20 h using 20-100 x more ligase. 
B.5 Subcloning protocol 
The rapid subcloning protocol of Struhl (1985) was used. The DNA fragments 
were separated by electrophoresis through low melting point (LMP) agarose 
(1 %) (Seaplaque) in Tris-acetate buffer (50 mM, pH 8.2, no EDTA, no EtBr). The 
gel was stained with EtBr after electrophoresis and the DNA bands were viewed 
under UV light (310 nm), as briefly as possible. The desired bands were excised 
using sterile scalpel blades, in as small a volume as possible. The gel slices were 
melted at 70 ·c for 5 min in a microfuge tube and the required amounts (2 µI 
vector DNA, 8 µI insert DNA) were added hot to the prepared ligation mixture 
containing ligation buffer, ligase and water (10 µ1). The ligation was incubated at 
room temperature for 3 h. Before transformation of E.coli competent cells, the 
gelled ligation reactions were melted at 70°C for 5 min, and then diluted with 4 
volumes of TE buffer (Appendix A). 
B.6 The preparation and transformation of competent E. coli cells 
Competent cells of E.coli were prepared essentially as described by Dagert and 
Ehrlich (1979). An overnight culture of E. coli was diluted 1:1 000 into 50 ml 
pre-warmed (37°C) YT medium and grown with shaking to early exponential 
phase (OD(i()() = 0.3-0.6) (2-4 h). The culture was cooled on ice for 5 min, and the 
cells were collected by centrifugation at 5 000 x g. The cell pellet was washed 
once with 50 ml of ice cold 0.1 M MgC12, and resuspended in 25 ml of ice cold 
0.1 M CaC12• After 1 h on ice the cells were collected by centrifugation and 
resuspended in 5 ml of 0.1 M CaC12• The competent cells were kept on ice for at 
least 1 h before use or aged overnight at 4 ·c to improve their competency. For 
long term storage, competent cells were treated with glycerol to a final 
concentration of 15% (v /v) and the cells frozen at -70°C. Competent cells 
prepared in this way were suitable for use for more than 1 year. 
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Plasmid DNA {1-5 ng) or a fraction of a ligation reaction (20-100 ng DNA) was 
added to 100 µl of competent cells on ice. After 10 min the cells were induced to 
take up the DNA by heat shocking the transformation mix at 42 ·c for 5 min. 
One ml of LB medium was added and the transformation mix left at 42°C for a 
further 30 min to allow expression of the plasmid borne antibiotic marker. 
Controls included: competent cells with no DNA added; unrestricted plasmid to 
monitor transformation frequency and linearised and ligated plasmid to monitor 
ligation efficiency. The transformation frequency was in the order of 3 000 to 
8 000 colonies per nanogram of unrestricted plasmid DNA. 
B.7 Nucleotide sequencing 
B.7.1 Primer annealing reaction 
The supercoiled DNA (6-10 µg, in TE buffer) was diluted to a final volume of 20 
µl in distilled water. Alkaline denaturation in 0.2 N NaOH (5 min at room 
temperature) was followed by the addition of 5 µl of 3 M sodium acetate (pH 
5.2), 25 µl of distilled water and 150 µl of ethanol. This mixture was chilled to -
70°C, centrifuged at 4 ·c for 20 min in a microfuge and washed with 200 µl of 
ethanol (70%). The DNA pellet was dried and resuspended in a final volume of 
10 µl of sequencing buffer (40 mM Tris-HCl, pH 7.5; 20 mM MgCli,; 50 mM NaCl) 
and 12 ng of primer. This mixture was annealed for 15 min at 40°C immediately 
prior to sequencing. The primers used were the forward sequencing primer as 
supplied in the Sequenase DNA sequencing kit (US Biochemical Corp., 
Cleveland, Ohio) and the Ml3 reverse sequencing primer (Amersham). 
B. 7.2 Sequencing reactions 
DNA sequencing was done by the dideoxy chain termination method of Sanger 
et al. (1977) according to the protocol of Tabor and Richardson (1987), using T7 
DNA polymerase and a "Sequenase" sequencing kit supplied by the US 
Biochemical Corporation, Cleveland, Ohio. The DNA chain was radiolabelled 
with [a..3SS]dA TP (1200 Ci/mmol; Amersham). 
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B.7.3 Gel electrophoresis and autoradiography 
The sequencing reactions were analyzed on standard 6% denaturing acrylamide 
urea sequencing gels. The composition and running conditions of the gels were 
as described in the Amersham M13 Sequencing HandbCX>k. After electrophoresis 
the gels (0.2mm thick) were dried onto Whatman No. 3 filter paper using a Dual 
Temperature Slab Gel Dryer (Model 1125B; Hoefer Scientific Instruments, San 
Francisco). Gels containing 355-labelled DNA were placed under XAR-5 
autoradiographic film and exposed for 1-2 days. The autoradiographs were 
developed using Kodak GBX X-ray developer and fixer. 
B.8 Radioactive labelling of DNA probes 
DNA probes were labelled with [a..32P]dCTP to high specific activity by nick-
translation (Rigby et al. 1977). The reagents were obtained in kit form 
(Amersham) and used according to the suppliers specifications. Contaminating 
nucleotides were removed from the radioactively labelled probe preparation 
using a Sephadex G50 spin column as described by Maniatis et al. (1982). 
Radioactively labelled probes were stored in lead containers at -20°C. Probes 
were denatured by boiling (5 min) in a fume hCX>d just before use. 
B.9 DNA hybridization 
DNA fragments resolved by agarose gel electrophoresis were transferred to a 
Hybond-N+ hybridization membrane (Amersham) according to the 
manufacturer's instructions. After staining the agarose gel with ethidium 
bromide, and obtaining a polariod picture, the gel was soaked in 0.25 M HCl for 
30 min to partially hydrolyse the DNA by acid depurination. After rinsing 
briefly in distilled water the gel was soaked in denaturing solution (Appendix A) 
for 30 min. The gel was again rinsed in distilled water followed by a 30 min soak 
in neutralizing solution (Appendix A). The gel was placed on a glass surface and 
a pre-wet (with neutralizing solution) piece of Hybond-N+ membrane was 
placed on top of the gel. After removal of all air bubbles between the gel and the 
membrane, three sheets of Whatman 3 MM filter paper, wetted in neutralizing 
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solution, were laid onto the membrane, followed by a 4 cm thick layer of 
absorbent paper. A light weight was placed on top of this, and transfer left to 
continue for 60 to 90 min. After transfer, the membrane was placed on a pad of 
absorbent filter paper which had been soaked in 0.4 M NaOH to fix the DNA to 
the membrane. The membrane was rinsed briefly in 5x SSC (Appendix A). 
Hybridization and washing conditions were essentially according to Maniatis et 
al. (1982). The membrane was gently shaken in pre-hybridization solution 
(Appendix A) for 4 h at 65°C, while the probe was being prepared. The 
radioactively-labelled probe to be used was denatured by boiling for 10 min and 
was added to the pre-hybridization fluid. Hybridization was carried out at 65°C 
overnight. The membrane was washed in 1 x SSC at 65 ·c, for 30 min, and after 
checking the radioactivity by means of a Geiger-counter, the washing was 
terminated and the membrane sealed in a plastic bag. The membrane was 
exposed to autoradiographic film (XAR-5) overnight at-70°C. 
B.10 SOS polyacrylamide gel electrophoresis (SOS-PAGE) 
Discontinuous SDS-PAGE was done according to the method of Laemmli (1970), 
using a Hoefer SE600 vertical slab electrophoresis unit (Hoefer Scientific 
Instruments, San Fransisco, CA, USA). The 1.5 mm thick gel spacers were used. 
The resolving gel was prepared and degassed before pouring. Isopropanol was 
layered on the gel to promote a sharp interface. After the gel had polymerized 
(30 min), the isopropanol was removed by rinsing with the stacking gel buffer, 
and the stacking gel was cast. 
Samples were prepared in sample treatment buffer (Appendix A) and placed in a 
boiling waterbath for 2 min before being loaded onto the gel. Electrophoresis 
was continued at 35 mA (constant current)/gel until the dye front migrated to 
the end of the gel (four to five hours). 
After electrophoresis the gels were stained for 3 h in coomassie blue staining 
solution with gentle agitation, destained and dried. 
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The acrylamide gels (10%) were prepared according to the following table: 
Solution Resolving gel Stacking gel 
Acrylamide solution 13.3 ml 2.6 ml 
Resolving gel buffer 10.0 ml 
Stacking ~el buffer 5.0 ml 
SDS (10% 0.4 ml 0.2ml 
Distilled water 15.0 ml 12.2 ml 
Ammonium persulphate 0.3ml 0.1 ml 
TEMED 0.1 ml 40.0 µ1 
B.11 Determination of protein concentrations 
Protein concentrations in solutions were determined by the biuret method as 
described by Cornall et al. (1949). Assays were performed in duplicate using 
new disposable test tubes (13 X 175 mm). The reaction contained protein 
solution (1.5 ml) and biuret reagent (1.5 ml) (Appendix A). After 15 min at 37°C, 
the absorbance of the reaction was spectrophotometrically monitored at 540 nm. 
Protein concentrations were calculated using a standard curve (BSA Fraction V; 
0.05 to 2.5 mg ml-1). Protein samples were diluted such that the absorbance did 
not 0.3 (approximately 2 mg protein), as this corresponds to the upper limit for 
linearity for this method. 
B.12 Fermentation end product determination 
Acetate, butyrate, acetone, butanol and ethanol were measured using a Hewlett 
Packard 5880A gas chromatograph fitted with a flame ionisation detector. A 
glass column (1.86 m X 4 mm) packed with 10% diethylene glycol adipate on 80-
100 mesh chromosorb-W-HP (Supelco) was used with propanol as an internal 
standard. The column temperature was a linear gradient from 60 to 180°C at 
2o·c per min. The detector temperature was 300°C and the injector temperature 
was 250°C. The carrier gas was nitrogen at a flow rate of 30 ml min-1. 
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E.coli strains, genotypes, and references 
E. coli strain Genotype/ description Reference/ origin 
AB1157 F- thr leu his pro arg lac gal ara xyl DeWit and Adelberg 
mtl str (1962) 
AB1884 uvrC34 (ABl 157 derivative) Howard-Flanders et al. 
(1966) 
AB1885 uvrB5 (ABl 157 derivative) Howard-Flanders et al. 
(1966) 
AB1886 uvrA6 (ABl 157 derivative) Howard-Flanders et al. 
(1966) 
C600 supE44 hsdR thi-1 thr-l leuB6 lacYl tonA21 Appleyard (1954) 
CC118 araD139 Mara, leu)7697 AfacX74 phoA~O Man oil and Beckwith 
galE galK thi rpsE rpoB argEam recAl (1985) 
CSH50 ara Mlac pro) str A thi- (<)>80dlac+) Miller (1972) 
CSR603 recAl uvrA6 phrl (AB1886 derivative) Sancar and Rupert (1978 
ET8051 rbs IacZ::IS1 gyrA ~(glnA-rha)VIII Pahel and Tyler (1979) 
F19 this studi-- nitroreductase deficient Santangelo et al. (1991) 
(CC118 erivative) 
HB101 leuB6 tryr38 met-70 recA13 supE44 rpsL20 Boyer and Roulland-
hsdS20(rf ,rf) ara-14 proA2 lacY1 galK2 Dussoix (1969) 
JA221 recA1 leuB6 trp ~5 hsdR- hsdM+ lacY1 Beggs (1978) 
(C600 derivative) 
JM103 endA hsdR surE sbcB thi1 strA Yanisch-Peron et al. 
~(lac proAB) - (1985) 
K514 thr-1 leuB6 thi-1 supE44 lacY1 Wood (1966) 
tonA21 rk-,mk + (C600 derivative) 
LK111 lacJq lacZ~15 lacY+ (K514 derivative) Zabeau and Stanley 
(1982) 
N14-4 uvrD thrA xyI7 ilvA metL arglOOO thi-i IysC Ogawa et al. (1968) 
(W3623 denvative) 
YMC11 ~(glnG-glnA) thi endA hsr hutCK Afac U169 Backman et al. (1981) 
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AppendixD 
One- and three-letter codes used for amino acids 
Amino acid Codes Code Amino acid 
Alanine Ala A A Alanine 
Arginine Arg R C Cysteine 
Asparagine Asn N D Aspartic acid 
Aspartic acid Asp D E Glutamic acid 
Cysteine Cys C F Phenylalanine 
Glutamine Gln Q G Glycine 
Glutamic acid Glu E H Histidine 
Glycine Gly G I Isoleucine 
Histidine His H K Lysine 
Isoleucine Ile I L Leucine 
Leucine Leu L M Methionine 
Lysine Lys K N Asparagine 
Methionine Met M p Proline 
Phenylalanine Phe F Q Glutamine 
Proline Pro p R Arginine 
Serine Ser s s Serine 
Threonine Tor T T Threonine 
Tryptophan Trp w V Valine 
' 
Tyrosine Tyr y w Tryptophan 
Valine Val V y Tyrosine 
AppendixE 
Plasmid vectors and phage restriction maps 
Pstl 
Fapl 
V.pl 
~ 
Boll 
Geul 
pEcoR251 
Hoel 
Pstl 
Baml 
Aaull 
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pEcoR251 (3349 bp) is a derivative of the pCL series vectors (Zabeau and Stanley, 
1982), and was a gift from M. Zabeau, Biotechnology Business Development, 
Ghent, Belgium. This is a positive selection vector used routinely by insertional 
activation of the EcoRI endonuclease gene at either the BglII or Hindlll site. 
Asel 
BgU <3600 
Oral 
Plasmid and phage restriction maps 
Aatll HlndlN < Clal < 4363 < EcoRI 
EcoRV< Raal 
Nhel 
pBR322 
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< Sall 
1000 
Bgll 
pBR322 (4361 bp; Sutcliffe, 1978) is a common E. coli cloning vector. This 
plasmid was constructed in vitro using the Tcr gene from pSC101, the origin of 
DNA replication (ori) from the ColE1 derivative pMB1, and the Apr gene from 
transposon Tn3. 
Pvul 
2000 
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pUC19 
Hg!Ell 
XmaI 
HglEll < Ndel 
Marl 
:,:pl 
Pvul 
PYull 
EcoRI 
Banll / Sacl 
Smol < Aval / Kpnl / Xmol 
BomHI 
Xbol 
HlncN < kcl < SoU 
/.Q-~ Pstl 
~- Hlndlll < Sphl 
500 
Pvull 
SacI SmaI XbaI PstI HindIII 
agtgaattCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGcgtaatca 
EcoRI KpnI BamHI Sall SphI 
HincII 
Acer 
---BspMI 
pUC19 (2686 bp; Yanisch-Perron et al., 1985) is a small, high copy number E.coli 
cloning vector. The pUC series of plasmids were constructed using portions of 
pBR322 and M13mp19. The nucleotide sequence of the multiple cloning site 
polylinker (in the lacZ gene) is shown below the circular plasmid map. pUC18 
differs from pUC19 in the orientation of the multiple cloning site polylinker. 
Fapl 
AYOII 
9911 
Apar 
Plasmid and phage restriction maps 
BlueScript 
ApaU 
Kpnr Xhor Clar EcoRV 
GGTACCGGGCCCCCCCTCGAGGTCGACGGTATCGATAAGCTTGATATCGAATTC _. 
Drarr Salr Hindrrr EcoRr 
Acer 
HincII 
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Pstr BamHr Xbar Eagr Sacrr Sacr 
_. CTGCAGCCCGGGGGATCCACTAGTTCTAGAGCGGCCGCCACCGCGGTGGAGCTC 
Smar Sper Notr ~~~~~-
Bstxr 
BlueScript-SK (2959 bp; Stratagene, San Diego, CA) is a small, high copy 
number E.coli cloning vector specifically designed for exonuclease III shortening 
techniques. The nucleotide sequence of the multiple cloning site polylinker (in 
the lacZ gene) is shown below the circular plasmid map. BlueScript-KS differs 
from BlueScript-SK in the orientation of the multiple cloning site polylinker. 
Plasmid and phage restriction maps 
= 0::;: O'l...c en 
coxn_ 
I ' I 
ISSOL with phoA 
TnphoA 
- I 
u==-== o- E ==u 
C ::J -+-' ::J E ::J = 0 ::J C 
·- > en > > o ...c o > ·-
IQ_ n_ n_ U)Q_U)XCO Q_I 
I I Jt~IZIIIZZZ2 I I 
Tn5 
1 kb 
::;: 0 
(J) ...c 
n_x 
I I 
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A partial restriction map of the transposon TnphoA (Manoil and Beckwith, 1985) 
showing the position of Tn5 relative to the leftward (ISSOJ and rightward (ISSOR) 
insertion sequences. IS50L and ISSOR are represented as thick solid bars, Tn5 is 
represented as a thick slashed bar, and phoA is represented as a thin solid line. 
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Appendix F 
Source code for chromatographic software 
STARTUP.SRC 
l O RD4 PRcx;R.AM NAME • STARTUP, SllC 
200 DEF!NT .\,C,8,L-P,V: DEFD8L O,JC:,R,S: OEFSTR E,f,I,Q,T,X,Y: DEFSNG B 
210 CALL GMOOE 
220 P11GE-O: LINTS-1 
230 CALL GPAGE(PAGE) 
240 CALL LtVI.L(LINTS) 
250 CALL CLRSCJl 
260 CALL DISP (PAGE) 
270 PAGE•l: LINTS•l 
280 CALL GP AGE (PAGE) 
290 CALL LEVI.L(LIN"!S) 
300 CALL CLRSCR 
J 10 LX•lJS: LY•l55 
320 CALL HOVE (LX, LY) 
330 LX-585: LY•lSS 
340 CALL OLINE (LX, LY) 
350 LX•S85: LY•llS 
360 CALL DLINE(LX,LY) 
370 LX•l35: LY•llS 
380 CALL DLINE(LX,LY) 
390 LX•lJS: LY•lSS 
400 CALL DLINE(LX,LY) 
410 LX•255: LY•lSS 
420 CALL HOVE (LX, LY) 
430 LX•255: LY•llS 
440 CALL DLINE(LX,LY) 
450 LX•.US: LY•lSS 
4 60 CALL MOVE (LX, LY) 
410 LX•465: LY•llS 
00 CALL DLINE(LX,LY) 
490 LX•lJS: LY•lSO 
500 CALL HOVE (LX, LY) 
510 LX•l20: LY•lSO 
520 CALL DLINE(LX,LY) 
S30 LX•l35: LY•l20 
540 CALL MOVE (LX, LY) 
550 LX•l20: LY-120 
560 CALL DLnn: (LX, LY) 
570 LX•515: LY-150 
580 CALL HOVE ILX, LY) 
590 LX-600: LY•l50 
600 CALL DLINt(LX,LY) 
610 LX-585: LY•l20 
620 CALL !<1VE (LX, LY) 
630 LX-600: LY•l20 
640 CALL DLINt(LX,LY) 
650 LX•90: LY•l55 
660 CALL HOV!. (LX, LY) 
670 LX-120: LY•l55 
680 CALL DLIHt(LX,LY) 
690 LX•l20: LY•ll5 
700 CALL DLINE(LX,LYJ 
710 LX•90: LY•ll5 
720 CALL OLINE (LX, LY) 
730 LX•90: LY•l55 
HO CALL DLINl.(LX,LY) 
750 LX•600: LY•155 
?60 CALL l«JV!.(LX, LY) 
170 LX•630: LY•l55 
710 CALL DLIIIE(LX,LY) 
790 LX•630: LY•l15 
800 CALL DLIME(LX,LY) 
110 LX•600: LY•ll5 
820 CALL DLINE(LX,LY) 
130 LX•600: LY•l55 
840 CALL DLINE(LX,LY) 
150 LX•90: LY•l45 
860 CALL MOYE (LX, LY) 
1'70 LX•'° t LY•l4.S 
880 CALL DLIWl(LX,LY) 
I 90 LX•'° I LY•l 20 
,oo CALL DLIMl(LX,LY) 
910 LX•IO I LY•UO 
,20 CALL OLI111 (LX, LY) 
no LX•IO 1 LY•lSO 
,40 CALL 01,IWl(LX,LY) 
,so LX•60: LY•lSO 
HO CALL DLIJll(LX,LT) 
,10 LX•iO: LY•l Z.S 
no CALL DLIIII (LX, LY) 
''° LX•tCh LY•U5 
1000 CALL DLilf!. (LX, LT) 
1010 u:-no I LT-145 
1020 CALL MOVZ(LX,LY) 
1030 LX•660: LT•l45 
1040 CALL OLINE (LX, LY) 
1050 LX•660: LY•l20 
1060 CALL OLINE (LX, LY) 
1070 LX•6•0: LY-120 
1010 CALL DLilf!. (LX, LY) 
10,0 LX•640: LY•lSO 
1100 CALL DLIN"t (LX, LY) 
1110 LX•6'° I LY•lSO 
1120 CALL OLINJ! (LX, LY) 
1130 LX•HO I LY•l25 
lUO CALL DLINE(l.X,LY) 
1150 U:•6301 LY•l25 
1160 CAl.L Dl.IlfE (l.X, LY) 
1163 PAGE•l 
1166 CALL DISP(PAGE) 
1110 U:•90: LY•lH: LN-30: LJl•l5 
1110 CALL 111.)(FIL(LX,LY,LW,LB) 
11'0 U:•1201 LY•l21: LW•l5: LB•lO 
1200 CALL ILJU'IL(U:, LY, LW, LB) 
1210 LX•l351 l.Y•lU: LW•l21: l.8•15 
1220 CALL ILXFIL(LX,LY, LN',LB) 
1230 LX-46.S: LY•lU: LN'•l20: LB•l5 
12•0 CALL ILXFIL(LX,LY, LW,LB) 
1250 I.X•515: l.Y•l21: LN•l5: LB•lO 
1260 CALL BLKFIL (LX, LY, LW, LH) 
1270 LX-600: LY•l14: !..W-31: LB•l5 
1280 CALL BLKFIL(LX,LY,LW,LB) 
1290 LX•90: LY•l70: LN•JO: LH•l5 
1300 CALL BLICFIL(LX,LY,LN,LH) 
1310 LX•l20: LY•l60: LW•lS: LB•lO 
1320 CALL BLXF!L(LX, LY, LN,LB) 
1330 LX•l35: LY•l70: LW•121: LB•lS 
1340 CALL BLXFIL(LX,LY,LW,LB) 
1350 LX•4.65: LY•170: LW•l20: LB•l5 
1360 CALL BLXFIL(LX, LY, LW, LB) 
1370 u-sas: LY•l60: LW-15: LB-10 
1380 CALL BLXFIL(LX,LY,LN,LB) 
13'0 LX•600: LY•l70: LW•Jl: LB•lS 
1400 CALI. BLJffIL(LX, LY, LN, LB) 
1470 LX•270: LY•SO: [ST•· BPLC 
100 CALL TEXTB(LX,LY,!.ST) 
1490 LX•270: LY•U: !.ST•" SYSTF.MS SOF"l'NAAE 
1500 CALL TEXTB(LX,LY,!.ST) 
1550 LX•310: LY•210: tST•·veuion 1.2• 
1560 CALL TtXTB(LX,LY,EST) 
1570 LX•302: LY•250: EST•·Preu any key" 
1580 CALL TEXTB(LX,LY,EST) 
15,o IF INKEY$•"· THEN 1S,O 
1600 CHAIN "A:BPtc• 
10 REM PROGP.»I NAME• RPLC.SRC 
12 Rr.M 
" 20 
RD< 
RD< 
HPLC.SRC 
JO RD< •• BPLC Sy•t-• •oft111&re written for a Beck!llan 340H BPLC by 
•o ll!M 
50 REM 
60 l&l 
70 llDI 
•• Jo•eph D. Santangelo in the department of Microbiology at the 
•• Un1ver•1ty of Cape Town; Rondebosch 7700; South Africa,· u•ing 
•• an IBM-PC. 
80 l!M •• Analoq data fro• a Beck••n 160 detector is converted to 
,o REM • • digital data by an t.agle Electronics PC-2 6 AID converter. 
100 RDI •• TM bu• ad.d.r••• of the PC-26 e&rd lllUSt be selected as 
110 RDI • • 700 (Mix) . 
120 REM 
130 REM •• These software programs run on IBM and compatible PC's, i;~ :: :: providing a Hercules aonochro .. graphics card 1• installed. 
170 REM 
180 RDI •••• •• •• •• •• •• •••• •• •• •••• •••• •• •• •••• •• •• •• •• ** ** ** ** ** • • •• • • •• * 0 * 
190 RDI 
200 D!.FINT A,C,B,L-P,V: DtFDIL 0,X,ll,S: OtFSTll t,F,I,0,T,X,Y: OEFSNG B 
210 LlllTS•l: PAGt-0 
2U CALL GP11GE(PAQE) 
216 CALL U:VEL(LINTS) 
211 CALL CLRSCR 
21' CALL DISP (P11GE) 
220 REM lllflflflfffflllllllllltt Ml.MU GtNtJIATIClf tfffllllltttttttttttllfttf 
230 LX•2•0: LY•Z. 
231 CALL l«Jvt (LX, LY) 
232 Lx-•n: LY•2• 
233 CALL DLINE(LX,LY) 
23• LX••71: LY•U 
235 CALL DLINE(U:, LY) 
236 LX•240: LY••• 
23'7 CALL DLIJIEILX,LY) 
231 LX•240: LY•22 
239 CALL DLlNE(LX,LY) 
240 LX•411: LY•22 
2U CALL OLilfEILX,LY) 
H2 LX•411: LY•46 
243 CALI. DLUIE(U:,LY) 
2U LX•240: LY•O 
20 CALL OLIME(LX,LY) 
20 LX•2•0: LY••U 
20 CALI. OLilft(LX,LY) 
2SO LX-2601 LY•ll: ts-r-·artc DATA SYSTF.HS Hr.HU" 
260 CALL TI:XTll(LX,LY,EST) 
2'70 LX•l231 LY•l7 
271 CALL t«JV! (l.X, LY) 
212 LX•S'6: LY•l7 
273 CALL DLINE(LX,LY) 
27', LX•596: LY•289 
275 CALL DLINE(LX, LT) 
216 LX•l23: LY•219 
2'7'7 CALI. OLilfE(U:,LY) 
271 LX•l23: LY•l5 
2'79 CALL DLINE(LX.,LY) 
210 L:1•596: LY•l5 
211 CALL DLIME(LX,LY) 
212 l.X•S96: LY•Ul 
213 CALI. Dl.IM!(LX.,LY) 
214 LX•l23: LY•291 
21S CALL DLI11t(LX.,LY) 
216 LX-1231 LY-219 
217 CALL OLINE (LX, LY) 
211 LX•lSI: LY•l12: !.ST•'"l) Record Daily Baseline• 
219 CALL TI:XTl(LX,LY, EST) 
2,0 LX•lSl1 LY•l39: EST•'"2) lecord C&l1})ration Chroaatogr-· 
291 CALL TI:XTl(LX, LY, UT) 
292 LX•l511 LY•l66: !.ST•'"l) Data Collection and Manual Integration" 
293 CALL TtXTl(IJC,LY, tsT) 
2'4 LX-1SI: LY•l'3: EST•'"•J Data Collection with Automatic Int•gration" 
29S CALL TI:XTIIU:,LY,UT) 
29' LX•lSI: LY•220: !.ST•'"5) D1•play a Stored ChroaAtograi• 
2 91 CALL TI:XTI I LX, LY, tsT) 
291 LX•l51: l.Y•2fl: EST•·6) Manually Integrate a Stored Chrc:aatogram" 
2 9' CALL TEXTI I LX, LY, !.ST) 
300 LX•l58: LY•2H: EST•"'?) Exit to HS-DOS ~•rating Sy•t-" 
302 CALL TI:XTl(LX,LY,EST) 
310 LX•2U: LY•l29: ES'?•"E.nter Selection Nullber ( 1 - 7 ) • 
315 CALL TI:XTl(LX,LY, !.ST) . 
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320 LX•l: LY•l43: EST•SU.INGS(19,32) 
330 CALL TI.XT8(LX, LY, EST) 
365 DEF Sr.G-0: ,on 1050,PEEX(l052): DEF SEG: POKE 106,0 'clear kbrd buffer 
310 as-nuans Ir o•-·" THEN 370 ELSE C80ICE-VAL(Q$) 
380 LX•216: LY•J21: EST•STllHIGS {33, 32) 
385 CALL TEX'?BILX,LY,EST) 
390 IF CBOICI.<l Oll CB0ICE>7 THEN GOSUB 600 ELSE 410 
400 GCTI'O 310 
410 ON CHOICE GOTO 460, 410, 480, 490, 500, 510, 520 
430 RDt 
.UO REM fffffffttflllfftftfftff GET SELECTED PRcx;RAM Utttfffffffftftfttffff 
<150 RF.M 
460 CHAIN "A:BASELINE" 
470 CHAIN "A.:CALIBRAT" 
480 CRAIN "A:MANINT" 
490 CBA.IN "A.:.\UTO!NT" 
500 CHAIN "A:DISPLAY" 
510 CHAIN "A:MANINTST" 
520 REM 
530 Rr.M fffffftfffffttfflffflf r.xn n .. OH BPLC SYSTEMS flfffffffffffltfftffff 
540 Rr.M 
550 LX-256: LY•J.43: EST•"Confir11 Selection (y/n}" 
555 CALL TEXTB(LX,LY,EST) 
Ho as-nncr.Ys: IF as-·· TREN s6o 
570 IF 0.S<>"Y" AND OS<>'"y'" TB.EN 310 
575 CALL 'I'MOOE 
577 CLOSE: CLS: ENO 
580 RDt 
590 REH fttfftftllffffllffffttttt ERR.OR SUBROUTINE ttttflttttttttttttttttUf 
600 LX•292: LY•343: EST•" INVllID ENTRY'": LINTS•O 
602 CALL LEVEL (LINTS) 
604 CALL TEXTB (LX, LY, EST) 
606 LINTS•l 
608 CALL LEVEL(LINTS) 
610 BEEP: roR LOOP • 1 TO 6000: NEXT 
630 RETURN 
MAN INT. SRC 
l O JU:M pao:;RAM NAME • MAN INT SRC 
•• UM 
96 REM 
100 RD!: tttttffttttttttttHffff Initialize th• 8255 fttttttUUUttffttttttt 
110 REH 
120 OUT ,a703,,B92 
194 RD!: 
196 REH 
200 REH fffttttfft Initilize the Screen and OiJnenaion Variables fffffttttttf 
210 REH 
220 DEFINT A,C,8,L-P,V: DEFDBL O,PC,Jl,S: DEFSTR E,F,I,Q,T,X,Y: OEFS'NG B 
230 DIM AST0(5010), 8STO (S010), PPCSTAJlT (1, 25), PPCEND (l, 2S), DP!tARF.A (2S), DPPCJt.T (25), 
DPDHT (25), EPXNAM$ ( 25), STORT (20), STDXMEAN (20), STDYMF..U (20), STOSLOPE (20}, 
ESTDNAMS ( 20) 
240 PAGE•O: LIHTS•l 
250 CALL GPAGl.(PAGE) 
260 CALL LEV!.L(LINTS) 
270 CALL CLlSCR 
280 CALL DISP (PAGE) 
29.C REH 
296 R!'J1 
300 RD1 fftffffUtt Conv.rt Date Fonaat fro• Merican to Europea.11 fffttttfff 
310 J.Dt 
320 £OATES• DATES: HID$(EDATtS,l,2) "'MIDS(DATU,.4,2): HID$(£0ATU,4,2}"' 
HID$(DATES,1,2) 
39.C REH 
J 96 REH 
400 RDI tHHUHttttfffffffffftt Startinq Prcapta tfttttttHttttttftttttttt 
410 REH 
4 12 CALL CLRSCI. 
413 LX•350: LY•30: EST•'"Data Collection and Ha.nu.l Integration'" 
414 CALL TtXTll(LX,LY,EST) 
.415 Otr Sr.G-0: POICE 10SO,PEEK{1052): DEF SEC: POll:E 106,0 'cl-r kklrd buffer 
416 FILES•'"'" 
418 LX•20: LY•l80: EST-" NAME OF FILE FO,. DATA STOllAGE (extension not 
permitted) " 
.420 CALL ffX'?ll(LX,LY, EST) 
-421 Ot•I111CEYS: IF Qt••• TB.EM .421 
.422 CBAJ.•ASC (Qt) 
423 tr (CBA.ll<>ll AMO CBAll<>I) AJfD (CBAll<l2 OR CBAJt.>126) TB.tN SOUND .CO, 10: 
QO?O .421 
424 IF CBAll•ll TREN 43S 
42S Ir CRAJ.-1 AJfD LEM(rILU)<l TBDI SCXJND 40, 10: GOTO 421 
426 Ir CRAJ.-1 AJIC Ll.N(rILES)>O TB!Jf rILU•LEFTS(rILES, (LEN(FILE$)-1)): 
Ga?O 421 
421 FILU•FILU~t 
421 LX•5l51 LY•ll01 EST-FILES+• • 
429 CALL ff.XTB(LX,LT, UT) 
430 GO?O .421 
435 IF MIDt(FIL&.t,2,l) o •:• ?BEW FILEt • •B:"+FILE.$ 
440 FOR LOOP• l TO LDl(FIL&.t) 1 IF MIDt(FILEl,LOOP, l) <> •.• TREJrl JrlEXT UX:. 
ELI& 442 
Ul GO?O 4.50 
442 LIWTl-0 
443 CALL LEVEL (Liftl) 
U4 LX•2411 LT-l21t EST•" EX'?EIISIClf NOT PUHI'?'l'F.D • 
445 CALL TI.XTl(LX,LT,UT) 
446 LIWTa•l I l&&P 
441 rca l,(X)Pl • l TO 5: FOR LOOP2 • 1 TO 5000: NEXT LOOP2: HEXT LOOPl 
441 CALL LEVEL (Lill'!'I) 
44 9 COTO 412 
450 IF LEM (Fil.Et) < 11 TRDI 4 M> 
4Sl LlllTS-0 
4S2 CALL L.EV!.L(LIH'?S) 
45l LX•2.56: LY•321: EST•• FILE NAHi. IS TOO LONC " 
4S.C CAI.L TtX'?B(LX,LT,&ST) 
45S Ltllff•l: BEU 
456 rca LOOPl • 1 TO 5: FOR LOOP2 • 1 TO SOOO: nrr LOOP2: NEXT LOOPl 
457 CALL L&V!.L(LIH'?S) 
4SI GO?O 412 
460 PAGE-l I LIN'?S•l 
462 CALL QPAGE (PAGE) 
46.C CALL UV!.L(LI11TS) 
466 CAI.I. CLUO. 
461 LX•20: LY•llO: l.ST-'"All YOO OSillG Alf UTEDIAL TRI~tl. TO START SAMPLING 
(Y/N) ?" 
470 CALL TEXTBILX,LY,EST) 
472 CALL DISP (PAGE) 
410 EXTJ.t • IJrlJCEYS: IF txnS • "" TllN 410 
490 IF r.rns • ,. 01. EX'TU • •n• Ol r.xns • •y• Oil EX'?RS • •y• TBEH 510 
500 SOU11C 40, 10: PAGE•l 
S04 CALL CLUCJt. 
S06 QO?O 461 
S10 PAG!.•O: LIJrl'?S•l 
520 CALL c.PAGE(PM.£) 
530 CALL LtVl.L(LtHTS) 
HO CALL CLUCJt. 
S9.C JI.D'I 
S96 JI.D'I 
600 REH ttttttttttttttttttftfft Dn.w Running Screen ftttttttttttttfffHfftff 
610 R.EH 
620 LX•30: LY-0: GOSUB 20010 
630 LX•30: LY•2 60: GOSU!l 20030 
632 LX•630: LY•260: GOSUB 20030 
634 FOR MAJ.JI: • 256 TO O STEP -10 
636 LX-30: LY-MAJU(: GOSUB 20010 
638 LX•2S: LY-MA..RJI'.: GOSUB 20030 
640 NEXT MAJUC 
642 FOR MAR.JC • 30 TO 630 STEP 20 
644 LX-H>Jt.JC: LY•260: GOSUB 20010 
646 LX-+O.RJC: LY•265: GOSUB 20030 
64 8 NEXT MAJUt: 
650 FOR MAJ.JC • JO TO 630 STEP 100 
652 LX-MAJl.JC: LY•265: GOSUB 20010 
654 LX-H>Jt.JC: LY•270: GOSUB 20030 
6S6 NEXT MAJUt: 
651 FOP. HAAK • 30 TO 630 STEP 200 
660 LX-H>Jt.K: LY-270: GOSUB 20010 
662 LX-H>Jt.X: LY•275: GOSUB 20030 
6U NEXT MARJ( 
666 LX•21: LY•291: EST•'"lS'": GOSUB 200SO 
668 LX•l21: LY•291: EST•'"20'": GOSUB 20050 
670 LX•221: LY•291: EST•'"25": GOSUB 20050 
672 LX•321: LY•291: EST•"30'": GOSUB 20050 
674 LX•421: LY•291: EST•""35'": GOSUB 20050 
676 LX•521: LY•291: EST•'"40": GOSUB 20050 
678 LX•621: LY•291: EST•'"45•: GOSUB 20050 
680 LX•281: LY•305: EST•'"TIHE (mina)": GOSUB 20050 
6'0 LX•619: LY•l'7: EST•EDATES: GOSUB 20050 
700 LX•30: LY-343: EST•"FILE • '"HILES: GOSUB 20050 
710 LX-450: LY•321: EST•'"SA111ple Number•'": GOSUB 20050 
720 LX•4SO: LY•343: EST•'"Run Time•'": GOSUB 20050 
730 CALL DISP (PAGE} 
7 96 REH 
800 JI.EH tffffffffUHt s-pl• Channel O -- External Trigger tttttffffffflfff 
810 RD4 
820 IF EXTll.$ • •y- Oil. EXTR$ • •y• THEN CHANNEL - 0 ELSE GOTO 900 
130 VALUE-0 
840 LX•30: LY•328: EST-'"Waiting for External Triqq9r ..... ": GOSUB 20050 
850 NRILE VALUE < 2500 
860 OUT ,B702, 2 
863 OUT ,B702, CRANNEt-,810+3 
lil66 VALUE•(INP(,B10l)AHD '8F)"256+INP(,B700) 
870 NEND 
894 REH 
896 RD4 
900 RD4 tttttttttfft O.ter.un• Injection Time of Chromatogr- tttftftftftt 
910 RD4 
920 Il1JtCT$ "' TIME$: MINS • INT (VAL (HID$ ( INJECT$, 4, 2))} 
930 IF HINS>24 THEN 1040 ELSE IF HINS>l5 THEM 1010 ELSE IF HINS<l5 THEN 970 
940 UM --------- HIMS • 15 ---------
9SO MIDS(IJrlJECTS,4,2) • •oo· 
9i0 QO?O 1100 
970 UM -------- HINS < 1S ----------
910 IF VAL (MIDI (INJECT$, 1, 2)) > 10 THEN HID$ ( INJECT$, 1, 2) • 
HID$ (STU (IHT ( (VAL (HID$ (INJECT$, 1, 2)) )-1)), 2, 2) ELSE MID$ (INJECT$, l, 2) • 
"0" +MIDS (STRS (INT ( (VAL (HIOS (INJE.CTS, 1, 2))) -1)), 2, 1} 
990 HIOS ( INJECTS, 4, 2) • HID$ (STU ( IHT ( (VAL IHIDS (INJECTS, 4, 2))) +45) l, 2, 2 J 
1000 GOTO 1100 
1010 J.I.M --------- 24 > HIMS > 15 ie: ainql• digit ----------
1020 MIDS (INJECT$, 4, 2) • .. 0 '"+HID$ (SU.$ ( INT ( (VAL (HID$ ( INJECTS, 4, 2))) -15)), 2, l) 
1030 QO'?O 1100 
1040 ll£M --------- MINS > 24 ----------
1050 HIDS (INJr.CTS, 4, 2) • HIDS (STU ( INT( (VAL (HID$ ( INJECTS, 4, 2))) -15)), 2, 2) 
1094 ll.M 
1096 REM 
1100 Jl.l.M ttftttftt s .. pl• Channel 1 -- Abaorba.noe Data free BPLC ttffttffff 
1110 REM 
1120 CRANH!.L-1: NOSM1PLS•O: LASTX•31: LASTY•256: ll.UNTIHE•O: BST0(0)-.006 
1130 LX•lO: LY•321: EST•STlING.$(35,32): «;OSUB 20050 
1140 LX•lO: LY•321: EST•'"Suipling ..... •: GO.SUB 20050 
1150 STAJI.TIME • TIMEA 
11S5 LX•30: LY•256 
1156 CALL MO'VE(LX,Ll) 
1160 NBILE RU1f'TIME <• 45 
1110 OUT ,a102, 2 
1173 OU'l' ,a702,CRAJfJrlE.L•,B10+3 
1176 VAI.UE•(IJrlP(U70l)AMC '8F)•256+INP(,B700) 
1110 JrlOSM1Pl.S • NOSNtPLS + 1 
11'0 ABVAL • 260 - ( (CIMT(VALU!./16)) +4) 
1200 Jt:UJl.ll'? IM!. • TIMEl 
1210 JI.UNTIME • ( ( oruu.TIME-STllTIHE) /60) +15) 
1215 Ir JI.CJITIM!. < BS'l'O(NOSN'IPLS-1) +.006 TBEJrl 1200 
1220 PL'?Il1.E • ((CIN'?((RUN'?IHE-15) 1 20))+30) 
1230 LX•PLTIME: LY-UVAL 
1240 CALL DLillE(LX,LY) 
1250 BSTO(MOIAMPLS) • JI.UW'l'IHE: ASTO(NOSAKPLS) • ABVAL 
1260 LX•540: LY•l4l: TEHP$•STJ.$(1tUM"l'IME) l f.ST-LEr?.S (TEMP$, 10): GOSUB 20050 
1270 LX•515: LY•328: EST•STJ.S(NOSAHPLS): GOSUB 20050 
1210 LX•'21: LY•34: l.ST-'?IHr.S: GOSUI 200SO 
1290 WEND 
1214 UM 
12'6 J.1.M 
1300 J.1.M ffttttttttff Store Data in a Sequential File (•FILES) tttttfttffttf 
1310 UM 
1320 LX•lO: Lr•321: EST-Sff.INGS(l5,32): GOSUB 20050 
1330 LX•lO: LY•321: £ST•·storinq Data ••••• ·: OOSUII 20050 
1335 FILEDATAt • FILES-t".DAT" 
1340 c::9'DI FILEDATM fO,. OUTPUT AS tl 
1350 111..ITE fl, !.DATU, IJrlJECTS, NOSAMPLS, JCUJtRTIME, STAR.TIME 
1360 ro• LOOP • 1 TO NOSAMPLS STEP 20 
1310 110 • UTO (LOOP) 
1371 AO • AITO (LOOP) 
1312 Ill • HTO(LCXJP+l) 
1373 Al • ASTO(LOOP+l) 
1314 12 • UTO (LOOP+2) 
1315 A2 • AITO (LOOP+2) 
137, Bl • UTO (LOOP+3) 
1317 Al • ASTO(LOOP+3) 
1371 84 • UTO(LOOP+4) 
1379 A4 • ASTO(l.OOP+4) 
1310 115 • ISTO (LOOP+5) 
1311 Al • ASTO (LOOP+S) 
1312 16 • HTO(LOOP+6) 
1313 A6 • MTO(LOOP+') 
1314 11 • ISTO(LOOP+1) 
1315 A.7 • AS'l'O(LOOP+7) 
1316 II • HTO(LOOP+II 
1311 Al • ASTO (LOOP+I) 
1311 119 • HTO(LOOP+9) 
lllt A9 • ASTO(LOOP+9) 
1390 B10 • ISTO(LOOP+lO) 
1391 AlO • AITO(LOOP+lO) 
13'2 Ill • ISTO(LOOP+ll) 
13'3 All • A5TO(LOOP+ll) 
13'4 1112 • BSTO(LOOP+l2) 
llt5 A.12 • U'?O(LOOP+12) 
llt6 Ill • IST0(I..OC9'+ll) 
13t1 All • ASTO(LOOP+ll) 
1391 114 • 1S'l'O(LOOP+l4) 
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1399 Al4 - ASTO(LCX:>P+l-4) 
1400 815 • !ISTO(LOOP+lS) 
1401 A.15 • ASTO{LOOP+lS) 
1402 BU • BSTO{LOOP+lfi) 
1403 Alfi • ASTO(LOOP+l6) 
1-404 817 • BSTO(LOOP+l7) 
UIOS Al7 • .UTO(LOOP-+17) 
1406 Bll • B!TO(LOOP+ll) 
1407 All • .UTO(LOOP+l8) 
1408 819 • 8STO(LOOP+l 9} 
1409 A.19 • A!ITO(LOOP-+19) 
1410 NRITZ fl, 80,AO, Bl ,Al, 82 ,A.2, Bl,AJ, B4,A4, 85,A.5, 86, A6, Bl ,A7, BB, AB, B9, 
A9, !HO, Al 0, Bl l, Al 1,812, Al 2, Bl 3, Al 3, 81<1, Al 4,815, A.15, Bl 6, Al 6, Bl 1, Al 7, 
Bll,Alt,819,AU 
1420 NEXT LOOP 
1430 CLOSE 
1600 LX-30: LY•J28: r.ST•SU.INGS (20, 32): GOSUB 20050 
1605 :.X•4: LY•343: EST•STIUNGS(79,32l: GOSUB 20050 
1610 LlC•18: LY•328: EST•"R.aw data 1• stored, do you wiah to continue ... 
Manual Inteqrat1on (y/nl 1•: GOSUB 20050 
1615 BEEP 
1620 0$•1NXEY$: IF Q$-•• THEN 1620 
1630 IF as • ·y" OR as • "y" THEN 1700 
1640 IF OS • "N" OR QS • "n" THEN 5020 
1650 SOUND 40,10: GG!O 1620 
1694 UH 
1696 llM 
1700 UH fttftttftftfflttftfffff Manual Integration fttftfttttftftfltttttttt 
l 710 UH 
1720 LX•l8: 1Y•328: EST•STR.ING$ (74, 32): GOSUB 20050 
1730 LX•lO: LY-0 
1 HO CALL MOVE(LX,LY) 
1750 LX•lO: LY•259 
1760 CALL OLINE (LX, LY) 
1770 LINTS-2 
1780 CALL LEVEL (LINTS) 
1890 posx-10: NUMSTRTS-0: NUMENDS-0 
1894 PLTI'Df • CINT( ((BSTO(l0)-15) •20) +30) 
1896 PLTtND • CINT( ((BSTO(NOSAHPLS-10)-15) •20)+30) 
1900 SAMPOINT - CDBL 1 (NOSAHPLS-20) / (PLTEND-PL'M'EN)) 
1910 GOSUB 10130 
1930 llEM ----------------------- Input Control Co111111and ---------------------
1940 IHOVE.S - INJl:EY.$: IF IHOVE$ - "" THEN 1940 
1942 IT LEH(IMOVE$)>1 AND IHOVE$-CHRS(O)+"H" THEN HOVE-28: GOTO 1980 
1943 IF LEM(IMOVES)>l AND IH0VE$-CBR$(O)+"JC• THEM HOVE•29: GOTO 1980 
1945 MOVE-A.SC (IMOVE.S) 
1950 IF HOVE< 52 THEN 1940 
1960 IF HOVE < 55 TfiEN 1980 
1970 IF HOYT.>6S ANO POSX>29 AJilO POSX<631 THEM 2070 ELSE SOUND 40,10: 
GOTO 1940 
1910 Rl.H --------------------------- Hov• cur1or --------------------------
1990 IF MOVE • 28 THEN POSX2•P0SX+l: GOTO 2000 
1992 IF MOVE • 54 THEN P0SX2•POSX+l0: GOTO 2000 
1994 IT MOVE • 29 THEN P0SX2•P0SX- l: 00'1'0 2000 
1996 IF MOVE - 52 TBEN P0SX2•POSX-l0: GC11'0 2000 
1991 SOUMO 40, 10: GOO'O 1940 
2000 IF POSX2<10 THEN BllP: POSX2-10 
2002 IF POSX2>640 TBEN BEEP: P0SX2•640 
2004 LX•POIX: LY•O 
2006 CALL MOV't(LX,LY) 
2001 LX-POSX: 1'!•259 
2010 CALL OLINE (LX, LY) 
2012 LX-POSX2: LY-259 
2014 CALL MOVE(LX,LY) 
2016 LX•POSX2: LY-0 
2011 CALL OLINE (LX, LY) 
2020 POSX-POSX2 
2030 00'1'0 1940 
2040 llM ---------- Int•gration control Co1Mand1 ·---------
20SO Rl.M 
2060 kDI --------------------------- P .. k Start ---------------------------
2010 IF HOV'.£• 13 OR HOVt • 115 TBEM SOUND S23.2S,.5 ELSE 2230 
2010 J..Oal' • CINT( (POSl:-35) •SAMPOINT) 
2090 IF LOOP < l THEN LOOP • 1 
2100 IF LOOP > NOSAHPLS TR.EN LOOP • NOSAMPLS 
2110 LOWPOUf'?-0: FLAGS-'"FilS'?" 
2120 CCMPX • CIN'T((BSTO(LOOP)-15) •20)+30 
2130 N8ILE CCMPX <• POSX 
21'0 IF COMPX < POSX '?BEN 2110 
2150 IF FLAGt-'"FIRS'?" THEN NlMSTrrS-NUMSnTS+l: PJl:START(O,NUMS'n.TS)•J..Oal': 
rLAG.S•"NO" 
2160 PIUITAllT(l,N~STlTS)•LOOP 
2110 Ir ASTO(LOOP) > LCIIPOINT TBD LClfPOilfT • ASTO(LOOP) 
2110 LOOP • LOOP + 1 
2190 CaffX • CIWT( (BSTO(LOOP)-15) •20) +30 
2200 WEIIO 
2210 LX-POSX: LT•LOIIPOIN'T+l 
2211 CALL MCJVE (LX, LY) 
2212 LX•POSX: LY•LOIIPOINT+ll 
2213 CALL OLIO (LX, LT) 
2214 LX-PClaX+41 L'!•LOIIPOIW'?+ll 
221S CALL DLIR(LX,LT) 
221' QO'!O 1'40 
2220 ICM ---------------- Peak End ----------------------------
2230 IF NOVI,• H 01. flCl'YI • 101 TH!.11 SOUIID S23.2S, .S ELSE 2390 
2240 LOOP • cnrrc CPOIX-25) •SAMPOUI'?) 
22SO IF l.OOf > aoaANPLI TB!.N LOOP • NOI.MIPLS 
2260 IF LOOf C l TUii' L<X>P • l 
2270 LOIIPOIIIT-G I F'LAG,_"FIIS'T" 
2210 ca9X • Cill'!'((U'l'O(LCX>P)-15) •20)+30 
2290 IIIIILZ cxwx >- ,oax 
2300 IF aJMPX > POaX TB!.W 2340 
2310 Ir FI.AQ,-·,nrr- TllDI Nt»IIJIDI-W~DS+l: PJ(DfO(O,NUMEHDS)•LOOP: 
rLM.t-·ao· 
2320 PXEIID(l,Xt»UIIOS)•LOOP 
2330 IF Al'l'O(LCX>P) > LOIIPOilllT THO LOIIPOINT • ASTO(LOOP) 
2340 LOOP • LOOP - l 
23SO Cc>IPX • CllfT( (BSTO(LOOP)-15) •20) +30 
2360 MENO 
2310 LX-POSX: LT•L0ta0Il1T+l 
2311 CALL MO'l/t(LX,LY) 
2312 LX•POIX: LT•LOIIP0Ilf'?+ll 
2313 CALL OLINE (LX, LY) 
2314 LX•POSX-4: LY-LOWPOIN'T+ll 
2315 CALL DLIXE (LX, LY) 
2316 00?0 lt40 
2310 R!.M -------------------- c1 .. r Entry -------------------------
2Jt0 IF MOVI. <> 61 MD MOYE <> H THEN 2740 
2400 CAJICll-0 i LOIIPOill'T-0 
2410 IF N~STrrs < l THEN 2510 
2420 roa LOOP • l TO NUMSUTS 
2430 CQtPX • CINT((BSTO(PKSTAAT(O,LOOP))-15)•20)+30 
2440 IF COMPX • POIX TUN CAIICI.L - LOOP 
24SO NEXT LOOP 
2460 Ir CANaL < 1 ?II.Elf 2510 
2410 FOi LOOP • PJtSTAJ:"?(0,CANaL) TO PKSTAJ.T(l,CAHCEL) 
2410 IF AS'l'O(LOOP) > LOll1'0IlfT Till.JI LOIIPOINT • ASTO(LOOP) 
2 4 90 NEXT LOOP 
2SOO SOUND soc, .S: SOUND 32167,1: sanro 600,.S 
2Sl0 LX•POSX: LT•LOIIPOill'?+l 
2Sll CALL HOV'.E(LX,LY) 
2512 LX•POSX: LY-LOWPOINT+ll 
2513 CALL OLINE (LX, LY) 
2514 LX•POSX+4: LY•LOWPOIMT+l l 
251S CALL OLIN!. (LX, LY) 
2520 f'OR LOOP • CANCEL TO NUHSTRTS-1 
2530 PKSTAJ.T(O,LOOP) - PKSTAJ.T(O,LOOP+l) 
2540 PKSTART(l,LOOP) • PKSTART(l,LOOP+l) 
2550 NEXT LOOP 
2560 NUHSTllTS • NUMSTRTS - 1: GOTO 1940 
2570 IF NUMSTRTS <l A.HO NUMENDS<l TB.EN SOCJNO 40, 10: GOTO 1940 
2580 FOR LOOP • l TO NOMI.NOS 
2590 C04PX • CINT((BSTO(PJl:ENO(O,LOOP)J-15)•20)+30 
2600 IF CCMPX • POSX THEN CAHCEL • LOOP 
2610 N!.X"l' LOOP 
2620 IF CANCEL< l THEN SOUND 40, 10: GOTO 1940 
2630 F'OR LOOP• PKENO(l,CANCEL) TO PKEND(O,CANCEL} 
2 64 0 IF ASTO (LOOP) > LONPO INT THtN LONPO INT • A..51'0 (LOOP) 
2 650 N!.X"l' LOOP 
2660 SOUND 500, .S: SOUND 32167, 1: SOUND 600, .S 
2610 LX-POSX: LY•LOWPOINT+l 
2611 CA.LL HOVE(LX,LY) 
2672 LX-POSX: LY•LOWPOINT+ll 
2673 CA.LL OLINE (LX, L't) 
2674 LX•POSX-4: LY-LOWPOIN'?+ll 
2 67 S CALL OLINE (LX, LY) 
2 680 FOR J..Oal' • CANCEL TO NUHENDS-1 
2690 PKl.ND(O,LOOP) • PKt.ND(O,LOOP+l) 
2700 P!CENO(l,LOOP) - P!(END(l,LOOP+l) 
2110 NEXT LOOP 
2720 NUHENDS • NUHENDS - l: GC11'0 1940 
2730 ll£M ------------------------- Redo Fron:i Start -------------------------
2740 IF HOVE <> 82 AND !Clvt <> 114 THEN 2840 
2150 BEEP: LINTS-1 
2751 CALL LEV!.L (LINTS) 
21S2 LX•4: LY-328: EST-STRINGS(19,32): GOSUB 20050 
2153 LX-4: LY•JU: EST•STRINGS (19, 32): GOSUB 20050 
2154 LX•lO: LY-321: !.ST•"bdo Froa Start •• , •• '": GOSUB 20050 
21SS LX•227: LY•3U: EST•"CClilFIRM SELECT I Oil (y/n) '": GOSUB 20050 
2760 OS • INJC:EYS: IF QS • •• THEN 2160 
2770 IF Q$ • •y• OR QS - •y- THEN 2190 
2180 GOSUB 10130: GOTO 1940 
2 790 CALL CLJ.SCR 
2791 LX•30: LY•O: GOSUB 20010 
2792 LX•30: LY•260: GOSUB 20030 
2193 LX•630: LY•260: GOSUB 20030 
2794 FOR HAlU{ • 256 TO O STEP -10 
219S LX-30: LY.........UJc:: GOSUB 20010 
2796 LX-25: LY-MA.al(: GOSUB 20030 
2197 NEXT MAllJc: 
2798 FOll MAU • 30 TO 630 STEP 20 
2'799 LX.........a.K: LY•260: QOSUB 20010 
2800 LX-+I.U.k: LY-265: OOSUB 20030 
2101 NEXT MAit.i( 
2102 ro, MAM • JO TO 630 STEP 100 
2103 LX.........a.K: LY•265: QOSUB 20010 
2104 LX-+I.U.k: LY•210: QOSUB 20030 
210S NEXT MAit.Jc: 
2106 FOR MAM • 30 TO 630 STEP 200 
2107 LX.........a.K: LY•270: 00SU8 20010 
2101 LX-MAM: LY•275: QOSUB 20030 
2109 NEXT MA.all: 
2810 LX•21: LY•291: EST-"15'": QOSUB 200SO 
2111 LX•l21: LY•291: EST-'"20": QOSUB 200SO 
2112 LX•221: LY•291: EST-'"2S": OOSUB 20050 
2813 LX•321: LY-291: EST-'"30": QOSUB 200SO 
2114 LX-421: LY•291: EST-"35": QOSUB 20050 
211S LX•521: LY-291: EST-"40": QOSUB 200SO 
2116 LX•621: LY•291: EST-"45•: GOSUB 200SO 
2111 LX-211: LY•30S: EST-"TIHt (aina) "': GOSUB 200SO 
2111 LX•((CINT((BSTO(l)-15)'20))+30): L'!•ASTO(l) 
2119 CALL PLOT(LX,LY) 
2120 CALL MOY'!.(LX,LYl 
2121 ro, LOOP • 2 TO MOSAMPLS 
2822 LX-( (CINT ( (BSTO(LOOP)-15) •20)) +30): LY•ASTO(LOOP) 
2123 CALL DLINE(LX,LY) 
2124 NEXT LOOP 
212S 00'?0 1700 
2130 ll£M --------------------- Quit Int*ir&tion ------------------------
2140 IF MOVE <> 11 MIO M0Vt <> 113 THEN 2900 
21SO BEEP: LINTS•l 
2151 CALL LEV!.L(LIJrfTS) 
2152 LX•4: LY•321: EST-STUNGS(19,32): 005011 20050 
2153 LX-4: LY•3U: l.ST-STUJ«.S (19, 32) : OOSUB 20050 
2154 LX•30: LY-321: EST•"Quit ••••• •: GOSUII 20050 
2155 LX-221: LY-3431 EST-"CCIIIFIIIM SELECTICIII (y/n)": came 20050 
2160 Qt • INKEYS: IF 0, • •• THEN 2160 
2170 IF Qt<>"y'" AND Q$<>"Y" THEN 2110 
2172 CALL CLJ.ICR 
217 4 CALL '?MOOE 
2116 l.Ulf '"A:BPLC" 
2110 QOSUB lOll01 c;cro 1940 
2190 llM -----------· Proce•• Data -------------· 
2900 IF MCJVt <> 10 AND MOYE <> 112 THEN SOOND 40, 10: GOTO 1940 
2910 B!.t.P: LIM'?S•l 
2911 CALL LEVEL (LINTS) 
2912 LX-4: LY•3211 EST-STlINGt (79, 32): QOSUB 200SO 
2913 LX-4: LY•l4l: EST-STlINGS (79, 32) : oosua 200SO 
2914 LX•l01 LY-321: tS"?•"Proca••· •••• ": GOSUI 20050 
2tlS LX•221: LY•JO: EST-"CCIIIFIJIM SE.LECTICIII (y/n)": GOSUII 200SO 
2920 0, • INJtlTf: IF Qt • •• TBEN 2920 
2930 IF QI • "y• ca Qt • •y'" TBDI 2950 
2940 QOSUI 10130: QO?O U40 
2950 LX-4: LT•321: UT-STUNc.$(79,32): QOSUI 20050 
2955 LX-4: L'!•l01 EST-STRINGS(19,32): QOSUB 200SO 
2960 IF NUMSTITS - NUM!IIDS ?BEN 3030 
2910 B!.U: IF Nll4STA1'S>NUME1fDS THD 2910 
2915 LX•ll7: LY•J21: UT-"lftl"IBEl OF P!.Alt STARTS< NUMBER OF Pt.Al{ ENOS'": 
QOSUB 200SO 
2,11 00'?0 29'0 
2910 LX•ll1: LY•l21: UT--W~ER Of' pr.Al( STARTS > NUMBE• OF PEA.Jt ENDS'": 
QOSUI 20050 
2990 LX•l9$1 L'!•l4l: u-r-·Pni•• any key to continue ••••• •: OOSUI 20050 
3000 Ir INKtTt••• TU• 3000 
3010 OOSUI 10130: Qare 1'40 
3020 1.1'.M -------------------- Bu:tiol• Sort ---------------------------
3030 UK 
3040 c.BECJI: • l 
3050 DILE car.cs: 
JOiO CBECJI: • 0 
3010 roa. LOOP - 1 TO N1MSTJtTS-l 
3010 IF BSTO(PKS'l'.UT(O,LOOP)) <- ISTO(PltSTAlT(O,LOOP+l)) THEN 3120 
JOtO SIIAP PltSTAlT(O,LOOPI ,PICS'?'AlT(O,LOOP+l) 
3100 SIIAP PUTll'l'(l,LOOP),PKITAlT(l,LOOP+l) 
3110 CUCJI: - l 
3120 NU'T LCX'I' 
3130 11ZWO 
3140 CBI.CS: • 1 
3150 DILE CHI.CK 
3UO cno: • o 
3110 Fta LOOP • 1 TO NtMDIDS-1 
1110 IF ISTO(PJ(!JID10,LCX>P)) <• BSTO(Pltt.NC(O,LOOP+l)) THEN 3220 
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3190 SWAP P!CElfD(O,LOOP) ,PXF.NO(O,LCX)P•ll 
3200 SWM PK?NO(l,LOOP) ,PKEND(l,LOOHl) 
3210 CBECJI: - 1 
3220 MtX'l' I.,OC:. 
3230 WElfD 
3240 REM --------------------- Confira Order ----------------------------
3250 roJt. LOOP • l TO NUMSTJ.TS 
3260 IF PKSTART(O,LOOP) <• PJCE.ND(O,LOOP) THEN 3280 
3270 CHECK • CB.ECK + 1 
3 280 NIX'? LOOP 
3290 If CHECK < 1 THEN 3360 
3300 LX•4: LY•321: £ST-STUNG$ (H, 32): GOSUB 20050 
3310 81:EP: LX-11: LY•321: tST•"PEAX STARTS AND PEAX ENDS ARE NOT IN THE 
COPJlECT ca.Ctr: OOSUB 20050 
3320 LX•l95: LY•343: EST•"Pr•u any key to continue .•... ": GOSUB 20050 
3330 IF INXEYS•"" THEN 3330 
3340 GOSUB 10130: GOTO 1940 
3 35 O Rr.M -------------------------- I nteqrat ion ----------------------------
3360 LX•4: LY•328: EST•STRING$ (H, 32): GOSUB 20050 
3364 LX•l45: LY-328: EST•"Calculating ar•a for peak TIUll'lbsr": GOSUB 20050 
3366 LX-4D: LY-328: EST•"of"+STllS(NUHSTllTS): GOSUB 20050 
3380 LINTS-2 
3381 CALL !.tVI.L(LINTS) 
3382 LX-POSX: LY-0 
3383 CALL MOVE(LX,LY) 
33U LX•POSX: LY•259 
3385 CALL OLINE (LX, LY) 
3386 LINTS•l 
3387 CALL LEVEL(LINTS) 
3390 FOil LOOPl "' 1 TO NUMSTRTS 
3400 LX•435: LY•328: EST•ST11.$(LOOP1) 
3405 CALL Tt.X'TB (LX, LY, EST) 
3410 RD1 ----------------- B•••lin• (LSllL) c ... lculation• ------------------
3420 DSUMX-0: DSUHY•O: DXY-0: OXSQ-0: 8IG8P0INT•675: FLAGS•"NO" 
3430 DXHF.AJl•O: DYMEAH•O: DLXY•O: DLXS0-0: LOWPOINT-0 
3440 FOR LOOP2 • PIC!TAJlT(O,LOOPl) TO PKSTAllT(l,LOOPl) 
3450 OSUMX • OSUMX + BST0(LOOP2) 
3460 DSUHY • OSUHY + ASTO(LOOP2) 
3470 DXY • DXY + BSTO (LOOP2) •ASTO (LOOP2) 
3480 DXS0 • OXSO + 8STO(LOOP2) "2 
3490 If ASTO(LOOP2) > LC*POINT THEN LC*POINT "' ASTO(LOOP2) 
3500 NEXT LOOP2 
3510 PTSTllT • ((CIHT((8STO(PXSTAltT(0,LOOP1))-l5)•20))+30) 
3520 LINTS•2 
3522 CALL LEVEL(LIN'rS} 
3523 LX•PTSTJlT: LY•LONPOINT+ 1 
3524 CALL MOVE (LX, LY) 
3525 LX•PT!TllT: LY•LON'POINT+ll 
3526 CALL DLINE(LX,LY) 
3527 LX•PTSTRT+4: LY•LONPOINT+ll 
3528 CALL DLINE(LX,LY) 
3530 LON'"POINT • 0 
3540 Foa LOOP] • PXENO(l,LOOPl) TO Pl(I:NO(O,LOOPl) 
3550 OSUMX • OSUMX + BSTO (LOOP3) 
3560 D!UMY - OSUMY + ASTO(LOOP3) 
3570 OXY • DXY + BSTO(LOOP3) *A!TO(LOOP3) 
3510 DXSQ • OXSQ + BSTO (LOOP)) "2 
3590 IF .UTO(LOOPJ) > LOWPOINT TBE'N LONPOINT • ASTO(LOOP3) 
3600 NEXT LCX)PJ 
3610 PTENO • ( (CINT( (BSTO(PKEND(O, LOOPl) )-15) *20)) +JO) 
3620 LX•PTENO: LY•LONPOIN'?+l 
3622 CALL MOVE (LX, LY) 
3623 LX•PTEND: LY•LOICPOIN'r+l l 
3624 CALL DLINE(LX,LY) 
3625 LX•PTEND-4: LY•LONPOIN'?+l l 
3626 CALL OLINE(LX,LY) 
3 62 7 L INTS•l 
3621 CALL LEV!.L(LIN'?S) 
3 630 N•PKSTAJ.T ( 1, LOOPl )-PkSTAJtT (0, LOOP 1) +PJCEND (0, LOOPl )-n:tHD ( 1, LOOP 1) +2 
3640 OXHF.AJI • DSUMX/N: DYMrAN • DSUMY/N 
3650 DLXY•DXY-(DSUMX•DSUKY/N): DLXSQ-()XSQ-( (DSUMX"2) /M): SLOPE-OLXY/DLXSQ 
3660 RDII ------------ calculate ArN , Retention Tim• --------------
3670 FC.. LOOP4 • PltS'?AJ.T(O,LOOPl) TO Pl(I:ND(O,LOOPl)-1 
3690 DBASL - DYM!.Nf+StoPE• (BSTO(LOOP4)-DXHEAN) 
3700 DBASl • OYMI'.AH+SLOPE*(BSTO(LOOPHl)-DXMEAN) 
3710 DUPlSID • US(ASTO(LOOP4)-ASTO(LOOP4+1)} 
3720 OLIO.SID • US (DBASL-DIASR) 
3730 IF A.S'TO(I..CX:.4)<ASTO(LCXIP4+1) TUN DTD4PY1•ASTO(LOOP4+l) ELSE 
DTD4PYl•ASTO (LOOP4) 
3740 
3750 
3760 
3770 
3710 
3790 
3100 
3110 
3120 
3830 
3140 
JISO 
3160 
3170 
3190 
3900 
3910 
3920 
3121 
3922 
3923 
3924 
392~ 
3926 
3927 
3921 
3929 
3930 
3931 
3932 
3933 
3934 
3935 
3936 
3937 
3931 
39]9 
3940 
3941 
3942 
3943 
3944 
3945 
3946 
3947 
3941 
3949 
3950 
3951 
3952 
IF DBASL>DBA.Sl '?8!.H DTD1PY2•DIA!l ELSE OTEMPY2-0BASL 
DPKAJ.EA(LCXIP 1) -OPJt.Ur.A(LOOPl) + ( (BSTO ILOOP4 +l )-BSTO (LOOP4)) 
• (I. 5•ou, .. SID) + ( .5 *DLIIUID) +0T1'.MPY2-DT1'.MPY1)) 
IF ASTO(LOOPO>•BIC.JIPOIHT ?REX 3710 
DSD.TJ\T-&STO(LOOP4) t 8IGBPOIN'l'-ASTO(LOOP4): FL.IIG$•·ENO" 
IF AS'?O(UX:.4)•RIGBP0IN'? 01 FLM.S<>"!lfD" TREN 3100 
DEHOlt'l'•ISTO(LOOP4-l): n.AGS•-itO" 
NEXT UX:.4 
DPKIT (LOOPl) • Olliff.ff?+ ( (OENDltT-DS'?RTRT) /2) 
ll'.M ----------- Print a.tention '?1-• on scr-n ---------------
IS • STJ.4 (OPD.'r (LOOP!)) 
P'?X • CflT((DPO'?IL<X>Pl)-lS)•20)+21 
IF IIQI..POIII'! < 27 ?HZ• P'?Y • 27 ELSE PTY • HIGHPOINT 
Fca LOOPS • 2 TO , 
IF N1Dt(H,LOOP5,l} • •.• TBD PTY•PTY-3: GOTO 3920 
CU&IC'fta • Vll(MIDt(U,LOOPS, U)+l 
P"f'T•rrt-, 
CII Ca&ACTD. QOTO l'2l,3932,39ll,3947,3960,J966,3977,3918, 
JIM,4001 
LX_.TX+l1 l.1'•PTY1 QOSOI 20010 
LX-fTX+51 LT.PTT: QOIUI 20030 
QO'l"O 4030 
LX.PTX+l I LT-PTY1 QOIOI 20010 
LX-PTXUI LT.PTT: QOIUI 20030 
LX..PTX+,1 LT-PTY+l I QOIOI 20030 
LX•PTX+,1 LT-PTY+:Z I QOIUB 20030 
LX•PTX+5t LY•PTY+)t QOSUB 20030 
LX•PTX+l I LT•PTY+31 QOIUB 20030 
LX•PTXt LY-PTT+2: CX>IUB 20030 
LX:•PTX: LY•PTT+l I QOSUI 20030 
QOTO 4030 
LX•PTX+6: LY•PTY+J: QOIUI 20010 
LX•PTX+6: LY•PTY1 QOIDI 20030 
LX•PTX+51 LY•PTY+l: OOSUB 20030 
LX•PTX1 LY-PTY+l I CX>SUI 20030 
LX•PTX+2 l LY•PT'!+J: OOSUB 20030 
CilOTO 4030 
LX•PTX+i I LY•PT'!: CX>SOB 20010 
LX•PTX+i: LT•PTY+l I QOIUB 20030 
LX•PTX+51 LY•PT'!+J I QOIUI 20030 
LX•PTX+2: LY•PTT: QOSUI 20030 
LX•PTX+l: LY•PTY: QOSUI 20030 
LX•PTX: LY•PTY+l: QOSOB 20030 
LX•PTX: LY•PTY+2: OOSUI 20030 
LX•PTX+l: LY•PTY+31 QOSUI 20030 
CilOTO 4030 
LX•PTX+l: LY•PTY+31 OOSUI 20010 
LX•PTX: LT•PT'!+2: QOSUI 20030 
LX•PTX: LY•PT'!+l: QOSOI 20030 
LX•PTX+l: LY.PTT: OOSUI 20030 
LX.PTX+2: LY•PTY: QOSUB 20030 
LX•P'?X+J: LY•PTT+l: QOSUI 20030 
3953 LX•PTX+3: LY•PTY+2: GOSUB 20030 
3954 LX•PTX+4: LY•PTY: OOSUB 20010 
3955 LX•PTX+5: LY•PTY: GOSUB 20030 
3956 LX•PTX+6: LY-PTY+l: GOSUB 20030 
3951 LX•PTX+6: LY•PTY+2: GOSUB 20030 
3958 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3959 GOTO 4030 
3960 LX•PTX+l: LY•PTY+3: GOSUB 20010 
3961 LX•PTX+4: LY•PTY+3: GOSUB 20030 
3962 LX•PTX+4: LY•PTY: GOSUB 20030 
3963 LX•PTX+6: LY•PTY+l: GOSUB 20010 
3964 LX•PTX: LY•PTY+l: GOSUB 20030 
3965 GOTO 4030 
3966 LX•PTX: LY•PTY: GOSUB 20010 
3967 LX•PTX: LY•PTY+3: GOSUB 20030 
3968 LX•PTX+2: LY•PTY+3: GOSUB 20030 
3969 LlC•PTX+2: LY•PTY+l: GOSUB 20030 
3970 LlC•PTX+3: LY•PTY: GOSOB 20030 
3971 LX•PTX+5: LY•PTY: GOSUB 20030 
3972 LX•PTX+6: LY•PTY+l: G0SU8 20030 
3113 LX•PTX+6: LY•PTY+2: GOSUB 20030 
3974 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3975 LX•PTX+4: LY•PTY+3: GOSUB 20030 
3 916 001'0 4030 
397"1 LX•PTX+l: LY•PTY: GOSUB 20010 
3978 LX•PTX: LY•PTY+l: GOSUB 20030 
3979 LlC•PTX+2: LY•PTY+3: GOSUB 20030 
3 980 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3911 LX•PTX+6: LY•PTY+2: GOSUB 20030 
3912 LX•PTX+6: LY•PTY+l: GOSUB 20030 
3 983 LX•PTX+5: LY•PTT: GOSUB 20030 
3984 LX•PTX+4: LY•PTY: GOSUB 20030 
3915 LX•PTX+3: LY•PTY+l: GOSUB 20030 
3916 LX•PTX+3: LY•PTY+2: GOSUB 20030 
3917 GOTO 4030 
3911 LX•PTX: LY•PTY+3: GOSUI 20010 
3 919 LX•PTX: LY•PTY: GOSUB 20030 
3990 LX•PTX+2: LY•PTY: GOSUB 20030 
3991 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3992 LX•PTX+6: LY•PTY+3: GOSUB 20030 
3993 GOTO 4030 
3994 LlC•PTX+2: LY•PTY+3: OOSUB 20010 
3995 LX•PTX+l: LY•PTY+3: GOSUB 20030 
3996 LX•PTX: LY•PTY+2: GOSUB 20030 
3997 LX•PTX: LY•PTY+l: GOSUB 20030 
3991 LX•PTX+l: LY•PTY; GOSUB 20030 
3999 LX•PTX+2: LY•PTT: GOSUB 20030 
4000 LX•PTX+3: LY•PTY+l: OOSUB 20030 
4001 LX•PTJC+3: LY•PTY+2: GOSUB 20030 
4002 LX•PTX+4: LY•PTT+3: OOSUB 20030 
4003 LX•PTX+5: LY•PTY+3: GOSUB 20030 
4004 LX•PTX+6: LY•PTT+2: GOSUI 20030 
4005 LX•PTX+6: LY•PTT+l: GOSUB 20030 
4006 LX•PTX+5: LY•PTT: OOSUI 20030 
4007 LX•PTX+4: LY•PTT I GOSUI 20030 
4001 00'1'0 4030 
4009 LX•PTX-+i: LY•PTY+2: GOSUB 20010 
4010 LX•PTX+4: LY•PTY: OOSUI 20030 
4011 LX•PTX+l: LY•PTT: OOSUB 20030 
4012 LX•PTX: LY•PTY+l: GOSUB 20030 
4013 LX•PTX: LY•PTY+2: QOSUB 20030 
4014 LX•PTX+l: LY•PTY+3: GOSUB 20030 
4015 LX•PTX+2: LY•PTY+J: GOSUB 20030 
4016 LX•PTX+3: LY•PTY+2: GOSUI 20030 
4017 LX•PTX+J: LY•PTY+l: GOSUI 20030 
4030 Nl.XT LOOPS 
4040 NEXT LOOPl 
4100 ll!.M ------------------- Print Ba.rdcopy of Chranatogra/11 ---------------
4110 LX-t: LY•l21: EST-STUNCS(79,32): GOSUI 20050 
4112 LX-t: LY•l43: £ST-STRING$(79,32): OOSUB 20050 
4114 LX:•619: LY•l7: EST-STI.INGS:(10,32): GOSUI 20050 
4116 LX•621: LT•J4: EST-ST1.ING$ (I, 32) : GO.SUI 20050 
4111 BEU: LX•96: LY•321: EST•"Pr••• <(ah1ft] PrtSc-1> when thil meuage 
diuapNU": QOSUB 20050 
4120 LX•l95: LY•343: EST•"Pr•H any key to cont1nu• ..... ~: GOSUB 20050 
4130 IF IMKEYS • •• TBEN 4130 
4140 LX-t: LY•Hl: EST-STI.INGS (79, 32) : QOSUB 20050 
4150 FOR LOOP • 1 TO 5000: NEXT LOOP 
41'0 BEEP: LX-t: LY•321: EST-STJUNGS(79,]2): GOSUB 20050 
4170 IF INltlTt • ... TBEII 4170 
4110 ll!.M ---- Quant1tat1on --------------
4190 llM 
4200 J.l.H ------ lNd Standard Curv. Pa.r-etera frOfll A:STANDAJtDS .DAT ------
4210 LX-30: L't•J21: EST•"Loadinq Standard Curve Data, Pl•••• N&it ••. 
COSOB 20050 
4210 OPEN •A:STIIDRDS.DAT" .U f2 LEN • 35 
4240 FillD fZ, 2 AS EXUMl'l'OSS, 10 .U WAITS, 23 AS EOUMMYS 
4250 QE'? 12, l 
4260 NUMS'l'OS • CVI (ENll'ISTDSS): ES'?OATU - E0AIT$ 
4210 FIELD t:z,I AS ti.TS, I AS XMr.M$, I AS !MF.ANS, 8 AS £SLOPES, 3 A5 ENAHES 
4290 FOR L()C:» • l TO NUMS'?OS 
4300 GE? U. LCX»+l 
4310 STOit'? (LOOP) • CVD IERTS) 
4320 S?OXM!.M(LOOP) • CVD0CMF.AN$) 
4330 S'?O!Ml.All(LOOP) • CVD(YMUJIS) 
4340 STOSLC.E(LOOP) • CVD(ESLOPES) 
4350 ESTDN11H$(LOOP) - ENAMU 
4360 NEX'l' LOOP 
4370 CLO!ll 
4310 u:M ---------------- Ccapan J.•t•nt1on Till•• --------------------
4310 LX-t: LY'•l21: &ST-STRING$ (71, 32) : QOSUB 20050 
4400 LX•30: LY•321: ES'?•"PlN- wait ••••• •: QOSUB 20050 
4410 roa L()C:»l - 1 '?O 11~nns 
4420 If DPD?(LOOPl) < 34 ?BP UNQE • , 625 ELSE RANGE • .5 
4430 car.a: • 0: LOOP2 • 1 
4440 NBILI. CBECJC < 1 
4450 IF S'l'01tT(LOOP2)<(DPXltT(L00Pl)-RAHG!.) Cl 
STDaT(LOOP2)>(DPDT(LOOPl) +RANGE) TBEH 4490 
4460 CBECIC • 1 
4470 UIOIAM8 (LOOPl) • ESTDN»IS (100P2) 
4410 DPUMT (LOOPl )•STDTMP.AN (LOOP2) + (S'l'OSLOPE (LOOP2) • (OPD.P.EA(LOOP 1) -
S'?DXMUII (LOOP2 I) I 
4490 LOOP2 • L()C:»2 + 1 
4500 IF LOOP2 > Nta4STDS AIID CBI.CJ{ < l TBEN car.cit • 2 USE 4530 
4510 EPKNAHa(LOOPl) - "???• 
4520 DPDMT(LOOPl) • 0 
4530 Wl'.IID 
4540 lflXT LOOPl 
4550 llM ------------ Sten QuantitatN Data ---------------------
4510 FILEOJMT$ • FILU + • ,QN'r 
4590 OPEN FILEQUAIITt AS fl UN•27 
4600 FIELD fl, 2 AS ENUMSD.Tsa, 10 AS £STDT$, l AS FLAG$, 12 .U E0Up,f,4Y$ 
4610 LSET ENmaTI.TSa • MKU {Nll'ISTR'?S) 
4620 LSE'T ES'?D'U • UTOATU 
4625 LSE'T FLM.I • "YES" 
46.JO un !.D0"4Ya • • 
4640 PUT tl, 1 
4650 Flr.I.O fl, 3 AS EMN1Et, I 1J UD'?S, I AS EPXAlEAS, I AS EPMMT$ 
4 660 roa LOC:. • l TO NUMSff'?S 
4 no LH'? ZNIIMU • EPJOIAMI (LOOP) 
4610 LH.T EPDTI • KKDt(DPDT(LOOPII 
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4690 LStT EPJCAllAS • MXD$(DPICAJ.EA(LOOP)) 
4700 LSI.T !.PDM'U • Mlit:OS (DPJC»f'l'(LOCIP)) 
4710 Ptn fl, LOOP+l 
4 72 C NEXT LOOP 
4730 CLOSE 
4740 UM --------------------- Printout Qu&ntitated. Data -------------------
4750 LX•<I: LY•321: IST-ST1lINGS ('79, 32): GOSUB 20050 
4755 LX-4: LY•Hl: EST-STJ.INGS('19,32): OOSUB 20050 
4760 LX•240 ! LY•J21: [ST•"Check Printer Sta.tu•": GOSUB 20050 
4710 LX•l95: LY•)Ul EST-"Pn•• any key to oontinue .•.. ,": GOSUB 20050 
4780 If IHXEY$ • "" THEN 4180 
4790 OPEN "LPTl:" AS f3 
4800 NI0T8 f],10 
-4810 PRINT fl, CB.k$(27);CHJ.Sf13):C8Jl$(2): PRINT fl, CB.JU(l3);CB:ll$(10) 
4820 PRINT fl, TAB(l);"FILEI ";FILI$:TAB(34);"INJECTION TIME! 
INJr.CTS;TAB(64);EDATtS: PUNT 13, CBR$(13);CRR$(10) 
4830 PUNT fl, TAB(]) ;STRING$ P6, 205) 
4840 PRINT 13, TAB(5);"Peak No.";TABl20);"Peak Name";TAB(34); 
"Retention Time'"; TAB(55);'"Area'";TAB(70);'"Alllount• 
4850 PRINT f3, TAB(3);STRINGS(76,l96) 
4860 FOMAT1$ ft 
4870 FOMAT2S • •\ - - - - - \ - - - - - - - - - - - - -
4880 FOMAT3$ • '"tf,ftt fff.ttttff fftt.ffff'" 
4890 FOR U>OP - 1 TO NuMsTR.Ts- - - - - - - - - - -
4900 PRINT f3, USING FORMATlS;LOOP; 
4910 PRINT t3, USING FOR.MAT2S;EPKNAMS(LOOP); 
4 920 PRINT t3, USING FORMAT3$; DPPCR.T (LOOP l; DPKAJ\EA(LOOP); DPXAH'l' (LOOP) 
4930 NEX'? LOOP 
4940 PRINT 13, TAB(3);STJ.UIG$(76,205) 
4950 PRINT tJ, TAB(7) ;'"Qua.nt1tated data extrapolated fra11 standards recorded 
on: "; £STOAT!.$ 
4960 IF VAL(MIDS(ESTDATES,4,2)) • VM.(MIDS(tDATU,4,2)) THEN H90 
4970 IF (VAL(MIDS(ESTDATES,1,2)))-31 >• (VAI.(MID$(EDAT£$,1,2)))-31 THEN 4990 
4980 PRINT f3, CBll$(27);CHll$(69);TAJ(16J;'"WAllNING, STANDARD CURVE IS OLDER 
TRAN ONE MOITB l ! • ;CBJlS (27) ;CBJlS (70) 
4990 PRINT tJ, CBR$(27);CBJ.$(73);C8Jl$(1) 
5000 PRINT fl, CBRS (12) 
5010 CLOSE 
5020 LX•4: LY•328: tsT•STRINGS (79, 32): GOSUB 20050 
5025 LX•-4: LY•343: EST-STRINGS (79, 32): GOSUB 20050 
5030 LX-249: LY•328: EST•'"A.nother lh.in (y/n) 1": GOSUB 20050 
5033 BEU 
5035 DEF SEG-0: POKE 1050,PEEK(1052): Dr.F SEC: POKE 106,0 'cl .. r kbrd buffer 
5040 QS•IHKEYS: IF 0$•"" THEN 5040 
5050 IF QS<>"N" AND QS<>"n" THEN 5060 
5055 CALL CLRSCJ. 
5057 CRAIN "A:RPLC· 
5060 IF QS<>'"Y'" ANO QS<>•y• TIil.Ji SOtJlrilD 40, 10: GOTO 5040 
5070 CLF.All 
5080 GOTO 220 
9999 END 
10130 REM ffttfffffffftttff Inteqrat1on Curaor COINla.nd Menu ftfttttttffttttt 
10140 llD4 
10142 LINTS•l 
10144 CALL LEVEL(LINTS) 
10150 LX•4: LY•321: EST•STRINGS (79, 32) 
10160 CALL TEX'?l(LX,LY,UT) 
101 70 LX•4: LY•343: EST•STJ.I'NGS (79, 32) 
10180 CALL ff.XTl(LX, LY, tsT) 
10190 LX•27: LY•321: r.s-r-•cu1-.soa CCM4ANDS: Use L, a arrow 
key• - <shift> • lOX-
10200 CALL ff.XTl(LX,LY,ES'?) 
10210 LX•27: LY•343: EST-"lMTEGIATiai CCM0.NDS: Start End C&.tloel 
Redo Process Quit'" 
10220 CALL TEXTl(LX, LY, EST) 
10222 LIN'?S•2 
10224 CALL LEVEL(LINTI) 
10230 l!.TUJ.N 
20000 RD! fftttttffttfttttffftfft GIAPB-X SubroutinH fftttffffttfftttfffttt 
20010 CALL MOVE (LX, LY) 
20020 lETUJ.N 
20030 CALL DLINE(LX,LY) 
20040 RETURN 
20050 CALL ff.XTB(LX, LY, ts'?) 
20060 J.ETUJ.li 
MANINTST.SRC 
10 llM n.cxa.AM MAME • MANIN'?S'?.SlC 
.. llEM 
•• llEM 
200 RDf tttttttffff Init1l11• thal scr-n and Diaenaion Variable• ttttffffttt 
210 1124 
220 Dr.Fili'? A.,C,8,L-P,V: Or.FOIL D,K,l,S: DUSTI !.,F,I,Q,T,X,Y: D!.FSWG B 
230 DIM UT0(5010), U1'0(5010), PUTAn (1, 2S), PJCEMD (1, 25), OPXAJt.r.A. (25), DPKRT (25), 
OPlUIM'T (25), UD»lt (2S), STDR'? (20), STOXMEAN (20), STDYMEA.N (20), STDSLOPE (20), 
ESTDll»lt (20) 
240 PAGE-11 Lnrrl•l 
250 CALL Q.l~&(HG&) 
260 CALL 1.&VKL(LIW'l'I) 
2 70 CALL L&V&L (Llftl) 
294 UM 
29' lDI 
400 lDI tfffttfHffffftffffHtfft 1tartin9 Prcapts ffttttttfttttttfttttttttt 
410 I.DI 
4 12 CALL c.uca 
413 LX•l25: LY•J01 U'?-"Manual lnt~ration of a Stored Chroaatoqr-· 
414 CALL nrr•(LX,LY,U'?) 
415 DEF 1~1 POIIZ 1050,PEU(l0.52) 1 DEF HC1 PCICE 106,0 'cl .. r kbrd buffer 
416 FILU••• 
420 LX•20 1 LY•llO: !.S'?-"ll»IE C1I' FIL!. J"Ol IM'l'EGJt.ATIOlf (exten•ion not 
penitted) " 
421 CALL T!.XTJ(LX,LY,UT} 
422 CALL OISP (PAGE) 
423 QS•INKEYt: IF Qt••• TB!.N 423 !..LSE CB.U•ASC(OS) 
424 IF (CBAA<>ll AND CllAl.<>I) AJID (CB.AJ.<32 Oil CB.All>l26) TB.EN SOUND 40, 10: 
GOl'O 423 
425 IF CB.AJ.•13 '?B.!JI 4l5 
426 IF CB.AA ... AJIO L!Jl(FILU)<l TBDI SOOWD 40,10: 00'1'0 423 
427 IF CJI.All-1 AND LEN(FILU)>O TBDI' FILU•LEM$(FILE$, (LEN(FILES)-1)): 
GOl'O 429 
421 FILU•FILU+Ot 
42' LX•511: LY•llO: !.ST•FILU+• " 
4l0 CALL Tr.X"rl(LX, LY, EST) 
431 GOl'O 423 
435 IF MIDS(FII.U,2,1) <>•:•TREW FIL£$• '"!:'"+FILE$ 
-440 FOil LOOP• 1 '?O 11:Jf(FILU): IF MIDS(FILES,LOOP,l) <>•.•THEM NEXT LOOP 
!LSE 442 
Ul GOl'O 450 
442 LINTS-0 
443 CALL L&VEL(LIN'U) 
U4 LX•241: LY•l21: EST•'" !.XTENSIClf NOT PD.MI'M'!.D '" 
445 CALL TZX'?l(LX,LY, U'?) 
446 LINTl•l I BEU 
441 rca LOOPl • l '?O 5: Fca LOOP2 • 1 TO 5000: N!.XT LOOP2: NEXT LOOPl 
UI CALL U:VZL(Lill'H) 
40 QOfO 412 
450 IF Ulf(FIUt) < 11 '?BEIi 4iCI 
451 LINTS""° 
452 CALL LEVEL (LINTS) 
453 LX-256: LY•328: EST•" FILE NAME IS TOO LONG • 
454 CALL TEXTB(LX, LY, EST) 
4 55 L INTS•l: BEEP 
456 FOR. LOOPl - 1 TO 5: roR LOOP2 - 1 TO 5000: NEX'l' LOOP2: NEX'? LOOPl 
457 CALL LEVEL (LINTS) 
458 GOTO 412 
460 LX•20: LY•250: EST•"Reading Data, P leaae Nait.,.,, • 
462 CALL TtXTB(LX,LY,EST) 
465 rILEDATAS • FILES+• .DAT'" 
470 OPEN FIL£0A.TA$ FOR INPUT AS fl 
4 71 INPU'T fl, EDATES, INJECTS, NOSAMPLS, KURRTIME, STAllTIME 
4 72 FOR LOOP • l TO NOSAMPLS STEP 20 
473 INPUT tl, BO, AO, Bl, Al, 82, A2, BJ, A), 84, A4, 85, A5, 86, A6, 87, A7, 88, A.8, 89, 
A9, B10,Al0, Bl 1,A.11, 812, Al 2, B13,A13, Bl4,Al4, B15,Al5, B16,Al6, Bl 7 ,Al 7, 
818, All, 81 CJ, Al 9 
474 BSTO(LOOP) • BO 
475 A5TO(LOOP) • AO 
476 BSTO(LOOhl) • Bl 
471 ASTO(LOOP+l) • Al 
4 78 BSTO (LOOP+2) • 82 
479 A!TO(LOOP+2) • A2 
480 BSTO(LOOP+J) • 83 
481 ASTO(LOOP+J) • A3 
482 BSTO(LOOP+4) • 84 
483 ASTO(LOOP+4l • A4 
484 BSTO (LOOP+S) • BS 
485 ASTO (LOOP+5) • AS 
486 BSTO(LOOP+6) • 86 
4117 ASTO(LOOP+6) • A6 
488 BSTO(LOOP+7) • 87 
489 ASTO(LOOP+7) • A7 
490 8STO(LOOP+8) • 88 
491 ASTO (LOOP+I) - Al 
492 BST0(LOOP+9) • 89 
493 ASTO(LOOP+9) • A9 
494 BSTO(LOOP+lO) • 810 
495 ASTO(LOOP+lOJ • AlO 
496 8STO(LOOP+ll) • 811 
497 ASTO(LOOP+ll} • All 
491 8STO(LOOP+l2) • Bl2 
499 ASTO(LOOP+12) • Al2 
500 BSTO(LOOP+13) • 813 
501 ASTO(LOOP+13) • A.13 
502 BST0(L00P+l4) • 814 
503 A.!TO (LOOP+ 14) • AH 
504 BST0(L00P+15) • 815 
505 A.,'?O(LOOP+15) • Al5 
506 8STOILOOP+l6) • 816 
507 ASTO(LOOP+l6) • Al6 
501 BSTO (LOOP+ 17) • Bl 7 
509 ASTO(LOOP+l7) • Ali 
510 BSTO (LOOP+ 18) • 811 
511 A.,TO(LOOP+l8) • AU 
512 BSTO (LOOP+ 19) • Bl 9 
513 MTO(LOOP+19) • AU 
514 Nf.X'1' LOOP 
515 CLOSE 
520 PAG!.•O: LINTS•l 
530 CALL G1'AGE(PAGE) 
540 CALL LEVEL(LINTS) 
550 CALL CLUCI. 
594 llD4 
59' llD4 
600 It.DI ttttffttfttftttttttttff Draw Running Screen tttttttUfftttlfttlftttt 
610 R.DI 
620 LX•lO: LY-0: OOSUB 20010 
630 LX•JO: LY•260: OOSUB 20030 
632 LX•630: LY•260: QOSUI 20030 
634 FOil MARK • 256 TO O STEP -10 
636 LX•301 LY-MAU: 00SUI 20010 
631 LX•25: LY-MA.J.K: OOSUB 20030 
64 0 N r.xT MAJ.JC 
642 FOil MA.II( • 30 TO 630 STEP 20 
644 LX-+tA.JlK: LY•260: GOSUB 20010 
646 LX-MAJ.11'.: LY•2'5: QOSUI 20030 
641 Ntx'? MAJ.II: 
650 FOR MA.Ill'. • 30 TO 630 STU 100 
652 LX-MAJ.J{: LY•26S: GOSUI 20010 
6S4 LX-MAI.X: LY•270: GOSUB 20030 
6 S 6 NEXT MAJ.II: 
651 FOil MA.IX • 30 TO 630 STEP 200 
660 LX-MAJ.I: LY•270: GOSUB 20010 
662 LX-MAJ.I: LY•275: GOSUB 20030 
664 NU'? MAI.It 
6H LX•21: LY•291: r.s-r-•15·: GOSUB 200SO 
661 LX•121: LY•291: £ST•'"20•: GOSUB 20050 
no LX-221: LY-2'1: !.5'?•"25·: QOSUI 20050 
672 LX•l21: LY•291: !..!'?•'"30•: GOSUI 20050 
674 LX•421: LY-291: EST•"lS'": GOSUI 20050 
676 LX•521: LY•291: tST•·40'": GOSUI 20050 
611 LX•621: LY•Ul: EST••,t5•: GOSUI 20050 
HO LX•211: LY•30S: !.ST•'"TIHE (a ins)•: GOSUB 20050 
700 LX•lO: LY•JO: £!'?-"FILE• •+FILE$: C.OSUB 20050 
710 CALL OISP (PAGE) 
796 lDI 
100 UM tttffftttttttftfffffftff Draw Chrc:aatogru tfffttttftftlftttttttflff 
110 LX•((Cill'l((U'?O(l}-15)•20))+30): LY•ASTO(l) 
120 CALL PLOl' (LX, LY) 
130 CALL J«)YE (LX, LY) 
140 Fca LOOP • 2 1'0 NOSWIPLS 
150 U:•( ICIW'? ( (ISTO ILOOPJ-15) •20)) +30) : LY-ASTOi.LOOP) 
160 CALL CLINE (LX, LY) 
170 NU'? I..OC» 
1700 llM tttttttttffttffttttfffff Manual Inteqrat1on ffttttfftttfttttttfffft 
1710 llM 
1720 LX•ll: LY•321: !.ST-Sff.INC::,(74,32): COSUB 20050 
1730 LX•l01 LY•O 
1740 CAl.L MOVl.(LX, LY) 
1750 LX•l01 LY•259 
1160 CALL CI.IR (LX, LY) 
1770 LI11TS•2 
1710 CALL LEV!.l. (LIMTS) 
1190 POSX•lO: NtMSTlTS•O: NUMENDS-0 
1194 PL'?'?l'll • Clll'?( ( (BS'l'O(l0)-15) •20) +JO) 
119' PL'?'!.IID • Cill'?(((ISTO(llOSWIPLS-10)-15)•20)+30) 
1900 SAMPOIN"? • CDIL ( (NOSIIHPLS-20) / (PLTDIO-PLT?DI)) 
1910 QOSUI 10130 
19)0 llM --------------------- Input Control Co•and ---------------------
1940 IJ10VJ:.t • IlfnYSt IF IMOV!.t - •• T!lEJI 1940 
1"42 IF LEN(l,C:,VZS)>l AND IMOVEt-CBIS(O)+-"M'" T!lEJrl MOVE•21: GOTO 1980 
1"43 IF LEll(IIC)'VE$)>1 AJIO IMOV!.l<!lU(O}+'"J{• TBDI MOVE•29: GOTO 1910 
1 "45 tCIV!.-ASC (IMOVES} 
1950 IF MOVE < S2 '?REN 1'40 
1960 IF MOVE < 55 THEN 1910 
1'70 IF MOVt.>65 AJIO POIX>U AND P08X<U 1 THEN 2070 !.I.SE SOONO 40, 10: 
QOTO 1940 
1910 llM --------------------- Move Cursor --------------------------
1990 IF MOVE • 21 '?llN P0SX2•P0SX+1: 00'?0 2000 
19'2 IF MOVE • 54 '?REN P0SX2•POSX+l0: GOl'O 2000 
Chromatographic software 176 
1994 IF MOVE - 29 TBEN POSX2•P0SX-1: GOTO 2000 
1996 IF ~ • 52 TBZN P0SX2•POSX-l0: GOTO 2000 
1998 SOUND 40,10: GC11'0 1940 
2000 IF POSX2<10 THEN Br.I.P: POSX2•10 
2002 IF POSX2>640 TBEN BEEP: POSX2•640 
2004 UC•POSX: LY•O 
2006 CA.LL MOVt (LX, LY) 
2008 LX•POSX: LY•259 
2010 CALL DLIME(LX,LY) 
2012 LX•POSX2: L'/•25' 
2014 CALL MOVE(LX,LY) 
2016 LX•PO!X2: LY-0 
2018 CA.LL OLINE (LX, LY) 
2020 P0SX•POSX2 
2030 GOTO 19,40 
2040 REM---------· lnteqration Control Colftfflands ----------
2050 JU:M 
2060 REM ---------------------------- Peak Sta.rt ---------------------------
2070 Ir MOVE• 83 OR MOVE • 115 THEN SOU"HD 523.25, .5 tLSE 2230 
2080 LOOP • CINT( (POSX-35) •SAMPOINT) 
2090 IF LOOP < l TBE.N LOOP • 1 
2100 IF LOOP > NOSAMPLS THEN LOOP • NOS.t.MPLS 
2110 LOWPOINT-0: FLAG$•"FI1t.ST" 
2120 COMPX • cnrr ( (BSTO(LOOP)-15) *20) •30 
2130 WHILE COMPX <• POSX 
21-40 IF CCMPX < POSX THEN 2180 
2150 IF FLAGS•"FIR.ST" THEN NUHSTRTS•NUMSTRTS+l: P!<START (0, NUMSTRTS) •LOOP: 
FLAGS•"NO" 
2160 PXSTART(l,NUHSTRTS)•LOOP 
2170 IF ASTO(LOOP) > LC*POINT THEN LOWPOINT • ASTO(LOOP) 
2180 LOOP • LOOP + 1 
2190 CCJ4PX • CINT( (BSTO(LOOP)-15) •20) +30 
2200 WEND 
2210 LX•POSX1 LY•LOWPOINT+l 
2211 CALL MOVJ: (LX, LY) 
2212 LX•POSX: LY•LOWPOINT+ll 
2213 CAlJ.. OLINE (LX, LY) 
2214 LX•PO!X+4: LY•LONPOINT+l l 
2215 CALL OLINE {LX, LY) 
2216 001'0 l 940 
2220 REM ----------------------------- Peak End ----------------------------
2230 IF MOY"l. • 69 Oil MOVE • 101 TBI.N SOUND 523.25, .5 ELSE 2390 
2240 LOOP • CINT( (PO!X-25) •SAHPOINT) 
2250 IF LOOP > NOSAMPLS THEN LOOP • NOSAHPLS 
2260 IF LOOP < 1 THEN LOOP • 1 
2270 LOWPOINT-0: rLAGS•'"FIRST" 
2280 COMPX • CINT ( (BSTO(LOOP)-15) •20) +30 
2290 WHILE CCMPX >• POSX 
2300 IF CC>IPX > POSX THEM 2340 
2310 IT FLAGS•"FilST" THEN NUMENOS-NUMEMDS+l: PXENO (0, NUMENOS) •LOOP: 
FLAG$•"HO" 
2320 PKEND(l,MUMDIDS)•L(X)P 
2330 IT ASTO(LOOP) > LONPOINT TBEN LOWPOINT • ASTO(LOOP) 
2340 LOOP • LOOP - l 
2350 CCMPX • CINT((BSTO(LOOP)-15)•20)+30 
2360 WEND 
2370 LX•POSX: LY•LOIIPOIW'?'+l 
2371 CALL MOVE(LX,LY) 
2372 LX•POSX: LY•LOIIPOINT+ll 
2373 CALL OLINE (LX, LY} 
2374 LX•POSX-4: LY•LOICPOINT+ll 
2375 CA.LL CLIME (LX, LY) 
2376 GOTO U<tO 
2380 J.EM --------------------------- Clear Entry ---------------------------
2390 IT MOVE <> 67 AND HOVE <> gg TBl:N 2740 
2<t00 CAHCr.L-0 I LOIIPOINT-0 
2<tl0 IF NUMST1t'l'S < l THEM 2570 
2420 roll LOOP • l TO NUMSTllTS 
2430 CCMPX • CIMT( (BSTO(PJt:STAJlT(O,LCJa>))-15) •20) +30 
2440 IF CCMPX • POSX '?BEN CAHCl.L • LOOP 
2450 MEX"? LOOP 
2460 IF CANCEL < l TBDI 2570 
2470 FOil LOOP • PltSTllT (0, CNICEL) TO PJt:STAllT ( 1, CANCEL) 
2410 IF ASTO(LOOP) > LOWPOINT '?BEN LOlfPOIMT • .UTO(LOOP) 
200 NEX'? LOOP 
2500 SOUND 500, .5: SOOND 12767, 1: SOOIID 600, .5 
2510 LX•POSX: LY•LOIIPOINT+l 
2511 CA.LL MOY'E(LX,LY) 
2512 LX•POSX: LY•LOIIPOIN'?+l l 
2513 CALL OLINE (LX, LY) 
251'1 LX•POIX+4t LY•LOIIPOill'!'+ll 
2515 CA.Ll, OLINE ILX, LY) 
2520 F'Ol LCXlP • CANC:ZL TO NUMS'?a'l'S-1 
2530 PltSTll"l'(O,LOOP) • PltSTAH(O,LCX'.)P+l) 
2540 PUTAlT(l,LOOP) • PKS'?ll'?(l,LOOP+l) 
2550 NEXT LOOP 
2560 NUMSTJ.TS • Nl.l'ISTa'l'S - 1: QC7l'O U40 
2570 IF llUMSTa'l'S <l AIID ll!M!JIDS<l TllR SOUND 40, 10: GC71'0 U40 
2510 roll LCXlP - 1 TO NUMEWDS 
2590 CCM!'X • CIW'?( (BSTO(PXEIID(O, LCXIP) )-15) •20) +JO 
2600 IF caox • ,oax TD.R CAJICEL • LOOP 
2610 IRXT LOOP 
2620 IF CAIICZL < 1 '?UJI SCIOlfD 40, 10: QOTO 19<t0 
2630 roll~• PKEIID(l,CMCEL) TO PXEND(O,OJICEL) 
2640 IF Al'!'O(LOOP) > I.OlfPOIR'?' TBDI LOIIPOillT • A:!ITO(LOOP) 
2650 RX'T LOOf' 
2660 SOOND 500,.51 aom1D 321'1,l: SCIOlfD 600,.5 
2670 LX-POll1 LT•LOatOIWT+l 
2671 CALL ...,..(JJ<,LT) 
2612 LX•POll1 LT•i.c:.,OIWT+ll 
2,n CALL DLlft (LX, LT) 
2674 LX•POIX-41 LY•LOIIPOllr'T+ll 
2675 CALL OLIO (LI, LY) 
2610 F'Oll LCXlP • CMCEL '?O Wt.14l'JID1-l 
2610 PllllD(O,LOOP) • PRND(O,LOOP+l) 
2700 PKEJfO(l,LOOP) • PJCEIID(l,L(X)P+l) 
2710 REX'? LOOP 
2720 NUME>IDI • llUMENDI - l I c;oro 1940 
2730 llEM ------------------ Redo Froa Start ---------------------
2740 IF MOVE <> 12 AND MOVE <> 114 THEN 2140 
2750 IUJ': LIIITS•l 
2751 CALL LEVll (LI>ITS) 
2752 LX_.: LY•321: UT-S'TllING$ p,, 32) : OOSUB 20050 
275] LI_.: LY•34l: UT-S'TllINc:1(19,32): OOSUI 20050 
275,t LX•lO: LY•321: EST•"lledo rroa Start ••.•• ": GOSOI 20050 
2755 LX•227: LY•JO I u-r-·ct11FIJIIM S'tLECTICII (y/n) ": GOSUII 20050 
2760 Q$ • INXZY$: IF Q$ • •• Tll!:N 2160 
2770 IF QI • "y" OR Qt • •y• '?BEIi 2190 
2710 OOSUII 10130: QO'?O 1940 
27'10 CALL CLllSCll 
2791 Ll•lO: LY•O: C.OSOI 20010 
2192 LX•l01 LY•260: GOSUB 20030 
2191 LX•6l0: LY•2601 OOS011 20030 
2794 roll MAU • 256 TO O STU -10 
2795 LX•JO: LY-MAI.Jt: COSUI 20010 
2796 LX•251 LY1'lllJ{: GOSUI 20010 
2797 NEXT MARK 
2791 l'Oll MAM • JO TO 630 STEP 20 
2791 LX-MAll'.1 LY•260: QOSUI 20010 
2100 LX-MAll1 LY•26S: QOSUI 20030 
2101 NEXT M»Jt 
2802 TOR MA.JU( • 30 TO 630 STEP 100 
2803 LX"""""'-1UI': LY•265: GOSUB 20010 
2804 LX~: LY•270: GOSUB 20030 
2805 NEXT MAJlX 
2806 l'OR MAU - 30 TO 630 STEP 200 
2801 LX-+IAJU(: LY•270: GOSUB 20010 
2808 LX~: LY•275: OOSUB 200]0 
280 9 NEXT MARX 
2810 LX•21: LY•291: EST•"l5": GOSUB 20050 
2811 LX•l21: LY•291: £5'?•"20": OOSUB 20050 
2812 LX•221: LY•291: £ST•"25": GOSUB 20050 
281] LX•321; LY•291: EST-"30": GOSUB 20050 
28U LX-121: LY•291: EST-"35": GOSUB 20050 
2815 LX•521: LY•291: EST•"40": GOSUB 20050 
281' LX•621: LY•291: EST•"45": GOSUB 20050 
2817 LX•281: LY•305; EST•"TIME {111lna) ": GOSUB 20050 
2818 LX•((CINT(lBSTO(l)-15)•20))+30): LY•A!!ITO(l) 
2819 CALL PLOT(LX,LY) 
2820 CALL MOVE(LX,LY) 
2821 FOJ. LOOP • 2 TO NOSAHPLS 
2822 LX• ( (CINT ( (BSTO (LOOP) -15) *20) l +30) : LY•A.STO (LOOP) 
2823 CALL DLINE(LX, LY) 
2824 NEXT LOOP 
2825 GOTO 1700 
2830 Jll.M ------------------------- Q\.llt Integration ------------------------
2840 IF MOVE <> 81 MD MOVE <> 113 THEN 2900 
2850 BEEP: LINTS•l 
2851 CALL LEVtL(LIMTS) 
2852 LX•4: LY•328: EST•STRINGS (79, 32): GOSUB 20050 
2853 L.X-<t: LY•lO: EST-STRINGS(79,32): GOSUB 20050 
285,t LX-30: LY•J28: EST•"QUlt •••.. ·: GOSUB 20050 
2155 LX•227: LY•343: EST-"CClffIRM SELECTICJtl (y/n) ": GOSUB 20050 
2860 0$ • IWXEY.S: IF Q$ • "" '?BEN 2860 
2170 IF QS<>"y" AHO QS<>"Y" TB.EN 2880 
2176 CHAIM •A:BPLc• 
2110 QOSUB 10130: GOTO U40 
2190 Jll.M ------------ Proc••• Data--------------
2900 IF MOVE<> 80 AND !«)VE<> 112 THEN SOONO 40, 10: GOTO 1940 
2'110 BEU: LINTS•l 
2911 CALL L.EVEL(LINTS) 
2912 LX-1: LY•321: EST•STllING$(79,32): GOSUB 20050 
2913 L.X•<t: LY•343: EST•S"l'llINC$(79,l2): OOSUB 20050 
2914 LX•30: LY•328: EST•"Proceu ..... ": GOSUB 20050 
2915 LX•227: LY•34J: UT-"CC>IFUM SELECTiai (y/n) ~; GOSUB 20050 
2920 OS • INXEYS: IF OS • .... THEN 2920 
2930 IF QS • •y• a,. QS • "Y" TBEH 2950 
2940 GOSUI 10110: GO?O U40 
2950 LX-1: LY•l21: EST-STJlIMGS (79, 32): GOSUB 20050 
2955 LX-4: LY•l4l: EST-S'TUMCS (79, 32): OOSUB 20050 
2960 IF Ntl"ISTllTS • NUMENDS THEN 3030 
2970 BEU: IF NUHSTJ.TS>NUMENDS THEN 2980 
2975 LX•l37: LY•328: EST-'"llUMBEJ. OF PEA.JI: STARTS < NUMBER or PE.U: ENDS": 
GOSUll 20050 
2917 QOTO 2990 
2910 LX•137: LY-321: EST•"MUMBEll or PEAi( STARTS> NUMBER or PEAX £NOS": 
OOSUB 20050 
2990 LX•l 95: LY•JU: u-r-•Preu any key to cent inu• ..... ": GOSUB 20050 
3000 IF INICEYS••• TBZ.N 3000 
3010 QOSUB 10130: GOTO 1940 
3020 JlEM ------------------------- Bubb!• Sort ---------------------------
3030 llEM 
3040 CBECIC • l 
3050 NBILE CBECJt: 
3060 CBECX • 0 
3070 FC* LOOP • l TO Ntl"ISTJtTS-1 
3010 IF ISTO(PJt:START(O,U:X:.)) <• BSTO(PJt:STllT(O,LOOP+l)) THEN 3120 
3090 SNAP PltSTllT(O,LOOP),PltSTllT(O,LOOP+l) 
3100 SNAP PltSTAJlT(l,LOOP) ,PltSTAllT(l,LOOP+lJ 
3110 CBtcJt: • 1 
3120 NEX'?' LCXlP 
]130 Nl!ND 
3140 CBECJt: • 1 
l lSO NB ILE CBECX 
11'0 CllCX • 0 
3170 FCII. LOOP • 1 TO Nt.14ENDS-l 
3110 IF Bl'?O(PXEND(O,UXJP)) <• BSTO(PICEMD(O,LOOP+l)) THEN 3220 
JUO SIIAP PICENO(O,LOOP),PKEND(O,LOOP+l) 
3200 SNAP PKENO(l,LOOP),PKEND(l,LOOP+l) 
3210 CBECIC • l 
3 220 IIEX'T LCXlP 
3230 Nl!ND 
1240 llr.M ------------------ Confir. Order ----------------------------
3250 l"Ol ~ • 1 TO NUHSTJ.TS 
3260 IF PICSTAllT (0, UXJP) <• PKENO (0, LOOP) TBl:N 3280 
1210 cna - cna + 1 
1210 NEXT LOOP 
l2t0 IF CBECJ: < l THEN 3360 
3300 LX_.: LY•321: UT-S'?llING$ (79, 32) : GOSUB 20050 
3310 SEU: LX-17: LY•321: ES'?•"P£.M STU.TS AND PEAJC ENDS ARE NOT IN THE 
COD.EC'! c:aD!l": GOSUB 20050 
3320 LX•lt5: LY•lU: UT-"Pnu any key to continue ..... ": GOSUB 20050 
3330 IF IlllCEY$•"" TBZ.8 1330 
3340 QOSUB 10130: QO?O 1940 
3350 llr.M ------------------- Integration ----------------------------
3160 LX-4 1 LY•l21: UT-S'?'UJICS (79, 32): QOSUB 20050 
33,<t LX•l45: LY•l21: UT-"Calculat1J\9' area for peak number": GOSUB 20050 
31,6 UC_.7l: LY•l21: tsT-"o!"+STllS(NUMSTJ.TS): GOSUB 20050 
3310 LI1f'?S•2 
Jlll CALL LEVll(LI>ITS) 
3312 LX-POSX: LY•O 
331] CAL.I, MOVE I LX, LY) 
3314 LX-POSX: LY•2St 
331S CALL OLINE ILX, LY) 
3316 LIIITl•l 
lll7 CA.LL LEV!.L(LillTS) 
JltO FOil LCXll'l • 1 TO NUMSTHS 
3400 L1•4l5: LY•l21: EST•ST1l$(I.0C:.l) 
3405 CALL ttrra (LX, LY, UT) 
3410 llDI ------------ 1 .. eline (LSllL) Calculation, -----------------
3420 DSOHX-0: DSl.1'11'•0: DXY-0: OXSQ-o: BIQBPOINT-675: FLAG$••NO" 
JOO DXMr.All-0: DYM!.AM•O: DLXY•O: DLXS0-0: LOWPO!ll'?-0 
3440 FCII. LOOP2 • PltSTllT(O,LOOPl) TO PltSTllT(l,LOOPl} 
300 DltlllX • 0Sl.l'IX + BSTO(LOOP2) 
3460 OltMY • DSUMY + ASTO(LOOP2) 
3 410 DXY • DXY + BSTO (LOOP2) • ASTO ILOOP2) 
300 DXS0 • OXIQ + BIT0(1(X)P2) '"2 
300 IF ASTOCLOC»2) > LCWPOIRT THEN LCMPOINT • .UTO(LOOP2) 
350 0 N EX'? LCXlP 2 
3510 PTSTll'? • ((CIWT((BITO(PltSTA.RT(O,LOOPl))-15)•20))+30) 
3520 LillTl•2 
3522 CALL 11.VEL (LINTS) 
]52] LX•PTS'TJ:'!': LY•LOlfPOIMT+l 
lS24 CALL J«7VI. (LX, LY) 
l52S LX•PTS'?r!s LY•LC*POIM'?+ll 
3521 CALL DLIWE(LX, LT) 
3527 LX•PTSTJt'l'+,t: LY•LOIIPOIJIT+ 11 
3521 CALL DLINE(L.X,LY) 
3Sl0 LOWPOIJfT • 0 
3540 roa LOOP) • PKEND(l,LOOPl) '?O PKEND(O,LOOPl) 
3550 DStllll • 0St.14X + BSTO(LOOPl) 
3560 DltMY • Dlt.14Y + ASTOILOOPJ) 
3570 
3580 
3590 
3600 
3610 
3620 
)622 
3623 
3624 
3625 
3626 
3627 
3628 
3630 
36,40 
3650 
3660 
3670 
3690 
)700 
3710 
3720 
3730 
)7<40 
3750 
3760 
3T10 
3780 
3790 
3800 
3810 
3820 
3830 
3840 
3850 
3860 
3870 
3890 
3900 
3910 
3920 
3921 
3922 
3923 
3924 
3925 
3926 
3927 
3928 
3929 
3930 
3931 
3932 
3933 
3934 
3935 
Jg]fj 
3937 
3938 
3939 
3940 
39-41 
3942 
39.0 
3944 
39.S 
3946 
3941 
3948 
39,0 
3950 
HSl 
3952 
3953 
3954 
3955 
3956 
3951 
3951 
3959 
3960 
3961 
3962 
3963 
3964 
3965 
3966 
3967 
3961 
3969 
3910 
3911 
3912 
3913 
3914 
J97S 
3916 
3911 
3911 
3919 
3910 
3911 
3912 
3913 
3914 
3915 
3916 
3917 
3911 
3919 
39'0 
39'1 
3992 
3993 
3994 
3995 
39'6 
39'1 
3991 
3999 
4000 
4001 
4002 
4003 
4004 
4005 
4006 
4007 
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DXY - OXY + BST0(L00PJ)•A!5TO(LOOP3) 
DXSQ - OXSQ + BSTO(LOOPJ) "2 
IF A!TO(LCXlPJ) > LCWPOIJIT TBEN LONPOINT .. ASTO(LOOPJ) 
NEXT LC>C:.3 
PT!:HD • ((CllfT((B!TO(PKENO(O,LOCJPl))-15)*20))+)0) 
LX-PTEMD: LY-LOIIPOIH'l'+l 
CALL HOV! (LX, LY) 
LX•PTEND= LY•LOIIPOINT+ll 
CALL DLIHE(LX,LY) 
LX•PTEM0-41 LY•LOIIPOIH'hl 1 
CALL DLIHE(LX,LY) 
LINTS•l 
CALL LEVlL(LINTS) 
N•Plt:!!ITAJt.T {l, LOOPl )-PKSTM.T {O, LOOP 1) +-PXEND (0, LOOPl) -PKEND ( 1, LOOP 1) +2 
OXHEAH • DSUMX/N: OYME>Jrl • DSUMY/N 
OLXY•DXY- (DSUMX•OSUMY/N): DLXS~X:50- ( (0SUHX"2) /N): SL0P£-OLXY/DLXSQ 
RF.M ---------------- calculate Ar•• , Retention Time ---------------
FOR !..OOP4 • Plt:STAJ.T(O,LOOPll TO PKEND(O,LOOPl)-1 
DBA5L • DYM£AN+SL0PE• (BST0(LOOP4)-DXHEAN) 
DBA5R • DYM£AN+SL0PE• (BSTO(LOOP-4+1)-DXMEAN) 
OUPRSID • ABS(ASTO(LOOP4)-A5TO(LOOP4+1)) 
DLNRSID • ABS (08A5L-0BASR) 
Ir ASTO(LOOP4)<ASTO(LOOP4+1) THEN DTF.MPYl•ASTO(LOOP4+1) ELSE 
DTFl1PY1•A5TO (LOOP4) 
Ir DBASL>DBA!!IR THEN DTFMPY2•DBASR ELSE OTEHPY2-0BASL 
DPKAR.EA(LOOP l) -OPXARF.A. (LOOPl) + ( (BSTO (LOOP4 +l )-BSTO (LOOP4) l 
• ( (, 5•0UPRSID) + (. 5 *DLNRS ID) +D'TD4PY2-DTEMPY1) J 
IF ASTO(LOOP4)>•HIGBPOINT TBEM 3780 
DSTRTRT-BSTO(LOOP4): HIGH1'0INT•ASTO(LOOP4): FLAG$•"END" 
IF A!!ITO(LOOP4) •BIGB.POINT OR FLAGS<>"EMD" THEN 3800 
DEHDRT•BSTO ( LOOP4- l) : FLAG$•"NO" 
NEXT LOOP4 
DPKRT (LOOPl) • DSTllTRT+ ( (OENDlT-OSTRTRT) /2) 
REM ---------------- Print Retention Ti••• on scr-n ---------------
ZS• STU(DPKJlT(LOOPl)) 
PTX • CINT((OPKJlT(LOOPl)-15)*20)+21 
If HIGHPOINT < 21 THEN PTY • 21 ELSE PTY • HIGHPOINT 
fOJl LOOPS • 2 TO 6 
Ir MID$(Z$,LOOP5,l) •"."THEM PTY•PTY-3: GOTO 3920 
CH.AR.ACTER • VAL(MID$(ZS,LOOP5,l))+l 
PTY • PTY - 6 
a.I CBARACT!.Jl GOl'O 3923,3932,3938,3941,3960,3966,3911,3988, 
3994, 4009 
LX•PTX+6: LY•PTY: GOSUB 20010 
LX•PTX+S: LY•PTY: GOSUB 20030 
GOTO 4030 
LX•PTX+l: LY•PTI: GOSUB 20010 
LX•PTX+5: LY•PTY: OOSUB 20030 
LX•PTX.+6: LY•PTY+l: GOSUB 20030 
LX•PTX+6: LY•PTY+2: Q0SU8 20030 
LX•PTX+5: LY-PTY+3: OOSUB 20030 
LX•PTX+l: LY-PTY+3: OOSUB 20030 
LX•PTX: LY•PTY+2: OOSUB 20030 
LX•PTJ:: LY•PTY+l: QOSUB 20030 
GOTO 4030 
LX-PTX+6: LY•PTY+3: OOSUI 20010 
LX-PTX+6: LY•PTY: QOSOB 20030 
LX•PTX+5: LY•PTY+l: QOSUI 20030 
LX•P'?X: LY•PTY+l: 00SU8 20030 
LX•PTJ:+2: LY•PTY+3: OOSU8 20030 
GOTO 4030 
LX•PTX.+6: LY•PTY: 00SU8 20010 
LX•PTX.+6: LY•PTY+J: QOSUB 20030 
LX•PTX+S: LY•PTY+3: OOSUB 20030 
LX•PTX+2: LY•PTY: OOSUB 20030 
LX•PTX+l: LY•PTY: OOSUB 20030 
LX•P'?'X: LY-PTY+l: OOSUB 20030 
LX•PTX: LY•PTY+2: OOSUB 20030 
LX•PTX+l: LY•PTY+3: QOSUB 20030 
GOTO 4030 
LX•PTX+l: LY-PTY+3: OOSUII 20010 
LX-PTX: LY•PTY+2: QOSUB 20030 
LX•PTX: LY•PTY+l: QOSUB 20030 
LX•PTX+l: LY•PTY: QOSUB 20030 
LX•PTX+2: L!•P'?Y: QOIUB 20030 
LX•PTJ:+3: LY•PTY+l: QOSOI 20030 
LX•PTX+3: LY•PTY+2: QOIOB 20030 
LX•PTX+4: LY•PTY: QOIOI 20010 
LX•P'?X+5: LY•PTY: QOIOI 20030 
LX•PTX+6: LY•PTT+l: QOSUI 20030 
LX•P'?X+6: LY•PTY+2 1 QOIUI 20030 
LX•PTX.+5: LY•PTY+l: QOSUI 20030 
GOTO 4030 
LX•PTX+l: LY•PTY+l: QOSUI 20010 
U:•PTX+4: LY•PTY+3: QOSUI 20030 
LX•PTX+41 LY-PTY: QOSOB 20030 
LX•PTX:+6i LY•PTY+l: C.0101 20010 
LX•PTX: LY..PTY+l I QOIUI 20030 
00?0 4030 
LX•PTX: LY•PTY: OOSOI 20010 
LX-PTXt L1'•PT't+3t QOSOI 20010 
LX.PTX+21 L1'.PT1'+31 QOIOI 20030 
LX.PTX+21 LY-PTT+l I QOIOI 20010 
LX.PTX+l I L1'-PT1' 1 QOIOJ 20010 
LX-tff+5 a L1'-PT1'1 Q0801 20030 
LX-tff+l1 LY.PTY+l I QOIUI 20030 
LX.Pn+, 1 L1'-fff+21 QOIUI 20030 
LX-fTX+51 LY-PTT+l I QOIUI 20030 
LZ-rrz+41 LY-tTT•l I QOIUI 20030 
QOIIO 4010 
LZ-f'ft+l I L1'.PTY1 aoaul 20010 
LX-rff1 LY-fTT+l I aoaua 200]0 
LZ-PTX+21 LY.PTT+l I QOSOI 20030 
LJ:.PTX+51 L1'.PT1'+l I QOIOI 20010 
LX•PTX+,: LY.PT1'+21 QOSUI 20030 
LX•PTX+61 LY.PTT+l: t.lOaUI 20030 
LX•PTX+S1 LY•PTT: QOSDI 20030 
LX•PTX+4: LY•PT1'1 QOIOI 20030 
LJ:•PTX+31 LY•P'?Y+l I QOIOI 20030 
LX•PTX:+l: LY•PTY+2: QOSOI 20030 
GOTO 4030 
LJ:-PTX1 LY•PTT+31 QOIOI 20010 
LX•PTX: LY•PT'l: QOIUI 20030 
LX•PTX:+2: LY-PT'l: QOIOI 20010 
LX-PTX+5: L1'•PT1'+31 QOIUI 20030 
LX•PTX+6 1 LY•PTY+3: QOSUI 20030 
QOTO 4030 
LJ:-P'l'X+2: LY•PTY+l I QOSUI 20010 
LX.PTX+l: LY-PTY+l: QOSOI 20030 
LX•PTX1 L1'•PT1'+21 QOIOB 200)0 
LX•PTX:1 LY•PTY+l I QOSOB 20030 
LX•PTX+l: LY•PT't: QOSOB 20030 
LX•PTX+2: LY•PTT: QOIUB 20030 
LX•PTX+l I LY•PTY+l: OOSUB 200)0 
LX•PTX+l I LY•PTY+2: QOSUI 20030 
LX•PTX.•4 I LY•PTY+] I QOIOI 200)0 
LX•PTX+5 1 LY•PTY+l I COIUI 20030 
LX-PTX:+6 t LY•PTT+2: QOIUI 20010 
LX•PTX+li I LY•PTY+l: QOSUI 20030 
LX•PTX+5: LY•PTT: QOIUI 20030 
Lll•PTX+4: LY-PTT: QOIUI 20030 
40011 GOTO 4030 
4009 LX•PTX+6: LY•PTY+2: GOSUB 20010 
4010 LX•PTX+4: LY•PTY: GOSUB 20030 
4011 LX•PTX+l: LY•PTY: OOSUB 20030 
4012 LX:•PTX: LY•PTY+l: 00SU8 20030 
4013 LX•PTX: LY•PTY+2: OOSUB 20030 
4014 LX•PTX+l: LY•PTY+3: GOSUB 20030 
4015 LX•PTX+2: LY•PTY+3: GOSUB 20030 
4016 LX•PTX+3: LY•PTY+2: GOSUB 20030 
4011 LX-PTX•3: LY•PTY+l: GOSUB 20030 
4030 NEXT LOOP5 
4040 N!.XT LOOPl 
4100 RE.M -------------------- Print B.udcopy of Cnt'Olllatogram ---------------
4110 LX•4: LY•3211: EST•STRINGS(79,32): GOSUB 20050 
4112 LX•4: LY•HJ: EST•STRINGS(79,32): GOSUB 20050 
4114 LX•619: LY•l7: EST•STRING$(10,32): GOSUB 20050 
4116 LX•628: LY•H: EST-STRING$i8,32): OOSUB 20050 
4118 BEEP: LX•96: LY•328: EST•"Presa <[shift] PrtSc-1> when this me.9saqa 
diuap .. n": Gos:UB 20050 
4120 LX•l95: LY•343: EST-"Preas any key to continue ..... '": GOSUB 20050 
4130 If INKEY$ • "" 1'8.EN 4130 
4140 LX-41: LY•343: EST•STRINGS(H,32): GOSUB 20050 
4150 roR LOOP • 1 1'0 5000: NEXT LOOP 
4160 BEU: LX•4: LY•328: EST•STJUNGS(H,32): OOSUB 20050 
4110 IF INKEYS • "" Ta.EH 4110 
4180 RE.M -------------- Quant1tat1on -------------· 
4190 RE.M 
4200 REM -------- Read Stand.a.rd Curve Parameters frOIII A:STAHDARDS .DAT -----
4210 LX•30: LY•328: EST•"Loading Sta.nd&rd Curve Data ...• ,": GOSUB 20050 
4230 OPEM "A:STHDROS.DAT" AS f2 LDI • 35 
4240 flELD 12, 2 AS ENUMSTOS$, 10 AS r.DAIT$, 23 AS EDUMHY$ 
4250 GET t2, 1 
4260 NUMSTDS • CVI (OIUHSTOS.S): !STOA.Tr.$ • EDAITS 
4210 FIELD 12,1 AS !.JlTS, I A!! XMEANS, I AS YHEAHS, II A5 E!LOPtS, 3 AS ENAMES 
4290 roa LOCIP • 1 TO NUMSTDS 
4300 GET 12, LOOP+l 
4310 !TORT (LOOP) • CVD {!.JlT$) 
4320 STOXHEAH(LOOP) • CVD{XHEAH$) 
4330 STDYMf.AH(LOOP) • CVD(YH£AH$) 
4340 STDSLOP!(LOOP) • CVD(ESLOPES) 
4350 ESTDNAH$ (LOOP) • £NAME$ 
4360 NEXT LOOP 
4310 CLOSE 
4380 llM ---------------------- Canpar• Retention T.illl•• --------------------
4390 LX-4: LY•328: EST•STR1NG$(H,32): OOSUB 20050 
4400 LX•30: LY•328: EST•'"Pl .. H wait ••••• ": GOSUB 20050 
4410 l'OJl LOOP 1 • 1 TO MUMSTRTS 
4420 If DPKJlT(LOOPl) < 34 TBEN RANGE • . 625 ELSE RANGE - .5 
4430 CHEO: • 0: LOOP2 • 1 
4440 NBILE Ca.ECK < 1 
4450 IF STDJlT(LOOP2)<(DPKJlT(LOOP1)-RANGE) OJl 
STClT(LOOP2)>(0PJCRT(LOOPl) •RANGE) TBEH 4490 
44 60 CHECK • 1 
4410 
4410 
!.PKNNU(LOOPl) • ESTDNN4S(LOOP2) 
DPKAMT (LOOPl) •!!ITDYMEAN (LOOP2) + (STDSLOPE (LOOP2) • (OPMREA(LOOP l) -
STDXMEAN (LOOP2) ) ) 
400 LOOP2 • LOOP2 + 1 
4500 Ir LOOP2 > Nl.14S'?DS AHO ce.r.cic: < 1 THEN CHECK • 2 EL!l. 4530 
4510 UKNAMS(LOOPl) • '"777" 
4520 DPIWfl'(LOOPl) - 0 
4530 VEND 
4540 nrr LOOPl 
4550 Jll.M -------------------- !tor• Quantitated. Data ---------------------
45110 FILl.QUANTI • FILU + ".QNT" 
4590 OPEN FILEQUAHTS A!!1 11 LEM•21 
4600 FIELD 11, 2 A!!1 ENUMSTJ.TSS, 10 A!! ESTD'?S, 3 AS FLAG$, 12 AS EDU!+!Y$ 
4610 LS£'? ENUMl'!RTU • MIU$ (MtMS'?JtTS) 
4620 LSI:'? ESTD'U • E!!ITDATES 
4625 LSET FI.AG.I • "YU" 
4'30 LSET EI>U)9(YS • • 
4,40 PUT 11, 1 
4650 FIELD 11, 3 A!! EN.AMES, I AS EPDTS, I A5 EPJlAllF.A.S, I AS EPKAM'TS 
4 660 roa LOOP • 1 TO NUMSTlTS 
4610 LSET EN»JU • EPK'MAMS (LOOP) 
4610 I.SET l.PICRTS • MtmS(DPJCRT(LOOP)) 
4 690 LSI'? £PKAllA,J • Mimi (DPM.JlEA(LOOP)) 
4100 LSET UKAMTS • NICOi (OPDMT (LCXJP) l 
4110 PUT fl, LOOP+l 
4120 nrr LOOP 
4130 CLOSE 
4140 Jll.M ------------------- Printout Quantitated Data -------------------
4150 LX-4: LY•321: EST-STJlINGS(19,32): OOSUB 20050 
4155 LX-4: LY•30: U:T-STAINGS(19,32): GOSUB 20050 
4160 LX-240: LY•321: E.ST-·Cheek Printer Status•: OOSUB 20050 
4110 LX•l 95: LY•30: E!IT-•PreH any lr:ey to continue ••••• ": GOSUB 20050 
4110 Ir INKEYS • "" TB!.N 4110 
4790 !»Ell "LP'?l 1" AS fl 
4100 WIDTH 13,10 
4110 Pl HIT 13, CBU (27) ;CBJlS (13) ;CBJl$ (2): PllINT 13, Cfill$ (13) ;CHR$ (10) 
4120 PJ.IJIT f), '?Al(l);"FILEI •;rILES;TAl(34);'"INJECTia.l TIME! 
INJEC'U;TAl(64);EDA'?U: PJ.UIT 13, C8U{ll);C8J.$(10) 
4130 PllllT 13, '?AB(3);ST1.Il1G.S(16,205) 
4140 PUllT 13, TAB(5) ;"Peak Mo. ";TAB(20); .. , .. 1r: N ... ";TAB(34); 
"J.etention Ti.Me"; TAB(55);"Area•;TAJl(10);"Mount" 
4150 PRill'? 13, '?Al(l) ;ST'JlillCI (16,196) 
4160 l'OIHATU • If 
4170 l'OIMAT21 • "\ - - - - - \ - - - - - - - - - - - - -
4110 l'OIHATlS • "If.flt 111,111111 1111,1111" 
4190 roa LOOP - 1 TO wuMST•Ts- - - - - - - - - - -
4900 PUN"? 13, USING rOI.MATU;LOOP; 
010 PaIWT fl, USING rORMA.'US;UICM»IS(LOOP); 
4920 PUN"? fl, USING r0I.MAT3S; OPD.T (LOOP); DPD.llA(LOOP); OPKAMT (LOOP) 
4 93 0 NEXT LCX>P 
4940 PUNT fl, TAB(]) ;S'BIWCS p,, 205) 
4950 PlIN'? 13, TAJ(1) ;"Quantitated data extrapolated froa standards recordAd 
on; '";UTDATU 
49'0 Ir VAL(HICS(E!ITDA'?U,4,2}) • VAJ..(MIDS(£DATES,4,2)) THl.H 4990 
4910 IF (VAL (MIDS (ESTCA'HS, 1, 2))) -31 >• {VAL (MID$ (ECATES, 1, 2))) -31 TBEN 4 990 
4910 PUll'? fl, CHU (27) ;CBJ.$ (69) ;TAl(U); ·MM.Nillf., STMOAlD cuavr. IS OLDER 
TB.AN ONE Mal'?B ! ! ";CDS f21) ;CBU (10) 
4990 PJ.Ilf'? 13, CBU(21);CUS(7l);CBU(l) 
5000 Pltll'? 13, CHU (12) 
5010 CLOSE 
5020 LJ:-4: LY•l21: E!l'?-S'?UNGS(19,321: COSUB 20050 
5025 LX-41 LY•30: U:T-STaINGS(19,32): OOSUB 20050 
5030 HU I LX-222: LY•321: zs-r-·Int-irate Another (y/n) ?" 1 OOSUB 20050 
5035 DEF S~01 POii:! 1050,P!.l:Jt:(1052): C!.F Sr.G: POI(! 10,,0 'clN.r lr:brd buffer 
5040 Ol•INJt:IYS1 Ir os-·· '?IIEII 5040 
5050 Ir Qt<>·•· A11D QS<>'"n" '?BI.N 5060 
5051 CHAIN "A:RPLC" 
5060 IF QS<>"Y- .UC QS<>•y• TllW SOUND 40,101 GOTO 5040 
5010 CLL\J. 
5010 Q01'0 220 
9'99 END 
10130 lDt lltllllllllltllll Inteqration Cursor C.0-and Menu fllflflfllfllfll 
10140 J.DI 
10142 LINTS•l 
10144 CALL LEYEL(LINTS) 
10150 LX•4: LY•l21t z:sr-snIN.:;.f(19,32) 
10160 CALL '?l!XTB(LX,LY, UT) 
10170 LX•41 LY•34l1 !.ST-SnIN.:;.f(19,32) 
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10180 CALL ff.XTB(LX,LY,EST) 
101 to LX•27: LY•l21: UT-"CUJtSOI. CClfol'IANOS: Uae L lo J. .arrow 
key• -- <shift> - lOX" 
10200 CA.LL ffXTB(LX,LY, UT) 
10210 LX•21: LY•JO: tsT-"IHTtGR.ATIClf CCMHANDS: Start End CAJ'loel 
Jted.o Proc.•• Quit• 
10220 CALL TEX'TB(LX,LY,EST) 
10222 LINTS•2 
10224 CALL L.EV£L(LIN'?S) 
10230 RETURN 
20000 RF11 fttflfftttttttfffttttff GRAPB-X SubroutinH fffttttttttttftttfffft 
20010 CALL !CW (LX, LY) 
20020 RETURN 
20030 CALL DLINE(LX,LY) 
20040 RETURN 
20050 CALL T!:XTB(LX,LY,EST) 
20060 iH'.TURN 
DISPLAY.SRC 
10 k.EH PRCX.ilAM NI.ME• OISPLAY.SRC 
94 REH 
96 REH 
200 IU:14 fffffflfftt Init111H the Scr .. n and D1111enaion Variables ttfftttlttl 
210 RD4 
220 DEFINT A,C,B,L-P,V: OEfDBL O,K,ll,S: DEFSTR t,F,I,0,T,X,Y: DEFSNC B 
230 0 IM ASTO (5010), BSTO (5010), PICSTART ( 1, 25), PKr.ND (1, 2 5), DPKARr.A (25), 
DPKltT (25), DPUMT (25), EPKNAMS (25), STOJ.T {20), STOXME"111 (20), STOYMEAN ( 20), 
STOSLOPE ( 20), IST0NAM$ (20) 
240 PAGE•l: LINTS•l 
250 CALL C.P11GE (PAGE) 
260 CALL LEVEL (LINTS) 
294 JtrJ,4. 
296 REM 
400 J.r.M tftffllllfttfftfflltffttf Starting PrOfflpts ffftttttttfffftfftffftfff 
410 J.D4. 
412 CALL CLRSCR 
413 LX•.440: LY•JO: EST--Diaplay a Stored Chro111atogram" 
414 CALL TEXTB(LX,LY,EST) 
415 DEF SEC-0: POKE 1050,PEU:(1052): DEF SEG: POJtE 106,0 'clear kbrd buffer 
416 FILES••• 
420 LX•20: LY•l80: EST-"10.ME Of' FILE TO DISPLAY (exten•ion not pel"lllitted) • 
421 CALL TEXTB(LX, LY, EST) 
422 CALL DISP (PAGE) 
423 Q$•INKEY$: Ir Q$•"" TBEN 423 ELSE CBAR•ASC(Q$) 
424 IF (CBAll<>l3 ANO CB.AR<>I) AND (CRAll<32 OR CBAll>126) THEN SOUND 40, 10: 
GOTO 423 
425 IF CB.AR.•13 TBEN 435 
426 IF CB.AR•I AMO LEN(FILE$)<1 THEN SOOND 40, 10: COTO 423 
421 IF CB.AR-I "1110 LDl(FILES)>O THEN FILE$•LEFT$(FILU, (LEN(FILE$)-l)): 
GOTO 429 
428 FILES•FII.U+<JS 
429 LX•415: LY•llO: EST•FILE$+" " 
430 CALL TEXTB(LX,LY,E!T) 
431 GOTO 423 
435 IF MID$(FILE$,2,l) <>":•THEM FILU • "B:"+FILES 
440 FOil LOOP• 1 TO LEN(FILE$): IF MID.S(FILE$,LOOP, 1) <>"."THEM NEXT LOOP 
ELSE 442 
441 GOTO 450 
442 LINTS-0 
443 CALL LEVEL (LINTS) 
444 LX•2U: LY•328: EST•• EXTDISiai NOT Pr.R.MITl"ED " 
445 CAI.L TEXTB (LX, LY, EST) 
446 LINTS•l: BEU 
441 FOil LOOPl • 1 TO 5: FOil LOOP2 • 1 TO 5000: NEXT LOOP2: NEXT LOOPl 
448 CALL LEVEL(LINTSI 
449 GOTO 412 
450 IF LEM(FILl.$) < 11 THEN 4'° 
451 LINTS-0 
452 CALL LEVEL(LINTS) 
453 LX•256: LY•321: EST•" TILE NNtt IS TOO LONG " 
455 CALL TEXTB(LX,LY,UT) 
456 Lil'IITS•l: BEU 
451 FOil LOOPl • l TO 5: FOi. LOOP2 • 1 TO 5000: NEXT LOOP2: NEXT LOOPl 
458 CALL LEVEL(LINTS) 
459 GO'l'O 412 
4 60 LX•20: LY•250: U'?-"J.N.dinq Data, Pleue Mait ••••• " 
462 CALL TEX'l'B(LX,LY,ES'?) 
465 FILl.DATAS • FILES+" .OAT" 
410 OPEN FILEOATA,$ roa IMPUT A! tl 
4 71 IMPtr? fl, £DATU, INJEC'?S, NOS»IPLS, JrullTIME, STAJt'?IHE 
412 FO'- LOOP • 1 TO NOSAMPLS S'?U 20 
413 INPUT tl, 80, l+IJ, Bl, Al, 82, A2, 83, Al, 84, A4, 85, A5, 86, A6, 81, A1, Bl, Al, 89, 
A,, 810, AlO, 811,All, 812 ,Al 2, Ill ,All, 814,Al4, 815, Al 5, Bl6,Al6, Bl1, Al?, 
Bll,Al8,819,Al9 
414 BSTO(LOOP) • 10 
415 MTO(LCOP} • AO 
416 BSTO(LOOP+l) • Bl 
411 M'l'O(LCX)f+l) • Al 
418 al'l'O(LODP+2) • 82 
419 AIT0(1,00f+2) • A2 
no UTO(LOOP+]) • 83 
481 UTO{L(X)f+3) • Al 
412 BSTO (LOOP+4) • 84 
483 AITO(L<X»+4) • A4 
484 B1TO(LOOP+5) • 15 
'85 AITO(LOOP+.5) • A! 
486 UTO(LOOf+') • a, 
481 AITO(LOOP+,) • A' 
UI UTO{LCOP+7) • 81 
48' AITO(LOOP+1) • A1 
4 90 BS'l'O (LOOP+I) • 118 
491 ASTO(LOOP+I) • Al 
492 BST0(LOOP+9) • 19 
4 93 ASTO (LOOP+ 9) • A9 
494 BS'?0(LOOP+10) • BlO 
495 A!TO(LOOP+lO) • AlO 
49' BSTO(LOOP+ll) • 111 
491 ASTO(l.OOP+ll) • All 
491 BITO(LOOP+l2) • 112 
4'9 A!TO(LOOP+l2) • Al2 
500 BSTO(LOOP+ll) • 113 
501 Al'?O(LOOP+ll) • Al) 
502 UTO(LOOP+l4) • 814 
503 Al'?O(LOOP+14) • Al4 
504 1S'?O{LOOP+l5) • 815 
505 A!TO(LOOP+l5) • Al5 
506 BSTO(LOOP+UI • 816 
501 ASTOILOOP+U) • AU 
508 UTO(LOOP+l1) • 811 
509 A!TO(LOOP+l1) • Al 1 
510 BSTO(LOOP+ll) • 818 
511 A!TO(LOOP+ll) • All 
512 ISTO (LOOP+ U) • 819 
513 ASTO(LOOP+l9) • AU 
514 NUT LOOP 
515 CLOS& 
520 rILE,QOAIITt-rn.u+• .an· 
525 OPEN FIU.QUANTS AS fl LEN • 27 
530 Fil.LO fl, 2 U l.MU~TllTU, 10 .U lSTOTS, 3 AS EfLAC$, 12 AS EDUMMY$ 
535 GET tl, l 
540 NUMSTJ.TS • CVI (DIUMSTJtTSS) 
550 l.STOATE.S • ESTOTS 
555 FLAG$ • £FLAGS 
556 IF FLAG$ <> "YES" TRI.N CLOSE: KILL FILEQU"111T$: FLAG$•"NO•: GOTO 575 
560 FIELD fl, 3 AS ENN4E$, 8 A! EPKRTS, 8 AS tPKAll.A.$, 8 .U EPPCAMT$ 
565 FOR LOOP • l TO NUMSTRTS 
566 GET 11,LOOP+l 
561 EPKNAMS(l.OOP) • r.NN4ES 
568 DPKRT(LOOP) • CVD(EPKRTS) 
5 69 DP KAJlE.A (LOOP) • CVD ( EP KM.EA$ ) 
510 DPKMfl'(LOOP) • CVDlEPKN4T$) 
511 NEXT LOOP 
572 CLOSE 
515 PAGE•O: LINTS•l 
580 CALL GPAGE(PAGE) 
585 CALL LEVEL (LIH'l'S) 
590 CALL CLUO 
594 R.F.M 
596 RDt 
600 R.DIJ tttHffUIIHtttfffffllf Draw R.unnlnq Scr-n tffUtUUlfltflltttftl 
610 UM 
620 LX•JO: LY-0: OOSUB 20010 
630 LX•JO; LY•260: OOSUB 20030 
632 LX•630: LY•260: GOSUB 20030 
634 FOil HAJlJ( • 256 TO O STEP -10 
636 LX•30: LY--+IAIU{: OOSUB 20010 
638 LX•25: LY-MAU: OOSUB 20030 
640 NEXT MAM 
642 FO'- MAJlJ( • 30 TO 630 STEP 20 
644 LX"""-DJC: LY•260: GOSUB 20010 
646 LX~J(: LY•265: GOSUB 20030 
648 NEXT MAU 
650 FO'- MAJlJ( • lO TO 630 STU 100 
652 LX"""-DJC: LY•265: GOSUB 20010 
654 LX"""-Alllt: LY•210: GOSUB 20030 
656 NEXT MAU 
658 FOR MARJ( • JO TO 630 STEP 200 
660 LX"""-AJlJ(: LY•270: GOSUB 20010 
fi62 LX"""-Allll'.: LY•275: C.OSUB 20030 
664 NEXT MAM 
666 LX•21: LY•291: EST-'"15": OOSUB 20050 
668 LX•l21: LY•291: EST•"20": GOSUB 20050 
670 LX•221: LY-291: r.sT-·25•: C.OSUB 20050 
612 LX•321: LY•291: EST•'"30": GOSUB 20050 
614 LX•421: LY•291: EST•"35": GOSUB 20050 
616 LX•521: LY•291: tST•"40": C.OSUB 20050 
611 LX•621: LY•291: l.ST•"45": C.OSUB 20050 
680 LX•211: LY•305: EST•"TIME {min•)'": GOSUB 20050 
700 LX•30: LY•343: EST•"FILf. • •+FILE$: QOSUB 20050 
710 CALL CUP (PAGf.) 
796 llD1 
800 lEM tttttfttfffftllUttfttftt Draw ChroaatoqrM tllttlltttttttttllttllll 
110 LX•((CHIT((ISTO(l)-15)•20))+)0): LY•ASTO(l) 
820 CALL PLC7l' (LX, LY) 
130 CALL !«)VE (LX, LYI 
840 FOi LOOP • 2 TO NOSAMPLS 
850 LX•( (CINT ( (BSTO(LOOP) -15) •20)) +30) : LY•ASTO (LOOP) 
860 CALL OLINE (LX, LY) 
810 NEXT LOOP 
1100 l£H Httffffttfttttttttff Draw Q\lant1tat1on Data ttfftfttttttttfHIIHI 
1110 If FLAQ..$ • '"'!ES" THEM 1100 
1114 LX-4: LY•l21: EST-STU NC$ (79, 32) 
1115 CALL Ttx'?B(LX,LY,EST) 
1116 LX-C: LY•Hl: EST-ST1lINC$ (19, 32) 
1711 CALL '?t.xTB (LX, LY, EST) 
1111 LIN'?S•O 
1719 CALL Ltvn (LINTS) 
1720 LX•lU : LY•321: EST•" Ch.roaatogr- B.a• Not Been Integrated " 
1130 CALL TEXTB (LX, LY, EST) 
1134 LIN'?S•l 
1136 CA.LL LEVIl(LIMTS) 
1140 LX•l95: LY•JU: ES'?-"Preu any key to c:ontinue., .. ,• 
1150 CALL TEXTB (LX, LY, f.ST) 
1155 If INUYS••• TllN 1755 
1160 GOTO 4100 
1100 lf.M ------- Print Qua11t1tated Data on S•~nd 4 Graphic• Paqe ----------
1110 PAGZ•l: LIN'?S•l 
1120 CALL C.PAG!. (PAGEi 
1130 CALL Ltvn (L HITS I 
1840 CALL Ct.I.SCI 
1150 LX•ll: LY•20: ES'?-"FIL!.: "+FILE$ 
1155 CALL TEXTB (LX, LY, EST) 
1160 LX•2H: LY•20: EST•"IMJECTION TIME: "+INJECT$ 
1165 CALL TEXTB (LX, LY, ES'?) 
1870 LX•611: LY•20: f.ST•EDATES 
1175 CALL TUTl(LX,LY,EST) 
1880 LX•ll: LY•l4: EST-STUNC$(16,205) 
1185 CALI. TEXTB(LX,LY,EST) 
100 LX•J 61 LY•O: U'?-"PN.k llo." 
105 CALL TUTB(LX,L'!,!.ST) 
1900 LX•l 71: LY-41: En••Peak N••" 
1905 CALL TUTl(LX,LY,EST) 
1910 LX•2'7: LY-48: EST•" .. tention Ti ... 
1915 CALL TU'?B(LX,LY,EST) 
1920 LX-4H1 LY-411 tST•"Ar.._• 
1925 CALL TU'?B (LX, LY, EST) 
1930 LX-6211 LY-48: ES'?•"Alllount" 
1935 CALL Tl.XTI (LX, LY, EST) 
19,f;O LX•ll1 1.1'•'2: U'?-1TllNC.S(76,196) 
1945 CALL Tll't'B(LX,L1',1ST) 
1950 FOi LOOP! • 1 1'0 Nt.14STl'l'S 
1960 LY•62+(LOOP1•14): ES'?•STllS(LOOPl) 
1970 IF LEW (UT) >2 '?UW LX-4S &I.SE LX•54 
lMO CALL '?tXTB(LX,LY,ES'?) 
lHO LX•l981 LY•62+(LOOPP14) 1 l.ST•EPKNAMS (LOOPl) 
2000 CALL T!XTB(LX, LY, UT) 
2010 TIMPS-STJ.SIDPD.T(LOOPl)) 
2020 LX•324: LY•62+U.oc:»1•14): tST•LtFTS (T!MU, '1) 
2030 CALL TEXTB(LX,LY, ES'?) 
2040 TIMPI-STJ.l(OPKAll.A(LOOPl)): CBECJC-0: LOOP2•1 
2050 WBILE cno: < l 
2060 TS'?.S-ttIDS (TEMP$, LOOP2, 1) 
2010 IF '?STS<>•." '?UN 2110 
2080 LX-486-(9•LOCJP21 
2090 U'?-LEF'U(TEMPS, LOOP2+6) 
2100 CB.f.CJl:•l 
2110 LOOP2•LOOP2+1 
2120 lffJID 
2130 LY•62+(LOOP1•14) 
2140 CALL '?EXTB(LX,LY,UT) 
2145 Ir DPltNff (LOOPl) •O TBDI LX•612: EST•• 0 .OOOO•: GOTO 2240 
21SO TDU'S-STJ.S(DPltNff(LOOPl)): CBECJt•O: LOOP2•1 
2UO WBILE CUO: < l 
2110 Tl'?S-ttIDl(T!.MPI, LOOP2, 1) 
2110 IF TSTS<>"." TUN 2220 
2UO LX-639-C,•LOOP:ZI 
2200 UT-L&l"U rrr.MPS, LOOP2+4) 
2210 CBECJl:•l 
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2220 LCX)p2•LOOP2+1 
2230 WDID 
22'0 LY•62+(LOOP1'1') 
2250 CALL Tl.XTB(LX,LY,EST) 
2260 NIX'? LOOPl 
2210 LX•ll: LY•62+( (NUMSTlTS-tl) •14): EST•STJlHIG$ (76,205) 
2280 CALL TtxTB(LX,LY,!.ST) 
2290 LX•54: LY•62+( (NUMSTJt.TS+2) *14): £ST•"Quant1tate<i data •xtrapolated from 
standards recorded. on: "+ESTOATES 
2300 CALL TtxTB (LX, LY, EST) 
2310 IF VAL(HIDS(ESTOATES,4,2)) • VAL(MIDS(EOATt.$,4,2)) THEN 2390 
2320 !F (VAI.(HIDS(ISTOATE$,l,2)))-31 >• (VAI.(MIDS(EDATES,1,2)))-31 TB.F.N 2390 
2330 LIH1'S•O 
2340 CALL LEVE.I. (LINTS) 
2350 LX•140: LY•62+((NUMSnTS+JJ•14): EST•" WARNING, STANDARD CURVE IS 0LD£R 
THAN ONE MCWTB " 
2360 CALL TEXTJS(LX,LY,EST) 
2390 PAGE-0: LIN'I'S•l 
2400 CALL LEvtL (LINTS) 
2410 CALL GPAGE (PAGE) 
3730 REH ------------------ Print Retention Ti.JIies on Screen ----------------
3740 FOR LOOP l • l TO NUMSTRTS 
3750 LX - CINT( (DPKRT(LOOPl)-15) *20) +30 
3760 CRECK-0: LOOP2-0 
3770 WHILE CRECK<l 
3780 LY•LOOP2 
3790 CALL GETPT (LX, LY, Ce.£0:) 
3800 LOOP2•LOOP2+1 
3810 N£ND 
3815 PTX • CINT((DPKRT{LOOPl)-15) 1 20)+27 
3820 HIGH.POINT • LOOP2-l 
3830 IS• STllS(DP!t:RT(LOOPl)) 
3850 IF BIGJIPOINT < 27 Te.EN PTY • 27 ELSE PTY • BIGBPOINT 
3860 FOR LOOP5 • 2 TO 6 
38"10 IF HIDS(U,LOOP5,l) ••,•THEN PTY•PTY-3: GOTO 3920 
3890 CB..UACTER • VAL(HIDS(U,LOOP5,l))+l 
3900 PTY • PTY - 6 
3910 Cli' CB.U.ACTER GOTO 3923,3932,3931,3947,3960,3966,3917, 
3981, 3994, 4009 
3920 LX•PTX+6: LY•PTY: GOSUB 20010 
3 921 LX•PTX+5: LY•PTY: G0SU8 20030 
3922 GOTO 4030 
3923 LX•PTX+l: LY•PTY: GOSUB 20010 
3924 LX•PTX+5: LY•PTY: G0SU8 20030 
3925 LX•PTX+6: LY-PTY+l: G0SU8 20030 
3926 LX•PTX+6: LY•PTY+2: 00508 20030 
3927 LX•PTX+S: L'!•P'l'Y+3: GOSUB 20030 
3928 LX•PTX+l: LY•PTY+3: GOSUB 20030 
3929 LX•PTX: LY•PTY+2: GOSUB 20030 
3930 LX•PTX: LY•PTY+l: GOSUB 20030 
3931 GOTO 4030 
3932 LX•PTX+6: LY•PTY+l: GOSUB 20010 
3933 LX•PTX+6: LY•PTY: GOSUB 20030 
3934 LX•PTJ:+5: LY•PTY+l: GOSUB 20030 
3935 LX•PTX: LY•PTY+l: GOSUB 20030 
3936 LX•PTX+2: LY•PTY+3: GOSUB 20030 
3937 GOTO 4030 
31J38 LX•PTX+6: LY•PTY: GOSUB 20010 
3939 LX•PTX+6: LY•PTY+3: GOSUB 20030 
J 940 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3941 LX•PTX+2: LY•PTY: GOSUB 20030 
3942 LX•PTX+l: LY•PTY: GOSUB 20030 
3943 LX•PTX: LY•PTY+l: GOSUB 20030 
3944 LX•PTX: LY•PTY+2: GOSUB 20030 
3945 LX•PTX+l: LY•PTY+J: GOSUB 20030 
3 94 6 GOTO 4030 
3947 LX•PTX+l: LY•PTY+3: GOSUB 20010 
3948 LX•PTX: LY•PTT+2: OOSUB 20030 
3949 LX•PTX: LY•PTY+l: GOSUB 20030 
3950 LX•PTX+l: LY•PTY: GOSOB 20030 
3951 LX•PTX+21 LY•PTY: GOSUB 20030 
3952 LX•PTXt3: LY•PTYtl: GOSUB 20030 
3 953 U•PTX+l: L't•PTYt2: GOSUB 20030 
3954 U•PTX+4: L't•PTY: GOSUB 20010 
3955 LX•PTXt5: LY•PTY: GOSUB 20030 
39Sfi U•PTX+6: LY•PTY+l: GOSUB 20030 
3 957 LX•PTX+6: LY•PTY+2: QOSUB 20030 
3 951 LX•PTX+5: LY•PTY+3: GOSUB 20030 
3 95 9 GOTO 4030 
3960 LX•PTX+l: LY•PTT+3: GOSUB 20010 
3 9fil LX•PTX+4: LY•PTY+3: GOSUB 20030 
3962 LX•PTX+4: LY•PTY: QOSUB 20030 
3963 LX•PTX+61 LY•PTY+l I QOSUB 20010 
3964 LX•PTX: LY•PTY+l: QOSUB 20030 
3 965 GOTO 4030 
3966 LX•PTX: LY•PTY: GOSUII 20010 
3967 LX•PTX: LY•PTY+3: QOSUB 20030 
3 961 LX•Ptt+2: LY•PTYt3: QOSOI 20030 
3969 LX•PTl:+2: LY•PTY+l I QC.SUI 20030 
3970 LX-PTl:+31 LY-PTY; QOSOI 20030 
3 911 Llt-PTl:+S I LY-PTT: QOSOI 20030 
3972 LX-l'Tl:+11 LY-PTY+l I QOSUI 20030 
1971 LX-l''n+l1 LY-PTY+21 QOSUI 20030 
3914 LX-tff+51 LY-PTT+] 1 QOIUI 20030 
3915 LX-fff+4 r LY-PTY+31 QOSUI 20030 
3916 QO!O 4030 
3917 LX-PTX+l; LY-PTYz QOSOI 20010 
3971 LX-tff1 LY-Pfftl: QOSUI 20030 
3979 LX-P'n+21 LY..Pff+3t QOIUI 20030 
3910 LX-Pff+J I LY ... TY+3: QOSUI 20030 
3911 LX-Pfftlz LY-PTY+21 CilOIOI 20030 
3912 LX-P'!Xtl1 LY-PTY+l I QOIUI 20030 
3913 LX•PTX+5: LY-PTY1 QOSOI 20030 
3914 LX-PTX+4: LY•PTY: QOIUI 20030 
3915 U-PTX+31 LY•PTY+l1 QOSUB 20030 
3916 LX•PTX+l: LY•PTY+2: QOSUB 20030 
3917 GOTO 4030 
3911 LlC•PTX: LY•PTY+3: QOIUI 20010 
3919 LX•PTX: LY•PTY: QOSUI 20030 
3990 LX•PTX+2: LY•PTY: QOSOI 20030 
3991 LX•PTX+5: LY.PTT+] 1 QOSOI 20030 
]'92 LX-PTX+, 1 LY•PTY+3: oosua 20030 
3993 QOTO 4030 
3994 LlC•PTX+2: LY•PTY+3: QOSUB 20010 
399S LX-PTX+l: LY•PTY+31 00101 20030 
3996 LX•P'?X1 LY•PTY+21 OOIUI 20030 
3991 LX-PTX1 LY•PT'Ytl: QOIUI 20030 
3991 LX•PTXtl: LY•PTY1 GOIOI 20030 
3999 LX•PTX+2: LY•PTYz 00101 20030 
4000 LX•PTX+l: LY•PTY+l: QOSUI 20030 
400 l U•PTX+3 1 LY•PTY+2 1 QOIUB 20030 
4002 LX•PTX+4: LY•PTY+3: OOSUI 20030 
4003 LX•PTX+S: LY•PTYt3: QOSUI 20030 
4004 LX•PTX+6: LY•PTY+2: QOSOI 20030 
400S LX•PTX+6 1 LY•PTY+l: OOSUI 20030 
4006 LX•PTX+S I LY•PTY: QOIUI 20030 
4001 LX•PTX+4: LY•PTY1 QOIUB 20030 
4001 GOTO 4030 
4009 LX-PTX+6: LY•PTY+2: OOSUB 20010 
4010 LlC•PTX+4: LY..PTY: GOIOI 20030 
4011 LX•PTX+l: LY•PTY: GOSOI 20030 
4012 LX-PTX: LY•PTY+l: GOSUB 20030 
4013 LX•PTX: LY•PTY+2: GOSUB 20030 
4014 U:•PTX+l: LY•PTY+3: GOSUB 20030 
4015 LX•PTX+2: LY•PTY+3: GOSUB 20030 
4016 LX•PTX+): LY•PTY+2: GOSUB 20030 
4017 LX•PTX+l: LY•PTY+l: GOSUB 20030 
4030 NEXT LOOPS 
4040 N£XT LOOPl 
4100 REH -------------------- Print .B.ardcopy of Ch.romatoqraJ11 ---------------
4102 LX-4: LY•328: EST-STRING$ (79, 32): GOSUB 20050 
4103 LX-4: LY•343: £ST•STRINGS(79,32): GOSUB 20050 
4104 LX•92: LY•J28: EST•"Mould You Like a Hardcopy of the ChrOlllatoqra.lfl 
(y/n) ?·: G0SU8 20050 
4105 Q$•Il0CEY$: IF QS••• TH!:H 4105 
4106 IF Q$••1r Oil Q$•"n• THEN 4180 
4101 IF QS<>·r AHO QS<>•y• THEN SOUND 40,10: GOTO 4105 
4110 LX-4: LY•)28: EST•STR.INGS(79,32): GOSUB 20050 
4112 LX•4: LY•l43: EST•S'?RINGS(H,32): GOSUB 20050 
4118 BEEP: LX•96: LY•328: tST•·Pr••• <[•hift) PrtSc-1> wh•n thi1 m•su.ge 
diuap .. ra•: GOSUB 20050 
4120 LX•l95: LY•343: EST•·Pr••• any lc•y to continue. .": GOSUB 20050 
4130 IF IN!t:£YS • "" Te.EN 4130 
4140 LX•4: LY•343: EST-STUNG$ (79, 32): GOSUB 20050 
4150 FOJ. LOOP - l TO 5000: N£X'? LOOP 
4160 BEEP: LX-4: LY•l28: EST•STRINGS(H,32): GO!UB 20050 
4170 IF IN!t:EY9 • ... Te.EN 41 70 
4180 REM ----------------- Print B.ardcopy of Quantitat•d Data ------
4190 IF FLAG$<>·YF.!• TBEN 5020 
4200 LX•4: LY•l21: EST•STRING$ (79, 32): GO.SUB 20050 
4210 LX-4: LY•343: £ST•,'TR1NGS (79, 32): GOSUB 20050 
4220 U•H: LY•328: EST•·Nould You Lik• a Ba.rdcopy of the Quantit.a.tad Data. 
(y/n) ?": OOSUB 20050 
4230 0$•INKEY$: IF 0$•"" TH£H 4230 
4240 IF QS•"ll" Cl. Q$•"n· TBtN 4600 
42SO IF QS<>"Y-- AND QS<>"y" THEN SOUND 40, 10: Gal'O 4230 
4260 LX-4: LY•321: EST•STRING$ (79, 32): GOSUB 20050 
42"10 U:•4: LY•l43: EST•STJ.INGS (79, 32): GOSUB 20050 
4210 LX•240: LY•328: EST•"Cheek Printer !tatu•": GOSUB 20050 
4290 LX•l95: LY•343: EST•·Pr•n any lc•y to continue .... ,": GOSUB 20050 
4300 IF IN1".EY$ • •• THEN 4300 
4310 OPDI •tPTl: • AS fl 
4320 NID1'8 fl,10 
4330 PRINT tl, C8R$(2"1);CBJ.$(73J;CBR$(2): PRINT tl, CHR${13);CHRS(l0) 
4340 PRINT t], TAB(l);-FILEl •;FILES;TAB(34);'"INJECTION TIME! 
INJEC"l'$;TAB(64);EDATU: PRINT #3, CBJ.S(l3);CRJl.$(10) 
4350 PJ.INT fl, TAB()) ;STllINc;.$ (16,205) 
4360 PRIN'!' tl, TAB(5);•Pea.k No.";TA.B(20);"P•alc N&Me•;TAB(J4); 
·11etent ion Ti .. " ;TAB (55): ·.1.rea• ;TAB (70); ·Mount• 
4370 PJ.INT t3, TAB(l) ;STRINC..S (76,196) 
4310 FORMA.TlS ft 
4390 l'OIIMAT2S • "\ - - - - - \ - - - - - - - - - - - - -
4400 FORMA.Tl.S • "tt.ttt ttt.tttttt tttt.fftf" 
4410 roa LOC» - 1 TO NuMST1tTs- - - - - - - - - - -
4420 PRINT fl, USING FORMATlS; LOOP; 
4430 PRINT fl, USING FORMAT2$;EPXNN1$(LOOP); 
4440 PJ.INT fl, USIMG FoaKAT)S;DPDT(LCX)P) ;DPKAllA(LOOP) ;DPMM? {LOOP) 
4450 NErr LOOP 
4460 PRINT fl, TAB(]) ;Sn.ING$ (76,205) 
4410 PUNT t3, TAB (7); "Quantitat•d data •xtrapolated from. 1tandard1 
recorded on: "; ESTDATEt 
4410 IF VAL(MIDS(ts'!"OATU,4,2)) • VAL(MIDS(F.DATU,4,2)) TREN 4510 
4490 IF (VAL(MI0t(ESTDATE$,l,2)))-3l >• (VAL(HID$(EDATE$,l,2)))-31 THEN "4510 
4500 PJ.INT fl, CBJ.S(27);Cll$(69);TAB(l6);•1fAJt.NINC, STANDAIU) CURVE IS OLDER 
TUN OME MClilTB I !";CDS(21);CBU(?O) 
4510 PUNT tl, CBU(27);CJlJ.S(73);C8U(l) 
4520 PlIHT fl, CBU(l2) 
4530 CLOSl. 
4600 J.l.M -------------- Vi•w Qu.ntitated Data on th• CRT ----------------
4610 IF rJ.AG..t<>"Yts" THEN 5020 
4620 LX-4: LY-321: EST-STJ.INGS (79, 32): oosua 20050 
4630 LX-41 LY•34l: l.ST-STllINGS(79,32): OOSUB 20050 
4640 LX•56: LY•321: EST•·Nould You Like to View the Quantltated Oat• on the 
O'T (y/n) ?": GOSUB 20050 
4650 QS-INKl.YS: Ir os-·· TBEJI 4650 
4660 IF Q$•"11" ca. QS••n• TBDI 5020 
4'70 If QS<>•Y" AlfO QS<>•y" Te.EM SOUND 40, 10: Gal'O 4650 
4610 PAGJ:•l: Llll'?S•l 
4690 CAl.L QPAGr. (PM.!.) 
4100 CALL LEV!..L (LINTS) 
4110 CA.L.L DISP (PAG!.) 
4720 LX-41 LY•343: l.ST-S'l'UNGS (H, 32) 
4130 CA.L.L TE.XTB(LX,Lr,EST) 
4140 LlC•163: LY•Hl: r.s-r-•Preu any key to return to chro11atogrM1 .••.. " 
4750 CA.L.L T!.X'?l(LX,LY,tS'l') 
4760 Dl.F sr.c:;..01 PC:S:l. 1050,Pll1".(1052): DEF SEC: POKE 106,0 'cl .. r lcbrd buffer 
4770 tr IN!ttYS•"• TR!.lf 4710 
4710 PAGE-0: Llll'?S•l 
4790 CALL QPAGE (PJiGt) 
4100 CALL LEV!..L (LllfTI) 
4110 CALL DISP (PAGE) 
5020 LX-4 t LY•3211 UT-ITJ.I11QI (7t, 32) : GOSUB 20050 
5030 LX-4: LY•34l: UT-S'l'lINGS (79, 32) : QOSUB 20050 
5040 BEU: Lll'.•240: LY•321: U'?--View Another (y/n)?": GOSUB 20050 
5050 DEF SEG-0: PCS!. l0S0,PUK(l0S2): DU SEC: POKE 106,0 'el .. r lcbrd buff•r 
5060 Ql•INKEYS: Ir QS••• TBDI 5060 
S010 IF Qt<>•w• ANO Q$<>•n• T.UN 5110 
5100 CRAIN "A:BPLC• 
5110 IF QS<>·Y- AlfD Qt<>•y• TREN SOUND 40, 10: c:;oro 5060 
5120 CLl.AI. 
5130 QOTO 220 
uu arc 
20000 UM ttfftffHHHffttffHH C1'APB-X Subroutines HttttfttHUttttttttt 
20010 CALL MOYE (LX, LY) 
20020 lETUJJI 
20030 CALL DLiltlLX,LY) 
20040 l.E'?UJJI 
200SO CALL T!.XTB(LX,LY,£ST) 
20060 J.E'?Oll 
CALIBRAT. SRC 
10 llM ncx;UiM 11N1! • CALIBJ.AT.sac 
•• llM 
.. llM 
100 lDI tttffffttffHHHttfffff Initialise the 1255 HHHHHHtttttttttlt 
110 J.D( 
120 OUT 611703, iB92 
194 '-DC 
196 J.Dt 
200 J.Dt tttfttfttft Initilise the scr-n and 01 .. naion Variabl•• tttfffffftf 
210 J.D( 
230 DEJ"I'NT A, C, 8, L-P, V: OEJ"DBL D, 1"., J., S: DEFSTll l., F, I, Q, T, X, Y: D!.f!NG B 
235 FILU•·A:11'11DlDr 
240 DIM AST0(5010), UTO (5010), PltSTll'l' ( 1, 25), PllND (l, 2S), SSTDX (25), 
SS'?DY (2S), SS"?DXY(2S), SITDXSQ(25), SS'!"OJ..T (2S), N (25), !.STDN»t$ (25), 
DPJ{U.l'..A 125), DPDT (25), DPIWIT 125), E.PIOfN1S (25) 
2SO P11GE•01 LIN'l'S•l 
260 CALL QPM.!.(PAGZ) 
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270 CALL LEV'EL (LIH"!'S) 
280 CALL Cl.llSCJl 
290 CALL OISP (PAGE) 
294 JU'.M 
296 llr.M 
JOO REH fffffffllfft Convert Date Fora.at frOf!I Arnerica.n to r.uropean ftftftftf 
310 REM 
320 EDATtS • OATES: MIDS(E.DATU,1,2) • MIDS(DATF.S,-4,2): 
HIDS(r.DATU,4,2) • MIOS(DATU:,1,2) 
394 RrJoll 
3 96 RDt 
400 REH ftfltftfftfHIIIIHHIIII Starting Pranpta flllllfflltffttfflffffllt 
410 ROIi 
411 IF !.REPtA'U • ·ns" TBEM 452 
412 LX•40: LY-28: EST•"Thi• progr .. 1• ct.signed for the input of stand.a.rd 
data. It 1• recolllfllended": GOSUB 20050 
413 :.X•4: LY•56: EST•"that at 1 .. at five runa are made, ao that an accurate 
standard curve can De": GOSUB 20050 
-414 LX•-4: LY•84: EST•"d•rived. After each run you will select peak atart:11 
and ends, £roll which ar-•·: GOSUB 20050 
-415 LX•4: LY•ll2: EST•'"will D• calculated. Once thia is complete, the 
retention ti.Illes will b,e '": OOSUB 20050 
416 LX•4: LY•l40: EST•'"displayed on line 24 and you will b,e pro111pted for the 
peak naJl'le and the uount. •: GOSUB 20050 
417 LX•4: LY•l68: EST•'"After .. ch input you will ••• the valu•• displayed. 
and a1ked if they are": GOSUB 20050 
418 LX•4: LY•l96: EST•'"correct. If you have made an error, it can b4i 
ad:)u1ted at this time.'": GOSUB 200SO 
420 LX•225: LY-328: EST•'"Do you wi1h to continue (y/n)'?": GOSUB 20050 
421 DEF SEG-0: POKE 1050,PEE.X(l052): DEF SEG: POl<E 106,0 'clear kbrd buffer 
422 o.s-noa:.YS: IF QS•"'" TBI.N 422 
423 IF QS•'"Y" OR QS•"y" TBI.N 452 
424 lf Q,$•"N" Oil QS•"n" TBEN CHAIN •A:BPLC" ELSE SOUND 40, 10: GOl'O 421 
4 52 LX•4: LY•328: EST•STR.ING$ p 9, 32) 
453 CA.LL TEXTB(LX,LY, EST) 
455 LX-167: LY-321: EST•'"Jwad.ing 1y1t- parwneter1, pl•••• wait •• ,,," 
456 CA.LL TEXTB(LX,LY,EST) 
460 PAGE•l: LINTS-1 
470 CA.LL GP-'GE(PAGE) 
480 CA.LL LEVEL(LIN'l'S) 
4 90 CALL CLI\SCJl 
557 OPEN "A:STNDJlDS .TMP" AS t1 LEN•45 
558 rIELD fl, 2 AS EHUMRUNS$, 2 AS EHUMST0S$, 10 AS TODAY$, 3 AS FLAG$, 
28 AS EDU~Y$ 
559 GET fl. 1 
560 IF FLAGS<>"YES" TH.EN NUMRUNS•l: NUMSTOS-0: GOTO 564 
562 NUMRUNS • CVI (ENUMRUNS$): NUMRUNS • NUHRUNS+l: NUHSTOS • CVI (ENUHSTDSS) 
564 CLOSE 
570 LX•95: LY•l 14: EST•" UE YOU USING AN EXTERNAL TRIGGER TO START 
SAMPLING {y/n) 1 " 
572 CALL TEXTB(LX,LY,EST) 
5i.3 CALL DI!P (P-'GE) 
575 DEF SEG-0: POKl. 1050,P££J{{l052): DEF SEG: POKE 106,0 'clear kbrd buffer 
580 EXTRS • INJt:EYS: IF EXTRS • "'" THEN 510 
590 IF EXTll.$ <> "N" AHO EXTRS <> "n" AND EXTR$ <> "Y- AND EXTRS <> "y" THEM 
SOOND 40, 10: GOTO 575 
594 REH 
5 96 REH 
600 REH fffftttlllllltfllllllllt Draw Running Scr-n fftfftfftfffllffffllfff 
610 REH 
612 PAGE•O: LINTS•l 
614 CALL GPAG[ (PAGE) 
616 CALL LEVEL(LIHTS) 
611 CALL CLR.SCR 
620 LX•30: LY-0: OOSUB 20010 
630 LX•lO: LY-260: GOSUB 20030 
632 LX•630: LY•260: GOSUB 20030 
634 FOl MARIi: • 256 TO O STEP -10 
636 LX.•30: LY-+IAU: OOSUB 20010 
638 LX•25: LY-MAll: QOSUB 20030 
64 0 N EX'? MAJJt 
642 FOl MARJ: • 30 TO 630 STU 20 
644 LX--MAAlt:: LY-260: c;osun 20010 
646 LX~JI'.: LY•265: c;osua 20030 
648 NF.X'T MAU 
650 roa MAJ.)( • JO TO 630 STEP 100 
652 LX-MARJt:: LY•265: GOSUB 20010 
654 LX~Jt:: LY•270: GOSUB 20030 
656 NEXT MAU 
658 rOl MAJ.It: • 30 TO 630 S'?!.P 200 
660 LX-MARJI'.: LY•270: GOSUB 20010 
662 LX-MAJ.11:: LY•27S: <.OSUB 20030 
664 NEXT HAU 
666 1x-21: LY•2 91: l!!IT-'"15'": oosua 2ooso 
668 LX•l21: LY•29l: EST••20•1 GOSUB 20050 
670 LX•221: LY•291: r.n--2s·: QOSUB 20050 
672 LX•32l: LY•291: EST•"30": COIUB 20050 
674 LX•421: LY•29l: EST•'"35": QOIUB 20050 
676 LX•521: LY•2tl: ES1'•'"40": t'X.1108 20050 
671 LX•621: LY•2'l1 EST••45•1 t'X.lltJB 20050 
680 LX•2ll1 1?•3051 I.ST•'"TIM! (aina)": QOSUB 20050 
690 LX•6il 91 L'f•l 11 U'?-&DA.Tl.$: QOSUB 20050 
700 LX•lOt LY•34la u-r-•rtLE • •+rIU$1 GOIIUB 20050 
710 LX•4501 L'f•l211 zn-·Saapl• N1.aher -·: QOSUB 20050 
720 LX-4501 L!•3431 r.rr-•aun Tiae -·: c.olUB 20050 
730 CALL DIIP CPM:I.) 
196 I.EM 
100 IDI fllffffffffffff S•pl• Ch.annal O - Exter~l Tri999r ftftfffftttfltf 
110 REM 
120 IF UTI.$ • •y• ca EXTU • "y" THE• CUIINEL • 0 l.LSE GOTO 1100 
130 GOSOB 10000 
140 LX•JO: LY•3211 UT--..1t1nq for Exterrwtl Tr ig~r ••••• ": GOSUB 20050 
850 NBILI. VALUE < 2500 
860 oosua 10000 
870 lfEND 
194 It.EM 
196 JtD1 
1100 REM Httffllll S•pl• Channel l - Abscrbanee Data froa HPLC tHHHftt 
1110 llM 
1120 CBAM'NEL-1: MOS»IPLS•O: L.ASTX•311 L.ASTY•256: RUM'I'IHE•O: BST0(0}-,006 
1130 LX•lO: LY•321:· l.ST-STJ.lllc.$(35,32): QOSU8 20050 
1140 LX•30: LY•321: ES1'•"Saaplinq ••••• ": QOSUB 20050 
1150 S"l'.UTIM! • TIMD 
1155 LX•301 LY•256 
1156 CALL MOVE(LX,LY) 
1160 IIBILE JtUHTIME <• 45 
1170 t;OltJB 10000 
1110 NOS»IPLI • NOIAMPLS + l 
1190 ABVAL • 260 - ((CIWT(VALUE/1'))+4) 
1200 11:UlltTIME • TIMER 
1210 RUNTIME • ( ( (KUllTIMZ-STllTIMt) /60) +15) 
1215 Ir lUHTIME < BSTO(NOSAMPLS-1) +.oo, THEN 1200 
1220 PL'l'IME • ( (CIHT( {J.UWTIME-15) 1 20)) +30) 
1230 LX-PLTIME: LY•UVAl., 
1240 CALL DLI'NE(LX,LY) 
1250 BS'?O(WOSAMPLS) • RUNTIME: AS1'0(WOSAMPLS) • ABVAL 
1260 LX•540: LY•3431 TEMP$-ST1S(RUNTIME): l.ST-LI.f"rS(Tl.KP$, 10) 
1265 CALL Ttr?B(LX,LY,UT) 
1270 LX•515: LY•321: tST-STlt(NOSAMPLS) 
1275 CALL TEXTB(LX,LY, UT) 
1210 LX•6i21: LY•34t UT-'?IM!.S 
1285 CALL TEXTB(LX,LY,EST) 
1290 WI.NO 
1294 REM 
1296 REM 
1 700 REM ftllfftttftt ftfftfttffff Ma.nual Integration Ifft ffffftfttffHlff U f 
1710 REM 
1720 LX•18: LY•328: EST•STJI.INGS(74,32): GOSUB 20050 
172 5 LX•628: LY•34: EST•STRINGS (8, 32) : GOSUB 20050 
1730 LX•lO: LY•O 
1740 CALL MOVE(LX,LY) 
1750 LX•lO: LY-259 
1760 CALL OLIN!. (LX, LY) 
1770 LINTS•2 
1780 CALL LEVEL(LINTS) 
1890 POSX•lO: NUHSTRTS•O: NUMENOS-0 
1894 PLTI'EN • CINT(((BSTO(l0)-15)*20)+30) 
1896 PLTEND • CIHT(((BSTO(NOSN4PLS-10)-15)•20)+30) 
1900 SAMPOIN'? • COBL ( (NOSAHPLS-20) / (PLTEND-PLTI'EH)) 
1910 GOSUB 10130 
1930 REM ----------------------- Input Control Co111111a.nd ---------------------
1940 IHOVES • INJ:EY$: IF IMOVES • "" THEM 1940 
1942 IF LEH(IMOVES)>l AHO IMOVES-CBRS(O)+'"M" THEN MOVE•28: GOTO 1980 
1943 IF LEN(IMOVES)>l AHO I!'1:JVE$-C8R$(0)+"l(" THEN HOVE•29: COTO 1980 
1945 !'IJVE•ASC {IKJVES) 
1950 IF MCIVE < 52 TB.EN 1940 
1960 rr MOVE < 55 THEN 1980 
1970 If HOYY.>65 AHO POSX>29 AHO POSX<631 THEN 2070 ELSE SOONO 40, 10: 
GOTO 1940 
1980 REM ---------------------------- Hove Cur1cr -------------------------
1990 IF MOVE • 28 THEN P0SX2•POSX+l: COTO 2000 
1992 IF MOVE • 54 TB.EN P0SX2•P0SX+l0: GO'l'O 2000 
1994 If HOV'! • 29 THEN POSX2•P0SX-1: GOTO 2000 
1996 IF MOVE • 52 THEN P0SX2•POSX-l0: GO'l'O 2000 
1991 SOUND 40, 10: GOTO 1940 
2000 IF POSX2<10 THEM BEEP: POSX2•10 
2002 IF POSX2>640 TREN BEU: POSX2•640 
2004 LX•POSX: LY•O 
2006 CALL MOVE(LX,LY) 
2001 LX•POSX: LY•259 
2010 CALL OLIN!. (LX, LY) 
2012 LX•POSX2: LY•259 
2014 CALL MOVt. (LX, LY) 
2016 LX•POSX2: LY-0 
2011 CAL.I. OLIN!. (LX, LY) 
2020 POSX•POSX2 
2030 GOTO 1940 
2040 REM ---------- Integration Control Coa111a.nd1 ----------
2050 R£H 
2060 REM ---------------------------- P .. k Sta.rt ---------------------------
2070 IF MOVE• 13 OR MOVE• 115 '1'Bllrf SOUHO 523.25, .5 ELSE 2230 
2080 LOOP• CINT((POSX-35)*SAMP0INT) 
2090 Ir LOOP < 1 'l'BEN LOOP - 1 
2100 rr LOOP > NOSAMPLS '?HEN LOOP • NOSAMPLS 
2110 LOWPOIHT-0: FLAG.S•"fIJtST• 
2120 C04PX • CIN'l'((BSTO(LOOP)-15) 1 20)+30 
2130 IIBIL! CCMPX <• POSX 
2140 IF CCMPX < POSX THEN 2180 
2150 IF 1"1.>tGS•"FIJ.ST" TBEJI NUHSTRTS•NUHSTITS ... l: 
PKS'l'ART (0, HIMSTR'l'S) •LOOP: FLAG.s•"NO" 
2160 P!tSTART(l,NUHSTRTS)•LOOP 
2170 IF AS'l'O(LOOP) > LOMPOIN'l' THEN L0lf1'0IMT • ASTO(LOOP) 
2110 LOOP .. LOOP + l 
2190 CCl4PX • CINT((8ST0(LOOP)-l5)•20)+JO 
2200 ftND 
2210 LX•POSX: LY•LOIIPOIMT+l 
2211 CALL MOVE (LX, LY) 
2212 LX•POSX: LY•LOWPOIHT ... 11 
2213 CALL OLINE (LX, LY) 
2214 LX•POSX+4: LY•LOWPOINT+ll 
2215 CALL OLINE (LX, LY) 
2216 GOTO U4 0 
2220 Jt.EM ----------------------------- Peak End ----------------------------
2230 IF MOVE• 6i9 OR KJV1! • 101 THEN SOOND 523.25, .5 r.Lst 2390 
2240 LCXJP • CINT ( (POSX-25) •SAMPOINT) 
2250 IF LOOP > NOSAKPLS THEM LCXJP • NOSNtPLS 
2260 IF LOOP < l THEN LOOP • l 
2210 LOIIPOINT--0: FL.liG.S•"FilST'" 
2210 CCMPX • curr ( (BSTO(LOOP)-15) 1 20) +30 
2290 WBILE CCMPX >• POSX 
2300 Ir CCMPX > POSX TBlN 2340 
2310 IF FL.JiGt••FilST" '?BEN NUMENDS-NUMEHDS+l: Plt:EHD (0, NUMENOS) •LOOP: 
FLAG$•"MO• 
2320 PU.ND(l,NUMDIOS)•LCXJP 
2330 Ir AS'l'O(LOOP) > LOMPOINT THEN LClfPOINT • ASTO(LOOP) 
2340 LOOP • LCXJP - l 
2350 CCMPX • CINT ( (BS'?O(LCXJP)-15) 1 20) +30 
2360 WEHD 
2370 LX•POSX: LY•LOIIPOINT+l 
2311 CA.LL MOV!.(LX,LY) 
2372 LX•POSX: LY•LOIIPOINT+ll 
2373 CA.LL OLINE (LX, LY) 
2374 LX•POSX-4: LY•LOIIPOINT+l l 
2315 CALL OLINE (LX, LY) 
2376 QOTO 1940 
2310 lEM ------------------------ c1 ... r Entry ---------------------------
2390 IF MOYE <> 6i7 ANO HOV!. <> 99 TBlN 2740 
2400 CAHCll--0: LOIIPOIHT-0 
2410 Ir NI.MSTl'?S < 1 TBDI 2570 
2420 f'OR LOOP • 1 TO NUMS'RTS 
2430 CCMPX • CIN'l'( (BSTO(PU'?.UT(O, LCXJP) )-15) 1 20) +30 
2440 IF CCMPX - POSX TBJ:.W CANCll • LOOP 
2 450 NtXT LOOP 
2460 Ir CANC'EL < l THEN 2570 
2470 roa LOOI' - PJtSTAAT(O,CANC'EL) TO Plt:STAJ.'1'(1,CANCEL) 
2410 IF ASTO(LOOP) > LOlf!'OIN'? TBEH Ltltf!'OINT • ASTO(LOOP) 
24t0 NEXT LOOP 
2500 SOUIID 500, .S: SOUND 32767, 1: SOUND 600, .S 
2510 LX•POSX: LY•LOIIPOINT+l 
2Sll CAl.l. MOY!:(LX,LY) 
2512 LX•POISX: LY•LOIIPOINT+l 1 
2513 CA.LL DLINE (LX, LY) 
2Sl4 LX•POSX+41 LY•LOIIPOINT+l l 
2515 CA.LL DLIR (LX, LY) 
2520 roa LOOI' • CAIIC!L TO NUMSTR'?S-1 
25]0 PKSTAl'?(O,LOOP) • PJtSTAl'?(O,LOOP+l) 
2540 PltS'?AH(l,LOOP) • PKSTAA'?(l,LOOP+l) 
2550 NEXT LOOP 
2S60 NUNSTITS • NUMl'?HS - 1: c.a?O 1940 
2570 IF NUMl'?lTS <l AND Nt.14ENDS<l 'l'BJ:.H SOON'O 40, 10: GO'l'O 1940 
2SIO FOi LOOI' • 1 TO NUM!.HOS 
2590 CCMPX • CINT( (BS'?O(PKEHO(O, ~) )-15) 1 20) +30 
2600 Ir CCMPX • POSX THEN CAIICll • LOOP 
2610 WEr? LOOP 
2620 IF CMIC!.L < l TUJI SOUHD 40, 10: COTO 1940 
2630 roa LOOP • PU.ND(l,CANC!.L) TO Plt:EHD(O,CAHCtL) 
2640 IF AS'l'O(LOOP) > LClfPOINT '?BEN Ltltf!'OINT • ASTO(LOOP) 
2 6SO lfEXT LOOP 
2HO SOUND 500, ,Sr SOUND ]2767, l: SOUND 600, .5 
2670 LX•POSX: LY•LOIIPOIN"J'+l 
2671 CALL MO'n(LX,LY) 
2672 LX•POSX: LY•LOIIPOIN'?+l l 
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2673 CALL OLINE (LX, LY) 
2614 LX-PO:SX-4: LY•LONPOINT+ll 
2 675 CALL DLINt (LX, LY) 
2680 FOR LOOP • cANaL TO HUMENDS-1 
2690 PICr.ND(O,LOOP) • PKr.ND(O,LOOP+l) 
2700 PICEND(l,LOOP) - PXENO(l,LOOP+l} 
2 710 NEXT LOOP 
2720 NOMI.NOS • WUMENDS - 1: GOl'O 1940 
2no Ilr.M ------------------------- Redo rro111 Start -------------------------
2740 If MOVE<> 12 AND l«)V!. <> 114 TB£N 2140 
2750 BEEP: LIH1'S•l 
2751 CALL LEVT.L(LINTS) 
2752 LX•4: LY•J21: EST•!TilINGS (79, 32): GOSUB 20050 
2753 LX•4: LY•J43: EST-STRINGS (19, 32): GOSUB 20050 
275.4 LX•lO: LY•328: EST•'"Jledc fro• Start ••... '": G05UB 20050 
2755 LX•227: LY•343: EST•"COffIRH SELl.CTIOf (y/n) ": GOSUB 20050 
2760 Q$ • INXEYS: If OS • "'" TBEN 2760 
2770 IF Q$ • "y" OR QS • "Y" THEN 2790 
2780 GOSUB 10130: GO?O 1940 
2 790 CALL cu.sea 
2791 LX•JO: LY•O: GOSUB 20010 
2792 LX•JO: LY•260: GOSUB 20030 
2793 LX•630: LY•260: GOSUB 20030 
2794 roR MAJUC • 256 TO O STEP -10 
2795 LX•30: LY-+tAJtX: GOSUB 20010 
2796 LX•25: LY""f1ARX: GOSUB 20030 
2797 N£XT MARX 
2 798 FOR MAlU( • 30 TO 630 STEP 20 
2799 LX-tO.IUC: LY-260: GOSUB 20010 
2 800 LX-HAJU(: LY'•2 65: GOSUB 20030 
2801 NEXT MARI( 
2802 FOJ. M1J\X - 30 TO 630 STEP 100 
2803 LX-tO.IUC: U•265: GOSUB 20010 
2104 LX-MAJUC: U•270: OOSUII 20030 
2 80 5 NEXT MARK 
2806 FOR MAU - 30 TO 630 SUP 200 
2807 LX-tO.IUC: LY•270: GOSUB 20010 
2808 LX-MAIU(: LY•275: GOSUB 20030 
2 80 9 NEXT MARX 
2810 LX•21: 1'.!•291: EST•"l5'": GOSUB 20050 
2811 LX•l21: U•291: EST-"20'": GOSUB 20050 
2812 LX•221: LY•291: EST-"25": OOSUB 20050 
2813 LX•321: LY'•291: EST-"30": OOSUB 20050 
2814 LX-421: u-291: r.sT-"35": GOSUB 20050 
2815 LX•521: LY•291: tsT-"40": GOSUB 20050 
2816 LX•621: LY•2!H: EST-"45": GOSUB 20050 
2817 LX•211: LY•305: £ST•"TIHE (ainal ": GOSUB 20050 
2818 LX•((CINT((BSTO(l)-15)*20))+30): LY'•ASTO(l) 
2819 CALL PLOT(LX,LY') 
2820 CALL MOVE(LX,LY) 
2821 FOJ. LOOP • 2 TO NOSAMPLS 
2822 LX• ( (CINT ( (BSTO {LOOP) -15) *20)) +JO): LY•ASTO (LOOP) 
2823 CALL DLINE{LX,LY) 
2824 NEXT LOOP 
2825 GOTO 1700 
2830 ll£M ------------------------ Quit Int~ration ------------------------
2840 Ir MOVE <> 11 AND I«>V!. <> 113 THEN 2900 
2850 BEU: LINTS•l 
2851 CALL LEVll(LINTS) 
2852 LX•4: LY•321: EST-STRING.S (79, 32): GOSUB 20050 
2153 LX-4: LY•JO: UT-STUNG$(79,32): GOSUB 20050 
2854 LX•JO: LY•321: t!T•"Quit ••••• ": GOSUB 20050 
2855 LX-227: LY•343: EST•"CONrIJtM SELECTION (y/n)": GOSUB 20050 
2860 Q$ • INKtYS: tr 0$ • •• THEN 2160 
2170 tr QS<>"y" ANO Q$<>'"Y- TBF.M 2110 
2112 CALL CLJlSCR 
2176 C.RAIN '"A:8PLC"' 
2880 GOSUB 10130: GO?'O 1940 
2190 llM -------------· Proce•• Data--------------
2900 IF MOVE<> 10 AND l«)V£ <> 112 THEN SOOND 40, 10: GOTO 1940 
2910 BttP: LINTS•l 
2911 CALL LEVE.L (LINTS) 
2912 LX-4: LY•J21: EST-STRIMG.9(79,32): QOSUB 20050 
2913 LX•4: LY'•H3: ES'?-STlINGl(79,32): QOSUB 20050 
2914 LX•30: LY•321: EST•'"Proceu ....... : GOSUB 20050 
2,1s LX-227: LY•343: EST•'"CONFIN'I SE.LECTI<*I (y/n)'": GOSUB 20050 
2920 QI • INKlYS: IF QI • •• THEN 2920 
2,30 Ir QI • •y• ca QI • •y .. THEN 2950 
2940 QOSUB 10130: QOTO 1940 
2,50 LX-4: LY•321: &S'?-ST1lIMGS(79,32): OOSUB 20050 
2955 LX-4: LY'•30: tST-STUNC$(7',32): QOSUI 20050 
29'0 IF NUMSTITS • NUH!MOS TBDI 3030 
2970 BEU: Ir NUMS"?RTS>NUH!NDS TBEN 2910 
2,75 LX•ll7: LY•l21: U'?--WUMBEl Of' PEA){ STARTS < NUMBEJt Of' PEA){ !.HOS'": 
C.OSUB 20050 
2'77 GOTO 2 990 
2910 LX-137: LY•J21: EST-"MUMBEI. OI" PF.IJC STAATS> NUHBEl or PF.IJC ENDS'": 
C.OSUB 20050 
2990 LX•l95: LY'•l4Ji UT- .. PNH any key to ccntinue ••••• ·: GOSUB 20050 
3000 IF IJIJaYI••• TBEll 3000 
3010 oosoa 101301 c;aro lHO 
3020 llM --------------- lu»le Sort ---------------------------
3030 llM 
3040 CU.CK • l 
3050 1111 ILi CUC:1'. 
3060 CllCll • 0 
3070 roa LOOP • l TO 11:MITl"?S-l 
3010 IF IITO(Pl:rtAI.T(O, toe::.)) <• UTO(PKSTllT (0, LOOP+l)) TB&Jrl 3120 
3090 S1IAP PKl'?Aa"T(O,LOOP),PklTAHIO,LOOP+l) 
3100 S1IAP PD'?Aa"T(l,LOOP),PUTAr?(l,LOOP+l) 
)110 CIIJrl'.•l 
3120 llEX'T toe::. 
3130 111,111) 
3140 CBEC'X • l 
3150 WIIILE CBEC'I 
3160 CllCJ( • 0 
3170 rca LOOP• 1 TO ltMllfDS-1 
3110 IF BITO(PIEND(O,LOCPI) <- BSTO(Pl(EJID(O,LOOP+l)) TBtlf 3220 
JUO SWAP PJCE•D(O,LOOP) ,P.UND(O,LOOP+l) 
3200 SNAP P1'END(l,LOOP) ,PUND(l.LOOP+l) 
3210 CBECI • l 
3220 NUT LOOP 
3230 Ill.ND 
3240 I.EM ----------------- Confint Order ----------------------------
3250 !'Ol LOOP • l '?O NUMSD.TI 
3260 IF PIITAJ.T (0, LOCP I <• P.UND (0, LOOP) TB.£N 3210 
1210 car.a - c.111,a + 1 
3210 NEXT LOOP 
3290 IF CUCK < 1 TBEW 3360 
3300 LX-4: LY•l21: UT-STU NCI {79, 32) I QOSOB 20050 
3310 BEUi LX-171 LY•l21: EST•'"PEAI STAATS AND PEAi ENOS M.E NOT IN THE 
COllr.cT c:aor.r: QOSOB 20050 
3320 U:•19Sz LY-3431 U'?-'"PreH any key to ccntinu.., ••• •: GOSUB 20050 
3330 IF INX!TI••• Tllll 3330 
3340 QOSOB 101301 GOTO 1'40 
3350 I.EM ---------------- Inteq-ration ---------------------------
3360 LX-4: LY•l21: U"f-STlINCI {79, 32) : QOSUI 20050 
3364 LX•l45 1 LT-3211 UT-·Calc:,,;alat1"9 ana for pealr: n\aber": QOSUB 20050 
3366 LX-4731 LY•l21: U'?-"of•+snt(IIUMSTITS): C.OSUB 20050 
3310 LINTS•2 
3311 CAU LEVEL(LillTS) 
3382 LX•POSX: LY•O 
3313 CALL !4()1,{E(LX,LY) 
3384 LX•POSX: LY•2S9 
JJ85 CALL DLINt {LX, LY) 
3386 LINTS•l 
3387 CALL LEVEL (LINTS) 
3390 f'OJl LOOP l • l TO NUHSTRTS 
3400 LX•-435: LY•l28: EST•STRS(LOOPl) 
3405 CALL TEXTB(LX, LY', EST) 
3410 RDII ----------------- Baaelin• (LSRL) Calcula.t1ons -----------------
3420 DSUMX-0: DSUMY•O: DXY-0: DXSQ-0: 81GBP0INT•67 5: fLAG.$•'"NO'" 
3430 DXMEAN-0: OYMEAN•O: DLXY•O: OLX!Q-0: :.OWPOINT-0 
3440 FOR LOOP2 - P!<STAJtT(O,LOOPl) TO PK!ITAJlT(l,LOOPll 
34SO OSUMX - OSUMX + BST0{LOOP2) 
3460 OSUHY' • DS\JHY + ASTO (LOOP2) 
3470 DXY • OXY + BSTO(LOOP2)•ASTO(LOOP2) 
3480 DXSQ • OXSQ + BST0{LOOP2)"2 
3490 IF ASTO(LOOP2) > LC*'POINT TB&N LC*POINT • ASTO(LOOP2l 
3500 NEXT LOOP2 
3510 PTSTI.T • ((CINT((BSTO(PKSTAJlT(O,LOOPllJ-15)•20))+30) 
3520 LINTS•2 
3522 CALL I.EVEL(L!NTS) 
3523 LX•PTSTllT: LY'•U::efPOINT+l 
3524 CALL HOVE (LX, LY) 
3525 LX•PTSTllT: LY•LCIIPOINT+ll 
3526 CALL DLINE(LX,LY) 
3527 LX•PTSTRT+4: LY•LCWPOUIIT+ll 
3521 CALL DLINE(LX,LY) 
3530 LC*POINT • 0 
3540 roa. LOOP]• PKENO(l,LOOPl) TO PKEND(O,LOOPl) 
3550 DSUMX • DSUMX + BSTO(LOOP3) 
3560 D!UMT • OSUMT + ASTO{LOOP3) 
3570 OXY • DXY + BST0(LOOP3)*AST0(L00Pl) 
3510 OXSQ • OXSQ + 8STO(LOOP3) "2 
3590 tr ASTO(LOOP3) > LOWPOINT THEN LCNPOINT • ASTO(LOOP3) 
3600 NEXT LOOPJ 
3610 PTEND • ( (CINT( (8STO(PXEND(0, LOOPl) )-15) *20}) +30) 
3620 LX•PTEHD: LY•LOWPOINT+l 
3622 CALL HOVE(LX,LY') 
3 623 LX•PTEHD: LY•LOWPOIN'I'+l l 
3624 CALL OLINE (LX, LY) 
3625 LX•PT&M0-4: LY•LOWPOINT+ll 
3626 CALL DLINE(LX,LY) 
3627 LINTS•l 
3628 CALL LEVEL(LINTS) 
3630 N•PX!TAJtT (1, LOOPl) -Pl".START (0, LOOP l) +PKEND (0, LOOP 1 )-PXEND ( l, LOOP l) +2 
3640 DXHEAN • OSUMX/N: OY'HEAN • DSUHY/N 
3650 DLXY•DXY-(OSUMX*DSUMY/N): OLXSQ-OXSO--( (DSUHX'"2) /N): SLOPE-OLXY/DLXSQ 
3660 RD4 --------------- calculate Ar•• , Retention Time ----------------
3670 roa LOOP4 • Pl".STAJtT(O,LOOPl) TO PJCEND(O,LOOPl)-1 
3690 DBAIL • DYMEAN+SLOPE• (BST0(LOOP4)-DXM&AN) 
3700 DBA!l • DYMEAN+SLOPE*(BSTO(LOOP4+1)-0XMEAN) 
3710 DUPRSID - ABS(MTO(LOOP4)-ASTO(LOOP4+1)) 
3720 DLNJ..SID • ABS (DBASL-DBASR) 
3730 IF ASTO(LOOP4)<ASTO(LOOP4+1) THEN DTEMPYl•ASTO(LOOP4+1) 
E.LSE DTr.MPYl•ASTO(LOOP4) 
3740 
3750 
3760 
3770 
3710 
37'0 
3100 
3110 
3120 
3130 
3140 
3150 
3160 
3110 
3190 
3900 
3910 
3920 
3921 
3922 
3923 
3,24 
3925 
3926 
3927 
1,21 
3,2, 
3930 
3931 
3932 
3933 
3934 
3935 
393' 
3937 
3931 
3939 
3940 
3941 
3942 
3943 
3944 
3945 
3946 
)9.'7 
3941 
390 
3950 
3951 
3t52 
3953 
Jt5• 
3955 
3956 
3957 
3t51 
3959 
lHO 
JHl 
3H2 
3963 
39'4 
39'5 
396i 
3967 
lHI 
3969 
3970 
3971 
3972 
3973 
3974 
3'75 
IF D&AJL>DBASJ. TB.EN DTEMPY2•0BA!ll ELSE OTEMPY'2-0BASL 
DPKUEA(LOOP 1) -OPIC.Ut.A (LOOPl) + ( (BSTO (LOOP4 +l )-BSTO (LOOP4)) 
t ( {. 5•DUPlSID) + (, 5 *DLWllS ID) +DTD4PY2-0TD4PY1}) 
IF ASTO(LOOP4) >•BIGBPOINT TB&M 3780 
OSTRTIT-UTO(LOOP4): BIGBP0INT•ASTO(L00P4): FLAGS•'"END'" 
Ir UTO(LOOP-4) •BIGBPOINT OJ. rLAG.S<>•EJilD" THEN 3800 
DENDJlT•ISTO(LOOP4-1): F'LIIGS••No• 
NUT LOOP4 
DPllT (LOOPl) • DSTITIT+ ( (DENDJlT-DSTRTllT) /2) 
JlD'I ---------------- Print btention Ti••• on sc.r-n ---------------
11 • S'?J.$(0Pl".HILOOP1)) 
PTX • CilfT((DPlt'lT(LOOPl)-15)•20)+27 
Ir RICJI.POINT < 27 TRElf PTY • 27 ELSE PTY' • HIGHPOINT 
roa LOOPS • 2 TO 6 
Ir MIDI ( U, LOOPS, l) • •. • THEN PTY•PTY-3: GOTO 3 920 
CILUACTEI. • VJ.L(MIDS(l$,LOOP5,l))+l 
PTT • PTT - 6 
al CBAJ.ACTt.l GOTO 3923,3932,3931,3947,3960,3966,3977, 
3911,3994,400, 
LX•PTX+6: LT•PTY: QOSUI 20010 
LX•PTX+5: LY•PTY: QOSUB 20030 
COTO 4 030 
LX•PTX+l: U•PTY: GOSUI 20010 
LX•PTX+5: LT•PTY: QOSUI 20030 
LX•PTX+6: LT•PTY+l: QOIUI 20030 
LX•PTX+6: LY•PTY+2: QOSUB 20030 
LX•PTX+5: LY•PTY+l: QOSUB 20030 
LX•PTX+l: LT•PTY+3: QOSUB 20030 
LX•PTX: LY•PTY+2: OOSUB 20030 
LX•PTX: LY•PTY+l: QOIUB 20030 
QOTO 4030 
LX•PTX+61 LY•PTY+3: OOSUB 20010 
LX•PTX+6: LT•PTY: OOIUI 20030 
LX•PTX+5: LY•PTY+l: OOSUB 20030 
LX•PTX1 LY•PTY+l: OOSUB 20030 
LX-PTX+2: LY•PTY+3 1 QOIUB 20030 
QOTO 4030 
LX•PTX+,: LY•PTY: QOSUB 20010 
LX•PTX+6: LY-PTY+3: OOSUB 20030 
LX•PTX+5: LT-PTY+J: QOSUB 20030 
LX•PTX+2: LY•PTY: QOSUB 20030 
LX-PTX+l: LY-PTT: QOSUB 20030 
U:•PTX: LT-PTY+l: GOSUB 20030 
LX•PTX: LY•PTY+2: QOSUB 20030 
U:•PTX+l: LY'•PTY+3: QOSUB 20030 
QOTO 4030 
LX•PTX+l: LY•PTY+3: QOSUB 20010 
LX•PTX: LY'•PTY+2: QOSUI 20030 
LX•PTX1 LY•PTY+l: QOSUB 20030 
U:-PTX+l: LY-PTY: OOIUB 20030 
LX-PTX+2 I LT•PTY: QOIUI 20030 
LX-PTX+3: LT•PTY+l: QOSUI 20030 
LX-PTX+J i LT-PTY+2: QOIOI 20030 
LX•PTX+4: LY•P'!'Y: QOIUI 20010 
LX•PTX+5: LY•PTY: QOSUB 20030 
LX•PTX+6i LY•PTY+l: QOIOB 20030 
LX-PTX+i: LY•PTY+2; QOSUI 20030 
LX•PTX+5: LY•PTY+l: ~UI 20030 
001'0 4030 
LX•PTX+l I LT•PTY+J I QOIUI 20010 
U:•PTJ:+4: LY•PTY+3: QOSUB 20030 
U:-PTX+4: LY•PTY: QOIUB 20030 
LX•PTX+6: LY•PTY+l1 QOSUI 20010 
LX•PTX: LT.PTY+l: QOSUB 20030 
001'0 4030 
LX•PTX: LY•PTY: QOSUI 20010 
LX•PTX: LY•PTY+3: QOIUI 20030 
LX•PTX+2 1 LY•PTY+l: QOIUI 20030 
LX•PTX+2: LY•PTY+l: QOSUB 20030 
LX-PTX+l I LY•PTY1 QOIUB 20030 
LX-PTX+5: LY•PTY: QOSOB 20030 
LX•PTX+,1 LT•PT'Y+l: QOSUB 20030 
LX-PTX+i: LY•PTY+2: QOSUB 20030 
LX•PTX+S: LY•PTY+3: QOSUI 20030 
LX•PTX+4: LT•PTY+3: -QOSUB 20030 
Chromatographic software 182 
3976 GOTO 4030 
3977 LX-PTX+l: LY-PTY: GOSUB 20010 
3978 LX•PTX: LY•PTY+l: GOSUB 20030 
3919 LX•PTX+2: LY•PTY+3: GOSUB 20030 
3980 LX•PTX+S: LY•PTY+): QOSUB 20030 
3 981 LX•PTX+6: LY•PTY+2: GOSUB 20030 
3982 LX•PTX+6: LY•PTY+l: QOSUB 20030 
3983 LX•PTX+5: LY•PTY: GOSUB 20030 
3984 LX•PTX+4: LY•PTY: GOSUB 20030 
3985 LX•PTX+l: LY•PTY+l: OOSUB 20030 
3986 LX•PTX+l: LY•PTY+2: OOSUB 20030 
3981 GOTO 4030 
3988 LX•PTX: LY•PTY+3: GOSUB 20010 
3989 LX•PTX: LY•PTY: GOSUB 20030 
3 990 LX•PTX+2: LY•PTY: GOSUB 20030 
3991 LX•PTX+S: LY•PTY+J: OOSUB 20030 
3992 LX•PTX+6: LY•PTY+): GOSUB 20030 
3993 GOTO 4030 
3994 LX•PTX+2: LY•PTY+J: GOSUB 20010 
3995 LX•PTX+l: LY•PTI+): GOSUB 20030 
3996 LX•PTX: L't•PTY+2: GOSUB 20030 
Jg97 LX•PTX: LY•PTY+l: OOSUB 20030 
3998 LX•PTX+l: LY•PTY: GOSUB 20030 
3999 LX•PTX+2: LY•PTY: GOSUB 20030 
4000 LX-PTX+): LY•PTY+l: GOSUB 20030 
400 l LX•PTX+J: LY•PTY+2: GOSUB 20030 
4002 LX•PTX+4: LY•PT!+): GOSUB 20030 
4003 LX•PTX+5: LY-PT!+): GOSUB 20030 
4004 LX•PTX+6: LY•PT!+2: GOSUB 20030 
4005 LX•PTX+6: LY•PTY+l: QOSUB 20030 
4006 LX•PTX+5: LY-PTY: GOSUB 20030 
4007 LX•PTX+4: LY•PT!: GOSUI 20030 
4008 GOTO 4030 
4009 LX•PTX+6: LY•PT!+2: GOSUI 20010 
4010 LX•PTX+4: LY•PTY: GOSUI 20030 
4011 LX•PTX+l: LY•PT!: GOSUI 20030 
4012 LX•PTX: LY•PT!+l: GOS08 20030 
4013 LX•PTX: LY•PTY+2: GOSUB 20030 
4014 LX•PTX+l: LY•PTY+3: GOSUB 20030 
4015 LX•PTX+2: LY•PTY+3: GOSUB 20030 
4016 LX•PTX+3: LY•PT!+2: GOSUB 20030 
4017 LX•PTX+3: LY•PTY+l: QOSUB 20030 
4030 NEXT LOOPS 
4 04 0 NEXT LOOP 1 
4050 LX•4: LY•328: E!!!T•STRINGS (79, 32) 
4052 CALL TEXTB (LX, LY, EST) 
405,4 LX•4: LY•34l: EST•STRIMG$ (79, 32) 
4056 CALL TtX'?B (LX, LY,EST) 
4058 LX•92: LY•l28: EST•"llould you like a hardcopy of the ch.ron.atograa 
(y/n) 1" 
4060 BEEP 
4062 CALL TEXTB(LX,LY,EST) 
4064 QHP.DCPYS•IHKEY$: IF QSRDCPYS•"" TBDi 4064 
4066 IF QlillDCPYS-"lC" OR OBJ.OCPYS•"n" TBEN 4180 
4068 IF Oft.RDCPYS<>"Y" AHO QBAOCPYS<>"y" THEN SOUND 40, 10: GOl'O 4064 
4070 LX•,4: LY-321: EST-!TRINGS (79, 32) 
4072 CALL TUTl(LX,LY,UT) 
4100 llM ------------------ Print Ba.rdcopy of Ch.ron.atograa ---------------
4110 LX•4: LY•32t: EST-STRING$(79,32): 00SUB 20050 
4112 LX•4: LY•JO: EST-STRING$ (79, 32): 00SUB 20050 
4114 LX•619: LY•l7: tsT-STRING.$(10,32): GOSUI 20050 
4116 LX•62t: LY•34: £ST•STJ.ING$ (t, 32) : 00SUB 20050 
4118 BEEP: LX•96: LY•l21: EST•"Pr••• <(•hift] PrtSc-1> when thi• meHage 
diuapean": GOSUI 20050 
4120 LX•l 95: LY•34l: tsT-"Pr.H any key to continue •.. , . ": GOSUB 20050 
4130 IF INXEU • "" THEN 4130 
4140 LX•,I: LY•30: EST-STRINGS (79, 32) : 00SUB 20050 
4150 roR LCXJP • 1 TO 5000: NEXT LOOP 
4160 BEU: LX-4: LY•32t: EST-STRIMGS(19,32}: GOSUB 20050 
4170 IF IHXEYS • "" THEN 4170 
4180 llM ----------------- Enter Standard Value• ---------------------
"190 Rf.M 
4192 LX•,4: LY•32t: f.ST•STRINGS (79,32) 
4194 CALL TEXTB (LX, LY, EST) 
4196 LX-4: LY•343: EST-STRIHG$(79,32) 
4191 CALL TEXTB(LX, LY,EST) 
4200 roa LCXJP • l TO NUMSTJ.TS 
4210 LX•30: LY•32t: !.ST-"PK NO.:"+STJ.$(LOOP) 
4215 CALL TEXTB(LX,LY, UT) 
4220 TDtP1$•S'?U (DPKKT (LOOP)) 
4222 TDIP2S•U:M$(ffMPU, 1) 
4224 LX•U11 LY•l21: EST•"PJ: RT1·+TE.MP21 
"226 CALL TEXTl(LX,LY,UT) 
4221 LX•2,IO: LY•343: EST•"t.nter Peak N••:":UICNAHS(LOOP)•"" 
4230 CALL TEXTB(LX,LY,EST) 
4231 OS•Ilfll'tt: IF Qt•"" TllW 4231 
4232 CBAJ.•ASC(Qit) 
42ll IF (CBAa<>ll MD CB.Aa<>I) AIID (CBAJ.<65 ca CBAR>,O) AND 
(CRAa<t1 ca CBAJ.>122) TUW SOUliD 40, 10: GOl'O 4231 
423,1 
,1235 
4236 
4231 
4231 
4239 
42,10 
42"1 
4242 
4243 
4244 
4245 
.. 2 .. , 
4241 
4248 
4249 
4250 
4251 
4252 
,1253 
4254 
4255 
425, 
4251 
42SI 
4259 
4260 
4261 
4262 
4263 
4264 
4210 
4290 
4300 
4310 
4320 
4321 
"322 
4323 
rr cau.-ll TBDI ,1241 
IF CJIAa.-e AIID l,D(EPDAMl(LCX>P))<l TBD SOOlfD 40,10: GOTO 4231 
IT CIIAl.-e AJR> LD (&PJOIAMI (LCX>P) )>0 TBDI EPKNAM$ (LOOP)• 
LZMfCU-(LOOPI, (LEW(UKUNS(LOOP))-11), 00'!'0 4231 
.,.,,_ (LOOP) -CP- (LOOP) +QS 
LX•3'41 LY•l,131 ES"r•I.PIOIAld(LCX>P)+• " 
CALL ffftl (LX, LY, UT) 
coro Ull 
LX•lll1 LY•3211 ES"r•"PK W»IZI "+EPIOL\Mt (LOOP) 
CALL ffX'!'l(LX,l..Y, UT} 
LX•,11 l..Y•34l1 1.IT-ST'1.IWC:,(1t,l2) 
CALL '!'I.X'n(LX,LY,UT) 
LX•Z091 LY-3411 &IT•"t.nter Peale Aaount: • 
CALL ffX'!'l{LX,LY, UT) 
TDIPt••• 
0S•INKEY$: IF os-·· Tll!N 4241 
C&U•ASC(Qt) 
IF (CBAJ<>ll AND CB.AJ.<>I MO CJIAP.<>46) AND (CBAJ<4t OR CB.ll>57) 
T8!N SOUIID 40, 10: GOl'O 420 
IF CRAJ.•13 T&D 4251 
IF CllAl.-t AND LDl(TDfPf)<l TUii SOOlfD 40, 10: 00'1'0 "248 
IF Cv.1.-t AND LD(TDfU)>O TBEN TEHPS•LUTS(TDtPS, (LEM(Tt.MPS)-1)): 
GO?O 4255 
TDlPl-'l'Dffl+<)I 
LX•lt l I LY•3U t ES'?-'l'DDI+" 
CALL TEXTl(LX,LY,UT) 
coro uu 
Lx-u,1 LY•32t: EIT•"PJ: »ff: •+u:n, (TEMPI, t) 
CALL T!XTl(LX,LY, UT) 
DPIUIH'? I LC><:.' I •VAL (TE.MP II 
LX•41 LY•3U: EIT-STJ.IWGI (19, 32) 
CALL Tt.X'!'l(LX,LY,EST) 
BEEP: LX•ll,: LY•3,4): ES'?•"Ar• th••• value• correct (y/nl ?" 
CALL TEXTll(LX,LY,EST) 
DU Sr.,..-Q1 POU 1050,Pl.0(1052) 1 DEF S!.G: POKE 106,0 'clear keyboard 
Ql•INK!.Y$; IF QI••• TllX 42 ,0 
IF Qt•"Y- oa Qit•"y" THEW 030 
IF Qit<>"W" AND Qlo•n• TBJ:ll SOOXD 40, 10: 00'1'0 4210 
LX•4: LY•32t1 EST-SffIWC.,(19,32) 
CALL TEXTB(LX,LY, UT) 
LX•4: LY•lU1 EST-STJ.IWGl(19,32) 
CALL TEXTl(LX,LY, UT) 
4325 GOTO 4210 
,l]JO LX•4: LY•328: EST•STRINC.$(79,32) 
4331 CALL TEXTB(LX, LY, EST) 
032 LX-4: LY•l43: £ST•STRING$(H,32) 
4333 CALL TEXTB(LX,LY,EST) 
4340 Nf.XT LOOP 
4350 IF NUMRUNS > l TREN 4390 
4355 LX-30: LY-328: l.ST•"Stor1n9 data, plea•• wait .... ,'" 
060 CALL TEXTB (LX, LY, EST) 
4361 OPEX.. "A:!TMDRDS.1'4:P" AS fl LEM•,4S 
4362 FIE.LO fl, 2 AS EMUHRUHSS, 2 AS ENUHSTD!S, 10 AS TODAYS, J AS fLA.GS, 
28 AS EOUHHY$ 
4363 LSET ENUHRUHS$ • HXI$ (NUMRUNS) 
4364 LSET ENUHST0S$ "'Hlt:IS(NUHSTRTS) 
4lfi5 LSET TOOAYS • [DATES 
4366 LSET FLAGS • '"!ES'" 
061 LSET EDUl44Y$ • " 
4368 PUT fl, 1 
4369 f1£LD 11, I ,\S XS, 8 AS YS, 8 AS XYS, 8 AS XS0$, 8 AS ERTS, 2 AS ENS, 
3 A!I ENA.MS 
4310 fOR LOOP • l TO NUHSTRTS 
4311 LSET XS '"'HXD$(DPJO.R.l.A(LOOP)) 
072 LSET YS • MKD$ (DPKAfifl' (LOOP)) 
4373 LSET XYS • MJt:0$(DP!Cllr.A(LOOP) *OPKN1T(LOOPll 
074 LSET XSO$ • MMJS(DPKA.J.EA(LOOP)"2) 
015 L!ET DTS • HKD$(DPIO.T(LOOP)) 
4376 LSET £NS • MJt:IS (NUMRUNS) 
4377 LSET DiAMS • EPXHAMS(LOOP) 
4378 PU'l' fl, LOOP+l 
,1379 NEXT LOOP 
080 CLOSE 
4385 GOTO 4130 
,1390 llEM ------------------- Identify Standard• , SUffl Data -----------------
4395 UM 
4396 LX•30: LY•328: EST•"C&lculatin9 LSRL pa..r.a,neter• •.... " 
4391 CALL TtxTB(LX,LY,EST) 
4400 OPDi '"A:ST'HORDS.1'4:P" AS fl L£N•,l5 
4405 FIELD fl, I AS XS, I AS YS, 8 AS XYS, 8 AS XS0$, 8 AS EllTS, 2 AS ENS, 
3 AS ENA.MS 
4410 roR LOOP • l TO NUHSTDS 
4420 GET tl, LOOP+l 
4430 SSTDX (LOOP) • CVD (XS) 
4440 !STOY (LOOP) • CVO (YS) 
4450 SSTDXY(LOOP) • CVC(XY$) 
4460 SSTDXSO(LOOP) • CVD(XS0$) 
4470 SSTDRT(LOOP) • CVD(ERT$) 
400 N (LOOP) • CVI (ENS) 
4 4 90 ESTDNAHS ( LOOP l • ENAHS 
4500 NEXT LOOP 
4510 roR LOOPl • 1 TO NUMSTRTS 
4512 CRECJt'.-0: LOOP2•1 
4Sl4 NBILE CRECJ: < 1 
4516 IF EPIOfAMl(LOOPl)<>ESTDNAM$(LOOP2) TBJ:N 4536 
4511 SST0X(LOOP2) -sncx (LOOP2) +DPIOJlEA(LOOP 1) 
4519 LS!T XS• MK0$(SSTOX(LOOP2}) 
4520 SST0Y(LOOP2) •SSTDY (LOOP2} +DPKAMT (LOOPl I 
4521 LS!T YI • MKDt (SSTDY (LOOP2)) 
4522 SSTDXY (LOOP2) •SST0XY (LOOP2 I+ (DPKAREA(LOOPl) *DPJWff (LOOPl)) 
4523 LSET XYS • HXDS(SST0XY(LOOP2)) 
4524 SST0XS0(LOOP2) •SSTCXSQ (LOOP2) + (DPKAll!.A (I.OOPl) "2) 
4525 LSET XSQ$ • MKDS(SSTCXS0(LOOP2)) 
4526 SSTDKT (LOOP2) •SST0H (LOOP2) +DP!O.T (LOOP l) 
4521 LS!T ERTS • HKDS (SSTDJ.T(LOOP2) I 
4521 N (LCXJP2) -M (LOOP2) +l 
4529 I.SET EN$• MK1S(N(LOOP2)I 
4530 LSET ENAKI • ESTDN11M$ (LOOP2) 
4531 PUT tl,LOOP2+1 
4534 car.ex - 1 
4536 LOOP2 • LOOP2 + 1 
4531 IF LOOP2>NUMST0I ANO Cll!CJt:<l TH.EN csr.cx-2 ELSE 45S8 
45,40 NUMSTOS • NUMSTDS+l 
4542 SSTDX(NUMSTOS)-OPR.AJlEA (LOOP!) 
45U UE'? XS• MKDS(SSTOX(NUMSTDS)) 
,15,1,1 SSTDY(MUMSTDS) -OPKAMT (LCXJP 1) 
,15,15 Lll!T YS • MKDS (SSTDY (NUMSTCS)) 
,154, SSTDXY (MUMSTDS) •DPJ:IJ.EA(LCXJP l) *DPUHT (LOOP 1) 
45"1 LSE'? XYS • H1'D$(SSTOXY(NUMSTDS)) 
4S41 SST0XSQ(NUMSTDS)-0PltAllEA(LOOP1) "2 
4549 I.SET xso• • MKDt (SSTDXSQ(NUMSTDS) I 
4550 SSTORT(NLMS'?DS)•DPD.T(LOOPl) 
4551 Ur? ERTt • MJ:Dl (SSTDRT(NUMIT'DS)) 
45S2 N (lfUMIT'DS) •l 
,1553 LSET tNt • MJ:U (N (NUMSTOS)) 
45S,1 !.STONMI (Nll'IS'?DS)•UJOI.NU (LOOPll 
4555 urr EJIAMS • ES'?DN.AMI (NUMSTOS) 
455, PUT 11,Nll'IS'?DS+l 
45SI WEND 
4560 NEXT LOOPl 
45'2 FIELD fl, 2 AS &NUMJ.UlfU, 2 AS EMUMSTDSS, 10 AS TODAYS, 3 A:5 FLAG$, 
21 AS WLMff$ 
,15,, LSET tWUNa.UNU • JUI$ (lfUMJt.UNS) 
,l5H Lat'? ENUMST'CU • MJl:U (NUMST'CS) 
,IS10 LSE'? TCl)AYI • WA'?U 
4S12 LSE'? FLAGt • "YES" 
4S14 LSET EOUMIYS • " 
451' PUT fl, l 
4511 CLOSE 
4730 IF QUDCPYt•"ll" ca QBJ.OCPYS•"n" THEN 5020 
4140 a.EM --------------- Printout QuantitatN Data -------------------
"150 LX-4: LY•321: !.ST-S'?RINQl(79,32) 
4152 CALL TE.XTB (LX, LY, ES'?) 
"15" LX-4: LY•lO: EST-STlillr:$(79,32) 
"156 CALL TD'?B(I.X,LY,EST) 
4151 BEU: LX•240: LY•l21: EST-"Chaclr: Printer Statu•" 
4160 CALL '?z.x'?I (LX, LY, EST) 
41,2 U:•lt5: LY•J,431 !.ST-"Pr••• any Jcey to continue ••... " 
41U CALI. TUTB(LX,LY,ES'l') 
4110 IF INJ:EYI • "" TUN 4110 
"190 OPEN "LPTl: • AS fl 
4100. NID'?B t], 10 
4110 PUN'! fl, CllU(21);CD$(1J);C8U(2)i PRIMT 13, Clill$(13);CHR$(10) 
020 PUNT fl, TAB(t);"FILEI ";FII.Et:TAB(3,l);"J.Ull NUMBER! ";NUMJlUNS; 
TAB(60;WATU: PUNT fl, CBU(lll ;CBltS(lO) 
4tl0 PRilfT fl, TAB()) :snn1c.t p,, 205) 
040 PlllfT fl, '?AB(5);"Peall: No.";TAB(20);"Peak N&IM";TAB(34);"Retent1on 
Tt.ae" ;TAB (55); "Area" ;TAB (10); "Jiaount" 
USO UIXT fl, TAB(J) ;SffINc.t (16, 19') 
,1160 FOIHATll • " ff 
4110 FOMAT2$ • •\ - - - - - \ - - - - - - - - - - - - -
4110 FOIIMATlt • "ft.tit tff.ttffff tttt.tttt" 
400 roa ux::. • 1 TO NuMBTKTs- - - - - - - - - - -
,1,00 PRINT 13, USING FOI.MATU;LCXlP; 
4910 PUllT fl, USING FORMAT2S;UXHAMS(LOOP); 
4t20 ,anrr fl, USIIIG FOIUQ.TlS; DPDT (LCXJP); DPD.ll.A(LOOP); DPKAMT (LOOP} 
4930 NEXT LOOP 
4"40 PlIWT fl, TAB(l) ;SffilfG.I (16,205) 
4'90 PlIXT fl, caU(21);CD.t(13);CBU(l) 
SOOO PRI'NT fl, CBU (12) 
5010 Cl.08E 
5020 LX-4: LY•l2t: EST-S'?UNc:$(79,32) 
5022 CALI. TEXTI (LX, I.Y, EST) 
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5024 LX-.f: LY-343: l.ST-STlt.INGS (1', 32) 
5026 CALL T&XTB(LX,Ll',EST) 
5028 LX•l 61: LY•l21: tsT-"lapeat" 
5030 CALL TUTB (LX, LY, EST) 
5032 LX-261: LY•321: l.ST-"Proc:eH" 
5034 CALL TE.XTB (LX, LY, EST) 
5036 LX•liS: LY•321: EST-"Stop" 
5031 CALL TUTB(LX,LT,!.ST) 
5040 LX•465: LY•l21: !.ST•"Quit" 
5042 CALL Tt.XTB(LX,LY,EST) 
5044 LX•2Jl: LY•l4J: EST-"Enter your choice., ... " 
50-46 CAI.I. TUTl(LX,LY,EST) 
5050 DEF SEG-0: POKE 1050,PUJl:(1052}: Dr.F SEG: POKE 106,0 'cle•r kbrd buffer 
5060 IMOV!.S•INJCE'U: Ir IMOV'ZS•"" TBEX 5060 ELSE MOVE•A5C(IMOVE$) 
5070 IF i!«J'V!.>79 MD MJVE<l4) Ol (MOVE>lll AND K>VE<ll6) THEN 5085 
5080 SOUND 40, 10: GOTO 5050 
5015 RI.M ---------------------------- Repeat Run ---------------------------
5090 IF MOV!.<>82 »ID MOV!.<>114 THEN 5130 
5095 CLOSE 
5100 Ctr.Alt. 
5110 EREPr.ATS-·ns· 
5120 PAGE-0: GOTO 230 
5130 llI.M ------------------------------ Stop ------------------------------
5140 IF MO't'Z<>IJ AND l«)Vl.<>115 TBEN 5110 
5150 CLOSE 
5160 CLF.AJ. 
5 162 CALL CLllSCJl 
5170 CHAIN "A:BPLC" 
5180 REM ------------------------------- Quit ------------------------------
5190 IF !10VE<>ll AND MOVE<>113 THEN 5250 
5200 CLOSE 
5202 LX•4: LY•321: EST-STJ.IMGS(''11,32) 
5203 CALL TEXTB(LX,LY,EST) 
5204 LX-C: LY•lO: EST-STRIMGI (19, 32) 
5205 CALL Tl'.XTB (LX, LY, EST) 
5206 LIMTS•O 
5207 CALL LEVEL(LIMTS) 
5201 BE:EP: LX•ll2: LY•34l: EST-" Ent•r Y to confinn loaa of data " 
5209 CALL TEXTB (LX, LY, EST) 
5210 LIHTS•l 
5211 CALL LEVEL (LINTS) 
5212 Q.S•INKE'!.S: IF OS•"" THEN 5210 
5213 IF QS<>"Y" AND QS<>"y" TBZ.N 5020 
5214 CALL Cl.J.SCl 
5220 KILL "A:STllDllOS.TMP-
5230 CLUJ. 
5240 CRAIN "A:B.PLC" 
5250 JlEH ----------------------------- Proce•• ----------------------------
5260 IF MOVE<>IO AND MOVI.<>112 T8D SOOND 40, 10: GOTO 5050 
5261 LX-4: L'!•321: EST-STRIMGS(19,32) 
5262 CALL T&XTB (LX, LY, EST) 
5263 LX-.e: L'!•343: EST-STlIMGS (19, 32) 
5264 CALL TEXTll(LX,LY,EST) 
5265 LX•30: LY•321: ES'?•"Pr~aainq data, pleaae wait ••... • 
5266 CALL TEXTB(LX,LY,tST) 
5270 CLOSE: ULL "A:STNDlOS .OAT" 
5210 OPDf '"A:STHDll01.1MP" AS fl LEN•45 
5290 Fil.LO fl, 2 AS EMUMJlUNU, 2 AS ENUMSTOSS, 10 AS TODAY$, 3 AS fl.AG$, 
21 AS r.Dt.MffS 
5300 GET fl, l 
5310 MtJMlUNI-CVI (DIUMJlDMU): HtJMITDS-CVI (EMUMS'?DS$) 
5330 FIELD fl, I AS XS, I AS YS, I AS XYS, I AS XSQS, I AS Elt.TS, 2 A5 EN$, 
3 AS ENAH,f 
53'10 OPEN "A:STNOaDS.DAT'" AS 12 LEN•35 
5350 Fil.LO 12, 2 AS ENtJMSTDSS, 10 AS EST0ATE$, 23 AS £DUMMY$ 
5360 I.SET ENUMSTDU • HKU (NtJMSTDS) 
5370 LSE'I' ESTDATEt • TODAYS 
5310 LSE'? EDIJMIIYS • " 
5390 PUT t2, 1 
5400 FIELD t2, I AS ESTOITS, I AS XMr.ANt, I AS YMl.ANS, I A5 £SLOPE.$, 
3 AS ESTON»lt 
5410 FOi WC::. • 1 TO HtJMSTOS 
5420 c;rr tl.LCX:.+l 
5430 SIMX • CVD(XS) 
5440 SUMY • C'VO(YS) 
5450 SIMXY • CVD (XYI) 
54'0 SUMXSQ • CVD(XSQt) 
5410 Sll'IH • CVD (EHS) 
5410 N • CVI (EN8) 
5490 STDRT • Sl.14:kT/ll 
SS00 STDl04r.Alf • SUMX/ll 
5510 STDYMUJI • SUMY/11 
5520 SUMLXl.Y • S1MXY-(StJMX•St1i1Y/N) 
5530 SUMLXSQ • SUMUQ-( (SUIIX"2) /NI 
5540 STDILOPE • SUMLXLY/SUMLJCSQ 
5550 LSET UTDRT8 • Mlm$ (STCr!) 
S560 LIE'? XMI.Allt • MJIDS 1S'?DXM£AII) 
5570 LIE'? 1"MJ'.A11$ • MKD8 (S'?DYMEM) 
5510 I.HT ULOH,I • MKDI (STDILC»E) 
S590 I.HT UTDIIAMt • EJIAM$ 
S600 POT f2,I.Om'+l 
5610 RX'! LOJf 
5620 CLOa& 
5630 LX-11 LY-3211 UT-l'rUIICl(19,32) 
5632 CALL TD'!9CJ..X,LY,ZIT) 
5634 LX-11 LY•JU1 UT-ITUIICl(19,32) 
5636 CAL.I. TUTl(ll,LY,EIT) 
SUI LX•ll6r LY-3211 &1T-•1t•nclarCU File Baa a.en Updated." 
56-40 CAL.I. TUTl(ll,LY,&l'r) 
5642 IIUr LJ:•lA1 LY•l4lr UT-·PreH any key to return to ••nu., ••• " 
5 6-4 4 CALL TIX'n (LX, LY, IIT) 
5660 IF IWllYt-•• '?ID .5HO 
5670 KILL •.1.11T11DSDl.'!MP• 
5610 CLP..U 
5690 CB.All •A1U1,C• 
9999 DID 
10000 UJt tttttff S•plin9 SubrDYtine tor S•lected Channel (-CHANNEL) fHHt 
10010 lDIJ 
10020 OU'!' ,a102,2 
10030 OOT ,uo2,cBANNn•,a10+3 
10040 VAI.O'E•(INP(U/Ol)MD ,ar) •256+INP (lB.700) 
100.50 lETtJU 
10060 lDIJ 
10070 lDIJ 
10130 llDI ftfttHHHHtftt Int ... ration Curaor ca-and Menu ffffffffffffffff 
10140 llDIJ 
10142 LI11Tl•l 
10144 CALL LEV1L(Ll1ITS) 
10150 LX•4: LY•32t: EST-S'RINGt("79,32) 
10160 CALL TEXTB(LX,LY,UT) 
10170 LX•4: LY•343: !.S'?-STJ.IWC.,(79,32) 
10110 CALL TEXTJl(LJ:,LY,UT) 
10190 LX•27: LY•3211 UT-"CO'I.SOA CCM4ANDI: Uae L l ll arrow 
keya - <ahift.> • lOX" 
10200 CALL ffl'Tl(LX,LY, UT) 
10210 LX•27: LY•34l: UT-"Ilffr.GlATiaf CC>IHAJIDS: Start End Cancel 
ledo Proce•• Quit• 
10220 CALL T!.X'?I (LX, LY, U'?) 
10222 LINTl•2 
10224 CALL LEVEL(Llll'U) 
10230 ll'?UU 
20000 REH tffffftftffffffffffftff GllAPB-X Subroutinea tltlfftfftffttttfffftt 
20010 CALL Jr«:)V't(LX,LY) 
20020 llETUllN 
20030 CALL DLINE(LX,LY) 
200-40 RETURN 
20050 CALL TEXTB (LX, LY, EST) 
20060 RETUJlN 
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